Single-cell imaging and mathematical modelling of the hypoxia-inducible factor signalling network by Bagnall, James Steven
Single-cell Imaging and Mathematical 
Modelling of the Hypoxia-Inducible Factor
Signalling Network
Thesis submitted in accordance with the requirements of the 
University of Liverpool 
For the degree of Doctor in Philosophy by
James Steven Bagnall
September 2011
Abstract
Hypoxia-inducible Factor (HIF) is an oxygen-sensitive transcription factor present in all 
multicellular life, including humans. It is responsible for mediating the cellular response 
to hypoxia, a situation in which oxygen supply falls below adequate levels. In the 
presence of oxygen HIF is constitutively degraded and inactivated. In the absence or 
reduction of oxygen, HIF escapes degradation and accumulates. Once accumulated, HIF 
elicits an adaptive response by inducing a diverse array of genes affecting the processes 
of cell fate, vascularisation and red blood cell production. However, there are many 
instances of the pathological activation of this pathway, which is known to cause serious 
and maladaptive issues, as found in cancer.
HIF is functional as a heterodimer comprised of an 02-sensitive alpha subunit (HIF-a), 
of which there are two isoforms (-la and -2a), and an 02-insensitive beta subunit (HIF- 
p). The Oa-dependent destabilisation of HIF-a is carried out by the prolyl hydroxylase 
domain proteins (PHDs). Importantly, several of the PHDs are themselves HIF target 
genes, thereby forming a delayed negative feedback loop. Delayed negative feedback 
loops are a common signalling motif able to confer dynamic properties to the signalling 
network. The resulting kinetics may have the capacity to encode additional information 
into the system and alter the course of downstream gene expression. The dissection and 
understanding of this requires a high-degree of characterisation of the temporal profile 
of response. Live-cell imaging offers an experimental system ideally suited to this 
approach. To date, the dynamics of HIF-i accumulation have not been investigated in 
this detail and so it was a main aim of this study to depict the temporal properties of the 
HIF signalling system.
The dynamic response of HIF-a protein to hypoxia and re-oxygenation was imaged by 
live-cell time-lapse confocal microscopy. Interestingly, it was observed that the hypoxic 
accumulation of HIF-a was heterogeneous and transient. The duration of HIF-a 
accumulation was found to be a distinctive and robust temporal feature of the response. 
This assorted data was used in building a mathematical model depicting the HIF-PHD 
feedback motif. Subsequently, the model was utilised to accurately predict the 
consequence of loss of the PHD feedback. Additionally the model provided predictions 
on how HIF-a dynamics are differentially responsive to varied hypoxic and re­
oxygenation conditions.
Live-cell imaging of the HIF-a response also provided insight into the novel subcellular 
localisation pattern of the HIF-2a protein, which differs distinctly from HIF-ia. HIF-2a 
was found to reside in several types of subcellular bodies. The dynamic interplay and 
flux of protein in and out of these bodies was investigated. Evidence gathered supports 
the involvement of HIF-2a in aggresomes and PML bodies and also the involvement of 
the subcellular landscape in the HIF regulatory network.
Overall, research arising from this thesis offers new insights into the intracellular spatial 
and temporal dynamics of the HIF signalling system.
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Chapter i: Introduction
1.1 Cell signalling
The maintenance of highly ordered organisms requires cells to be able to sense 
and respond to various environmental and chemical cues. This is further 
complicated in multicellular organisms, whereby the maintenance of the whole 
organism requires cells in different local environments (e.g. across tissues) to 
communicate with one another, and for the survival of the whole organism to be 
prioritised over the constituent cells. Individual cells are able to communicate 
extracellular and intracellular signals through transduction pathways, often 
leading to changes in gene expression which in turn leads to changes in the 
cellular protein make up, eliciting an appropriate response. There is a vast array 
of biological complexity underlying this simple notion, due to the wide range of 
stimuli and arrangements of signal transduction. Often stimuli are considered 
simply as biologically produced cytokines or hormones, though cells can also 
sense environmental cues such as pH, temperature and shear-stress etc. 
Additionally, eukaryotic cells are also able to detect the availability of molecular 
oxygen (02) and it is the transduction pathway underlying the ability of cells to 
sense and respond to 02 with which this study is principally interested.
1.2 Oxygen biology
Life began in a strongly anoxic environment 3.7 billion years ago and this 
environment remained anoxic until the arrival of the first photosynthetic 
organism, cyanobacteria, approximately 24-3.2 billion years ago (Taylor and 
Pouyssegur 2007; Saker, Moreira et al. 2009). These early organisms were 
capable of utilising water as an electron donor and this process released 
molecular oxygen as a by-product, which alongside other geological factors led 
eventually to the significant rise in available atmospheric oxygen (Falkowski 
2006; Thannickal 2009) (Fig 1.1). The emergence of oxygen has had a 
profound effect upon life and is linked with a dramatic increase in the 
complexity of living things (Raymond and Segre 2006; Berner, Vandenbrooks et 
al. 2007). The effect that molecular oxygen has had on the development of life 
can be broadly separated into three categories; (i) oxidative-metabolism, (ii) 
oxygen-toxicity and (hi) oxygenic biosynthesis.
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Fig i.i. Timeline showing the relationship between atmospheric 02 concentrations, 
evolutionary diversification and biological complexity. Also indicated is the increasing number 
of NADPH oxidase (NOX) homologs, specialised 02-reducing enzymes dedicated to reactive 
oxygen species production. Figure taken from Thannickal et al. (2009).
1.3 Aerobic respiration
A critical step in the evolution of life occurred when certain microbes adapted to 
the increasing availability of oxygen and developed aerobic respiration, 
oxidising organic matter to water. Aerobic respiration offers a very prolific form 
of energy production, in which oxygen is used as a terminal electron acceptor. 
This process of energy production is now carried out by mitochondria in 
virtually all eukaryotic cells, thus providing enough energy for the 
diversification of high-order life. Nevertheless the initial advantage of aerobic 
respiration was balanced against the toxicity of oxidative metabolism.
1.3.1 Oxygen Toxicity
Oxygen toxicity arises from the partial reduction of oxygen resulting in the 
formation of reactive oxygen species (ROS), which are defined as highly reactive 
oxygen radicals (Wiseman and Halliwell 1996). ROS are capable of damaging 
DNA/RNA, oxidising lipids and oxidising proteins (Stadtman 2006; Adibhatla 
and Hatcher 2010). Aerobically respiring organisms have therefore developed 
strategies to minimise ROS damage, including restricted oxygen exposure, 
repair mechanisms and anti-oxidant defences (Hetz and Bradley 2005; 
Buonocore, Perrone et al. 2010). In addition, aerobically respiring organisms 
have also developed ways in which to usefully utilise ROS, as found in the 
processes of sperm-egg fertilisation, the immune response against invading
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microbes and several intracellular & extracellular signalling systems 
(Thannickal and Fanburg 2000). It is also possible that one of the driving forces 
of multicellular life was the arrival of oxygen, and that increased size and 
multicellularity evolved in part to reduce the dangers of oxygen toxicity by 
reducing the exposure of cells/mitochondria to oxygen (Henry and Harrison 
2004; Zhao, Zhou et al. 2010).
1.3.2 Oxygen-derived biosynthesis
Together with energy production and toxicity, the arrival of usable atmospheric 
molecular oxygen led also to the generation of new metabolites and secondary 
gene products, such as indoles, penicillin and sterols (Falkowski 2006). The 
emergence of these new biologically active compounds enabled new biochemical 
reaction networks, further increasing the potential for biological complexity. 
This is illustrated with the connection between sterols and molecular oxygen 
availability, in which molecular oxygen is an absolute necessity for sterol 
biosynthesis. Sterols are classified as a subgroup of steroids; the best known 
example being cholesterol, an organic compound that is often considered a 
defining feature of eukaiyotes (Espenshade and Hughes 2007). In mammalian 
biology, cholesterol is an integral component of cell membranes as well as a key 
precursor molecule for the formation of bile, vitamin D, cortisol, aldosterone, 
progesterone, estrogen and testosterone (Galea and Brown 2009). Ultimately it 
has now been estimated that oxygen plays a role in 103 reactions in the 
metabalome, making it one of the most used compounds in various biosynthetic 
pathways (Raymond and Segre 2006).
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Fig 1.2. Anatomy of the human body with measured 02 values of several tissues indicated. 
Values used were from Carreau et a/.and Wiener et al. (Wiener, Feola et al. 1976; Carreau, El 
Hafny-Rahbi et al. 2011) Many of these values are of a specific tissue and so conflicting 
information exists in the literature for a definitive oxygen tension for an organ. Specifically there 
are several citations reporting low kidney oxygen tensions.
1.4 Sensing oxygen and maintaining homeostasis
In the context of modern biology, a wide-array of organisms have evolved a 
dependency on the availability of oxygen and die in anoxic or hypoxic 
conditions. For unicellular life this dependency extends to simply finding and 
living in the optimal environment. However complex multicellular life needs to 
maintain oxygen homeostasis over many cells and tissues, regulating the needs 
of both the whole organism and individual cells. Across a multicellular 
organism, such as Homo sapiens, different tissues and organs have varying 
degrees of oxygenation (Fig 1.2) (Birol, Wang et al. 2007; Evans, Gardiner et al. 
2008; Carreau, El Hafny-Rahbi et al. 2011). This variability is attributable in 
part to the differing vasculature, metabolic demands and cellular functions, best
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illustrated by the 02 requirements of the brain; an organ accounting for 2% of 
human body mass but 20% of total body-wide 02 consumption (Nilsson 1996). 
Oxygen homeostasis can be disrupted at a number of levels and in a number of 
ways. So though dysregulated, disrupted or altered oxygen homeostasis is a 
common feature of many processes, the precise manifestation of these changes 
can be complex. Normoxia is a term used to describe the ordinary resting 
oxygen tension, whether describing atmospheric or tissue oxygenation status. 
As the cellular make-up of the body experiences different physiological oxygen 
tensions, so to is there a great range of normoxic tensions. In the atmosphere, 
21% 02 is considered normoxia, whereas in the upper airways 12% is said to be 
the norm and in the retina as low as -1% are normal (Wangsa-Wirawan and 
Linsenmeier 2003; Taylor and McElwain 2010). Alteration to normoxia occurs 
in two ways, either oxygen levels are increased or decreased. Most research 
focuses on the decrease from normoxia, known as hypoxia. The opposite 
situation is hyperoxia. Hyperoxia is often used to describe 02 tensions above 
atmospheric levels, but could be correctly used to describe cells exposed to 
levels above physiological norms, such as found in most cell culture conditions. 
Changes from normoxia can therefore occur at various levels: atmospheric, 
body-wide or tissue-specific. The mode of alteration is also said to have a 
consequence. The hypoxic or hyperoxic episode can be described as acute, 
chronic, transient, prolonged, intermittent or as a combination. Acute episodes 
are characterised as rapidly occurring changes (seconds-hours), as discussed for 
stroke and myocardial infarction and also in the case of wounding, in which 
oxygen is introduced to tissues not normally exposed to the atmosphere. 
Chronic insults are opposite to acute, in which changes from normoxia are 
gradual (days-weeks) as is the case for atherosclerosis and often cancer. 
Transient and prolonged situations also skew the nature of the insult as pre­
insult conditions are either reached rapidly, or slowly; acute and prolonged will 
often have severe-to-fatal consequences in the context of stroke. Intermittent 
insults place a different stress upon the tissue, occurring as a cycle of 
alterations. This is known to occur in the prevalent disorder of sleep apnoea, in 
which patients experience pauses or periods of abnormally slow breathing 
(Belaidi, Joyeux-Faure et al. 2009). On the cellular level, intermittent hypoxia 
can often be a feature within solid tumours due to transient changes in blood 
flow (Toffoli and Michiels 2008). Finally the last complication in the
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manifestation of altered oxygen homeostasis is re-oxygenation. Re-oxygenation 
is a cycled feature of intermittent disorders, as well as a common event 
following many hypoxic episodes characterised by reduced/obstructed blood 
flow. Resolving of the blood flow issues results in reperfusion, the rapid return 
of oxygenated blood to the affected area. As mentioned earlier, re-oxygenation 
brings a host of problems and is not a simple reset to normoxia (Shi 2009). A 
principal requisite of oxygen homeostasis is the ability to sense oxygen 
availability and mediate the appropriate response. As previously discussed, 
oxygen has impacted a number of biological processes, including bioenergetic 
status, ROS production and biosynthetic pathways. There are therefore 
numerous postulated biological events capable of relaying information 
concerning the availability of molecular oxygen (Chimploy, Tassotto et al. 2000; 
Giaccia, Simon et al. 2004; Agbor and Taylor 2008; Malthankar-Phatak, Patel 
et al. 2008). Despite this, mammalian oxygen sensing can be broadly considered 
in two categories (i) organism level regulation and (ii) cellular level regulation. 
1.4.1 Molecular mechanisms behind regulated breathing 
In human physiology, oxygen homeostasis is maintained at the level of the 
whole organism via breathing and the circulatory system. Underpinning this 
system is the oxygen sensitive organ, the carotid body, which is found in the 
neck at the carotid bifurcation (Lopez-Barneo, Ortega-Saenz et al. 2009). The 
carotid artery is well-irrigated by blood, screening continuously and rapidly 
detecting chemical changes, such as pH, C02, glucose and 02. On the molecular 
level, the 02 responsiveness of the carotid body is mediated through the 02- 
sensitive K+ channels, which are inhibited by the absence or reduction of 02. 
The hypoxic stimulation of these channels then leads to the sending of afferent 
projections onto brainstem respiratory nuclei and serves to provoke 
hyperventilation, thereby increasing blood 02 levels. (Joseph and Pequignot 
2009). The breathing response to insufficient oxygen is rapid occurring within 
seconds. This is indicative of the body’s absolute reliance on available 02, as 
even brief periods of restricted breathing (hypoxemic hypoxia) can have severe 
if not fatal consequences within minutes. The reason for this is the reliance of 
neuronal cells on aerobic respiration to maintain sufficient ATP levels, which 
when sufficiently hindered leads to disruption of ATP-sensitive K+ channels. 
The disruption of these channels results in ‘irreversible ionic derangements’ 
resulting in Na+ and Ca2+ overload (Yamada and Inagaki 2002).
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1.4.2 The ubiquitous cellular response to altered oxygen levels
As well as the carotid body’s ability to govern the body-wide hypoxic response, 
all cells of the body are able to elicit their own response to 02 availability. This 
can be considered to be the generic cellular response to 02 and this is chiefly 
governed by the transcription factor, Hypoxia-Inducible Factor (HIF). The role 
of the HIF-driven cellular response to hypoxia is to mediate an appropriate 
change in gene expression and therefore these adaptive changes occur in the 
order of hours. The mode of cellular adaptation is broad and this is evident in 
the sheer range of processes governed or affected by HIF activity (Semenza 
2003; Lee, Bae et al. 2004). A primary purpose of the adaptive response is to 
drive the formation of new vasculature in a process known as angiogenesis. 
Cells secrete the cytokine VEGF which serves to stimulate blood vessel 
formation, enriching the blood supply for nearby tissues and therefore 
increasing the oxygen delivery to nearby cells. The production of VEGF is 
regulated by the activity of HIF and the activity of HIF is dependent on 02 
availability. This mode of action confers a functional feedback system for tissue 
level oxygen homeostasis. Angiogenesis is an important adaptive process to 
overcome hypoxic microenvironments but this is not the only adaptive 
physiological response mediated by HIF signalling. HIF is also known to drive 
erythropoiesis via the transcription of erythropoietin (EPO), a cytokine that 
signals bone marrow to produce erythrocytes which are red blood cell 
precursors. The increase in red blood cell production increases the capacity of 
the blood to carry and deliver oxygen and thus reduces tissue hypoxia. These 
two processes alone have garnered much research interest in hypoxia. Aside 
from its medical importance, there is sufficient interest in hypoxia for the 
potential benefits to professional sports training or high-altitude activities. For 
the purpose of this thesis, this facet of hypoxia research represents more of a 
curiosity than a driving force. However, interesting insights are often made from 
this avenue of research, including the active measurement of body-produced 
free radicals during exercise, the bizarre ability of some individuals to hold their 
breath underwater for over 15 minutes, genetic dispositions to altitude sickness 
and the effectiveness of hypoxic training regimes etc (Hendriksen and 
Meeuwsen 2003; Bailey, Young et al. 2004; Lindholm and Lundgren 2009; 
Sahlin, Shabalina et al.; Ding, Liu et al.). Outside of these interests, HIF has still 
far-reaching implications.
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HIF is found in all multicellular life and has evolved alongside the geological 
changes in atmospheric conditions, as well as the biological changes apparent 
from the increasing complexity of life (Rytkonen and Storz 2010). There has 
been a growing interest in the HIF system, due to its role in many physiological 
and pathological processes, including metabolism, vascularisation, 
erythropoiesis, autophagy, atherosclerosis, ageing, wound-healing, 
embryogenesis, inflammation, transplantation, sleep apnoea, ischaemic insult 
and perhaps the most researched aspect, the role of the HIF signalling system in 
cancer and tumour progression (Lee, Bae et al. 2004; Murdoch, Muthana et al. 
2005; Katschinski 2006; Belaidi, Joyeux-Faure et al. 2009; Bellot, Garcia- 
Medina et al. 2009; Lau, Henriksnas et al. 2009; Zhang, Shao et al. 2009; 
Brigati, Banelli et al. 2010; Cassavaugh and Lounsbury 2011).
Ischaemia describes a situation in which blood supply to a tissue becomes 
restricted, with the flow falling below normal tissue tolerance. The decrease in 
blood flow precedes a decrease in blood-borne supplies, importantly including 
oxygen. An ischemic insult therefore leads to a subsequent period of hypoxia. 
There are a number of medical conditions that cause ischaemia and therefore 
hypoxia occurs as a secondary event in a number of pathological contexts. A 
widely known setting for ischaemic insult can be found in strokes, in which a 
haemorrhage or embolism leads to rapid loss of blood flow to the brain. Another 
well known source of ischaemic insult is in the occurrence of ischaemic heart 
disease, a prevalent cause of cardiac arrest often arising from atherosclerosis. As 
well as decreased oxygen delivery to the heart, the loss of heart function and 
therefore system wide blood flow can lead to hypoxic events occurring 
throughout the body. As indicated earlier, different tissues have varying 
oxygenation statuses and differing metabolic demands and this further 
transpires into differing sensitivities and responses to hypoxia (Fig 1.2). Two of 
the most consequential and sensitive areas to oxygen deprivation are the heart 
and the brain due to their high metabolic demands and importance. The effects 
of hypoxia on these tissues can be quite immediate, occurring within minutes. 
However, the time-scale of the initial damage arising from ischaemia occurs 
faster than a plausible transcription factor-mediated response and so the role of 
HIF in ischaemic pathologies is largely in prevention or treatment of secondary 
events that come about hours after the initial insult. Several references have 
suggested the pre-conditioning activation of the HIF system to have a
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neuroprotective affect against ischaemic stroke, investigated both in vitro and 
in vivo (Shi 2009). However, there is evidence to suggest a double-edged sword 
mechanism, in that activation of HIF-l can promote apoptosis in cortical 
neurons. A significant portion of damage after an ischaemic insult (as found in 
cerebral ischaemia or myocardial infarction) occurs hours after the initial 
damage and is characterised by a large degree of apoptosis (Krijnen, Nijmeijer 
et al. 2002; Broughton, Reutens et al. 2009). It is thought that HIF may have a 
role to play in this wave of apoptosis, either preventitive or conducive (Helton, 
Cui et al. 2005; Li, Qu et al. 2007; Malhotra, Tyson et al. 2008). Prevention of 
the damage could positively affect the recovery, predisposition to further 
complications and/or quality of life of the patient.
A further pathological instance of deregulated HIF can be found in cancer and 
tumour progression. Mutations within the HIF system are known to be partially 
responsible for the development of cancer, such as in the case of von Hippel- 
Lindau disease. Furthermore, numerous factors of cancer often lead to the 
pathological activation of the pathway and this often has maladaptive 
repercussions (Maxwell, Pugh et al. 2001). For example, as tumours develop 
they often outgrow their blood supplies, hypoxic regions begin to form and this 
in turn leads to HIF activation (Fig 1.3). Activation of the HIF pathway in 
cancerous cells has been shown to increase malignancy and is associated with 
poor prognosis for some cancers (Zhou, Schmid et al. 2006). In light of the 
current understanding of downstream HIF regulation, it is now known that HIF 
can encourage almost every aspect of metastasis (Lu and Kang 2010). As well as 
increasing the invasive ability of cancer, the pathological activation of HIF can 
also confer resistance to chemotherapy (Liu, Ning et al. 2008; Nardinocchi, 
Puca et al. 2009). In spite of the many oncogenic properties of HIF-l, there are 
several instances of the reverse. There has been debate whether HIF-l plays a 
pro- or anti-apoptotic role. There is considerable evidence for both arguments 
and it is now well-established that HIF may act in either capacities (Piret, 
Mottet et al. 2002). The pro-apoptotic role of HIF-l has been surmised to 
contribute to significantly longer survival times in patients diagnosed with lung 
carcinoma (Volm and Koomagi 2000). However, it is also appreciated that the 
hypoxic tumour environment acts as a selection pressure, encouraging the 
emergence of the more aggressive phenotypic traits. Nevertheless it appears
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HIF activation has a greater role to play in the detrimental effects in cancer than 
the anti-tumourigenic effects (Semenza 2003).
Normal Tumour
Fig 1.3. Graphic depiction of dysregulated oxygen homeostasis arising from tumour growth and 
abnormal vasculature, as occurs in many solid tumours.
In summary, a controlled oxygen microenvironment is a hallmark feature in 
many physiological events, critical throughout embryogenesis and development, 
an important factor in stem cell biology, a cue in the immune response and 
relevant to spermatogenesis amongst other well-documented events (Yun, 
Maecker et al. 2002; Wenger and Katschinski 2005; Novak and Tyson ; Eliasson 
and Jonsson ; Gale and Maxwell ; Patterson and Zhang 2010). It is very difficult 
to overemphasise the pervasive importance of oxygen to a multicellular 
organism such as humans. This importance extends to the HIF signalling 
network which has evolved and intertwined with the cellular oxygen 
microenvironment creating an interdependence between the two. The 
involvement of HIF in the critical physiological events listed, as well as roles in 
the pathological events discussed has made the molecular HIF network an 
increasingly desirable pharmaceutical target. It is therefore an important goal to 
better understand the regulatory motifs governing HIF activity with a view 
towards the stronger rationale behind the development of future therapeutics 
(Nangaku, Kojima et al. 2006; Niatsetskaya, Basso et al. ; Smith and Talbot).
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1.5 Canonical oxygen-dependent HIF signalling
The transcription factor HIF has emerged as a central element involved in the 
cellular response to altered oxygen availability. HIF-i was initially discovered by 
Greg Semenza’s group in 1993 and shown to be the transcription factor that 
confers the hypoxia-inducibility of the EPO gene, the hormone controlling red 
blood cell production (Semenza and Wang 1992). Since then, it has been found 
that HIF can mediate wide changes in gene expression and is implicated in 
regulating over 400 genes (Elvidge, Glenny et al. 2006) influencing such diverse 
functions as apoptosis, cell-cycle, differentiation, immune response, energy 
metabolism, cell migration and angiogenesis (Table 1.1) (Piret, Mottet et al. 
2002; Lee, Bae et al. 2004; Semenza 2011). Furthermore, in a study by Glenny 
et al. (2006), it was shown that HIF was responsible for up-regulating 53% of all 
hypoxia-inducible genes in the MCFy cell line (Elvidge, Glenny et al. 2006).
HIF is functional as a heterodimeric transcription factor compromised of an 02 
regulated a-subunit and a constitutively available p-subunit. Both the protein 
stability and the transcriptional activity of HIF are governed by the availability 
of molecular oxygen. In the presence of oxygen, HIF-a is hydroxylated at two 
proline residues found within the oxygen-dependent degradation domain 
(ODD) (Fig 1.4). The hydroxylation is catalysed by the intracellular prolyl 
hydroxylases 1-3 (PHDs) and requires molecular oxygen as well as iron, 2- 
oxoglutarate and ascorbate. The tumour suppressor protein von Hippel Lindau 
protein (pVHL) is then able to interact with the hydroxylated HIF-a subunit, 
leading to ubiquitination and subsequent degradation by the 26S proteasome 
(Maxwell, Wiesener et al. 1999). This mechanism therefore confers an oxygen- 
sensitive control of HIF-a protein levels. The transcriptional activity of HIF is 
regulated by a further hydroxylase, known as Factor Inhibiting HIF-ia (FIH). 
FIH is able to hydroxylate an asparagine in the C-terminal of HIF-a in a manner 
similar to the PHDs. This modification prevents HIF from recruiting CBP/psoo, 
a necessary co-activator for the transcriptional activity of HIF (Fig 1.4) (Lee, 
Bae et al. 2004; Taylor and Pouyssegur 2007).
In sufficiently hypoxic conditions, HIF-a escapes the hydroxylation events and 
is able to accumulate in the nucleus and bind with HIF-p. The complete 
heterodimer, HIF, is then able to activate genes containing a hypoxic response 
element (HRE) consensus sequence (-RCTTG-) in their promoter or enhancer 
regions (Fig 1.4). As well as acting as an transcriptional inducer, HIF has also
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been shown to act as a repressor, reducing the expression of several notable 
genes, such as; P53, FADD and ENTi among others (Lee, Lee et al. 2001; 
Eltzschig, Abdulla et al. 2005; Hindryckx, De Vos et al. 2010) The mechanisms 
for this activity remain poorly understood, though it appears it is not mediated 
through direct-interaction but possibly through co-operative action with other 
proteins.
A B
Hypoxia
Fig 1.4 A representation of (A) the canonical HIF oxygen sensing pathway and (B) the featured 
negative feedback loop within the canonical HIF signalling pathway.
An additional regulatory aspect to HIF signalling, which is of interest to this 
study, is the presence of an auto-regulatory negative feedback loop within the 
core HIF signalling motif (Epstein, Gleadle et al. 2001; Stiehl, Wirthner et al. 
2006). Both PHD2 and PHD3 themselves are target genes for HIF and therefore 
upon the hypoxic activation of HIF are subject to up-regulation. This signalling 
motif is commonly referred to as a delayed negative feedback loop, with the 
delayed aspect arising from the time needed for transcription and translation of 
the PHDs. Delayed negative feedback loops are a common signalling motif in 
dynamic systems (and necessary in oscillatory systems) (Yeger-Lotem, Sattath 
et al. 2004; Novak and Tyson 2008). Typically this motif is commonly viewed as 
a standard mechanism for homeostasis, though it also offers the potential for 
encoding additional complexity within the HIF transduction pathway; a concept 
paramount to this thesis which will be discussed in greater depth later.
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Function Effect Mediated by
Angiogenesis TMRNA; VEGF, ENG, LEP, LRPi, TGF-Ps
Apoptosis jMRNA: NIP3, NIX, RTP801
Autophagy TMRNA; BNIP3, BNIP3L(Bellot, Garcia-Medina et al. 2009)
Cell Adhesion TMRNA; MIC2
Cell Migration TMRNA; ANF/GPI, c-MET, LRPi, TGF-a
Cell Proliferation TMRNA; Cyclin G2, IGF2, IGF-BP1-3, WAF-i, TGF-a, TGF-P3VEGF, HGF, & FGF (Tamama, Kawasaki et al. 2011)
Cell Survival TMRNA; ADM, EPO, IGF-BP1-3, NOS2, TGF-a, VEGF
Circadian Clock Synergistic relationship with CLOCK to TMRNA of Vasopressin (Ghorbel, Coulson et al. 2003)
Cytoskeletal Structure TMRNA; KRT14, KRT18, KRT19, VIM
Differentiation
Inhibits differentiation via synergistic relationship with NOTCH to TMRNA; at least PGKi 
(Sainson and Harris 2006). Promoting of adipogenesis via TMRNA; GLUti, GLU4, IRS3 (Shimba, 
Wada et al. 2004)
DNA repair TMRNA; TwistfSun, Ning et al. 2009) Inhibitory relationship with myc leads to JMRNA & Protein; NBS1 (To, Sedelnikova et al. 2006)
Drug Resistance TMRNA; MDR (Comerford, Wallace et al. 2002)
Erythropoiesis TMRNA; EPO
Glucose Metabolism ALDA, ALDC
HIF-i Response TMRNA; EGLNt, EGLN3
Immune Function HIF regulates a myriad of genes associated with Macrophage, Monocyte and Neutrophil function (Murdoch, Muthana et al. 2005)
Iron Metabolism TMRNA; Ceruloplasmin, Transferrin, Transferrin receptor
pH Regulation TMRNA; Carbonic anhydrase 9
Stem Cell Maintenance JMRNA; Oct-4 (Covello, Kehler et al. 2006), pref-i (Lin, Lee et al. 2006), DECi (Yun, Maecker et al. 2002)
Transcriptional Regulation TMRNA; DECi, DEC2, ETS-i, NUR77
Vascular Tone TMRNA; aiB-adrenergic receptor, ADM, ETi, NOS-2, Haemoxygenase-i
Table 1.1. A non-exhaustive table of HIF-mediated biological processes and the mode of 
regulation. This table is heavily adapted from Lee et al. 2004 with additional contributions 
referenced (Lee, Bae et al. 2004)
1.6 Alternative 02-dependent HIF pathway
For simplicity, convenience and effect, the mechanisms of HIF regulation 
detailed below have been divided into (^-dependent and 02-independent modes 
of action. A degree of caution must be taken in this segregation, as there is 
significant possibility of crossover e.g. NF-kB, HuR and ROS may contribute 
both to the 02-dependent and 02-independent regulation of HIF.
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The canonical oxygen-dependent HIF signalling pathway is well established, 
however there are alternative modes of HIF regulation that are directly or 
indirectly dependent on the availability of molecular oxygen. The regulatory 
mechanisms discussed below outline the complexity of molecular oxygen as an 
environmental cue/stimulus and how some of this complexity is integrated 
within the HIF pathway. However, the mechanisms discussed below are far 
from an exhaustive overview of all non-canonical interactions. Major 
transcriptional hubs, such as HIF, are often exposed to a staggering amount of 
crosstalk and modulation and therefore only the most salient crosstalk events 
are discussed, both for the alternative 02-dependent HIF pathway and the 
following section detailing 02-independent regulation of HIF. Notable crosstalk 
events not discussed in the text are listed in Table 1.2 (found at the end of the 
section).
1.6.1 Mitochondria & reactive oxygen species
Perhaps the best researched and most controversial alternative HIF regulatory 
mechanism is the involvement of ROS in mediating the HIF hypoxic response. 
Essentially the proposed mechanism can be separated into two aspects, (1) the 
hypoxia driven production of ROS and (2) the integration of ROS into the 
canonical oxygen sensing pathway. Biological ROS has been shown to be 
primarily produced by mitochondria as a result of an active electron transport 
chain (Murphy 2009). The electron transport chain is composed of a uni­
directional sequence of four complexes functioning as electron 
acceptors/donors. These complexes are termed Complex I, II, III and IV, in 
which IV acts as the terminal acceptor complex donating the electrons to reduce 
02 to H2o. Complex I,II and III leak a portion of the electrons transferred 
causing the partial reduction of 02 and formation of the superoxide anion 02- 
(Turrens 2003). The superoxide anion is then converted to other forms of 
cellular ROS, such as H202 or the highly reactive hydroxyl radical when in the 
presence of transition metals (Thannickal and Fanburg 2000). The availability 
of cellular molecular oxygen affects the activity of the electron transport chain 
and therefore the production of ROS. Classical physics suggests increasing 02 
should increase ROS production. However the opposite effect has also been 
several times reported, in which hypoxia leads to an increase in ROS 
(Hamanaka and Chandel 2009). The hypothesised molecular mechanisms
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controlling hypoxia-mediated ROS production centre on Complex III as the 
source (Hamanaka and Chandel 2009). The other side of the involvement of 
ROS in Oa-sensing is how the hypoxia-produced ROS translates into a 
physiological hypoxic response. ROS has been shown to function in a number of 
signal transduction pathways, particularly redox-sensitive pathways such as 
NRF2 and NF-kB (Bowie and O'Neill 2000). It is therefore possible that some 
hypoxic sensitivity is conferred through these separate signalling systems and 
these may have downstream implications on the activity of the HIF signalling 
system (Malec, Gottschald et al. 2010). However, it has also been suggested that 
ROS may have a more direct affect on the HIF signalling system and is capable 
of stabilising HIF protein by modulating PHD hydroxylation activity. This effect 
is proposed to occur via the ROS-driven conversion of Fe2+ to Fe3+, where Fe2+ 
is a necessary cofactor of the PHDs (Gerald, Berra et al. 2004; Patten, Lafleur et 
al. 2010). This mechanism is suggested to work within a range of hypoxic 
tensions and is abated at near-anoxia at which point the PHD hydroxylation 
rates become overwhelmingly diminished (Guzy, Hoyos et al. 2005).
1.6.2 NF-kB crosstalk
NF-kB is a dimeric transcription factor that affects a wide and diverse array of 
cellular activities, representing a major transcriptional hub (Pahl 1999)- It is 
principally known as a stress response factor involved in inflammation and the 
immune response, and is activated by a plethora of stimuli, such as cytokines, 
oxidative stress, bacterial toxins and DNA damage etc (Bowie and O'Neill 2000; 
Janssens and Tschopp 2006; Culver, Sundqvist et al. 2010). Amongst these 
activating stimuli, hypoxia has been shown to also stimulate NF-kB and there 
are several molecular mechanisms proposed to explain this (Culver, Sundqvist 
et al. 2010). (i) The first potential mechanism relates to the previously discussed 
production of ROS in hypoxia and the subsequent activation of NF-kB via the 
ROS-induced post-translational modification of Inhibitor of icBa (IicBa), a 
negative-regulator of NF-kB (Imbert, Rupee et al. 1996). (ii) Another 
hypothesised mechanism is the potential hydroxylation of the Inhibitory Kinase 
Kinase (IKK) component of the NF-kB transduction pathway by PHDl, and to a 
lesser extent PHD3 (Cummins, Berra et al. 2006). (hi) A more recently 
elucidated possible mechanism is via the hypoxic activation of 
calcium/calmodulin-dependent kinase 2 (CaMK2) which leads to the activation 
of the NF-kB signal transduction pathway (Cai, Liu et al. 2008; Culver,
-16-
Sundqvist et al. 2010). These are just a few of the reported possibilities of 
hypoxic NF-kB activation, regardless their potential importance is in the ability 
to integrate NF-kB signalling into the canonical HIF system (via crosstalk 
mechanisms). There have been several studies detailing crosstalk mechanisms, 
demonstrating the NF-kB regulation/modulation of the HIF system. The 
foremost idea is the regulation of HIF-ia mRNA by the activity of NF-kB 
(Belaiba, Bonello et al. 2007; Rius, Guma et al. 2008). It is therefore 
conceivable that the cellular NF-kB status can serve to prime the canonical HIF 
response. A lesser-characterised mechanism is centered around the 
sequestering of FIH by IkBcx. FIH has been shown to bind to a range of ankyrin 
repeat domain containing proteins, including IkBq (Cockman, Webb et al. 
2009). It has been suggested that increased expression of IkBcl leads to the 
sequestration of FIH away from HIF-a and therefore promotes the 
transcriptional activity of HIF (Schmierer, Novak et al. 2010). These regulatory 
events and their effect on the output of the HIF system is further complicated as 
HIF activity has been shown to also affect NF-kB (Walmsley, Print et al. 2005). 
This complexity is made more overwhelming when the temporal arrangements 
of both pathways are considered, especially regarding the elucidated oscillatory 
nature of NF-kB signalling (Nelson, Ihekwaba et al. 2004).
1.6.3 Translational regulation of HIF-a
Hypoxia is cited to cause a global change to cellular protein synthesis 
(Koumenis, Naczki et al. 2002). During periods of hypoxia the energy status of 
the cell changes and several adaptive responses occur to minimise the 
expenditure of ATP. One such event is to reduce the energy used in the process 
of translation. Change in global protein synthesis could be expected to affect the 
steady-states/equilibria in several signalling arrangements, including that of 
canonical HIF regulatory systems. This mechanism itself can mediate some 
forms of hypoxic response. Additionally, in periods of hypoxia reduced protein 
synthesis itself may be beneficial to preferentially maintain/induce the synthesis 
of proteins relevant to the hypoxic stress (Young, Wang et al. 2008). This has 
been proposed to occur for HIF-a mRNAs in a IRES-mediated (internal 
ribosome entry sequence) fashion, of which IRES elements are described to 
promote the translation initiation within the mRNA nucleotide sequence (Lang, 
Kappel et al. 2002). However, a further paper has refuted the proposed function 
of IRES elements in mediating translation of stress pathway proteins,
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suggesting that the observed increased in protein expression correlates mainly 
with increased mRNA production (Young, Wang et al. 2008). Despite this there 
are other suggested posttranscriptional regulatory events that are in some way 
Oa-sensitive. The first of these is mediated through the interaction of HIF-ia 
mRNA with the RNA-binding protein, Human Antigen R (HuR) (Sheflin, Zou et 
al. 2004; Galban, Kuwano et al. 2008). HuR has been shown to affect HIF-ia 
mRNA trafficking and stability, depending on the activating conditions; one 
such activating stimuli is hypoxia (Sheflin, Zou et al. 2004). Furthermore HuR 
has been implicated in regulating a number of mRNAs in a hypoxia-mediated 
fashion, including pVHL (Masuda, Abdelmohsen et al. 2009). The hypoxic 
regulation of HuR may therefore work in tandem with the canonical HIF 
response, although this mechanism is probably sensitive to crosstalk events as 
HuR is implicated in regulating many signalling systems (Lebedeva, Jens et al. 
2011). The final 02-sensitive posttranscriptional regulatory mechanism is the 
role of microRNA and the hypoxic response. MicroRNAs are short non-coding 
RNAs that are capable of destabilising mRNA or repressing translation of 
mRNA. Since their official discovery in 1993, microRNAs are increasingly 
accepted in the central dogma of the flow of information from DNA and as such 
have been implicated in regulating a vast array of cellular processes (Lee, 
Feinbaum et al. 1993; Lu, Li et al. 2009; Robinson 2009). Unsurprisingly there 
has been a series of emerging evidence implicating microRNA in the hypoxic 
response; both in response to hypoxia and modulation of the canonical HIF 
response (Kulshreshtha, Ferracin et al. 2007; Huang, Le et al.). Firstly, many 
microRNAs are known to change expression pattern in response to hypoxia and 
this postulates microRNAs as a broad component in the cellular response to 
hypoxia (Kulshreshtha, Davuluri et al. 2008). More specifically several 
microRNAs have been revealed to target HIF-ia mRNA, such as miR-ipga, mir- 
155, miR-2ob and microRNA cluster miR 17-92 (Taguchi, Yanagisawa et al. 
2008; Lei, Li et al. 2009; Rane, He et al. 2009; Bruning, Cerone et al.). miR2ob 
has been shown to be down-regulated in response to hypoxia and this is in 
accordance with data also showing HIF can repress expression of miR2ob. 
However, HIF-ia is down-regulated by this microRNA and therefore forms a 
double-negative feedback loop which has implications for the HIF response to 
hypoxia. More recently it has been shown that microRNA-155 is HIF-i inducible 
and as well as destabilising HIF-ia, constituting a feedback loop cited to
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oscillatory potential to the HIF system (Bruning, Cerone et al. 2011). As a near 
fundamental aspect of gene expression, microRNAs represent a broad 
mechanism of regulation, sensitive to widely varied stimuli. It is therefore likely 
that alongside the oxygen-dependent regulation of HIF that microRNAs feature 
also in the Oa-independent regulation of HIF (Cha, Chen et al.).
1.7 02-independent regulation of the HIF pathway 
Though most research centred on HIF concentrates on the response and role of 
this transcription factor in hypoxia there are many studies detailing oxygen- 
independent regulation of the HIF pathway. These mechanisms therefore may 
serve to prime the HIF pathway, or to provide context, integrating various signal 
transduction networks into the HIF hypoxic response.
1.7.1 HSP90 and Racki
A study by Liu et al. (2007) demonstrated that Heat shock protein 90 (HSP90) 
and receptor of activated kinase C (Racki) compete for binding to HIF-ia and 
this competition regulates HIF-ia protein stability. HSP90 binding promotes 
stability and conversely Racki destabilises HIF-ia in a PHD/pVHL independent 
manner (Liu, Baek et al. 2007). Racki is known principally as a scaffold protein 
interacting with protein kinase C, though there are a host of other researched 
interactions affecting various cellular processes (McCahill, Warwicker et al. 
2002). Both Racki and HSP90 have been shown to bind to the PAS domain of 
HIF-ia (Fig 1.5), in which Racki promotes the ubiquitination and subsequent 
proteasomal degradation of HIF-ia (Liu, Baek et al. 2007). HSP90 is an 
abundant stress-response protein involved in the folding, activation and 
stabilisation of target proteins both in stressed and basal conditions (Sreedhar, 
Kalmar et al. 2004). Dysregulation of HSP90 is a common hallmark in cancer, 
often leading to the stabilisation of overexpressed oncogenes (Hahn 2009). It is 
therefore possible that this pathway may have significant 
physiological/pathological implications on the HIF system, affecting the 
potential 02"dependent response of HIF.
1.7.2 Deubiquitinases; VDUl and VDU2
The Oa-dependent regulation of HIF-a protein stability hinges upon its 
sequential post-translational modification, culminating in its ubiquitination and 
ensuing degradation (Taylor and Pouyssegur 2007). The ubiquitination event is 
typically portrayed to occur in a one-way manner though there has been 
significant research into the regulated reversibility of this process via a class of
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proteins known as deubiquitinases (DUBs). Currently there are almost 100 
known human DUBs and two of these have been implicated in the HIF system, 
namely pVHL protein-interacting deubiquitinating enzyme 1 and 2 (VDUl and 
VDU2) (also known as USP33 and USP20 respectively) (Li, Wang et al. 2002; 
Li, Wang et al. 2005). The initial characterisation of VDUl and VDU2 by Li et al 
(2002a, 2002b)(Li, Na et al. 2002; Li, Wang et al. 2002) showed that these 
proteins are targeted for proteasomal degradation by pVHL. However a further 
paper by this group has shown that ectopic expression of VDU2 acts to stabilise 
HIF-ia protein and this is proposed to occur via the deubiquitination of HIF-ia 
(Li, Wang et al. 2005). There are still significant questions remaining as to the 
stimuli regulating VDU2 and whether this mechanism may play a significant 
role in the physiological and/or pathological context.
1.7.3 Growth factor regulation
The extensive signalling transduction network of mitogen-activated protein 
kinase has also been found to regulate HIF signalling, sensitising HIF activity to 
a number of intergratable stimuli, notably including growth factors. Of the 
numerous MAPK effectors, HIF-i regulation has been chiefly attributed to the 
efforts of P38 and P42/44 (Mylonis, Chachami et al. 2006; Nys, Van Laethem et 
al. 2010). Various modes of HIF-a regulation by MAPK have been reported, 
including the contentious issue of p42/p44 phosphorylation of HIF-ia; a 
mechanism proposed to originally effect HIF-ia protein abundance and later 
reported to effect transactivation potential, involving the enhanced P300 
recruitment to HIF-ia (Sang, Stiehl et al. 2003). It has even been suggested that 
P42/P44 does not directly affect HIF-i, but the potentiality of downstream gene 
expression as has been shown for the hypoxic expression of VEGF mRNA (Yang, 
Wang et al. 2009). Other modes of MAPK activation of HIF signalling include 
the psS/akt stimulated increase of HIF-ia mRNA, translation and protein 
stabilisation (Khurana, Nakayama et al. 2006; Nys, Van Laethem et al. 2010). 
The Phosphoinositide 3-kinase signalling has a similar role to the MAPK 
network, acting as a broadly activated transducing network also responsive to 
growth factors. Again similar to MAPK signalling, PI3K has also been shown to 
regulate the HIF system, though there is more clarity on how this is achieved. 
Growth factor activation of phosphoinosiltide 3-kinase signalling enables 
mammalian target of rapamycin (mTOR) to facilitate the translation of HIF-ia 
mRNA and this has been shown to be sufficient for the normoxic stabilisation of
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HIF-ia (Dery, Michaud et al. 2005). This arm of regulation has also been found 
to function in response to re-oxygenation (Harada, Itasaka et al. 2009).
Oa-dependent
PHDs The PHDs hydroxylate HIF-a, a process which uses molecular oxygen. The hydroxylated 
HIF-a is then targeted for proteasomal degradation. PHD2 & 3 are HIF target genes.
ROS ROS production increases during hypoxia, which then reduces the hydroxylation potential 
of the PHDs by affecting the redox state of the iron co-factor.
NF-kB Hypoxia induces the NF-kB system via several potential mechanisms. NF-kB activation 
leads to an increase in HIF-ia mRNA.
micro RN As Mir2ob is down-regulated in response to hypoxia. This in turn leads to a stabilisation of 
HIF-ia mRNA, a known target of mir2ob.
HuR The protein HuR is responsible for stabilising and enhancing the trafficking of HIF-ia and 
possibly pVHL mRNA in response to hypoxia.
P53 A lot of contradictory information exists. Hypoxia induces P53 atypically. P53 is then able to 
either downregulate, upregulate or have no effect on HIF-i (Sermeus and Michiels 2011).
HIF-3a HIF-3a protein levels are increased in response to hypoxic inhibition of the PHDs and the 
activity of HIF-1/2. HIF-3C1 is then able to competitively inhibit HIF-ia&-2a for HIF-i(3
O2 consumption Hypoxia leads to changes in mitochondrial 02 consumption which affect cellular availability 
of molecular oxygen for use in PHD-mediated hydroxylation of HIF-a.
Chromatin
Remodelling
Multiple mechanisms. Hypoxia causes changes to various HATs and HDACs affecting the 
promoters of several HIF target genes (Kenneth and Rocha 2008).
Nitric Oxide iNOS is induced by HIF-ia increasing NO. NO has a diverse set of consequences, regulating 
HIF-ia protein stability as well as transcriptional activity (Brahimi-Horn, Mazure et al. 
2005).
NRI2 NRF2 is a redox-sensitive transcription factor activated by intermittent hypoxia. NRF2- 
dependent Trxi enhances HIF-i signalling (Malec, Gottschald et al. 2010). HIF-i is capable 
of downregulating NRF2 (Loboda, Stachurska et al. 2009).
Oa-independent
HSP90 vs Racki HSP90 and Racki compete for binding to HIF-ia. HSP90 promotes protein stability and 
conversely Racki destabilises HIF-ia in a PHD/pVHL independent manner (Liu, Baek et al. 
2007).
VDU2 VDU2 deubiquitinates HIF-ia, thereby reducing the extent of proteasomal degradation.
HAF HAF is an E3 ubiquitin ligase targeting HIF-ia for proteasomal degradation. While also able 
to bind to HIF-2Q, this interaction increases HIF-2a transactivation.
Cytokines and 
Hormones
A rich assortment of cytokine led regulation of HIF reviewed extensively by Haddad et al 
2005. Expectantly occurs with a large degree of overlap with NF-kB regulation of HIF.
TCA Cycle 
Intermediates
Several TCA intermediates inhibit PHD activity, thereby stabilising HIF-a. This is 
considered a pathological mechanism rather than physiological (Fong and Takeda 2008).
pH Acidosis promotes nucleolar sequestration of pVHL, thereby stabilising HIF-a. (Mekhail, 
Gunaratnam et al. 2004)
CommDi CommDi protein is able to bind to HIF-ia which disrupts HIF-i heterodimerisation. This 
process also disrupts HSP90 binding. CommDi is also able to inhibit NFkB signalling.
Table 1.2. Overview of several salient HIF regulatory mechanisms. Abbreviations used in the table 
(not used elsewhere); The Citric Acid Cycle (TCA), Hypoxia-associated Factor (HAF), Nuclear factor 
erythroid-derived 2 (NRF2).Though these mechanisms have been divided into 02-dependent or 
independent, there is significant possibility of crossover, in that many oxygen-independent 
mechanisms may also activate NRF2, HuR, Chromatin Remodelling, P53, Nitric Oxide etc. further 
outlining the complexity of regulation supporting the HIF signalling network.
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1.8 Protein members of the canonical HIF pathway
The canonical HIF pathway members are currently considered to be; the HIF-a 
isoforms (excluding HIF-3a which is included below for the sake of completion), 
HIF-p isoforms, PHD isoforms, pVHL and FIH.
1.8.1 HIF-a (HIF-ia, HIF-2a and HIF-aa)
HIF-a is the oxygen-labile subunit of the heterodimeric complex with HIF-P 
and is currently known to occur as three isoforms HIF-ia, HIF-2a and HIF-sa. 
Of these three isoforms, HIF-ia and HIF-2Q form transcriptionally active 
heterodimers (when bound with HIF-p), whereas the role of HIF-3a is less 
certain. Understanding explicitly the roles and functions of these isoforms is a 
current aim within the field of hypoxia research.
DNA ARNT O2 dependent Transactivation
binding dimerization degradation domain
HIF-ia
(826*111)
bHLH TAD
I I
p402 p564
HIF-2a
(870*111)
p405 p531
Fig 1.5. Domain representation of the transcriptionally active HIF-a isoforms with the 
hydroxylated proline residues labelled. Basic domain arrangement adapted from Lee et al 
(2004)
1.8.1.1 HIF-ia
The HIF-ia isoform is constitutively and ubiquitously expressed across all 
tissues and is therefore often thought of as the major a isoform (Gradin, 
McGuire et al. 1996). The gene is highly conserved and found as an orthologue 
in all multicellular life, which reinforces the importance of this transcription 
factor (Rytkonen, Williams et al. 2011). Furthermore, HIF-ia is necessary for 
healthy embryogenesis. HIF-ia knockout mice have been found to be embryonic 
lethal at E11 and this arises due to incorrect vasculature amongst other 
problems (Krishnan, Ahuja et al. 2008). The research interest in the HIF-ia 
isoform is further piqued due to the specific roles it appears to play in various 
pathologies, including the association of cancer malignancy, chemoresistance 
with increased HIF-ia expression (Lu and Kang 2010). There are two Homo 
sapiens mRNA transcript variants of HIF-ia: a 248ibp (NM_ooi53o) and a 
22o8bp (NM_i8i054) variant, in which the longer transcript translates to
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having an additional C-terminal sequence. Conventionally most research, 
including our own, has focused on the shorter transcript as the main variant. 
The translation of this shorter transcript results in an 827 aa, !20kDa protein 
that is found predominantly in the cell nucleus. The nuclear import of HIF-ia 
occurs in an importin-dependent manner via the nuclear localisation signal 
found in the C-terminal between residues 718-753 (Fig 1.5) (Depping, Steinhoff 
et al. 2008). Once inside the nucleus HIF-ia (as the heterodimeric complex) is 
free to bind to the target DNA consensus, the HRE. This consensus is shared by 
the transcriptionally active a units, nevertheless the different a subunits have 
overlapping and separable target gene expression profiles. A study examining 
the genome-wide analysis of HIF DNA binding in MCF7 cells found ~70% of 
HIF-a binding genes uniquely bound HIF-ia over HIF-2a and -21% of genes 
bound both isoforms (Mole, Blancher et al. 2009). Further work by Imamura et 
al 2009 examined the effect of HIF-i/2a siRNA knockdown in colon cancer 
cells and found HIF-ia was solely responsible for the hypoxia induction of 
-30% of HIF-dependent genes and jointly responsible alongside HIF-2Q for 
-50% of HIF-dependent genes (Imamura, Kikuchi et al. 2009). So despite the 
similarities between the two transcriptionally active isoforms HIF-ia has 
distinct and broader roles.
The hypoxic sensitivity of HIF-a is underpinned by the hydroxylation and 
polyubiquitination of the protein and these are the most widely-regarded post- 
translational modifications of the a-subunits. However, emerging work has 
demonstrated the occurrence of other post-translational modifications 
including phosphorylation, SUMOylation and S-nitrosation (Brahimi-Horn, 
Mazure et al. 2005). Of these modifications phosphorylation is the best 
characterised. Phosphorylation of HIF-ia has been proposed to occur through a 
variety of kinases and to occur on a variety of residues. However a common 
consensus is that the phosphorylation of HIF-ia leads to the increase in 
transcriptional activity of the HIF heterodimer (Brahimi-Horn, Mazure et al. 
2005). Conversely, more recent evidence indicates that the SUMOylation of 
HIF-ia has the opposite effect, repressing the transcriptional output of HIF-1 
(Huang, Han et al. 2009; Kang, Li et al. 2010; Xu, Zuo et al.). The SUMOlyation 
of HIF-ia has been proposed to occur via the activity of the E3 ligase PIASy, 
potentially on residues K391 and K477 (Kang, Li et al. 2010). Moreover, the 
SUMOylation of HIF has been suggested to be enhanced by the hypoxia-
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inducible protein RWD-containing sumoylation enhancer (Carbia-Nagashima, 
Gerez et al. 2007). Finally S-nitrosation, the process of attaching a nitroso group 
to a sulphur atom, is also suggested to impact HIF-ia functionality. Once again, 
the clarity of this mechanism is lacking and it is suggested to increase and 
decrease HIF-ia stability as well as aiding the recruitment of the psoo co­
activator to HIF-ia (Brahimi-Horn, Mazure et al. 2005).
HIF-ia is also known to have HIF-P independent functions, affecting the 
processes of differentiation, DNA repair and possibly elements of the circadian 
clock. HIF-ia is able to synergistically interact with the Notch pathway, an 
evolutionary-conserved signalling system with many roles in cell-to-cell 
communication and differentiation. This synergistic relationship, involves the 
heterodimerisation of HIF-ia with Notch intracellular domain. The HIF-ict- 
Notch heterodimer is then able to express a subset of Notch target genes 
(Gustafsson, Zheng et al. 2005). Though the exact mechanism hasn’t been 
decisively proven, there is a wealth of publications which further imply a strong 
relationship between hypoxia and Notch, with HIF-ia likely to play an 
important role (Poellinger and Lendahl 2008; Mukherjee, Kim et al. 2011). 
Additionally, HIF-ia may also have a role in the circadian clock by means of a 
similar mechanism. HIF-ia synergistically acts with CLOCK in the induction of 
vasopressin mRNA, though it is possible that this mechanism acts via classical 
up-regulation of hypoxia-inducible genes in a HIF-p dependent manner. 
Finally, competition of HIF-ia with Myc for binding to Spi leads to a reduction 
in protein levels of NBSi, a component of the MRN trimeric complex 
responsible for recognising DNA breaks (To, Sedelnikova et al. 2006).
1.8.1.2 HIF-aa
In contrast to the ubiquitous tissue expression of HIF-ia, HIF-2a has more 
limited tissue expression profile (Wiesener, Jurgensen et al. 2003). 
Transcription of the HIF-2a gene, also known as EPASi, leads to the production 
of a fully spliced 26i3bp transcript (NM_ooi43o) and the subsequent 
translation of this mRNA results in a Syiaa -qokDa protein. The HIF-2a 
protein maintains the same domain structure but shares a 48% overall amino 
acid conservation with HIF-ia, with a greater degree of conservation within the 
bHLH, PAS and transactivation domains (Fig 1.5) (Iyer, Leung et al. 1998). The 
modes of hypoxic regulation of HIF-2Q are the same as for HIF-ia, in that 
protein stability and transcriptional output are regulated by the 02-sensitive
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activity of the PHDs and FIH. Despite utilising the same core signalling motif 
and proteins, the profile of hypoxic induction is apparently different between 
the two a-isoforms (Bracken, Fedele et al. 2006). HIF-2a is often cited as being 
stabilised at higher (^-tensions and is often shown to accumulate at later time- 
points than HIF-ia (Hohnquist-Mengelbier, Fredlund et al. 2006). Certainly 
both a-isoforms are non-redundant; mutations within HIF-2a are associated 
with differing pathologies; there are also high-instances of genetic variations in 
the HIF-2Q gene within populations living at altitude amongst other non­
redundancies (Peng, Yang et al. 2010). Furthermore HIF-2Q knockout mice like 
HIF-ia are embryonic lethal but with differing phenotypes, not surviving past 
E16.5 partly due to impaired lung formation as opposed to cardiac defects found 
in the HIF-ia knockout condition (Loboda, Jozkowicz et al. 2010).
HIF-2a has not yet been as thoroughly researched as the HIF-ia isoform and 
therefore there is less known about the functional post-translational 
modifications of HIF-2a outside of the well-characterised hydroxylation and 
polyubiquinitation events. However there are several papers detailing evidence 
that expands the knowns of alternative post-translational modifications of HIF- 
2a. Phosphorylation is a commonly appreciated post-translational modification, 
understandably so as the genome is cited to encode 518 separate kinases 
(Manning, Whyte et al. 2002). This type of modification has been shown to 
occur for HIF-2a at Thr 234 mediated by protein kinase Di (PKDi) and this 
interaction is exclusive to the HIF-2a isoform. The modification was shown to 
prevent the involvement of HIF-2a in affecting genomic instability, which in 
turn would explain some of the associated differences between the contributions 
of the a-isoforms to cancer progression (To, Sedelnikova et al. 2006). There has 
also been evidence suggesting the role of acetylation in regulating HIF-2a, 
wherein the redox-sensing deacetylase known as Sirtuin 1 (SIRTi) regulates the 
transcriptional output of HIF-2a via the deactylation of lysine residues within 
the HIF-2a amino acid sequence (Dioum, Chen et al. 2009). Lastly, there has 
been data to indicate that HIF-2a like HIF-ia is SUMOylated and this 
modification is catalysed by the HIF-ia acting enzyme SENPi (van Hagen, 
Overmeer et al. 2010).
Essentially HIF-ia and HIF-2a exhibit significant functional and regulatory 
overlap. Nevertheless there is a continued drive to explore the divergent aspects
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of these two isoforms with a view to more specifically targeted therapeutics 
involving the transcriptionally active HIF system.
1.8.1.3 HIF-3C1
HIF-sa is currently at the fringes of our understanding of the HIF hypoxia- 
responsive signalling system. The most appreciated fact is that HIF-sa mRNA is 
subject to extensive splicing resulting in many transcript isoforms which all lack 
the C-terminal transactivation domain found in HIF-i/2a. HIF-sa splice forms 
are therefore generally regarded as being either transcriptionally inactive or at 
least weakly active (Fig 1.6) Currently there are 10 documented human splice 
forms, named HIF-sai through to HIF-saio, though a recent study has failed to 
validate the predicted HIF-sas and HIF-sas forms (Pasanen, Heikkila et al. 
2010). Several of the splice variants maintain the oxygen-dependent 
degradation domain and are therefore hypoxia-inducible, accumulating with 
decreased PHD activity. This is in spite of the HIF-sa ODD containing only a 
single prolyl hydroxylation site. It has been further shown that as well as 
hypoxia-induced protein stabilisation, the HIF-sa transcripts are up-regulated 
by HIF-i activity (Pasanen, Heikkila et al. 2010). Most explored roles for HIF- 
3a are centred on the interaction of HIF-sa with the canonical HIF pathway. 
These interactions are inhibitory, exerted through competitive binding with 
HIF-p or potentially through inhibitory binding of HIF-sa4 to HIF-ia, an effect 
that has been shown for the mouse homolog of HIF-sa4 known as IPAS 
(Maynard, Evans et al. 2005). HIF-sa therefore potentially acts as a negative 
feedback in the regulation of the HIF-ia mediated hypoxic response, affecting 
and shifting the steady-state levels as well as managing the inducibility of the 
canonical system.
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Fig 1.6 Domain representation of the HIF-sa isoforms, adapted from Pasanen et al. (Pasanen, 
Heikkila et al. 2010)
The exact roles and purposes of the HIF-sa transcripts are yet to be resolved. 
They are likely to be somewhat tissue-specific as suggested by the distinctive
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expression pattern of transcripts (Pasanen, Heikkila et al. 2010). A final 
noteworthy potentiality is the involvement of HIF-sa in the promotion of 
adipogenesis, a result attained via the ectopic expression of HIF-3C1 in 3T3-L1 
cells.
1.8.2 HIF-P/ARNT
HIF-P dimerises with HIF-ia/-2a to form transcriptionally active HIF-1/2. 
Though HIF-P is becoming synonymous with the cellular hypoxic response, it is 
not limited to this function and participates in several other pathways. Many 
biological products are known by several names and this is also the case with 
HIF-p which is commonly referred to as Aryl hydrocarbon receptor nuclear 
translocator (ARJNfT). In humans, HIF-p exists in two known isoforms HIF-ip 
and HIF-2p. These translate as a 790 aa and a 718 aa protein respectively that 
share a high-degree of sequence homology and are both localised in the cell 
nucleus (Hirose, Morita et al. 1996). Both isoforms are able to mediate the 
hypoxic response through the dimerisation to HIF-a, though whether the 
different HIF-ip dimerisation pairs have a functional consequence is currently 
unknown. It is known that the different isoforms have varied tissue expression 
patterns. Following in the same trend as for that of the a isoforms, HIF-ip is 
expressed ubiquitously and HIF-2p has a more limited expression profile, being 
predominantly found in embryonic, neural and kidney tissues (Maltepe, Keith et 
al. 2000). Unlike the a isoforms, HIF-p is considered insensitive to hypoxia, 
though there is some contention to this fact in certain cell lines (Stolze, 
Berchner-Pfannschmidt et al. 2002; Webb, Coleman et al. 2009). However, like 
the a isoforms, HIF-p is a member of the basic helix-loop-helix-PAS (bHLH- 
PAS) superfamily, a family of proteins sharing domain homology. A common 
property within this family is inter-family heterodimerisation. This 
heterodimerisation occurs between a-class subunits, such as HIF-a and the p- 
class subunits, such as HIF-P. Outside of HIF-a there are several other a 
binding partners of the a-subunits that interact with HIF-ip (Cowden and 
Simon 2002). The most widely cited of these is the aryl hydrocarbon receptor 
(AhR), a transcription factor with roles in metabolism of xenobiotics, mediated 
toxicity, development, cell-cycle, differentiation, the immune-response and UVB 
radiation sensing (Shimba, Wada et al. 2001; Puga, Xia et al. 2002; Esser 2009; 
Abel and Haarmann-Stemmann 2010). Here HIF-ip functions as a binding 
partner to activated AhR, facilitating DNA binding of the heterodimer to the
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relevant xenobiotic response element (XRE) consensus sequence, a sequence 
different enough from HRE as to exhibit no cross binding (Kinoshita, Kikuchi et 
al. 2004). Murine and Drosophila based research has yielded two more HIF-P 
binding partners known as Single Minded 1/2 (SIM-1/-2). Both SIM versions 
are thought to be strongly involved in the process of neurogenesis, with SIM-2 
having a suspected role in the causation of Down’s syndrome (Chrast, Scott et 
al. 1997). With regards to the mode of action of these proteins, very little is 
understood. They are primarily characterised as transcriptional repressors, 
though there is limited evidence showing they are also able to act as 
transcription factors (Woods, Farrall et al. 2008). Interestingly, repression has 
been seen in the attenuation of the hypoxic induction of EPO. This reduction is 
suspected to come about through SIMi and 2 competitive dimerisation with 
HIF-ip and then furthered by competitive binding of the SIM-HIF-|3 for the 
EPO gene (Woods and Whitelaw 2002).
1.8.3 Prolyl-hydroxylase domain proteins (PHDi, PHDa and PHD3)
The prolyl-hydroxylase domain proteins are a class of intracellular enzymes that 
catalyse the hydroxylation of proline residues, most notably known for the 
hydroxylation of the HIF-a isoforms. In the HIF canon, there are 3 considered 
PHDs, which are all homologous and a less widely discussed but related isoform 
known as PHD4. These enzymes require Fe2+ as a cofactor which sits at the 
catalytic core, enabling the reaction of;
Proline + a-ketoglutarate + Oa 4-hydroxyproline + COa + succinate
The iron co-factor is perpetually recycled from ferric ions (Fe3+) to the ferrous 
(Fe2+) redox state, promoting the continuous hydroxylase activity of the PHDs 
(Pan, Mansfield et al. 2007). This has lead to several studies examining the role 
of vitamin C in the hypoxic response, both physiologically and with regards to 
cell cultures as they may be vitamin C deprived. Vitamin C deficiency would 
prevent the recycling of the ferrous element, in turn reducing the hydroxylase 
activity of the PHDs and subsequently stabilising HIFa (Pan, Mansfield et al. 
2007). Contrary to this concern a recent publication demonstrated that vitamin 
C was not necessary as a co-factor for the HIF hypoxic response and could be 
substituted with glutathione (Nytko, Maeda et al. 2011). An additional necessity 
of the above reaction shown is the presence of the co-substrate a-ketoglutarate 
(also referred to as 2-oxoglutarate)(Gorres and Raines 2010). Interestingly a- 
ketoglutarate is produced as an intermediate of the citric acid cycle, thus tying
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the PHD co-substrate to metabolism (Fig 1.7.) (Koivunen, Hirsila et al. 2007). 
The reactions of a-ketoglutarate in both the citric acid cycle and proline 
hydroxylation leads to the production of succinate which then acts to reduce 
PHD activity by feedback inhibition of the chemical reaction. Furthermore, 
another citric acid cycle intermediary, fumarate, is also capable of inhibiting 
PHD activity due to its structural similarity to succinate (King, Selak et al. 
2006). This is a potentially important regulatory motif in which metabolic 
activity can modulate the hydroxylation of HIF-a (Qutub and Popel 2007). This 
mechanism is primarily considered of pathological importance rather than 
physiological due to the concentrations of the intermediates involved (Fong and 
Takeda 2008).
Isocitrate
Oxalocetate
Acetyl CoA
Succinate
Citrate
Aconitate
Fumarate
a-Ketoglutarate
Malate
A
Fig 1.7. Simplified overview of the main intermediaries of the citric acid cycle. The 
intermediate, a-ketoglutarate is highlighted due to its other role as a co-factor of the PHD 
enzymes.
However, the most relevant regulatory aspect of the hydroxylation process is the 
requirement of the PHDs for molecular oxygen. It is from this chemical process 
that the 02-sensitivity of the HIF transcription factor arises. The affinities of the 
PHDs for oxygen is apparently quite low, in the range of 230-250kM in contrast 
to the other known collagen modifying hydroxylase P4H, which has a kM value
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of 40 (determined using peptide fragments) (Hirsila, Koivunen et al. 2003). 
These low affinities allow for physio/pathological oxygen conditions to be 
limiting for the PHDs as 02 concentration ranges from an atmospheric limit of 
soopM (Hirsila, Koivunen et al. 2003). Moreover, cellular components that 
utilise 02 will compete when oxygen supply falls below demand; In cellular 
normoxic conditions -90% of the available oxygen is used by the mitochondria. 
This figures rises to nearly 100% in hypoxic conditions, as the affinity of 
cytochrome C for the available oxygen exceeds that of other enzymes including 
the PHDs (Agbor and Taylor 2008).
Enzyme
kM
a-ketoglutarate o2
PHDi 60 230
PHD2 60 250
PHD3 55 230
C-P4H-I 20 40
Table 1.3. kM values of the intracellular hydroxylase and collagen hydroxylase for co­
substrates, a-ketoglutarate and molecular oxygen. Values determined using peptide fragments. 
This table has been adapted from Hrsila et al. (2003).
Therefore, this leads ultimately to the paradigm that the rate of HIF-a 
hydroxylation by the PHDs is constrained by the cellular availability of 02 and 
this rate is further diminished with additional hypoxic insult(s).
The PHDs all have the same overall mode of enzymatic action, but in spite of 
this the different isoforms are not entirely redundant and there is on-going work 
resolving their individual roles. This is of particular relevance to therapeutic 
design targeting the HIF system. The HIF system has become an attractive 
therapeutic target due to its involvement with angiogenesis, cancer progression 
and tumour malignancy as well as altitude acclimatisation (Nangaku, Kojima et 
al. 2006; Niatsetskaya, Basso et al. 2010; Smith and Talbot 2010). The 
relationship between the PHDs and HIF means that the PHDs are a common 
point to target compounds against and therefore understanding the individual 
roles of the PHDs is a desirable aim.
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Cell/Tissue mRNA exoression Protein expression
PHDi PHD2 PHD3 PHDi PHD2 PHD3
Brain + ++ + ++ ++ +
Heart + +++ +++ N/A ++ ++
Skeletal Muscle + +++ ++ N/A + N/A
Liver ++ ++/+++ ++ +/- +/- +/-
Kidney + ++ + ++ ++ ++
Lung + + + + - +
Pancreas N/A ++ N/A + +/- +/++
Testis +++ ++ + ++ ++ ++
Placenta +++ N/A +++ ++/- ++ +++
Adipose tissue ++ +++ N/A - -
Endothelium N/A N/A N/A - ./++T+++ -/++
Epidermis, basal layer N/A ++ N/A
Epidermis, upper layer N/A - N/A
Carcinoma Cells + + +
Breast Cancer + ++ +/-
Testicular Cancer ++ + +/-
Osteosarcoma Cells + ++ +
Table 1.4. Tissue expression profiles of the different PHD isoforms (table adapted from 
Jokilehto et al. 2010). The criteria for the scoring of expression level was not included in the 
original publication. (Jokilehto and Jaakkola 2010)
I.8.3.I PHD1/EGLN2
PHDi mRNA and protein has been found to be expressed in numerous tissues 
and appears to have a more specialised requirement in the testis and placenta, 
where it is the most abundant PHD form with regards to mRNA. The PHDi 
gene, known as EGLN2, has recently been shown to encode two isoforms via a 
mechanism of alternative translation initiation leading to PHDip43 and 
PHDipqo nuclear localised proteins (Tian, Mole et al. 2006). The nuclear 
localisation is determined by a functional bipartite nuclear localisation signal 
found within the N-terminus, between residues 89-134. PHDi is the only PHD 
isoform with a predominant nuclear localisation and is therefore one of the 
distinguishing features amongst the PHDs (Metzen, Berchner-Pfannschmidt et 
al. 2003). The functional consequence or purpose of PHDi nuclear localisation 
remains unclear, although the forced cytoplasmic expression of PHDi shows no 
significant effect on HIF-ia hydroxylation (Yasumoto, Kowata et al. 2009). It is 
therefore a possibility that the nuclear localisation of the protein is of 
importance for other non-HIF related interactions. Indeed there is another 
suggested protein interaction partner for PHDi outside of HIF-a, the inhibitory 
k-B kinase p (IKKP) protein of the NF-kB pathway. PHDi has been postulated 
to hydroxylate proline P191 of IKKp and this in turn is suggested to confer 02- 
sensitivity to the NF-kB pathway (Cummins, Berra et al. 2006). This regulatory
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mechanism, as is the case for HIF-a, depends on the hydroxylase activity of 
PHDi. Though the hydroxylase mode of action is the same for all PHDs, their 
enzymatic rates and binding affinities differ and this could potentially confer 
some functional differences. PHDi has a lower measured HIF-a hydroxylation 
rate than the other PHDs, approximately 5-fold lower (Tuckerman, Zhao et al. 
2004). This coupled to the lower abundance of PHDi protein relegates PHDi to 
having a reasonably minimal role in the down-regulation of HIF signalling. 
1.8.3.2 PHD2/EGLN1
In contrast to PHDi, PHD2 is often considered the major regulator of HIF 
signalling and is the regulatory protein responsible for the suppression of HIF-a 
in normoxic conditions (Berra, Benizri et al. 2003). The protein is encoded by 
the EGLNi gene, producing a transcript coding sequence of I278bp 
(NM„02205i) and a 42kDa 426aa protein. The tissue expression profile of this 
protein is seemingly ubiquitous and is also often the most abundant detectable 
PHD isoform, reinforcing the idea that PHD2 is the major isoform involved in 
HIF regulation (Jokilehto and Jaakkola 2010). This claim is further supported 
as PHD2, alongside PHD3, shows comparatively high rates of HIF-a 
hydroxylation compared to PHDi and can therefore more significantly 
destabilise HIF. An interesting difference between the PHDs may be the 
differences in their affinity for the various HIF-a isoforms. It has been 
suggested that PHD2 preferentially hydroxylates HIF-ia over the HIF-2a form 
(Tuckerman, Zhao et al. 2004). Indeed the binding of HIF to the PHDs may be a 
regulated event as evidence has shown that osteosarcoma amplified 9 (OS-9) is 
able to facilitate HIF-ia and PHD2/3 binding (Baek, Mahon et al. 2005). More 
recently, this mechanism has been contested by Brockmeier et ah 2011 and 
shown to not occur on account of the different localisation of OS-9 to HIF-ia 
(Brockmeier, Platzek et al. 2011). Critically, PHD2 is cited to be the originator of 
PHDi and PHD3 which arose from duplication of the EGLNi gene (Taylor 2001; 
Rytkonen, Williams et al. 2011). This stated, it can be expected that the different 
PHD proteins have a strong degree of functional and characteristic overlap. 
Nevertheless unique characteristics for PHD2 exist, comparing to the other 
PHDs. One such is that PHD2 shows a different intracellular localisation, found 
predominately in the cytoplasm and this localisation is mediated by an N- 
terminus export sequence (Steinhoff, Pientka et al. 2009). The localisation of 
PHD2 appears to be of some significance as its been observed that the nuclear
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accumulation of PHD2 promotes a malignant cancer phenotype by encouraging 
anchorage independent growth. This effect is not dependent on the hydroxylase 
activity of PHD2 and therefore possibly implicates other roles for PHD2 outside 
of the regulation of HIF stability (Joldlehto, Hogel et al. 2010).
As well as certain differences in the protein function of the variant PHDs there 
are differences in the transcriptional regulation and this is particularly critical 
for the canonical HIF response; hypoxia is able to induce the transcription of 
PHD2 and PHD3 but not PHDi. In accordance, a putative HIF binding 
site/HRE consensus (ACGTG) found in the PHD2 gene has been shown to be 
functional, occurring 4i2bp prior to translation start codon (Metzen, Stiehl et al. 
2005). This hypoxia-inducibility is therefore HIF-dependent, forming a negative 
feedback loop in which HIF up-regulates its own inhibitor (Stiehl, Wirthner et 
al. 2006). Thus in the hypoxic situation HIF-a would become stabilised due to 
the reduced hydroxylation rate of the PHDs, PHD2 & 3 would be up-regulated 
compensating for their reduced activity with increased abundance which would 
then once again lead to destabilisation of HIF-a. This principal is of paramount 
importance to the current study described within this thesis as this motif has the 
potential to generate temporally meaningful response patterns. This will be 
discussed later in section 1.9.1.
1.8.3.3 PHD3/EGLN3
PHD3 is the smallest protein of the PHDs, weighing at 25kDa and encoded for 
by a 72obp coding sequence. The expressed protein appears to be the dominant 
PHD form for the pancreas and the placenta, though for other tissues is less 
abundant than PHD2 (Jokilehto and Jaakkola 2010). Unlike the nuclear 
localisation of PHDi and cytoplasmic localisation of PHD2, PHD3 is ubiquitous 
within the cell, found in both the cytoplasm and nucleus (Metzen, Berchner- 
Pfannschmidt et al. 2003). The tissue expression and intracellular expression 
patterns are the first discernible differences between PHD3 and the other PHDs, 
thus supporting the idea of a degree of non-redundancy. Additionally several 
publications have alluded to PHD3 specific phenomenon, including PHD3- 
regulated doxorubicin-induced apoptosis, TCP-1 ring complex association, 
neutrophil survival, a-ketoglutarate-induced apoptosis as well as the regulation 
of NF-kB via interaction with IKKp (Masson, Appelhoff et al. 2004; Liu, Huo et 
al. 2010; Tennant and Gottlieb 2010; Xue, Li et al. 2010; Walmsley, Chilvers et 
al. 2011).
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Within the HIF signalling pathway PHD3 plays a pivotal role, as alongside 
PHD2, PHD3 is up-regulated in a HIF-dependent manner and therefore forms 
another facet of the negative feedback regulation of HIF-a protein. The genomic 
region responsible for this up-regulation has been suggested to reside i2kb 
downstream of the transcription start site, an enhancer site within the first 
intron of the PHD3 gene. However, this may not be the only site to confer 
hypoxic sensitivity to the gene (Pescador, Cuevas et al. 2005). As is the case for 
PHD2, PHD3 binding to HIF-ia has also been suggested to be aided by the 
binding of OS-9 to HIF-ia. However, a possible discernible difference between 
PHD2 and PHD3 is the binding affinities for the HIF-a forms, in which PHD3 
may have a higher binding affinity for HIF-2a (Tuckerman, Zhao et al. 2004). 
1.8.4 Von Hippel-Lindau protein (pVHL)
pVHL is the Es-ubiquitin ligase responsible for targeting proline-hydroxylated 
HIF-a for degradation by the 26S proteasome. The full ligase activity is achieved 
through the complexing of pVHL with elongin B and C, cul2 and Rbxi (Clifford, 
Astuti et al. 2001). The pVHL protein itself exists as a 2i4aa long form weighing 
25kDa. The tissue expression pattern of pVHL mirrors that of HIF-ia in that it 
is ubiquitously expressed (Ohh 2006). On the cellular level pVHL is found in 
both the cytoplasm and nucleus and constantly shuttles between, enabling the 
degradation of HIF-a in both compartments (Berra, Roux et al. 2001). The 
importance of pVHL is mostly known due to its role in the disease of the same 
name, von Hippel-Lindau disease. Von Hippel-Lindau disease affects a patient’s 
predisposition to several malignancies, notably tumour development in the 
form of renal cell carcinoma, haemangioblastoma and phaeochromocytoma 
(Barontini and Dahia 2010). The disease state is explained as an autosomal 
dominant disorder carrying various genetic abnormalities in the pVHL gene. 
These genetic abnormalities result in either the complete loss of pVHL or a 
missense mutation altering the functionality of pVHL. The exact nature of the 
genetic abnormality is used as a sub-typing identification; type 1 is characterised 
by gene loss and type 2 variants (A, B and C) by missense mutations. 
Consequently the loss or alteration of pVHL often leads to the pathological 
stabilisation of HIF-a and this pathological up-regulation of HIF-a is 
responsible for many maladaptive features of the resulting cancers. Despite the 
importance of HIF-a in pVHL disease progression, there are a number of HIF- 
independent aspects that have been witnessed in type 2c patients. Type 2c
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patients have mutational defects in pVHL but no detectable change in HIF 
activity (Barontini and Dahia 2010). Part of the importance of this besides the 
clinical relevance, is that it implicates pVHL involvement in other pathways. 
Indeed, there is evidence supporting several pVHL interactions independent of 
the canonical HIF pathway. Firstly, pVHL has also been shown to interact with 
unassembled hydroxylated collagen IV chains (Grosfeld, Stolze et al. 2007). This 
postulates a role of pVHL in the maintenance of the extracellular matrix, 
something that is corroborated by observations in type 2c von Hippel-Lindau 
patients (Ohh, Yauch et al. 1998). Another elucidated pVHL interaction is with 
atypical protein kinase C X (aPKCX), a protein involved in cellular proliferation, 
survival and cell polarity. This interaction invokes the ubiquitin-ligase activity of 
pVHL and results in the degradation of PIP3 activated aPKCX. It is then 
suggested that pVHL regulation mat affect the role of aPKCX complexes in cell 
adhesion (Okuda, Saitoh et al. 2001). Following the likes of the PHDs, pVHL is 
also implicated in part regulation of NF-kB signal transduction pathway. In this 
capacity pVHL is cited to act as an adaptor to promote the inhibitory 
phosphorylation of the NF-kB agonist caspase recruitment domain-containing 
protein 9 (Card9) by Casein-Kinase 2 (CK2) (Yang, Minamishima et al. 2007). A 
further suggested HIF-independent activity for pVHL, is the mimicking of 
mdm2 in the regulation of P53 protein stability. This is made additionally 
interesting by the reported prospect that murine double minute 2 (MDM2) is 
also able to mimic pVHL in HIF-a ubiquitination, though little published 
supportive data has arisen from this initial hypothesis (Roe, Kim et al. 2006). 
The verity and scope of these HIF-independent functions are still yet to be fully 
understood and, though primarily relevant to pathological scenarios, 
physiological modulation of pVHL may also represent a mechanism for cells to 
tweak the HIF-response. In fitting with this, there are several detailed 
mechanisms regulating pVHL activity or availability. One such mechanism is 
the prior discussed hypoxia driven inactivation of pVHL via PIASy-mediated 
small ubiquitin-like modification (SUMO) modification (Cai, Verma et al. 2010). 
A further mechanism purports pVHL protein levels to be positively regulated by 
increasing cell density. This was observed in human renal proximal tubule 
epithelial cells (RPTEC) and NIH3T3 fibroblast cells (Baba, Hirai et al. 2001). 
Finally, it has also been reported that pVHL protein levels fluctuate over the
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course of cell cycle prompting a possibility in which the hypoxia-sensitivity of a 
cell is coupled to cell cycle progression (Liu, Xin et al. 2010).
1.8.5 Factor-inhibiting Hypoxia-Inducible Factor m (FIH)
The transcriptional activity of HIF is regulated by the hydroxylation of an 
asparagine residue within the C-terminus of the protein; AsnSos in HIF-ia and 
AsnSsi in HIF-2a (Lando, Feet et al. 2002). This post-translational 
modification is performed by the asparignyl hydroxylase known as Factor- 
inhibiting Hypoxia-Inducible Factor la (FIH) and represents one arm of the 
major oxygen-sensitive regulations of the HIF transcription factor. FIH was 
initially identified and characterised as regulating HIF transcriptional activity 
by Mahon et al. (2001) (Mahon, Hirota et al. 2001). The 4okDa protein is the 
translated product of losobp coding sequence and in line with the fundamental 
HIF signalling system, is ubiquitously expressed across tissues (Lisy and Feet 
2008). Once expressed, the protein is found to localise to the cytoplasm 
(Metzen, Berchner-Pfannschmidt et al. 2003). The catalytic mode of action of 
FIH is identical to the previously described prolyl hydroxylases with the only 
difference being the amino acid target. As the enzymatic activity occurs by the 
same reaction as the prolyl-hydroxylases, so to is the enzymatic activity of FIH 
dependent on the availability of oxygen, conferring another tier of 02-sensitivity 
to HIF. An important difference between the PHDs and FIH are the reported 
affinities of the enzymes for molecular oxygen, whereby the PHDs have kM 
values of -230-25OPM FIH was measured to be qojuM (Table 1.3) (Fandrey, 
Gorr et al. 2006). This would indicate that FIH is less sensitive to milder 
hypoxic-insults than the PHDs and that only severe hypoxia would affect the 
transcriptional regulation of HIF (Stolze, Tian et al. 2004). This could 
potentially promote a stratified HIF response in which varying degrees of 
hypoxia have different transcriptional outputs.
There is considerable postulation of HIF-a independent functions of FIH. This 
concept has been spurred with the discovery that FIH binds to ankyrin repeat 
domains, a domain structure featured in many proteins notably IkBq of the NF- 
kB pathway (Cockman, Webb et al. 2009; Cockman, Webb et al. 2009; 
Schmierer, Novak et al. 2010). However, the exact purpose and validity behind 
the proposed sequestration remains unsolved; specifically with regards to the 
impact, the sequestration may have on the HIF signalling network. An issue 
theoretically approached by Schmierer et al 2010.
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All of the prior discussed systems of HIF regulation, ranging from the alternate 
02 regulation, (Vindepenent regulation as well as the individual roles of the 
proteins of the canonical system represent only a fraction of the integrated HIF 
network. The interconnected web of regulatory events that govern phenotypic 
responses via HIF are extensively complicated. The discussed regulatory 
components of the system underlie a potential for significant intricacy in HIF 
signalling; it will be an ongoing challenge for the field to begin to understand 
and account for some of this complexity. Specific fields of study are now in place 
that attempts this integration of signalling complexity and we hope to employ 
some of the methodology and ideas into our own investigation into the HIF 
system.
1.9 Complex signalling systems
Transduction pathways are often portrayed in a static uni-directional manner, 
whereas they are often better depicted as a dynamic system, in which the 
temporal profile of the system is just as important as characterising the proteins 
involved. The temporal profile/kinetics of a signal transduction pathway 
represents a further way for the system to encode information and can often 
affect downstream gene expression. This is perhaps somewhat intuitive, as a 
transcription factor is unlikely to activate the exact same genes from a range of 
stimuli and prolonged stimulation may require the cell to respond in a different 
way to acute stimulation. The temporal profile of the pathway is capable of 
integrating this information, as has been shown in lineage patterning by Oct-4, 
cell-to-cell communication in synthetic bacterial systems and gene expression 
following TNFa stimulation of NF-kB (Basu, Mehreja et al. 2004; Ashall, 
Horton et al. 2009; Plachta, Bollenbach et al. 2011). This can be achieved 
through temporally sensitive transcription, as a result of chromatin 
remodelling, changes in co-activators etc or through protein-thresholds, in 
which newly synthesised protein can change the phenotype of the response 
dependent on the amount of newly synthesised protein (Behar, Hao et al. 2008; 
Ashall, Horton et al. 2009; Schwartz, Sarvaiya et al.; Plachta, Bollenbach et al.)
1.9.1 Delayed negative feedback loops
At the heart of temporally meaningful dynamic signalling systems are certain 
signalling motifs, one of which is a delayed negative feedback loop. With regards 
to the HIF system, there are several potential delayed feedback loops and the 
best characterised is the relationship between HIF-a and PHD2&3. The negative
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feedback aspect arises from the arrangement that HIF-a induces its own 
repressor, PHD2 and PHD3. The delay arises from the time needed for the 
transcription, translation and protein-folding of the feedback PHD proteins 
before they're fully active. Thereby the activity of HIF affects its own protein 
stability in the future, in doing so also affecting its future activity - conveying a 
potential dynamism to the HIF regulatory circuit. The importance of this delay 
has been theoretically appraised in work from Qutub et Popel 2007 (Qutub and 
Popel 2007).
1.9.2 Biological oscillations
The most striking examples of known dynamic signalling systems are the 
various biological oscillators that have been discovered, ranging from the 
physiological level oscillations such as for ovulation and sleep-cycles to cellular 
level oscillations apparent for cell-cycle to a range of complex intracellular 
oscillators. There are several intracellular oscillators now described; one of the 
earliest characterised was calcium oscillations, in which calcium stores are 
released into the intracellular space upon stimulation and this in turn activates 
feedback mechanisms generating sequential regenerative discharges (Dupont, 
Combettes et al. 2011). Since then several transcription factors have been 
demonstrated to oscillate, including the nucleo-cytoplasmic oscillations found 
in the NF-kB pathway (Nelson, Ihekwaba et al. 2004) and the ERK pathway 
(Shankaran, Ippolito et al. 2009), the synthesis-degradation cycles of pss 
(Geva-Zatorsky, Rosenfeld et al. 2006), and the oscillating gene-set under the 
control of the WNT pathway(Dequeant, Glynn et al. 2006; Mengel, Hunziker et 
al. 2010) It is these examples that have recently brought the delayed negative 
feedback motif to prominence. However, for oscillations to properly arise the 
system requires additional features on top of signalling motif. The system 
requires a sufficient degree of non-linearity, by which certain changes or 
measurements are not directly proportional to a driving-input (two interrelated 
values are not directly proportional to one another). There are many potential 
biological sources of non-linearity, including co-operative binding, reversible 
post-translational modification, multiple aa residue modification, stochiometric 
inhibition and saturated degradation points (Novak and Tyson 2008; Mengel, 
Hunziker et al. 2010). The importance of these oscillations hinges on the cell to 
decode meaning from the repetitive patterns of signalling and so subsequently 
much of the on-going work on these signalling systems aims at deciphering the
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potentially functional consequences of the oscillations (Basu, Mehreja et al. 
2004; Ashall, Horton et al. 2009). There has been headway towards this goal for 
some of the discussed intracellular oscillators. Work from our lab has showed 
the temporal profile of the NF-kB oscillations to affect downstream gene 
expression (Ashall, Horton et al. 2009). Although not a transcription factor, the 
frequency of calcium oscillations has also been shown to affect the downstream 
response (Dolmetsch, Xu et al. 1998). Though the biological oscillators are 
perhaps the most striking examples of temporally consequential signalling 
systems, they partly serve to illuminate the role timing and kinetics can have in 
determining the phenotype of a response - and this concept is not limited to 
oscillatory systems but is potentially applicable to any transitional state 
dynamics in a given signalling system (Covello, Kehler et al. 2006).
1.9.3 Integrated signalling systems
In addition to temporal complexity, transduction pathways are often portrayed 
as linear arrangements (as shown for the HIF system in Fig 1.4), whereby a 
single stimulus activates a single chain of events resulting in a defined response. 
However, they would be more accurately portrayed as transduction networks, 
integrating information from large volumes of separate and synergistic 
interactions which are translated into a meaningful biological response. As 
previously described, Oa as a stimulus can be biologically detected in various 
ways and affects numerous integrated cellular and physiological processes i.e; 
bioenergetic status, ROS, post-translational modifications etc . This is further 
complicated as 02 sensing does not act in an isolated fashion, but occurs 
alongside a plethora of separate stimuli activating a vast array of interconnected 
signalling systems.
These crosstalk events coupled with the aforementioned temporal aspects to cell 
signalling result in a significant degree of biological complexity, often to a level 
well beyond intuitive understanding. It is for this reason that scientific 
endeavour in biology has favoured dissecting this complexity, attempting to 
identify the biological interactions and components that constitute a living 
organism. However, research aimed at and addressing complexity has been 
made possible with the development of suitable tools and methods and this has 
lent momentum and credence to a several-decades-old-field that favours this 
less reductionist approach, namely the field of systems biology.
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1.9.4 Systems biology approach
There are varying definitions of systems biology but they often incorporate the 
same core concepts, such as the focus on how interactions between components 
generates network level behaviour and the integration of complexity over the 
reduction. This has become a more applicable idea in the post-genomic era as 
many components of biological systems of interest have been identified. 
Furthermore the various -omics and bioinformatics approaches are also able to 
funnel into the systems biology approach due to their systems-wide approach in 
data acquisition. However, another common facet of systems biology is the use 
of computational models to pry details and predict system level behaviour, 
which is often difficult to discern by standard experimental methods. 
Complexity in signalling networks can be increasingly addressed using a 
computational approach, analysing systems that are larger than intuition can 
process. Many of the mathematical models are benefitted from high-resolution 
quantitative data and this has meant that often systems biology has become 
synonymous with technologies which offer this. A common such technique is 
the live-cell confocal imaging of single cells as it provides quantitative, high- 
temporal and spatial resolution data, allowing also for the detection of signalling 
events such as; protein-translocations, protein-diffusion, changes in protein- 
stability and/or transcription. Also the ability to image single-cells ensures the 
ability to measure events that may be asynchronous across a population of cells 
(Nelson, Ihekwaba et al. 2004). This is important as dynamic signalling events 
can often be difficult to detect using bulk-cell assays as they rely on averaging 
the state of many single cells.
This approach has gained significant momentum over the last decade and work 
is ongoing in shaping this field to maximise the potential. We hope to use many 
of the practices and principles in our approach of the HIF signalling network, 
specifically investigating the dynamic properties of the pathway with the aid of 
computational models and quantitative data.
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i.io Project Aims
This project aims to work towards the larger frame-work hypothesis that 
differing temporal patterns in transcription factor output have phenotypic 
consequences. (i) As part of the work towards this larger goal we aim to 
characterise any distinct single-cell spatio/temporal dynamics active within the 
02-sensitive HIF signalling system, with a specific focus on the transcription 
factors HIF-ia and HIF-2a. This first aim will also experimentally explore the 
potential of the signalling system to give rise to oscillatory behaviour, a common 
motif which would expectantly incorporate distinct temporal patterns, (ii) 
Secondly the project aims to support and drive the building of a mathematical 
model describing the core HIF hypoxic response with a view to using the 
mathematical model to probe various details of the signalling arrangement, 
such as the response to intermittent hypoxia, the response to acute and chronic 
hypoxia, the response to varying severities and rates of 02-change as well as the 
aforementioned oscillatory potential of the system. This can hopefully provide 
new insights and/or to expand our current understanding on how the HIF 
system encodes information and this could potentially be used to strengthen the 
rationale in therapeutic drug design against this system.
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Chapter 2: Materials and Methods
-42-
2.1 Chemicals and Reagents
All chemicals were purchased from BDH Chemicals Ltd. All DNA 
oligonucleotides were purchased from Invitrogen (UK) or Sigma-Aldrich (UK). 
Tissue culture media were purchased from Gibco (Invitrogen, UK) and foetal 
calf serum from Harlan Seralab (UK). All restriction and DNA-modifying 
enzymes were purchased from NEB (UK) or Roche (UK) unless otherwise 
stated.
2.2 Cell treatments
A range of various drug and chemical treatments were used, most extensively 
with the HeLa cell line. Chemical agents used were purchased from either 
Calbiochem or Sigma-Aldrich (Table 2.1).
Chemical Purpose of use Used concentration
Actinomycin D Used to arrest transcription 5|Jg/ml
Cycloheximide Used to arrest protein translation lopg/ml
DMOG Used to inhibit the intracellular hydroxylases o.smM
MG132 Used to inhibit the 26S proteasome ipM
Nocodazole
Thymidine
Used to disrupt microtubule stabilisation
Used in G2/M cell synchronisation protocol
lopM
Table 2.1. A list of drugs used throughout the project. Their common purpose of use and doses 
used for stimulation of HeLa cells is also shown.
2.2.1 Hypoxic Incubation
Hypoxic cell culture and sample preparation was performed using a Don 
Whitley H35 Hypoxystation. Growth conditions were maintained at 37°C and 
5% C02 and the air humidified. Lysis and fixation protocols were carried out 
inside the incubator. The majority of hypoxic experiments were carried out at 
1% O2 unless otherwise stated.
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2.3 Plasmids
Plasmids were either purchased, donated or constructed during the project. 
Bought in plasmids came from one of three companies; SwtichGear Genomics, 
from the Addgene non-profit plasmid database or Clontech. A list of donated 
and purchased plasmids is shown below (Table 2.2). Additionally a detailed 
description (including cloning primers and diagnostic digests checks) of every 
plasmid used throughout the project is available in the appendix 1.1.
Plasmid name Source
pHIF-ia
pPHDi-EGFP
pPHD2-EGFP
pPHDs-EGFP
pcDNA3-hEPAS
pYFP-HIFi(3
pHIFiP-YFP
pRC-CMV-H A-p VH L
pEGFP-PHD2 A6-20
PEGFP-N1-PHD2 A181-220
pEGFP-PHD2 Al-lOO
PEGFP-N1-PHD2 A101-200
pEGFP-PHD2 A201-300
PEGFP-N1-PHD2 A301-426
PGL2.HRE-luc
EGLNi-luc
EGLN3-I11C
pIRES2-DsRedxp
Donated by Prof. S. Edwards, Liverpool
Retrieved from Addgene, reference 21400
Donated by Prof. R. Depping, University of Liibeck
Retrieved from Addgene, reference 21402
Donated by Dr. S. McKnight, UT Southwestern Medical Centre
Donated by Prof. J. Fandrey, Duisburg-Essen
Donated by Prof. J. Fandrey, Duisburg-Essen
Donated by Dr. M. Ohh, Toronto
Donated by Prof. R. Depping, University of Liibeck
Donated by Prof. R. Depping, University of Liibeck
Donated by Prof. R. Depping, University of Lubeck
Donated by Prof. R. Depping, University of Lubeck
Donated by Prof. R. Depping, University of Lubeck
Donated by Prof. R. Depping, University of Lubeck
Donated by Dr. G. Melillo, National Cancer Institute-Frederick
Purchased from SwtichGear Genomics
Purchased from SwtichGear Genomics
Purchased from Clontech
Table 2.2. A list of plasmids acquired during the course of the project and the corresponding 
source.
2.4 Cell Culture
2.4.1 Cell line growth requirements
HeLa cells (human cervix carcinoma), HeLa SI1PHD2 cells (stable knockdown 
for PHD2 abbreviated to SI1PHD2) and SK-N-AS cells (human neuroblastoma) 
were cultured in Minimal Essential Medium (MEM) supplemented with 10% 
(v/v) fetal calf serum and 1% (v/v) non-essential amino acids (Invitrogen). 
Growth conditions were maintained at 37°C and 5% Co2 in a humidified 
incubator (Sayo, Japan). HeLa and SI1PHD2 cells were cultured for a maximum 
of 10 passages and SK-N-AS for 8 passages.
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2.4*2 Cell line propagation
Cells were typically cultured in 75cm2 tissue culture flasks (Corning, UK) and 
were grown to 80-90% confluence, mostly sub-culturing every other day. The 
media was removed from the flask prior to washing with Ca2+ free phosphate- 
buffered saline (PBS) (GibCo). Cells were then incubated at 37°C in the presence 
of iml of ix trypsin/EDTA (Invitrogen) for 2-5 minutes. The trypsinisation 
process was inhibited through the addition of 9ml growth media. The total 10ml 
was then transferred and cells were pelleted by centrifugation for 5 minutes at 
loog and the supernatant removed, to remove traces of trypsin. The cells pellet 
was re-suspended in growth media. The cell count was determined using a 
particle counter (Beckman Coulter). Between 8xios and i.2xio6 cells were 
transferred to a new 75cm culture flask. The remaining cells were distributed to 
culture vessels for use in other experiment protocols (Table 2.3.).
Cell-culture vessel
96-well 
24-well 
35mm dish 
60mm dish 
750ml Flask
Growth area (cm2)
0.32-0.6
2
8
21
175
Number of Cells 
plated
5x103 
2.5 X 104
1 X 105
2 X 105
~ixio6
Table 2.3. Commonly used culture vessels and typical plating density(for a 2 days culture) used 
with the HeLa cell line.
2.4.3 Transfection
Cells were transfected using either FuGene®6, FuGene®HD, FuGene®HP 
Xtreme or Lipofectamine 2000 as per manufacturer’s instructions. The 
DNArreagent ratio was determined empirically, with the optimum conditions 
consisting of a cationic lipid (pi) to DNA (pg) ratio of 2:1 for HeLa and SI1PHD2
and 3:1 for SK-N-AS. Transfection volumes were altered depending on the
surface area of the tissue culture vessel to be transfected (Table 2.4).
Culture Vessel FuGene (pi) DNA (ng) Total Volume (pl)
24-well plate 0.6 0.3 30
35mm dish 2 1 100
60mm dish 5 2.5 250
Table 2.4. Transfection volumes used with differing culture vessels. A ratio of 2:1 for FuGene to 
DNA was used for the transfection of HeLa cells.
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2.5 Molecular Biology
2.5.1 Propagation of DNA
2.5.1.1 Production of Chemically Competent Cells
An aliquot of competent E.coli (DHga or DB3.1) were mixed with 2.5ml LB and 
incubated overnight at 37°C with shaking. The culture was transferred to 100ml 
of LB and further incubated in the same conditions for ~3 hours (or when the 
culture ODeoo reached 0.6). The culture was then chilled on ice for 10 minutes 
before being transferred into pre-chilled tubes. The bacteria were harvested by 
centrifugation at 3,ooorpm at 4°C 10 minutes. The remaining protocol was 
carried out in a cold room maintained at 4°C. The supernatant was discarded 
and the bacterial pellets re-suspended in 20ml chilled transformation buffer 
(lomM acidic PIPES, igmM CaCl2, 25omM KCL, SymM MnCL2 then adjust to 
pH 6.7 using KOH). The resuspended bacteria were centrifuged again for a 
further 10 minutes (3,500rpm, 4°C). The pellet was resuspended in 10ml TB 
buffer supplemented with 7% DMSO. It was incubated for 10 minutes on ice 
before being aliquoted. The aliquots were snap frozen by immersion in liquid 
nitrogen and then stored at -8o°C.
2.5.1.2 Transformation of Chemically Competent Cells
Routine propagation of plasmid DNA was performed using a suitable strain of 
competent cells, typically DHsa, DB3.1. XL-10 blue commercial cells 
(Stratagene) were used in the transformation of mutagenesis reactions or 
ligation reactions as per the supplied protocol.
looul of competent cells were thawed on ice and then incubated for 30-45 
minutes in the presence of i-25ng closed plasmid DNA in 1.5ml microfuge 
tubes. Cells were then heat-shocked at 42°C for 1 minute. Tubes were returned 
on ice for 2 minutes prior to the addition of a qoopl of LB (1% (w/v) bacto- 
tryptone; 0.5% (w/v) yeast extract; 1% (w/v) NaCl, pH 7.0). The tubes were 
incubated at 37°C with shaking for 45-6omin. The cells were then pelleted in a 
micro-centrifuge at n,ooog for 1 minute and qoojLil of supernatant then 
removed. The pellet was resuspended in the remaining ~loojil supernatant, 
lopl and qopl of the cell suspension were then plated onto LB-agar plates 
containing the appropriate selection antibiotic (sopg/ml ampicillin or 
kanamycin or 30pg/ml chloramphenicol as appropriate) and incubated 
overnight at 37°C.
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2.5.1.3 Small Scale Purification of Plasmid DNA (Plasmid Mini Prep)
E.coli cells containing plasmid DNA were cultured in 5ml LB broth with an 
appropriate selection agent for a minimum of 8 hours, typically overnight at 
37°C with vigorous shaking at 225rpm. 3ml of the culture was harvested by 
centrifugation at 6,8oog for 3 minutes. The remaining culture was stored at 4°C 
for future use for a maximum of 8 hours. DNA was then extracted using a 
Qiagen Plasmid Mini Purification Kit or the PureLink kit (Invitrogen) according 
to the manufacturer’s instructions. Plasmid DNA was eluted in either sopl TE 
(lomM Tris-HCl (pH 8.0), imM EDTA) when using the Qiagen Kit or loopl TE 
when using the Purelink kit. All purified plasmid DNA was quantified using 
spectrophotometry and confirmed using a suitable restriction endonuclease 
digest examined by gel electrophoresis (Table 2.5).
2.5.1.4 Large Scale Purification of Plasmid DNA (Plasmid Maxi
Prep)
A iL conical flask containing 200ml of LB broth was inoculated using iml from 
a Mini Prep culture and cultured overnight at 370C with vigorous shaking at 
225rpm. Cultures were harvested at 6,8oog for 15 minutes at 4°C. The QIAfilter 
Plasmid Maxi Kit (Qiagen) was used in accordance with the supplied protocol. 
DNA eluted from the anion-exchange columns was relatively dilute and was 
concentrated by isopropanol precipitation. The eluted DNA/isopropanol 
solution was centrifuged at 5,ooog for 60 minutes at 4°C. The supernatant was 
discarded and the DNA pellet washed with 1.5ml 70% (v/v) ethanol, then 
further centrifuged at i5,ooog for 15 minutes at 4°C. The pellets were air-died 
for 10-30 minutes and dissolved in loojil TE. The concentration of the plasmid 
was then determined using spectrophotometry and adjusted to a final 
concentration of ipg/pl, divided into 100pi aliquots (Table 2.5).
2.5.1.5 Small Scale Purification of Bacterial Artificial Chromosome
DNA (BAC mini prep)
E.coli cells containing BAC DNA were cultured in 5ml LB broth inoculated with 
chloramphenicol (soqg/ml) overnight. Cultures were then harvested in a 
benchtop centrifuge. The various buffers used for this protocol were taken from 
the Qiagen Mini Prep Kit. The supernatant was removed and the pellet 
resuspended in 250pi buffer Pi before being transferred to a fresh tube. 250pl 
buffer P2 was added to the tube and gently inverted 4-6 times and then 
incubated for less then 4 minutes 30 seconds at room temperature. A 35opl
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volume of buffer P3 was added to the tube and again gently inverted 4-6 times. 
The sample is then centrifuged for 20 minutes at i4,ooorpm at 4°C and the 
supernatant transferred to a new centrifuge tube. 650^! of chilled isopropanol is 
mixed with the supernatant to precipitate the DNA. The isopropanol 
precipitated DNA is pelleted by centrifugation for 20 minutes at 4°C. The 
isopropanol is then removed and the resultant pellet washed with 200pl of 70% 
EtOH. Excess ethanol is removed via pipetting and the pellet left to air dry 
before being resuspended in sopl water.
Technique 260/280 260/230 ~ng
Gel Extraction >1.8 0.00-0.2 5-30
PCR
purification >1.8 0.00-0.2 15-50
Mini Prep ~1.8 -1.8 7500
Maxi Prep -2.00 -2.00 600000
Table 2.5. Used DNA purification kits and their typical purity and yield. Purity is determined 
by the 260/280 and 260/230 ratio, in which 260/280 assesses protein contamination and 
260/230 assesses solvent contamination.
2.5.2 Manipulation of DNA 
2.5.2.1 PCR cloning
PCR cloning was used extensively to amplify DNA sequences in preparation for 
insertion into a plasmid backbone. The two main approaches employed were to 
amplify the sequence of interest (i) flanked with DONOR recombination sites 
for gateway mediated cloning (ii) flanked with restriction endonuclease sites for 
classical cloning. The DNA polymerase used for both of these approaches was 
the high fidelity, high processivity enzyme, KOD Hot Start DNA polymerase 
(Novagen). The generic PCR conditions used are indicated in Table 2.6. The 
amplified product was analysed by gel electrophoresis and then gel extracted 
before being used in further applications.
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Step Temp °C Duration No. of Cycles
Denaturation 95 15 seconds 1 cycle
Denaturation 95 30 seconds
Annealing 50-70 30 seconds 25-35 cycles
Extension 72 15-30 seconds/kb
Table 2.6. Generic PCR cycling parameters used with KOD Hot Start polymerase.
2.5.2.2 Site-directed Mutagenesis
Point mutations and deletions were introduced into plasmid backbones using
the Quik Change ® site-directed mutagenesis kit (Stratagene) as per 
manufacturer’s instructions.
2.5.2.3 Restriction Endonuclease Digest
Restriction endonuclease digest was carried out as either a single digest, 
sequential digest or simultaneous digest. For all reactions, DNA was incubated 
with the restriction endonuclease(s) in the presence of a supplied or suitable iX 
buffer. After the digestion, the cleaved DNA was either purified using the PCR 
purification kit (Qiagen) or ran electrophoretically on an agarose gel and 
extracted using a QIAspin kit (Qiagen).
2.5.2.4 g’phosphate removal
Linearised plasmid DNA was enzymatically modified to remove 5’ -phosphate 
in order to reduce the occurrence of self-ligation. This was performed by 
incubation of DNA with lU/pg of Shrimp Alkaline Phosphatase (SAP) for 15 
minutes at 37°C in iX concentration of the supplied buffer. DNA was then 
purified using the PCR purification kit (Qiagen).
2.5.2.5 DNA Ligation
The enzyme T4 DNA ligase (Roche) was used to anneal two complementary 
pieces of DNA to encourage the formation of a single circular plasmid. The 
ligation reaction was only performed for linear DNA containing compatible 
cohesive ‘sticky’ ends. The reaction was organised so that an appropriate 
amount of insert and vector DNA was used, typically a 3:1 molar ration of 
insert:vector. The 1:1 ratio was determined using the following equation;
Vector/Insert (ng/pl) X Insert/Vector (kb)
The resulting value was multiplied by three to determine the final 3:1 ratio. The 
reaction was made in a 20pl volume, using between 20-song of insert in the 
presence of iX the supplied buffer and lU T4 DNA ligase. Reactions were
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incubated on melting ice overnight. 2-4|il of ligation reaction was transformed 
into competent E.coli cells, often commercial XL-io blue cells (Stratagene), 
DHsa (invitrogen) for increased transformation efficiency.
2.5.3 DNA purification
2.5.3.1 Agarose Gel Electrophoresis and Gel Extraction of DNA
DNA fragments were separated by a suitable % (w/v) agarose gel using 
electrophoresis. The gel was made with iX TAE or iX TBE and run in the 
presence of the same corresponding buffer.
Agarose was added to either iX TAE or iX TBE and then heated for ^25-50 
seconds in a microwave, until all agarose had dissolved. iX SYBR safe 
(Invitrogen) was added to the agarose solution. DNA samples were combined 
with iX DNA loading buffer (Bioline) and electrophoresed against Hyperladder 
I DNA Ladder (Invitrogen) at 100mA for 30 minutes. Gels were imaged using a 
G-box gel imaging system (Syngene). For gel extraction, the gel was visualised 
using 302nm wavelength light from a trans-illuminator. Desired DNA 
fragments were excised from the gel by scalpel blade and then purified using the 
QIAquick Gel Extraction Kit (QIAgen) as per manufacturer’s instructions. The 
purified DNA fragment was eluted in either a 30 pi or 50 pi TE volume, 
depending whether yield or concentration of the fragment was more important.
2.5.3.2 Quantification of DNA yield and purity
Nucleic acid concentration was determined using a Nanodrop 
spectrophotometer (Labtech). Samples were suitably diluted to allow for a 
reading within a concentration range of 2ng/pl - 3,ooong/pl. The absorbance 
at 230, 260 and 280 was then determined for a i.spl volume of the 
sample/diluted sample. The ratio values for 260/280 and 260/230 were then 
noted, as they give an indication of the purity of the sample. The 260/230 
measurement is affected by the presence of solvents such as ethanol and the 
260/280 measurement is affected by protein contaminants.
2.5.3.3 DNA Sequencing
Automated DNA sequencing was carried out by the GATC biotech (Germany). 
Plasmid DNA templates were sent at a concentration of 30-ioong/pl in a 30pl 
volume, sufficient for 8 reactions. Oligonucleotide primers were sent at a 
concentration of lopmol/pl, also in a 30pl volume. Sequence analysis was 
performed using a combination of the Vector NTI (InVitrogen) plasmid
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database software, the MultiAlin online software 
(http://bioinfo.genotoul.fr/multalin/nmltalin.html) and NCBI BLAST searches.
2.5.4 Gateway® BP & LR reactions
The BP & LR reactions transfer the DNA of interest from amplicon to Entry 
vector and Entry vector to Destination vector respectively. Reactions were 
performed using the BP clonase™ ii and LR clonase™ ii kits (InVitrogen), used 
as per the supplied protocol. 2|al-5pl of the reactions was then used to transform 
into DHsa/DBs.i cells and plated on LB agar inoculated with the appropriate 
antibiotic. Positive antibiotic-resistant colonies were selected and their plasmid 
digested to ensure accuracy of the reaction.
2.6 Single-cell Imaging
2.6.1 Luminescence microscopy
Luminescence imaging was carried out on transfected cells in 35 mm glass 
bottom dishes (Iwaki, Japan) using a Hamamatsu Back thinned ORCAII 
counting camera attached to the Keller port of as Zeiss Axiovert 135 TV with a 
lox FLUAR objective (NA=o.5). Prior to imaging, cells were incubated on the 
microscope stage (37°C, 5%C02) for 1 h in the presence of imM luciferin 
(Biosynth AG, Switzerland). Oxygen levels were altered using a Pecon 02 
Controller attached to a small stage incubator.AQM Kinetic Imaging software 
was used for image acquisition and analysis of mean intensity luminescence 
over time was performed using AQM Advance (Kinetic Imaging, UK). Images 
were acquired using 10-30 min integration times.
2.6.2 Confocal microscopy
Confocal microscopy was carried out on transfected cells in 35mm glass bottom 
dishes in a humidified C02 incubator (at 37°C, 5% C02) using a Zeiss Axiovert 
200 with a 63X phase contrast oil immersion objective (NA =1.3). Oxygen levels 
were altered using a Pecon 02 Controller attached to a small stage incubator. 
Excitation of EGFP and EYFP was performed using an Argon ion laser at 
qSSnm and siqnm respectively. EGFP emitted fluorescence was reflected 
through a sos-ssonm bandpass filter from a sqonm dichroic mirror. EYFP 
emitted fluorescence passed through a siqnm dichroic mirror and was collected 
through a 530nm long-pass filter. DsRed-Express and mCherry fluorescence 
were excited using a green Helium Neon laser (543nm) and detected through a 
56onm long-pass filter. For the majority of two-colour imaging experiments,
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DsRed-express and EGFP were used as the FP tags. Data capture and extraction 
was carried out with LSM510 version 3.5 software (Zeiss, Germany).
2.6.3 Fluorescence Recovery After Photo-bleaching (FRAP)
Regions of interest in cells over-expressing EGFPHIF-2Q were photo-bleached. 
This was performed by imaging the cells every 2 seconds for 5 repetitions before 
bleaching, then imaging for a minimum of 2 minutes post-bleaching. Bleaching 
was carried out by using an Argon ion laser at 488nm at 100% output power for 
25-75 iterations. For these experiments an oil immersion objective was used 
with a numerical aperture of 1.3. The pinhole was set to 1 airy unit.
2.6.4 Immunocytochemistry
HeLa cells were plated at density of ixios in 35mm glass bottom dishes 
(IWAKI). Transfection was performed the following day when required. Cells 
were grown to 70-80% confluence prior to fixing. Cells were rinsed three times 
with PBS. Two methods of fixation were employed (i) Paraformaldehyde 
fixation and (ii) Methanol fixation. Paraformaldehyde fixation consisted of 
treating cells with 4% paraformaldehyde for 15 minutes then rinsing the cells 
three times with PBS. Cells were blocked for 30 minutes (blocking buffer: PBS 
containing 1% BSA and 0.1% Triton). Alternatively for methanol fixation, cells 
were treated with ice-cold methanol for 6 minutes at -20°C. Cells were then 
rinsed three times with PBS and then placed in a blocking buffer (PBS, 1% BSA). 
After fixation by either method, cells were incubated for one hour with primary 
antibody diluted (as indicated in Table 2.7) in the blocking buffer. Cells were 
then washed three times with PBS and incubated for a further 30 minutes with 
Cy3 labelled anti-mouse secondary antibody, diluted 1:500 also in the blocking 
buffer. During and after labelling samples were kept dark to minimise photo- 
bleaching.
cells.
2.6.4.1 Imaging of fixed cells
Confocal microscopy was used to visualise stained cells. Cy3 conjugates were 
excited using a 543nm laser line and emitted signal detected by LSM510 
photomultiplier detectors, after passing through a sbonm long-pass filter. FITC 
conjugates were excited using a 488nm laser line and emitted signal detected 
after passing through a 505-550nm bandpass filter, also using LSM510 
photomultiplier detectors. For instances of quantitative comparison of 
fluorescence, all images were taken together using the same detector settings.
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Fluorescence levels were quantified using either AQM Kinetic Tracker ver 6, 
LSM image browser or Cell Tracker Version 0.6.
Antibody Source Catalogue No Dilution Host Species
Anti-mouse Cy3 Jackson Lab. C2181-I 1:500
Anti-rabbit Alexa 
Fluor 555 Invitrogen A21428 1:500
Anti-rabbit Alexa 
Fluor 488 Invitrogen Allot 1:500
HIF-ia BD Biosciences 610959 1:200 Mouse
HIF-2U Abeam Ab2o654 1:200 Rabbit
RNApolII Upstate CTD4H8 1:100 Mouse
PML Santa Cruz SC5621 1:200 Rabbit
PHD3 NovusBiologicals NB 100-139 1:200 Rabbit
Table 2.7. List of primary and secondary antibodies used in immunocytochemistry with HeLa 
cells.
2.6.5 Image Analysis
Image analysis was performed using either AQM Kinetic Tracker, LSM image 
browser or Cell Tracker ver 6.
2.6.5.1 Image analysis by cell tracker
Concatenated time series data and single-images of fluorescence were analysed 
using Cell Tracker Version 0.6 to convert fluorescence images to quantified data 
(software website: www.dbkgroup.org/celltracker/) (Shen, Nelson et al. 2006). 
Two methods of using Cell Tracker were employed; full tracking or small circle 
tracking. Full tracking involved accurately drawing around either the cytoplasm 
or cell nucleus, whereas a small circle tracking used a drawn small region placed 
in a representative area of either the cytoplasm or cell nucleus. Small circle 
tracking is more prone to noisy measurements, but still provides largely similar 
data (Dr. D. Turner, thesis) Cell Tracker data was exported as mean intensity of 
fluorescence and saved in an excel format.
2.6.5.2 Image analysis by AQM kinetic tracker
AQM kinetic tracker was used to quantify wide-field luminescence data or to 
automatically detect and quantify speckle fluorescence from confocal images 
(see Chapter 6). Manual measurement of image intensity was performed by 
fixing a region of interest to the images. This method does not track the signal
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over time, only all signals from a fixed location over time. AQM kinetic tracker 
was also used to automatically detect signal. This required the manual setting of 
detection criteria, including size of object, distance away from other objects, 
object brightness and how many frames the object appears in Once these are 
empirically determined the program automatically records any object within the 
detection criteria. This approach was predominantly used in quantification of 
speckle fluorescence (see Chapter 6).
2.6.5.3 Image analysis by LSMsoftware
LSM Imaging software (LSM510 ver 3 or Zen) was used for confocal data 
capture and also as a basic image analysis tools. The software was used to 
quantify fluorescence for co-localisation studies or to examine emission spectra 
of a fluorophore following a lambda scan.
2.7 Bulk-cell Analysis
Bulk-cell analysis is defined here as cell biology techniques that involve the 
single-measurement of a population of cells.
2.7.1 Western Blotting
2.7.1.1 Sample preparation
Cells were typically plated into 6cm dishes (see table 2.2) and prepared or 
incubated according to specific experimental design. Cells were lysed after 
treatment or incubation protocols, ideally when at 80-90% confluency. After 2x 
PBS washes, lysis was performed by adding 200pl of lysis buffer (Tris-HCL 
50mM PH7.5, imM EDTA, imM EGTA, 1% Triton X-100, Sodium Fluoride 
50mM, smM Sodium Pyrophosphate, lomM Sodium (3-glycerophosphate, 
o.imM phenylmethylsulphonyl fluoride, protease inhibitor cocktail -sigma: 
P8340), followed by scraping the cells and centrifuging the collected the 
supernatant.
2.7.1.2 Measurement of protein concentration
Protein levels were determined for the lysates, using the BCA assay (Thermo 
Scientific). The assay was performed in 96-well plates, using a sample volume of 
20pi to 178.spl of reagent. A triplicate standard curve was included using BSA 
protein at concentrations (pg/pl) of; 0.00, 0.25, 0.50, 1.00 and 1.50. The signal 
present in the blank control was subtracted from all other measurements prior 
to calculation of protein concentration for each measured sample.
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2.7.1.3 Protein separation by SDS-PAGE
10% SDS-PAGE resolving gels were prepared in H2o (0.38M tris base, 0.1% 
SDS, 10% acrylamide, o.25ng/|ul APS and 0.125% Temed) and 4% stacking gels 
(0.14M tris base, 4% acrylamide, o.ysng/pl APS and 4% Temed). SDS-PAGE 
gels were cast using the Mini-PROTEAN 3 system alongside glass plates and 
0.75 mm spacers. Samples were boiled in the presence of an equal volume of 2x 
Laemlli buffer (25% v/v 0.5M tris, 20% v/v glycerol, 10% SDS, 0.1% w/v 
bromophenol blue and 5% v/v p-mercaptoethanol) 5 minutes before gel loading. 
Sample volume to load was determined using the calculated concentration, 
aiming to load even protein amounts for samples (on average 30-6opg/well). 
The gel was then resolved at a voltage of 120V submerged in running buffer 
(25mM Tris, i92mM glycine and 34mM SDS).
2.7.1.4 Transfer to nitrocellulose
Proteins were electrophoretically transferred from acryalmide gels to 0.2pm 
nitrocellulose membranes (Bio Rad) at 300mA for 90-minutes using a Bio Rad 
transfer tank filled with chilled transfer buffer (20% (v/v) methanol, 25mM 
Tris, 200mM glycine). Transfer was performed in 4°C cold room.
2.7.1.5 Detection of protein
Nitrocellulose membranes were washed by submersion in buffer (TBS-T; 2omM 
Tris, !40mM NaCl, adjusted to pHy.b, 0.1% Tween), in blocking buffer (5% w/v 
dried milk protein, 2omM Tris, !4omM NaCl, adjusted to pHy.b, 0.1% Tween) 
for 60-minutes. Blocking buffer was then removed and residual blocking buffer 
washed from the nitrocellulose membrane using TBS-T. Membranes were then 
incubated in the presence of primary antibody overnight at 4°C. All primary 
antibodies were made-up in a solution of 5% BSA in TBS-T, used concentrations 
and commercial sources of the antibodies are shown in Table 2.8. After 
primary antibody incubation, membranes were washed as previously and then 
submerged in secondaiy antibodies (conjugated with horse-radish peroxidase) 
solutions for 60-minutes and then re-washed; secondary antibodies were made 
in blocking buffer (Table 2.8.)-
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Antibody Source Catalogue No Dilution Host Species
Anti-mouse HRP Abeam Ab68o8 1:15000
Anti-rabbit HRP Cell Signalling 7074 1:5000
HIF-ia BD Biosciences 610959 1:1000 Mouse
HIF-2U Santa Cruz SC13596 1:500 Mouse
pVHL BD Biosciences 556347 1:500 Mouse
PHDi NovusBiologicals NB 100-137 1:1000 PHDi
PHD2 NovusBiologicals NB 100-138 1:1000 PHD2
PHD3 NovusBiologicals NB 100-139 1:1000 Rabbit
Table 2.8. List of antibodies used for western blotting and the corresponding source, dilution 
used and species raised in.
Membranes were then covered in a commercially available high sensitive 
chemiluminscent substrate reactive (SuperSignal®West Dura Extended 
Duration Substrate, Thermo Scientific)to HRP for 1-minute and excess 
substrate removed. Membranes were then imaged using a Syngene Gel Imaging 
G:Box, imaging every two-minutes and integrating subsequential images for up 
to 40-minutes. The integrated intensity of the bands was quantified using AQM 
kinetic tracker version 6.
2.7.2 Cell Proliferation Assay (MTS)
The CellTiter 96® Aqueous Non-Radioactive Cell Proliferation Assay (Promega) 
was used to determine an arbitrary count of viable cells in a population. The 
assay uses the change in absorbance of a tetrazolium compound [3-(4,5- 
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H- 
tetrazolium due to mitochondrial reductase activity as an indication of viability. 
Cells in suspension were prepared prior to plating, using a density of a 50,000 
cells/ml. Cells to be transfected were incubated with the transfection mixture at 
this stage prior to plating. Cells were dispensed into transparent 96-well plates, 
plating loopl of cell suspension per well. Plates were then incubated as 
indicated. For the proliferation assay, 20pl of room temperature reagent B was 
added to each well. The plates were incubated for 90 minutes before being
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analysed using a Multiskan* plate reader (Thermo scientific) at 492nm. Results 
shown were subtracted by a media and MTS reagent blank.
2.7.3 Luminometry
Cells in 24-well plates were transfected a day after plating with the indicated 
luciferase reporter construct with or without additional expression vectors and 
treated in triplicate After a determined incubation period, the media was 
removed and the cells were washed with Ca2+-free PBS. Cells were then treated 
directly in the 24-well plate with 2504! per well of lysis buffer (o.04g DTT, i.6g 
BSA, 123.12ml H20, 4ml iM Tris-phosphate pH 7.5, 1.6ml Triton X-100, 30ml 
80% glycerol, 32pi 0.5M EDTA and 1.28ml iM MgCl2). Cells lysis was 
performed at room temperature under gentle shaking. ATP was then added to a 
final concentration of imM before 90pi of the lysate was transferred to a white 
opaque 96-well plate (Greiner). An Envision 2103 Multilabel reader (Perkin- 
Elmer) was used for the assay protocol. 200pl 25mM luciferin (buffered in pH8 
lomM Tris-phosphate) was added to each sample. Luminescence signal was 
recorded every 0.1 seconds for 5 seconds. All measurements were summed for a 
final value.
2.7.4 RT-qPCR
2.7.4.1 RNA extraction
The RNeasy Mini Kit (Qiagen, Germany) was used in the extraction of RNA 
from HeLa cells. The RNA extraction was performed on cells grown in 6cm 
dishes. Upon extraction, the media was removed and the cells rinsed with PBS. 
350pl of lysis buffer RLT containing p-mercaptoethanol (1% (v/v)) was added 
directly onto the cells. The cells were then scraped and the lysate was frozen at - 
8o°C. All lysates from a single time course were collected before resuming the 
extraction protocol. Homogenisation of the lysate was performed using a 
QIAshredder (Qiagen), as detailed in the kit protocol. Samples were eluted in 
30pl of RNAse free water. The elute was assessed for RNA quantity and purity 
as detailed using spectrophotometry.
2.7.4.2 Reverse Transcription
Reverse transcription of extracted RNA (to cDNA) was carried out using the 
Superscript® VILO cDNA Synthesis Kit (Invitrogen). The reaction consisted of 
ipg sample RNA, iX Superscript® Enzyme Mix, iX VILOtm Reaction Mix made 
up to a 20jul total volume using DEPC-treated water. Reactions were then 
performed using a Px2 Thermal Cycler (Thermo) for 10 minutes at 25°C, then
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6o minutes at 420 and finally 5 minutes at 85°C. The resulting cDNA was then 
diluted 20-fold prior to use in quantitative-PCR.
2.7.4.3 Q-PCR
Q- PCR reactions were carried out in triplicates. 20pl reaction mixtures were 
made using ipl of cDNA combined with soonM forward and reverse primers 
(primers used shown in Table 2.9), lx SYBR Green PCR master mix (Roche) 
and Raze free H20. Temperature cycling was performed using a LightCycler 480 
(Roche) using the parameters in Table 2.10.
RT-qPCR primers
Cyclophillin A (for) gctttgggtccaggaatgg HIF-ia (for) tgctcatcagttgccacttc
Cyclophillin A (rev) gttgtccacagtcagcaatggt HIF-ia (rev) tcctcacacgcaaatagctg
pVHL (for) ggtcacctttggctcttcag HIF-2Q (for) gccacccagtaccaggacta
pVHL (rev) gctgtccgtcaacattgaga HIF-2Q (rev) ggcagcaggtaggactcaaa
FIH (for) ctttaagccgaggtccaaca PHD2 (for) tgcagatgagagagcacg
FIH (rev) caacctctcttcccctcctc PHD2 (rev) ttagcgaccgaatctgaagg
PHDi (for) actgggacgttaaggtgcat SIAHi (for) gcagtcctgttttggctttc
PHDi (rev) aaatgagcaaccggtcaaag SIAHi (rev) tcagctgtacgattgcgaag
PHD3 (for) agatcgtaggaacccacacg
PHD3 (rev) ttctgccctttcttcagcat
SIAH2 (for) agccgagaactttgcctaca
SIAH2 (rev) cacaccgtcatgaatcgaac
Table 2.9. RT-qPCR primers used. Target transcript indicated by primer name with 
corresponding sequence adjacent. For denotes forward primer (s’-s’) and Rev denotes reverse 
primer (3’-5’)-
Results were analysed using the Advance Relative Quantification function the 
LightCycler® 480 software (version 1.5.0.39) to calculate the fold change based 
on the threshold cycle for each PCR reaction using the 2-AACT method (Pfaffl, 
Morgan et al. 2002). The target gene was normalised to house-keeping gene 
cyclophillin A, with time o used as the calibrator.
Step Temp Duration Rani]) Rate (°C/s) Cycles
Pre-Incubation 95°C 300 s 4.4 1
Amplification 95°C 10 s 4-4
45
6o°C 30 s 2.2
■ . ■■ ...^
■BHI
Cooling 40°C 10 seconds 1.5 1
Table 2.10. RT-qPCR cycling parameters used with LightCycler 480 (Roche).
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2.8 Mathematical Modelling
Mathematical modelling and simulations were performed using Matlab 
software, version 7 and later. All model simulations and operations were carried 
out using the ODE45 numerical solver. Parameter fitting was performed using 
the ‘fminsearch’ function to determine minimum variables.
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Chapter 3: Protocol optimisation and 
generation of molecular tools
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3.1 Introduction and Aims
A fundamental aim of the project was to examine canonical HIF signalling at the 
single-cell level using live-cell time-lapse confocal microscopy in ambient and 
hypoxic 02 levels. In order to achieve this it was necessary to determine a 
suitable cell line, to generate relevant fluorescent fusion plasmids, to optimise 
and validate imaging in hypoxia as well as optimising image analysis protocols.
3.2 Results
3.2.1 Optimisation of experimental protocols
3.2.1.1 Choice of cell line
In our lab, cell behaviour in hypoxia has never been examined and therefore the 
suitability of the available cell lines was uncertain. One of the initial aims of the 
project therefore was to determine a cell line that can be used for the majority of 
the project, paying heavy consideration to the hypoxic response and ease-of-use 
for confocal microscopy. Our lab currently uses two cell lines considered to be 
highly suitable for live-cell confocal microscopy; the neuroblastoma cell line SK- 
N-AS and the cervical epithelial HeLa cell line (Gey GO 1952; Sugimoto, 
Tatsumi et al. 1984). The criteria that underpin their suitability are their ease- 
of-transfection, adherence, low instance of migration and clear cell morphology 
(which aids software image analysis). Additionally, both the SK-N-AS and HeLa 
cell line have been characterised and optimised for use with several transfection 
reagents including Amaxa electroporation, FuGene 6 and Lipofectamine 2000. 
From these two cell lines, HeLa cells have been most widely used in hypoxic 
research (Chilov, Camenisch et al. 1999; Taylor, Furuta et al. 2000; Hofer, 
Desbaillets et al. 2002). In an effort to keep our data comparable with others in 
the field, the HeLa cell line was initially chosen as a cellular model.
Oxygen functions as a complex stimulus affecting many important cellular 
processes such as cell cycle progression, cell death, migration, cellular energy 
production, transcription and translation (Lee, Bae et al. 2004; Van Hoecke, 
Prigent-Tessier et al. 2007). This project aims to utilise hypoxia extensively and 
so it was therefore necessary to broadly characterise the effect of reduced 02 on 
our HeLa cell line and to account for any potentially experimentally 
compromising changes to cell viability (Gardner, Li et al. 2001; Gordan, Bertout 
et al. 2007; Van Hoecke, Prigent-Tessier et al. 2007; Lomb, Desouza et al. 
2009). Alteration to growth and death rates would impact experimental design 
reducing our ability to account for cell-density between normoxic and hypoxic
61
samples. Furthermore, significant changes to cell death would impact the 
duration we would be able to examine the HIF response. We therefore sought to 
measure whether cell viability is perturbed by reduced oxygen over the course of 
24 hours.
3.2.1.2 Cell growth in hypoxic conditions
To measure cell viability, the commercially available MTS assay was employed 
(Cory, Owen et al. 1991). HeLa cells were plated into 96-well plates at two 
different densities and incubated at either 1% 02 or atmospheric 02 (performed 
in air, where O2 tensions are above 19%) for up to 48-hours. By using two 
densities we are able to negate changes in viability that may occur due to 
confluency. The results of the MTS assay indicate that cell viability increases for 
the first 24 hours when cells are incubated at 1% 02 (Fig 3.1). Cells exposed to 
48 hours of hypoxia showed a reduction in viability compared to the control 
when plated at a high density and cells plated at a lower density showed a 
similar degree of viability compared to control. This is perhaps indicative of an 
increased proliferation rate leading more rapidly to confluency which is then 
detrimental to the viability of the cells.
Examination of cells by light microscopy did not agree with results obtained by 
the MTS assay (data not shown). Similar growth rates and increased cells death 
were observed prompting us to question the accuracy of the MTS assay in 
determining cell viability for these experimental conditions. The MTS assay is a 
colourimetric assay in which the MTS reagent (3-(4,5-dimethylthiazol-2-yl)-5- 
(3“Carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) is reduced to 
produce formazan which has a known absorbance at490-500nm. The reduction 
of the MTS reagent is catalysed by cellular reductases, predominantly 
mitochondrial reductases. An elevated amount of functional mitochondria 
therefore result in an increased absorbance signal which serves as a proxy 
variable for viability. However, the hypoxic environment used will possibly 
affect the redox state of the cell as well affecting the mitochondria and therefore 
disturb the reduction of the MTS substrate to formazan (Makarov, Wiswedel et 
al. 2002). To address this issue cell growth was also assessed using a simple 
cell-count method. HeLa cells were plated into 6cm dishes and grown for 24- 
hours at either 1% 02 or atmospheric 02. After incubation cells were removed 
into suspension by trypsinisation and counted using a Coulter Particle cell 
counter. In contrast to the -25% increase in viability as measured by the MTS
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assay, hypoxia was found to reduce the cell count by 7.7% (n=i repetition). This 
finding is in accordance with a more extensive investigation into hypoxia and 
cell fate (Fan et al. unpublished).
Fig 3-1. HeLa cells were cultured in 96-well plates at either 0,2% or 1% 02 for up to 48-hours. 
To measure cell viability, MTS reagent was added to the cells and after 30 minutes the 492nm 
absorbance of the cell culture measured. Measurements are normalised to to as a percentage of 
viable cells. (A) MTS viability assay of cells shown as a percentage of hypoxia over normoxia. (B) 
Cell count of HeLa cells grown in hypoxia or atmospheric conditions for 24-hours. Count was 
performed automatically using a Coultier particle counter set to detect objects between 7 and 
22|ims.
3.2.1.3 Is HRE-luciferase inducible in HeLa and SK-N-AS cells by
incubation at 1% 02?
The next important criterion was to determine whether SK-N-AS and HeLa cells 
were HIF inducible and if the response occurred in accordance with published 
data.
SK-N-ASHeLa
in 5
« P
Tim* (hours)
Fig 3.2. HeLa cells and SK-N-AS cells were plated into 24-well plates and then transfected to 
express the PGL2-TK-HRE-luc reporter. After 24 hours of transfection, cells were incubated at 
staggered time points for up to 24 hours in 1% 02. All cells were lysed simultaneously and 
samples prepared for measurement by endpoint luminometry. Graphs show measurement of 
measured luciferase signal normalised to the normoxic control.
To determine HIF-inducibility cells were transfected to express a HIF 
responsive luciferase reporter termed PGL2-TK-HRE, incubated at 1% 02 up to 
24 hours and then the luciferase signal was measured by endpoint luminometry 
(Fig 3.2). We were able to measure a significant increase in luciferase signal 
after a minimum of 8 hours incubation, indicating that the cell-line is HIF-
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inducible despite existing in atmospheric culture conditions for several decades. 
(Gey GO 1952; Sugimoto, Tatsumi et al. 1984). The result verifies the PGL2-TK- 
HRE luciferase reporter plasmid which was kindly donated to our lab by Dr. 
Giovanni Mellilo and also serves to validate the recently installed Don Whitley 
hypoxystation which was used to incubate the samples.
3.2.1.4 Does the use of pre-equilibrated hypoxic medium affect the 
HRE-response to hypoxia?
Both HeLa and SK-N-AS cells are adherent and therefore are cultured as a 
monolayer submerged in growth media. Any manipulation of atmospheric 
oxygen would need to translate to a change in the dissolved 02-environment 
immediately surrounding the cell monolayer to achieve cellular hypoxia. There 
was an initial uncertainty as to whether the duration of time needed for 02 gas 
exchange when using hypoxia or re-oxygenation could significantly affect the 
assessed behaviour. The majority of this study is concerned with the HIF 
response to hypoxia and therefore we decided to assess the inducibility of the 
HRE-luciferase when using de-oxygenated media versus oxygenated media. 
HeLa cells were grown in 24-well plate format from a density of 12.5x105 
cells/cm2 and transfected with PGL2-TK-HRE for 24-hours prior to hypoxic 
incubation (1% 02). Upon incubation the media was removed from the cells and 
replaced with either media equilibrated in atmospheric normoxia or media 
equilibrated for 24 hours in 1% 02. No significant difference was found 
comparing the use of de-oxygenated media versus oxygenated media on the 
signal output of the HRE-luciferase reporter (Fig 3.3). Although the speed of 
de-oxygenation would be dependent on the culture vessels and depths of media, 
the difference was considered negligible for evaluating the HIF response (which 
occurs in the order of hours), theory and our data therefore encouraged us to 
disregard the use of pre-equilibrated media to induce hypoxia.
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Fig 3‘3* HeLa cells were plated in 24 well format and then transfected with pGL-TK-HRE- 
luciferase. After 24 hours of transfection, cells were incubated in either atmospheric 
unequilibrated media or 24-hour 1% 02 equilibrated media. Cells were lysed simultaneously and 
samples prepared for luminometry analysis. Results show the luminescence levels normalised to 
the normoxic control(n=i repetition in triplicate).
3.2.1.5 Analysis of HIF-m and HIF-2a protein response in HeLa cells 
exposed to 1% 02
Previous experiments using the HRE-luciferase had indicated the HeLa cell line 
as a suitable model to study the hypoxia-inducible HIF system (Fig 3.1. & Fig 
3.2.)- The HRE-reporter does not resolve whether the transcriptional activity is 
attributable to HIF-ia and/or HIF-2Q and so we therefore have little idea of the 
kinetics of the population wide-accumulation of these factors. Furthermore, 
before engaging in the single-cell imaging of the separate a-isoforms it was 
prudent to characterise the bulk-cell response of these factors to hypoxia. This is 
underlined by reports of the different sensitivities and response patterns of both 
isoforms to hypoxia (Bracken, Fedele et al. 2006). HeLa cells were plated at a 
density of 3.5*105 per 6cm dish and incubated at 1% 02 for several periods of 
time up to 24 hours. Additionally one sample incubated for 24 hours at 1% 02 
was further exposed to a 15-minutes re-oxygenation back to atmospheric 02. 
Western blot analysis was carried out using these samples probing for HIF-ia 
and HIF-2a protein (Fig 3.4.)* HIF-ia was detected at i2okDa and showed a 
transient accumulation over the 24-hour hypoxia time-course as well as 
showing the effective rapid degradation of protein upon re-oxygenation. 
Examination of HIF-2Q protein levels yielded varied results between repetitions, 
showing no distinct accumulation or re-oxygenation sensitivity. A similar 
finding was reported by Bracken et al. when also examining HeLa cells 
(Bracken, Fedele et al. 2006). Nevertheless, the cellular response to hypoxia was 
observable when probing for HIF-ia and the accumulation kinetics are in
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accordance with published data (Wang, Jiang et al. 1995; Stiehl, Wirthner et al. 
2006).
1% Oz Reox 1% O2 Reox
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Fig 3*4* Western blot of HIF-ia/-2a protein levels for samples prepared form HeLa cells 
incubated at 1% 02 over a course of 24 hours. An additional sample was prepared from cells 
incubated for 24 hours at 1% 02 and then exposed to a 15-minute re-oxygenation back to 
atmospheric conditions.
3.2.1.6 Dose-response of HeLa cells treated with DMOG
Due to the wide-reaching effects of reduced 02 on various cellular processes we 
considered use of dimethyloxallyl glycine (DMOG); a chemical mimic of hypoxia 
that inhibits the hydroxylases of the canonical HIF system. DMOG acts as a 
competitive inhibitor of hydroxylases activity, inhibiting their ability to bind the 
co-substrate a-ketoglutarate (Rey and Semenza 2010). This drug could be used 
to corroborate and further explore some of the claims or data arising from study 
using hypoxia. This is of particular relevance to the live-cell imaging by wide- 
field luminescence and confocal microscopy as the generation of signal requires 
02, an issue further discussed later in section 3.2.2.
Before we could begin to use this chemical agent, it was necessary once again to 
characterise the effects of DMOG use (again assessing if there were detrimental 
affects to cell viability which may compromise experimental design). We once 
again used the MTS assay and performed a dose-response curve in which HeLa 
cells were plated into 96-well format i-day prior to treatment. Cells were then 
treated with varying concentrations of DMOG ranging from o.oimM to 2mM 
for 24-hours (Fig 3.5.). Concentrations above o.imM caused a significant 
reduction to cell viability, in which the viable population was reduced by 75% at 
imM. As well as determining the effects of DMOG on viability it was necessary 
to also determine the suitable DMOG dose to induce the HIF system. HeLa cells 
were transfected for 24-hours using the HRE-luciferase reporter and then 
treated with a range of DMOG concentrations for 6 hours before lysis and 
analysis by luminometry. We found that concentrations from o.imM to imM 
significantly induced the reporter with o.smM proving to be the most 
substantially inducing dose (Fig 3.5). With regards to the previous experiment 
of DMOG on viability, imM and 2mM most likely show a reduced HRE-
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induction accredited to the reduced cell viability. For future experiments we 
therefore decided to use doses of o.smM and we tested the effect of this dose by 
time-course, again looking at cell viability and HRE-luciferase induction. The 
MTS assay showed a 37%±i8 reduction in viability within 8 hours of treatment 
which was followed by some degree of recovery as cells reached 90%±i.6 
viability compared to control (Fig 3.5.). In comparison, the fold induction of 
HRE-luciferase persistently increased across 24 hours of treatment reaching a 
total 37±io fold increase.
MTS Assay HRE-luciferase
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Fig 3*5* The effect of DMOG doses on HeLa cells measured by (A) MTS cell viability assay 
showing standard error of the mean (SEM) and (B) luminometry using cells ectopically 
expressing the HRE-luciferase reporter, showing standard deviation of triplicate measurements. 
(C) Time-course of HeLa cells treated with o.smM DMOG measuring effects on cell viability by 
MTS assay and shown as a percentage viability of treated over untreated cells. Error bars are 
calculated using the propagation of uncertainty to merge error bars from sextuplicate normoxic 
measurements and hypoxic measurements. Viability calculated as a % of treated over untreated. 
Treatment duration and doses are indicated (N=3 repetitions for A, B and D, N=2 repetitions for 
C). (D) Luminometry using cells ectopically expressing the HRE-luciferase reporter to assess 
HRE-inducibility by DMOG.
3.2.1.7 Is HRE-luciferase inducible by DMOG in HeLa and SK-N-AS 
cells?
During the course of previous experiments, we aimed to evaluate the effect of 
DMOG on various luciferase reporters in both HeLa and SK-N-AS cells. This
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was performed with the goal of further verifying the use of the HeLa cell line as 
the main model to use throughout the project and as a limited control on the 
specificity of DMOG. HeLa cells and SK-N-AS cells were plated into 24-well 
plates at a density of 25k/well and sok/well respectively and immediately 
transfected with a luciferase reporter sensitive (canonically) to either HIF, P53, 
NF-kB or CyclinD. Cells were then treated with o.imM DMOG for 8-hours 
before lysis and subsequent endpoint luminometry analysis. DMOG was found 
to only significantly activate the HRE-luciferase (Fig 3.6.). This is perhaps in 
contradiction to several publications suggesting crosstalk mechanisms with pss, 
NF-kB and cell-cycle (Cummins, Berra et al. 2006; Wen, Ding et al. ; Sermeus 
and Michiels 2011).
Fig 3.6. Endpoint luminometry analysis of samples prepared from (A) HeLa cells and (B) SK- 
N-AS cells ectopically expressing either HRE-luc, p53-luc, NF-luc or CycD-luc. Cells were 
stimulated for 8 hours using o.imM DMOG, denoted with +. Unstimulated control denoted with 
(n=i repetition performed in triplicate)
3.2.2 Oxygen sensitivity of reporter and expression molecular tools
Many commercially available expression plasmids are driven by the human 
cytomegalovirus immediate early promoter (CMVie promoter), a strong viral 
promoter/enhancer that has been in use as a research tool for several decades 
(Qin, Zhang et al. 2010). Its suitability as a generic promoter for the expression 
of proteins of interest stems from an accepted view that the promoter activity is 
constitutive and unchanged by experimental conditions. Nevertheless, there are 
several known human transcription factor binding sites contained within the 
CMVie promoter such as CREB/ATF, NF-i, SP-1, MDBP and of particular 
interest, NF-kB (Loser, Jennings et al. 1998). This project aims to image single­
living cells transfected with various fluorescent tagged proteins of the HIF 
pathway and the expression of these will be driven by the CMVie promoter. We 
we’re therefore concerned whether the CMVie promoter would be a suitable
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system for driving the expression of our fluorescent-tagged proteins, especially 
with regards to the use of hypoxia (Doran, Kulkarni-Datar et al. 2010) 
(Ramanathan, Hasko et al. 2005).
3.2.2.1 Does hypoxia regulate the CMV promoter?
To address this HeLa cells were plated into 24-well plate format and then 
transfected with CMV-luciferase. After 24 hours post-transfection, cells were 
then incubated at 1% 02 as part of a time-course up to 24 hours before analysis 
by endpoint luminometry. We found no significant change in fold induction 
over the time-course (Fig 3.7.)- This endpoint assay is a measurement of 
changes in fold induction over a population of cells, where as our work 
concerning the HIF system will focus on attaining data from the single-cell level. 
Single-cell asynchrony can be masked when using population-level 
measurements, we therefore looked at the CMV-luciferase response on the 
single-cell level using wide-field luminescence (Levsky and Singer 2003). Here 
HeLa cells were transfected for 24 hours with the CMV-luciferase before being 
imaged. Time-lapse data was then analysed using Kinetic Tracking Analysis as 
detailed in section 2.6.1. We found evidence of single-cell heterogeneity of 
light production, though the calculated population average of all cells showed a 
similar trend to that observed by endpoint luminometry.
Time (hours) Time (hours)
Fig 3*7* (A) HeLa cells were plated into 24-well format and transfected with CMV-luciferase. 
After 24 hours of transfection cells were incubated for up to 24-hours in 1% O2. Cells were then 
lysed simultaneously and samples prepared for analysis by endpoint luminometry. 
Measurement shows luminescence signal normalised to normoxic control. (B) HeLa ells were 
plated into 35mm imaging dishes and transfected with CMV-luciferase. After 24 hours of 
transfection cells were incubated in the presence of imM luciferin for 1 hour and then imaged 
for 24 hours by wide-field luminescence using a 20x objective. Image analysis was performed 
using AQM kinetic tracker to quantify single-cell level luminescence. Plots of single cell level 
luminescence are shown in blue and the calculated population average as a bold red line.
3.2.2.2 (^-dependent luciferase reaction
Additionally, the previous experiments (Fig 3.7.) provide information on the 
oxygen-dependent sensitivity of the luciferase catalysed reaction, a reaction
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requiring 02 in the conversion of luciferyl adenylate to oxyluciferin, AMP and 
light (Moriyama, Niedre et al. 2008). By comparing the signal trend for CMV- 
luciferase between luminometry (as performed in atmospheric conditions) and 
wide-field luminescence (as performed in hypoxic conditions) we can see no 
significant loss of signal, suggesting the technology to be suitable for hypoxic 
conditions as low as 1% 02 (Fig 3.7.). In fact, published work from Imamura et 
al. (2009) suggests luciferase to be functional at tensions as low as 0.2% 02.
Luciferase reaction schematic:
1. luciferin + ATP ----- ► luciferyl adenylate + PPi
2. luciferyl adenylate + Oxyluciferin + AMP + light
3.2.2.3 (^-dependent fluorophore maturation
Alongside luminescence, fluorescent proteins also have an oxygen-dependent 
step that underlies their abilities as detectable reporters, specifically the 
maturation of fluorescent proteins requires molecular oxygen (Fig 3.8) (Tsien 
1998; Zimmer 2002). This prompted concern that hypoxic conditions may 
impair the function of the fluorescent proteins and thereby their use as 
fluorescent fusion reporters. To explore this issue we characterised the several 
available fluorophores across a range of oxygen conditions.
1.Immature 2.Torsional Rearrangement 3.Cyclisation
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Fig 3.8. Fluorophore maturation process for Threonine-66, Glycine-67 and Tyrosine-68 of 
EGFP. Oxygen, Nitrogen and Carbon atoms are coloured red, blue and white respectively. Figure 
adapted from http://www.olympusmicro.com
Cells were transfected with either expression plasmids for unfused EGFP, EYFP,
DsRedxp or mCherry. Immediately after addition of the transfection reagent,
70
cells were incubated in either 0.2%, 0.5% or 5% 02 on the microscope stage, so 
that the initial fluorescence expression would occur in an oxygen-deprived 
environment. After 24 hours post transfection, cells were imaged for a total of 6 
hours, switching oxygen back to atmospheric levels after an hour of imaging. 
Whole cell fluorescence levels were quantified using Cell Tracker. Analysis of 
fluorescence indicated that EGFP was the most suitable fluorophore to use 
when imaging in hypoxia, as fluorescence was observed at as low as 0.2% 02 
(Fig 3.9.). EYFP was also seen to be applicable to imaging in hypoxia and was 
visible at 0.5% 02. DsRedxp and mCherry fluorescence was found to be severely 
impaired at tensions of 0.5% O2 and lower. Both these fluorophores require an 
additional oxidation event compared to the GFP variants (Gross, Baird et al. 
2000). An additional consideration for imaging mCherry in hypoxic to 
atmospheric conditions is that the high quantum efficiency of the fluorophore 
(compared to DsRedxp) can more easily lead to detector saturation (Chudakov, 
Matz et al. 2010).
Fig 3-9- Time-lapse imaging of HeLa cells transfected to express an unfused fluorescent 
protein: EGFP, EYFP, DsRedxp or mCherry. Immediately after addition of transfection reagent, 
cells were incubated in hypoxia so initial fluorophore expression occurred in an 02-deprived 
environment. After 24-hours post transfection, cells were imaged through a re-oxygenation step.
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Graphs depict mean average cellular fluorescence normalised to to. (n=>io cells for each 
condition)
3.2.3 Molecular tools to investigate HIF signalling 
3.2.3.1 Gateway® Cloning Rationale and Principle
A primary aim of this project is to image protein dynamics of the HIF signalling 
system. As we are employing a confocal microscopy approach, it was necessary 
to have access to expression plasmids encoding fluorescent fusion proteins of 
the canonical HIF pathway. Plasmids encoding fluorescent fusions for the 
intracellular prolyl-hydroxylases were kindly donated by Dr. E. Metzen and Dr. 
R. Depping. These molecular tools are used and described in Chapter 5. Despite 
having access to other fluorescent fusion proteins of interest, kindly donated 
from a variety of sources, these fusion forms were unsuitable for multiplexing 
and difficult to validate the impact of the fused fluorophore. In order to achieve 
this ambition, we employed the Invitrogen Gateway® System, as it allows for 
quick and efficient cloning as well as flexibility in terms of fluorophore 
orientation (N- or C- terminal) and fluorophore choice for multiplexed imaging 
(Fig 3.10). It was therefore an aim to use this system to produce fluorescent 
fusion expression vectors encoding HIF-ia, HIF-2a, pVHL as well as FIH. Each 
protein was to be either fused in an N-terminal, C-terminal or to be separately 
translated from the fluorescent protein using an internal ribosome entry 
sequence (IRES) contained within the plasmid. The IRES carrying plasmids are 
used as a control, as they allow the co-expression of both the protein-of-interest 
and EGFP from a single promoter, but the independent translation of the 
products (Pelletier and Sonenberg 1988; Hellen and Sarnow 2001).
PCR amplicon
attBI attB2
Coding sequence
BP Cionase
LR Cionase
Fig 3.10. Schematic representation of the Gateway® Invitrogen homologous recombination 
cloning strategy, which was employed to generate plasmids encoding fluorescent tagged 
proteins. Orange indicates coding sequence of interest and green denotes fluorescent protein 
coding sequence. The recombination sites are shown as blue and red.
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3.2.4 Fluorescent fusion HIF-ia plasmids
3.2.4.1 Cloning of HIF-ia
HIF-ia is the major oxygen labile isoform of the HIF-i transcription factor 
(Semenza 2003; Lee, Bae et al. 2004). The previous 02~dependent fluorophore 
maturation data indicated (Fig 3.9.) that the EGFP was the most suitable 
fluorescent protein to couple to HIF-ia. EGFP was also the preferred 
fluorophore of choice due to a well characterized short folding time and higher 
quantum yield, which may compensate for the HIF-ia short half-life (Chudakov, 
Matz et al. 2010). To introduce HIF-ia into the gateway vectors the 248ibp 
HIF-ia coding sequence was PCR amplified from a previously donated 
(Professor S. Edwards, University of Liverpool) HIF-ia expression plasmid 
using the Gateway® primers (appendix 1.1) and protocols. These amplicons 
were then used to produce a C-terminally tagged HIF-ia, N-terminally tagged 
HIF-ia and an IRES containing plasmid. The three plasmids produced are 
referred to as; pG-HIFia-EGFP, pG-EGFP-HIFia and pG-HIFia-IRES-EGFP 
(left to right is in the N- to C- orientation in all plasmid names throughout the 
thesis). In these three plasmids, transcriptional control of the HIF-ia coding 
sequence is under the viral CMV promoter (Fig 3.11). All plasmids were 
confirmed by restriction digest (data not shown) and the coding sequences for 
HIF-ia and EGFP were sequenced (detailed maps and information for the 
plasmids are available in appendix 1.1).
3.2.4.2 Transcriptional activity of expressed HIF-ia plasmids
The function of fused proteins may be compromised due to the presence of the 
additional amino acid sequence, effectuated through alterations to protein 
folding as well as domain and recognition site exposure (Yewdell, Lacsina et al. 
2011). Subsequently, it is necessary to validate the functionality of the fused 
proteins. Luminometry was used to examine the ability of exogenous HIF to 
activate the HRE-luciferase reporter plasmid (Fig 3.11). HeLa cells were 
transfected with the pG-TK-HRE-luciferase reporter and either an unfused 
EGFP control or one of three HIF-ia expressing plasmids. After 24 hours 
transfection, cells either were exposed to 1% 02, o.smM DMOG or remained 
unstimulated for 8 hours.
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Fig 3.11. (A) Diagram of developed fluorescent HIF-ia encoding plasmids. Detailed plasmid 
maps can be found in the appendix 1.1. (B) Immunocytochemistry of HeLa cells expressing 
fluorescent fusion HIF-ia encoding plasmids. Yellow scale bar denotes 20pm. Cells were fixed 
24-48 hours after transfection. (C) Endpoint luminometry analysis of samples prepared from 
HeLa cells co-expressing HIF-ia fluorescent plasmid variants alongside the pG-TK-HRE 
luciferase reporter. Additionally, transfected cells were exposed to either 1% 02 or o.smM 
DMOG for 8-hours. Results are normalised to unfused EGFP normoxic control. Statistical 
significance assessed using one-way ANOVA; p-values ^0.05 are shown as * and p-values ^0.01 
are shown as **. (n= 3 repetitions)
Both hypoxia and DMOG stimulation were found to significantly induce the 
HRE-luciferase signal, though o.smM DMOG showed significantly more 
potency to do so than 1% 02. Expression of all HIF-ia plasmids elevated the 
HRE-luciferase signal over the EGFP control. In normoxia induction was found 
to be 2i±ii fold for pG-HIFia-IRES-EGFP, io±2 fold for pG-HIFiaEGFP and 
5±1 fold for pG-EGFP-HIFia. The difference between the IRES plasmid and the 
fused forms was found to be statistically insignificant.
3.2.4.3 Localisation of expressed HIF-ia plasmids 
Although luminometry data strongly suggested that the HIF-ia expression 
plasmids were functional, all expression plasmids were additionally assessed by 
immunocytochemistry (Fig 3.11) to ensure that the construct was fluorescent
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and the localisation in accordance with previously reported work. HeLa cells 
were transfected with each one of the HIF-ia expression plasmids and after 24- 
48 hours post transfection, were fixed and antibody labelled using anti-HIFia 
(methodology detailed in section 2.6.4). All expression plasmids produced 
nuclear localised fluorescence and the EGFP signal and antibody detected signal 
correlated appropriately. There was some concern that the IRES expression 
plasmid also led to a perceived nuclear localised fluorescence where as the 
unfused EGFP would be expected to be ubiquitous. To confirm whether this was 
an issue with the fixation protocol used all plasmids were transfected and 
expression imaged in a live-cell context using HeLa cells (Fig 3.12). In this 
instance, pG-HIFia-IRES-EGFP fluorescence was found to be ubiquitous 
throughout the cell, in contrast to the fusion forms which were again found to be 
suitably localised to the cell nucleus (Chilov, Camenisch et al. 1999; Wotzlaw, 
Otto et al. 2007).
Fig 3.12. Live-cell confocal microscopy of HeLa cells ectopically expressing one of several HIF- 
ia expression plasmids or an unfused EGFP control plasmid. Images shown are 24 hours post 
transfection. Image width is representative of 6opms.
3.2.5 Fluorescent fusion HIF-2U plasmids 
3.2.5.1 Cloning of HIF-2U
HIF-2a is the second transcriptionally active oxygen labile isoform of the 
heterodimeric HIF transcription factor, originally characterised by Ema et al. in 
1997 (Ema, Taya et al. 1997). The potential protein dynamics of HIF-2a, as well 
as any observable differences compared to HIF-ia are also of interest to the 
study. HIF-2a was to be cloned and coupled to EGFP for the same reasons 
outlined for the cloning of HIF-ia. Nevertheless we were interested in 
potentially imaging cells co-expressing both fluorescent HIF-a isoforms, in 
which case we would need to couple one isoform to a fluorophore spectrally 
distinct from EGFP. The most common option is to use a fluorophore of the red- 
spectrum. As HIF-2Q is cited to show greater protein stability and stabilisation 
at higher 02-tensions, we thereby decided that HIF-2Q would be the most 
suitable to attach to the red fluorescent protein, specifically DsRed-express. The
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26i3bp HIF-2Q coding sequence was PCR amplified from the hEPAS myc- 
pcDNAs expression plasmid (appendix 9.1), again using the Gateway® primers 
and protocols and these amplicons were then used to produce pDONR entry 
vectors suitable for generating N-terminal, C-terminal and IRES-containing 
expression plasmids. The entry vectors were then used to produce three 
expression plasmids; pG-EGFP-HIF2a, pG-DsRedxp-HIF2a and pG-HIF2a- 
IRES-EGFP (Fig 3.13) (detailed maps and information for the plasmids are 
available in appendix 1.1).
Gateway ® 
Vector
pG-EGFP-HIF2ct
pG-DsRedxp-HIF2a
pG-HIF2a-IRES-EGFP
B. C.
pG-EGFP-HIF2a
pG-DsRedxp-HIF2a
pG-HIF2o-IRES-EGFP
M
a»
S8 1S U.
*
Fig 3*13* (A) Pictorial representation of developed fluorescent HIF-2a encoding plasmids. (B) 
Live-cell confocal microscopy of ectopically expressed HIF-2a plasmids in the HeLa cell line. 
Scale bar denotes lopms (C) Endpoint luminometry analysis of HeLa cells co-tranfected with a 
HIF-2Q fluorescent plasmid variant alongside the pG-TK-HRE luciferase reporter. Additionally, 
cells were exposed to either 1% O2 or o.smM DMOG for 8-hours. Results are normalised to 
unfused EGFP normoxic control. Statistical significance assessed using one-way ANOVA; p- 
values ^0.05 are shown as * and p-values ^0.01 are shown as **. (n= 3 repetitions)
3.2.5.2 Live-cell confocal imaging of HIF-2Q expression vectors
The newly generated HIF-2Q expression vectors were initially assessed by 
transfection into HeLa cells and observation by live-cell confocal microscopy
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(Fig 3.14). In accordance with expectations evenly distributed green 
fluorescence was observable in normoxic conditions following transfection with 
the IRES containing plasmid. Fluorescence signal was also detected in normoxic 
conditions after transfection with tagged HIF-2Q and the expressed protein was 
found to be nuclear, with few cells showing instances of cytoplasmic only 
localisation (Kara, Kobayashi et al. 1999; Konietzny, Konig et al. 2009). 
However, in startling contrast to HIF-ia, high-resolution imaging of fluorescent 
HIF-2a showed a non-homogenous localisation pattern, a phenotype 
characterised by the occurrence of punctate regions of high fluorescence 
intensity (speckles). This localisation pattern has been previously (though 
passively) reported and is the focal point of Chapter 6 (Hara, Kobayashi et al. 
1999; Konietzny, Konig et al. 2009).
3.2.5.3 Transcriptional activity of expressed HIF-2a plasmids
Cells were co-transfected with the pGL2-TK-HRE plasmid as well as a HIF-2a 
or an unfused EGFP expression vector. After 24-hours cells were then treated 
for 8-hours with o.smM DMOG or incubated in 1% 02. Cells were then lysed 
and samples prepared for luminometry analysis. In all instances, expression of 
the HIF-2a plasmid resulted in elevated luminescence compared to the 
expression from the unfused EGFP control vector. No significant difference was 
found between the fused and unfused forms of HIF-2a (Fig 3.13.) (detailed 
maps and information for the plasmids are available in appendix 1.1).
3.2.6 Fluorescent fusion pVHL plasmids 
3.2.6.1 Cloning pVHL
pVHL is a necessary component in the sequence of events that confers oxygen- 
sensitivity to HIF-a protein stability (Maxwell, Wiesener et al. 1999). Alongside 
this main role, there are several other regulatory points of interest including the 
transcription and posttranslational sensitive nuclear-cytoplasmic trafficking of 
pVHL and the implications of this on HIF-a regulation (Lee, Neumann et al. 
1999; Groulx and Lee 2002; Cai and Robertson). We were therefore interested 
in any identifiable pVHL dynamics, as well as engineering the ability to express 
the HIF-a alongside pVHL. The latter reasoning would require pVHL to be 
fused to a fluorescent protein with an emission spectra discernable from EGFP 
coupled HIF-a. To this end we further employed the gateway cloning system to 
generate three expression vectors; pG-pVHL-DsRedxp, pG-DsRedxp-pVHL and 
pG-pVHL-IRES-DsRedxp (Fig 3.14.). The pVHL coding sequence was
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amplified from the plasmid pRC-CMV-HA-pVHL, a gift kindly donated by MD 
William G. Kaelin. All plasmids were checked by restriction digest and the 
coding sequences verified by DNA sequencing.
3.2.6.2 Live-cell confocal imaging of pVHL expression vectors
pVHL expression vectors were characterised by live-cell confocal microscopy 
using HeLa cells ectopically expressing one of the several pVHL expression 
plasmids. Transfection of the pVHL-IRES-DsRedxp plasmid resulted in a 
uniform cellular distribution of fluorescence, where as transfection of tagged 
pVHL though also apparent in both the cytoplasm and nucleus was visibly more 
cytoplasmic, albeit marginally (Fig 3.14.)- The localisation pattern was the 
same for all observed cells indicating no asynchronous or heterogenous resting 
state. Importantly the cellular localisation pattern of pVHL agrees with 
published material, though as the localisation is not particularly distinct it is 
difficult to conclude whether the expressed protein is functional from this data 
alone (Lee, Neumann et al. 1999).
3.2.6.3 Assessment of pVHL expression vectors using the HRE-
luciferase reporter
In order to further examine the generated pVHL expression vectors, 
luminometry using the pGL2-TK-HRE-luc reporter was once again employed. 
HeLa cells were transfected with either a pVHL expression vector or a DsRedxp 
control plasmid before cultures were exposed to 8 hours of either control 
conditions, hypoxic incubation (1% 02) or o.smM DMOG treatment. Expression 
of pVHL led to a reduction in luminescence signal in all measured instances, 
when cells were stimulated with DMOG (Fig 3.14). The reason for this remains 
unknown. In all instances, the IRES form and fused forms were found to 
function similarly.
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Fig 3.14. (A) Pictorial representation of developed fluorescent pVHL expression plasmids. (B) 
Live-cell confocal microscopy of expressed HIF-2Q plasmids in the HeLa cell line. Scale bar 
denotes lopms (C). Endpoint luminometry analysis of HeLa cells co-expressing pVHL 
fluorescent plasmid variants alongside the pG-TK-HRE luciferase reporter. Additionally, 
transfected cells were exposed to either 1% O2 or o.smM DMOG for 8-hours. Results are 
normalised to unfused EGFP normoxic control. Statistical significance assessed using one-way 
ANOVA; p-values ^0.05 are shown as * and p-values ^0.01 are shown as **. (n=2 repetitions)
3.2.7 Fluorescent fusion FIH plasmids 
3.2.7.1 Cloning FIH
FIH regulates the transcriptional activity of HIF-ia and HIF-2a in an oxygen- 
dependent manner, an activity that can be speculated to modulate the 
transcriptional feedback potential of the HIF system (Mahon, Hirota et al. 
2001). Investigating whether co-expression of FIH with either HIF-ia /-2a 
affects HIF-a protein dynamics was therefore of interest. As per pVHL, FIH was 
cloned into entry vectors after PCR amplification from pEGFP-FIHi (donated 
from Dr. E. Metzen) before recombination into a DsRed-xp expression plasmid. 
Two FIH expression plasmids were produced from this; pG-FIH-IRES-DsRedxp 
and pG-DsRedxp-FIH (Fig 3.15.). Both plasmids were checked by restriction
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digest and the coding sequences verified by DNA sequencing (detailed maps and 
information for the plasmids are available in appendix 1.1).
3.2.7.2 Live-cell confocal imaging of FIH expression vectors
HeLa cells were transfected with either FIH expression plasmids for 24 hours 
and then imaged by live-cell confocal microscopy. Transfection of the IRES 
vector led to relatively evenly distributed red fluorescence throughout the cell 
(Fig 315 ) Fluorescence from DsRedxp-FIH was found to be cytoplasmic and 
thereby similarly localised to previous publications (Metzen, Berchner- 
Pfannschmidt et al. 2003). However, fluorescence expressed from the fused 
form was often found to form 'blob-like' aggregates around the cytoplasm that 
were unlike the punctate structures seen for HIF-2a (Fig 3.15). This may be the 
result of the fusion of DsRedxp, as this red fluorescent protein is known to exist 
weakly as a tetramer or is simply a result of protein aggregation following the 
expression of un-physiologically high levels of protein (Wall, Socolich et al. 
2000; Mayer and Buchner 2004).
3.2.7.3 Assessment of FIH expression vectors using the HRE-
luciferase reporter
The effect of ectopic FIH expression upon the transcriptional output from the 
HRE-luciferase was investigated. HeLa cells were transfected with either a FIH 
expression vector or a DsRedxp control plasmid before cultures were exposed to 
8 hours of either control conditions, hypoxic incubation (1% 02) or o.smM 
DMOG treatment. No significant change to luminescence levels was seen from 
the ectopic expression of FIH compared to the unfused DsRedxp control vector 
(Fig 3.15). Additionally no significant difference was measured between the 
fused and unfused forms of FIH.
80
A.
Vector / -ACMV {IRESH
pG-FIH-DsRedxp
pG-FIH-IRES-DsRedxp
Fig 3*15* (A) Pictorial representation of developed fluorescent FIH expression plasmids. (B) 
Live-cell confocal microscopy of ectopically expressed FIH plasmids in the HeLa cell line. Scale 
bar denotes lopms (C). Endpoint luminometry analysis of samples prepared from HeLa cells 
co-expressing a FIH fluorescent plasmid variant alongside the pG-TK-HRE luciferase reporter. 
Additionally, transfected cells were exposed to either 1% 02 or o.smM DMOG for 8-hours. 
Results are normalised to unfused EGFP normoxic control. Statistical significance assessed 
using one-way ANOVA; p-values ^0.05 are shown as * and p-values ^0.01 are shown as **. (n=3 
repetitions)
3.3 Discussion
The purpose of this chapter was to determine and optimise a suitable 
experimental system for the investigation of single-cell dynamics within the HIF 
pathway. To this end, I believe the aims were met; (i) the HIF-ia response was 
found intact in our HeLa cell line, confirmed by western blot analysis and 
luminometry (ii) hypoxia and DMOG were shown to not significantly affect cell 
fate within a 24-hour time period (iii) the use of fluorescent proteins in a 
hypoxic environment was addressed and EGFP concluded as the most suitable 
(iv) and finally the gateway system was utilised to rapidly develop a range of 
molecular tools for use in later confocal microscopy experiments.
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3.3*1 Suitability of the HeLa cell line for investigation into HIF-a 
dynamics
A common cause for concern within the field of cell biology is whether the often- 
immortalised research grade cell line is truly representative. This concern is 
furthered with regards to the response to hypoxia, as many laboratory available 
cell lines have existed in near atmospheric 02 conditions for decades. This 
propelled the current study to examine the HIF-a response using both western 
blot analysis and an endpoint luminometry assay. We concluded that the HeLa 
cell line was indeed suitable (despite almost 6-decades of atmospheric 02), as an 
intact transient HIF-ia response was observed comparable with other published 
examples, including in vivo assays (Fig 3, 4) (Gey GO 1952; Wang, Jiang et al. 
1995; Stiehl, Wirthner et al. 2006). Though hypoxic accumulation of HIF-ia 
protein was visible, we failed to detect a robust and convincing accumulation of 
HIF-2a protein, despite HIF-2a being detectable in HeLa cells (Fig 3. 4). A 
measured increase in HIF-2Q was considered not to be a critical criterion in cell 
line selection; partly due to the ‘secondary role’ HIF-2Q is cited to play in the 
cellular hypoxic response. Principally, the aim is to investigate and 
mathematically model the HIF-ia response, though it could be expected that 
HIF-2a may interject with and affect the PHD feedback loop (Aprelikova, 
Chandramouli et al. 2004). It is therefore of interest to hypothesise an 
explanation for the lack of hypoxic HIF-2a accumulation (or loss up on re­
oxygenation). There are several plausible possibilities that may explain the lack 
of measured HIF-2a induction. Firstly, HIF-2a accumulation has been cited to 
occur more slowly than HIF-ia in HeLa cells meaning that we may not observe 
as distinct stabilisation of protein within the 24-hour experiment time period 
used (Bracken, Fedele et al. 2006). The response may also be transient and 
asynchronous, making bulk-cell measurements of induction difficult (Nelson, 
Ihekwaba et al. 2004; Burrill and Silver 2011).
3.3.2 Imaging technologies in hypoxia
A mainstay of this project is the ability to measure events at the single-cell level 
in living cells. The main technological approaches employed towards this goal 
are wide-field luminescence and confocal microscopy, technologies based on 
bioluminescence and fluorescence respectively. A potential caveat with this 
approach is that bioluminescence and fluorescent proteins both require 
molecular oxygen in order to produce signal.
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3.3*3 Use of bioluminescence
Bioluminescence catalysed by luciferase is dependent on molecular oxygen. 
Additionally, the luminescence signal produced is also dependent on available 
molecular oxygen but also available cellular pool of ATP, which can be depleted 
or altered by hypoxia (Kara 2009). With regards to bioluminescence, endpoint 
luminometry assays do not suffer from 02-dependency as the reaction can be 
performed post lysis and thereby in an oxygen rich environment. However, 
bioluminescence is often applied to live-cell imaging in hypoxia, including the in 
vivo imaging of tumour growth (Jost, Collins et al. 2009; Hawes and Reilly 
2010). In this context, we attempted to validate the use of luminescence for live­
cell measurements in hypoxia finding levels as low as 1% 02 suitable. An 
extensive study into this issue was undertaken by Moriyama et al. 2008 in 
which they found a 32% loss of luminescence signal comparing atmospheric 
oxygen to 1% 02. The loss of luminescence was chiefly attributed to decreased 
cellular ATP. This finding may suggest the hypoxic sensitivity of 
bioluminescence to be cell-type dependent, arising from the cellular energy 
status. In this context, the high mitochondrial mass of HeLa cells may explain 
the relative insensitivity of bioluminescence to hypoxia observed in our own 
measurements (Ryan, Taylor et al. 2005). Nevertheless, the effect of hypoxia on 
cellular ATP remains an interesting prospect that can have diverse 
repercussions of the physiology of the cell (Matveev, Vinokurov et al. 1996; 
Tsujimoto 1997; DiGregorio, Ubersax et al. 2001). Creative methodologies have 
been recently developed allowing for the cellular and subcellular measurement 
of ATP levels over time, enabling the live-cell measurement of ATP levels 
following hypoxia (Imamura, Nhat et al. 2009). Using such methodology it 
would be possible to further address the use of bioluminescence in hypoxic cells 
and tissues as well as gaining a broader understanding of the contribution 
altered cellular ATP to the hypoxic response.
3.3.4 Use of fluorescent proteins
The other imaging technology employed, namely protein fluorescence, is also 
dependent on the availability of molecular oxygen. Furthermore the technology 
is widely relevant to many avenues of hypoxic research (including our own) as 
well as the in vivo imaging of tumour growth, tumour oxygenation and 
angiogenesis (Hoffman 2002; Hoffman 2004; Kuchimaru, Kadonosono et al.). 
The chemistry of fluorescent protein maturation has been the topic of several
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papers, in which the different fluorescent proteins have different maturation 
processes; GFP variants require a single oxidation event in order to fluoresce 
whereas RFP variants require two events (Gross, Baird et al. 2000; Zimmer 
2002). Interestingly, single oxidised RFP proteins are thought to fluoresce with 
a green emission and it is the second oxidation which is responsible for the 
characteristic red fluorescence (Gross, Baird et al. 2000). However, it has also 
been suggested that the maturation of DsRed is a branched process in which the 
fluorophore can mature to a green form, or red form. The maturation to a red 
fluorescent form is oxygen-dependent and so periods of sufficient hypoxia 
would shift DsRedxp fluorescence from red to green (Struck, Strongin et al.
2010) . These mechanisms may have implications for multiplexing GFP and 
DsRed variant proteins in hypoxic conditions.
However, to address the most pressing point, GFP variants are suitable for 
hypoxic imaging in tensions as low as 0.5% Oa. This is in accordance with a 
paper published by Vordermark et al. 2001 which found EGFP fluorescence to 
be sensitive to near anoxic conditions of -0.02% 02. This reinforces the use of 
GFP for hypoxic imaging, whether for research purposes, in vivo or ex vivo 
and/or clinical applications (Hoffman 2005). For example, in vivo assessment 
of tumour oxygenation is considered important due to the correlation with 
prognosis and even potential hypoxia-sensitive drug delivery (Avni, Cohen et al.
2011) (Thorwarth and Alber 2010) (Shinae Kizaka-Kondoh 2009). There are a 
number of methodologies in place to measure tumour oxygenation as common 
non-invasive techniques include the use of magnetic resonance imaging (MRI), 
positron emission tomography (PET) and single-photon emission computed 
tomography (SPECT) (Sun, Niu et al. 2010). Though measurements are also 
made on other features of the tumour, and a number of these markers utilise 
fluorescent protein technologies (Yu, Timiryasova et al. 2003; Ma, Taruttis et al. 
2009; Serebrovskaya, Edelweiss et al, 2009).
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Chapter 4: Single-cell imaging and initial 
mathematical modelling of Oa-stimulated
HIF-a dynamics
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4.1 Introduction
Many intracellular processes exist in a state of dynamic flux which often results 
in a perceived resting steady-state. This is suspected to be true for the HIF 
system, in which HIF molecules are continuously produced and degraded while 
at the same time also continuously shuttled between the nucleus and cytoplasm 
(Irisarri, Lavista-Llanos et al. 2009; Purvis, Radhakrishnan et al. 2009). 
Perturbations to the resting steady-state have the potential to cause a temporary 
transitional period as the system re-establishes a new steady-state, as has been 
addressed in the NRF2 response to oxidative stress (Zhang, Pi et al. 2010). This 
is the hypothesised process that governs the transient accumulation of HIF-a in 
response to a hypoxic-insult or any other HIF-a acting stimulus. Moreover it is 
hypothesised that the kinetics of the transitional state are meaningful and are 
able to encode differing contexts (Ni, Bruce et al. 2009). To properly address 
this issue it is necessary to characterise the kinetics of the HIF-a response. To 
this end, inhibition of the PHDs will be used to stimulate HIF-a accumulation 
and the ensuing accumulation will be visualised using time-lapse confocal 
microscopy of cells expressing fluorescent-tagged HIF-a. Currently, only a few 
attempts have been made at the live-cell imaging of the HIF hypoxic response; 
several of these have been live-cell measurements of HIF protein interactions, 
others include the in vivo imaging of tumours and reperfusion injury using HIF- 
orientated reporters (Serganova, Doubrovin et al. 2004; Liu, Qu et al. 2005; 
Wotzlaw, Otto et al. 2007; Choi, Chan et al. 2008; Konietzny, Konig et al. 2009). 
This leaves the single-cell level response over the course of hypoxia unexplored. 
The absence of these measurements is given more importance by the purported 
role of localisation dynamics in the HIF response as well as providing highly 
quantified data suitable for the movement towards mathematical modelling of 
pathways (Groulx and Lee 2002; Nakayama, Qi et al. 2009; Cai and Robertson 
2010; Hughey, Lee et al.). The mathematical modelling of the HIF signalling 
network has been of interest to several studies, initially in 2004 by Kohn et al. 
These mathematical tools complement our core biochemical understanding of 
the signalling proteins, allowing for the appreciation of the network behaviour 
in a range of contexts. This has important implications for the HIF-signalling 
systems given the range of pathological and physiological situations where HIF 
is activated (briefly summarised in section 1.3) (Eungdamrong and Iyengar
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2004; Krohn, Link et al. 2008; Toffoli and Michiels 2008; Taylor and McElwain 
2010).
4.2 Results
4.2.1 Validation of methodology for the single-cell imaging of HIF-a
4.2.1.1 Is HIF-a mRNA production regulated by hypoxia?
Several reports have suggested that not only is HIF-a abundance regulated at 
the protein level but also at the level of transcript, reporting both positive and 
negative regulation (Uchida, Rossignol et al. 2004; Mojsilovic-Petrovic, 
Callaghan et al. 2007; Bruning, Cerone et al. 2011). This would have important 
ramifications in our understanding of the signalling arrangement as well as 
future experimental design concerning the use of expression plasmids (if 
regulation was at the HIF-i promoter level). We investigated the hypoxic 
sensitivity of HIF-ia and HIF-2a transcript using quantitative real-time PCR. 
HeLa cells were plated at a density of 35ok/6cm dish in 5ml media then 
cultured over 24-hours at either 1% 02 or atmospheric conditions. Samples were 
lysed and prepared for time points; oh, 0.5I1, ih, 2h, 4I1, 8h and 24I1. No 
significant changes were measured for both HIF-a isoforms, indicating no 
discernible population-wide regulation of either promoter within 24-hours (Fig 
4.1). This data suggests therefore that use of the CMV driven HIF-a expression 
vectors should be suitable with regards to hypoxic promoter regulation and also 
refutes attention to transcript level regulation within the first 24 hours of 
hypoxia in our cell line.
HI1 -la-------Normoxia
Hypoxia
-------Normoxia
.5 3-
Time (hours) Tima (hours)
Fig 4.1. RT-qPCR measurement of samples prepared from HeLa cells that were incubated for a 
time course of 24-hours at either 1% 02 or atmospheric O2. (n=3 repetitions hypoxia and n=i 
repetition normoxia)
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4*2.1.2 Consequence of HIF-ioEGFP expression on hypoxic 
accumulation of endogenous HIF-a
A common concern when employing the CMV promoter is the relatively high 
expression level, especially as ectopic expression is often additional to the 
endogenous expression of a protein-of-interest (Mayer and Buchner 2004) (Qin, 
Zhang et al. 2010). To address this concern in our own experimental system, the 
population-wide accumulation of HIF-ia in HeLa cells expressing pG-HIFia- 
EGFP was investigated in order to determine whether the normal response was 
intact (and whether the endogenous response was comparable to the exogenous 
response). HeLa cells plated into 6cm dishes were transfected with pG-HIF- 
laEGFP prior to their incubation at 1% O2 for up to 24-hours. Samples were 
then lysed and analysed by western blot, probing with a HIF-ia antibody. The 
HIF-ia antibody detected both the !2okDa endogenous protein and the heavier 
fluorescent tagged HIF-ia found at about ~i47kDa (Fig 4.2). The accumulation 
pattern for both tagged and untagged was found to be similar to one another. 
Furthermore, the accumulation pattern was similar to that observed for non- 
transfected (assessed earlier in Fig 3.4.) and to previous reported accumulation 
profiles (Stiehl, Wirthner et al. 2006). However, there was a slightly elevated 
signal observed when comparing HIF-iaEGFP to untagged HIF-ia in the 
normoxic sample and re-oxygenated sample. Endogenous and exogenous HIF- 
2a protein was detected at QOkDa and nykDa respectively and was already 
apparent in the normoxic sample. The response profile for both species of HIF- 
2a was indistinct, similar to the untransfected response seen previously in Fig 
3.4. This result suggest the lack of endogenous HIF-2a induction is not specific 
to either the promoter activity or mutations within the HIF-2a sequence, as the 
exogenous HIF-2a also showed no increase, in accordance with observations by 
Bracken et ah (2006) in HeLa cells.
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Fig 4.2. Western blot analysis of HIF-a protein accompanied with a corresponding actin 
loading control. Samples were prepared from HeLa cells transfected with either HIF-iaEGFP or 
EGFPHIF-2a and incubated in 1% Oa over 24 hours with an additional sample being re­
oxygenated (labelled as Reox) for an additional 15-minute period.
4.2.2 Single-cell imaging of HIF-m stimulated using 1% 02
The real-time single-cell accumulation of HIF-ia protein in response to hypoxia 
has never been directly imaged (Liu, Qu et al. 2005; Krohn, Link et al. 2008). 
The presence of a delayed-negative feedback regulating this accumulation has 
prompted this study to investigate and characterise any potential dynamic 
events within this signalling network. To this end, HeLa cells were plated into 
35cm imaging dishes and transiently transfected with pG-HIF-iaEGFP. Cells 
were also co-transfected with a DsRedxp expressing vector which aids in the 
detection of transfected cells in the normoxic condition when HIF-ia is 
extensively degraded and thereby difficult to detect. After 24-48 hours 
transfection, locations expressing red fluorescence were selected and then 
imaged every 5 minutes over the course of 20 hours. Cells were either imaged as 
a normoxic control (~2i% 02) or hypoxic perturbation (1% 02). For the hypoxic 
condition, cells are initially imaged for an hour in atmospheric 02 conditions 
and then switched to 1% 02 for the remanding 15 to 25 hours (Fig 4.3).
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Fig 4.3. HeLa cells were co-transfected with pG-HIF-iaEGFP and pG-DsRed-xp. After 24 
hours of transfection, cells were imaged by time-lapse confocal microscopy in either (A) 
atmospheric O2 or (B) 1% O2. Images are of a single location over time, chosen from a selection 
of 15 locations per experiment repetition, from a total of three t repetitions.
4.2.2.1 Number of responding cells and method of calculation
We have assessed the cell responsiveness by eye. A consideration for this 
calculation is the loss of observable cells during the experiment, which can occur 
from cell death and cell migration (as the imaged location is fixed in position). 
Therefore strict criteria addressing cell loss needs to be in place. Here we 
decided that any cell dying or migrating out of the field of view within 200 
minutes of the first image were not counted. Ideally a more robust measurement 
method would be employed, one that is less open to experimenter bias. The 
robust measurement of responding cells would require use of strict quantitative 
criteria, such as a threshold equation to address whether a change in 
fluorescence intensity is meaningful or within experimental noise as well as
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improving the repeatability of the measurement method. However, this practice 
would require all visual information to be processed into a quantitative format. 
This is a very time-intensive step due to the manual to semi-automated 
functioning of the cell tracking software used and is therefore a difficult task to 
approach in an entirely systematic manner. And so we elected to use the less 
reliable but time wise by eye method, recording the categorisations for each 
experiment and dish-location so that the findings are open to dispute.
Prior to time-lapse imaging, it was evident that there was a greater ratio of 
detectable red fluorescence expressing cells compared to green, possibly 
indicating that exogenous expression of HIF-ia was not sufficient to saturate 
the degradation pathway for the majority of observed cells. Upon hypoxic 
exposure, 42% of red expressing cells (n=66 of 159 cells) showed an increase in 
green fluorescence over the experiment time period compared to 19% observed 
in the control condition (n=20 of 105 cells) (Fig 4.4). Only cells visibly 
transfected in the first images were considered for this calculation and only 
single daughters from dividing cells were counted to the total. This was 
considered justifiable as an increase in fluorescence in one daughter correlated 
with an increase for the other in 97% of instances (n= 37 of 38 daughter pairs).
Suitable cells that showed changes in green fluorescence and did not die or 
migrate out-of-view within 200 minutes were analysed by Cell Tracker, 
converting visual data into a quantitative format (cell tracking analysis 
described in methods). Many references describing the HIF-ia response to 
hypoxia suggest that HIF-ia dimerises with HIF-i(3 in the cytoplasm and then 
translocates to the nucleus (Chilov, Camenisch et al. 1999; Kaur, Khwaja et al. 
2005). By eye examination of the images indicated that the accumulated HIF- 
laEGFP was predominantly nuclear in almost all cases (Fig 4.4). The nuclear 
translocation of HIF following stabilisation was initially and convincingly 
demonstrated by Kallio et al 1998 and since then been repeated in various 
reviews of the pathway (Kallio, Okamoto et al. 1998; Webb, Coleman et al. 
2009). Quantitative examination of cytoplasmic fluorescence versus nuclear 
fluorescence in our data disagrees with the dogma that a translocation of HIF-1 
occurs upon hypoxic stimulation as no loss of cytoplasmic fluorescence was 
observed. In contrast cytoplasmic fluorescence could be seen to increase in 
several cases, only ever alongside nuclear fluorescence (Fig 4.4).
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Fig 4.4. (A) Live-cell confocal images and corresponding fluorescence intensity traces of 
cytoplasmic and nuclear HIFiaEGFP from HeLa cells exposed to 1% 02. The three cells shown 
depict the representative classifications of response kinetics. (B) % of red-fluorescent cells that 
show a visible change in HIF-iaEGFP intensity over the course of the experiment. 
Measurement of responding cells as determined by visual counting. (C) Classification of HIF­
iaEGFP response kinetics observed and percentage cells calculated to belong to each 
classification. Repetition 1, 2 and 3 are experimental repetitions, each reflecting a number of 
cells from imaging 15 locations.. (All nuclear cell traces are shown in the appendix 1.2)
A recent review by Majmundar et al. of HIF regulatory mechanisms omits 
entirely translocation as a regulatory event (Majmundar, Wong et al. 2010). 
Here, there were observed instances of spontaneous nuclear-to-cytoplasmic 
translocations (for less than 10 cells). This phenomenon is later explained in 
chapter 7 as a result of rupturing nuclear herniations, a feature unrelated to the 
HIF system. An additional observation was the common occurrence of a rapid 
increase in green fluorescence preceding cell death (Fig 4.5). This occurred in 
both the normoxic and hypoxic conditions. Using a similar counting criteria as 
previously outlined, it was found that up to 40% of HIF-ia expressing cells died 
(no significant difference was found between normoxic and hypoxic conditions) 
(Fig 4.5). The cause-and-effect relationship of this event in our data remains 
unexplored, but it does perhaps support the various papers implicating HIF in 
cell death (Volm and Koomagi 2000; Piret, Mottet et al. 2002).
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Fig 4.5. Images are taken from live-cell confocal microscopy of HeLa cells expressing 
HIFiaEGFP and then imaged in either 1% O2 or 21% O2. Chosen images highlight the nuclear 
accumulation of HIFiaEGFP prior to cell death. Percentage of dying cells is calculated and 
shown as an average from all three repetitions.
4.2.2.2 Analysis of single-cell response
Quantitative analysis of HIF-a fluorescence showed a very heterogeneous 
response. This heterogeneity was observed with regards to the accumulation 
pattern, timing, and. The range of accumulation patterns was visually counted 
and broadly categorised into (1) persistent accumulation (2) single-transient 
event and (3) multiple accumulations (Fig 4.4). A persistent increase in 
fluorescence was characterised as a slow ongoing increase and occurred in 
45-5% (n=30 of 66 cells) of responding cells; single-transient events were 
characterised by a increase and subsequent decrease in HIF-a fluorescence 
intensity, this often presented as a distinctive peak, observed in 44.0% (n=29 of 
66 cells) of responding cells; additionally multiple-peak accumulations were 
also present in the data-set with this response making up a small fraction of 
10.6% (n=7 of 66 cells) (see appendix 1.2 for all traces of nuclear 
fluorescence). Cell-to-cell variance has been suggested to be an important aspect 
of the tissue level response and so we pursued addressing this issue in our own 
data (Sigal, Milo et al. 2006; Cohen, Kalisky et al. 2009; Paszek, Ryan et al.). 
Such studies are only made possible using single-cell level technology; however, 
this also limits the range of corroborative evidence and so some degree of 
caution must be applied to the inferences made (potential sources of artefact are 
discussed later).
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Fig 4.6. Analysis of HIF-iaEGFP fluorescence from ectopically expressing HeLa cells 
stimulated with hypoxia. (A) Time to 1st response and duration of single-transient response. (B) 
Maximum amplitude of all cells Time-to-ist-response was calculated as the point in which 
fluorescence values reach half maximum. The duration was calculated as the time between the 
point at passing half maximum fluorescence and returning below this value.
Quantified data was then handled to address heterogeneity within features of 
the response, namely the time-to-ist-response, duration-of-ist-response and the 
maximum amplitude of response (Fig 4.6) amplitude (plots of all quantified 
nuclear fluorescence are available in appendix). To assign these values a 
thresholding system was applied to the data. A cell’s time-to-ist-response was 
determined at the time-point when fluorescence intensity crosses it’s;
Minimum fluorescence + (Maximum Fluorescence - Minimum Fluorescence)/2
Rationale for threshold (i) Calculating a threshold for each individual cell was found to 
be the most ideal method due to the high population variance in values, (ii) minimum 
fluorescence was used to determine the resting steady-state of the system, used instead of 
prestimulus fluorescence due to the occurrence of un-stimulated dynamics
The duration was also calculated using this, corresponding to the difference in 
the time-point above the threshold to the drop below the threshold. The time- 
to-ist-response was shown to vary considerably, spanning from ~i-hour up to 
~20-hours. This was in contrast to the duration of the transient response, 
which was found to be more robust ranging from ~2-hours to ~6-hours, with an 
average timing of ~3-hours (Fig 4.6). Again, in contrast the maximum 
amplitude of response was also found to be highly variable with values 
measuring across the entire dynamic range of the microscope detector. The 
relative heterogeneity between duration and timing was confirmed using the
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fano factor (variance over the mean) measurement of dispersion around the 
mean (Masuda and Doiron 2007; Paszek, Ryan et ah).
4.2.3 Single-cell imaging of HIF-2a stimulated using 1% 02 
Although no clear hypoxic accumulation (or re-oxygenation loss) of HIF-2a 
protein was detected in the bulk cell population, we aimed to examine whether a 
response was visible at the single-cell level, testing the hypothesis whether 
single-cell variability masks any population measurement. HeLa cells 
appropriately plated and incubated were transfected with pG-EGFP-HIF2a, as 
well as an unfused DsRedxp transfection control vector. After 24-48 hours of 
transfection cells were imaged in the same manner as HIF-ia (Fig 4.7). There 
were many more instances of visible/stabilised HIF-2a prior to hypoxic 
incubation as there were for HIF-ia. To counteract cell selection bias, cells for 
imaging were selected by red fluorescence only. As with HIF-ia, the majority of 
fluorescence was localised to the nucleus and there was no distinct change in 
localisation upon hypoxic stimulation. Remarkably accumulations of HIF-2a 
protein were visible and occurred primarily in the nucleus. All quantified 
measurements of HIF-2a used the nuclear fluorescence as a readout to compare 
to the imaging data from HIF-ia. Although one confounding variable for these 
measurements was the repeat presence of spontaneous nuclear to cytoplasmic 
translocations as well as the speckle-like localisation patterns, to be discussed in 
chapters 7 and 6 respectively. The occurrence of translocations was more 
pronounced for HIF-2a than HIF-ia, partly as the amplitude of the 
translocation was greater than a nuclear:cytoplasmic ratio of 1, therefore a loss 
in nuclear fluorescence was sometimes attributable to these localisation events. 
4.2.3.1 Analysis of single-cell response
In the normoxic condition, 18.5% of red fluorescing cells (n=i7 of 92 cells) 
showed a response with respect to changes in HIF-2a fluorescence over time 
compared to 52.5% of cells (n=62 of 114 cells) stimulated with hypoxia (Fig 
4.8). Variability was seen in the response pattern, manifesting as differing rates 
of accumulation and degradation occurring at differing times and with differing 
frequencies. To partly address the heterogeneity, the visualised hypoxic data 
was again classified into the categories; (1) persistent accumulation, (2) single­
transient accumulation and (3) multiple-accumulations. The single-transient 
category was the largest, accounting for 56.5% of responses (n=35 cells), the 
second-largest was the multiple-accumulations category, describing a further
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30.7% (n=i9 cells) and persistent accumulation was recorded for the remaining 
12.9% (n=8 cells) (Fig 4.8).
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Fig 4.7. Time-lapse microscopy of HeLa cells co-transfected to express EGFPHIF-2a and 
DsRed-xp. After 24-48 hours of transfection cells were imaged in either atmospheric 02 (A) or 
1% 02 (B). Images are of a single location over time, chosen from a selection of 15 locations per 
experiment repetition, from a total of three t repetitions.
96
A.
Fig 4.8. (A) HeLa cells ectopically expressing EGFP-HIF2Q were imaged by confocal 
microscopy while stimulated by hypoxia (1% 02) Traces of fluorescence intensity of cytoplasmic 
and nuclear EGFPHIF2a from HeLa cells exposed to 1% 02 accompany corresponding images. 
(B) % of red-fluorescent cells that show a visible change in HIF-iaEGFP intensity over the 
course of the experiment. (C) Classification of EGFPHIF-2a response kinetics observed and 
percentage cells calculated to belong to each classification. The classification of the cell traces 
shown are indicated using a circular graphic of the same colour scheme. Repetition 1, 2 and 3 
are experimental repetitions, each reflecting a number of cells from imaging 15 locations (All 
nuclear cell traces are shown in the appendix 1.3)
The quantified HIF-2Q data was subjected to analysis of time-to-ist-response, 
duration and max amplitude (Fig 4.9). The results matched those observed for 
HIF-ia; time-to-ist-response was found to be heterogeneous ranging across 20- 
hours of experimental time whereas durations of the transient peaks were found 
to be more robust lasting 2-4 hours (confirmed again by fano factor 
measurement). Also the maximum amplitude was again found to vary across the 
maximum dynamic range of the microscope photo-multiplier detector.
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Fig 4.9. Analysis of EGFPHIF-2Q (fluorescence) response kinetics from HeLa cells stimulated 
with hypoxia. (A) Time to 1st response and duration of single-transient response. (B) Maximum 
nuclear fluorescence of all cells. The duration was calculated as the time between the point at 
passing half maximum fluorescence and returning below this value.
4.2.4 Single-cell imaging of HIF transcriptional activity in hypoxia
In response to hypoxia, there is a transient accumulation of HIF-ia protein by 
western blot accumulation. The single-cell imaging of both HIF-ia and HIF-2a 
also depicted a transient response profile characterised with a robust duration 
and an unexpectedly heterogenous response time. To test whether this was 
similar with endogenous HIF activity, HeLa cells were transfected with the 
luciferase reporter, pGL2-TK-HRE. After 24-hours transfection, imM luciferin 
was added to the cells for a further hour and then cells were imaged by wide- 
field luminescence. The imaging data was quantified to the single-cell level 
response using the AQM kinetic tracker software as described in chapter 2. 
Once again, transiency and heterogeneity were aspects of the response profile. 
After analysing 60 cells, the time-to-ist-response was found to range from 
o.shrs to sohrs with an average of 2ohrs (Fig 4.10). Multiple responses were 
also observed, characterised by multiple transient accumulations. There was no 
evidence of robustness to the multiple responses in terms of; peak-to-peak 
timing, time-of-occurrence or relative peak amplitude (all traces of nuclear 
fluorescence can be found in appendix 9.3).
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Fig 4.10. HeLa cells were transiently transfected with the HRE-luciferase reporter, pGL2-tk- 
HRE-luc. After 24-hours transfection cells were incubated for an hour with imM luciferin and 
imaged by wide-held luminescence in (A) normoxia or (B) hypoxia; images show the light 
intensity detected. (C) Quantification of luminescence levels was performed using AQM kinetic 
tracker. Representative traces of 5 cells luminescence levels for the hypoxic imaging time-course 
are shown. (D) Box-and-whisker plot showing the response time, as calculated at the point of 
50% maximum increase in luminescence levels.
4.2.5 The response of HIF-a protein levels to re-oxygenation 
4.2.5.1 Bulk-cell response of HIF-a protein to re-oxygenation
The observed heterogeneity in HIF-a response time is not entirely concordant 
with the known governing molecular mechanisms, lacking receptor level 
stochasticity and are expectantly determined by a rapid inhibition of the 
intracellular prolyl hydroxylases (Lipniacki, Puszynski et al. 2007; Taylor 
2008). This prompted work to investigate the reverse scenario, rather than the 
hypoxic accumulation examine the re-oxygenation driven degradation of HIF-a. 
HeLa cells plated into 6cm dishes were incubated at 1% 02 for 6-hours, then 
lysed throughout a re-oxygenation (back to atmospheric 02) time-course of 120- 
minutes. Analysis of samples showed that HIF-ia protein is reduced to below 
detectable levels within 10-minutes, a similar value was reported by Marxsen et 
al (2004) (Fig 4.11). On the other hand, HIF-2a showed no decrease upon re­
oxygenation over the 120 minutes and perhaps even a subtle increase in protein.
99
Tima (min)
Fig 4.11. HeLa cells were incubated at 1% O2 for 6-hours and then exposed to a re-oxygenation 
time-course back to atmospheric O2 levels. (A) Western blot analysis of samples throughout re­
oxygenation, probing for HIF-ia and HIF-2a and an actin loading control. (B) Densitometry 
analysis of HIF-ia and HIF-2Q western blot protein bands. Values are normalised to to.
4.2.5.2 Single-cell response of HIF-ia protein to re-oxygenation
The same experimental re-oxygenation protocol was performed at the single-cell 
level, using time-lapse confocal microscopy of HeLa cells transiently transfected 
with HIFia-EGFP for 24-48 hours. Cells were then incubated on the microscope 
stage hypoxic incubator for 5-hours at 1% 02. Cells showing a visible nuclear 
green fluorescence signal were selected for imaging and imaged for an hour in 
hypoxia before reverting to atmospheric oxygen, imaging for a minimum further 
300-minutes. In this instance, 82% of cells (n=66 of 80 cells) visible for HIF- 
laEGFP at to were found to show a significant reduction in fluorescence 
intensity after re-oxygenation (Fig 4.12). The half-life of HIF-ia protein in 
response to re-oxygenation was found to be 26±14 minutes from a data set of 48 
cells.
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Fig 4.12. HeLa cells ectopically expressing EGFP fused HIF-ia or HIF-2a were imaged by 
confocal microscopy through the re-oxygenation from 1% 02 to atmospheric O2 after a 6-hours 
1% 02 hypoxic incubation. (A) Shows representative images from the time-course and (B) shows 
the cell traces of normalised nuclear fluorescence for some of the cells. Additionally, the y-axis 
for HIF-2a traces has been broken to better show the loss and re-accumulation of fluorescence.
4.2.5.3 Single-cell response of HIF-2Q protein to re-oxygenation
Confocal microscopy imaging of HIF-2a in hypoxia suggested a degree of 02- 
sensitivity not convincingly seen when examining the response by western blot 
analysis (shown previously in Fig 3.4 & 4.2). We sought to further investigate 
the oxygen sensitivity of HIF-2Q by transfecting HeLa cells with the pG-EGFP- 
HIF2Q expression vector and imaging expressing cells through a re-oxygenation 
event. Again, cells were selected that demonstrated green fluorescence after 5- 
hours of incubation at 1% 02. Cells were then imaged in the same manner as per 
HIF-ia re-oxygenation. Surprisingly, 82.6% of HIF-2Q cells (n=62 of 77 cells) 
showed a strong reduction in fluorescence after re-oxygenation (Fig 4.12). The 
measured decrease of HIF-2a gave a half-life value of 29±io minutes. It is worth 
noting, that HIF-2a protein showed a greater range of dynamism in response to 
re-oxygenation than observed for HIF-ia. Several cells showed a short increase 
in fluorescence following re-oxygenation prior to the major reduction. The point 
of decrease was used in the calculation of half-life. Upon further observation, 
15% of cells also showed re-accumulation events occurring after initial
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degradation. The increased dynamism and asynchrony of HIF-2Q, observed in 
both re-oxygenation and hypoxic imaging, may explain the lack of bulk-cell level 
detection of oxygen-dependent regulation of HIF-2a.
4.2.5.4 The effect of ectopic expression of HIF-a on cell fate during 
re-oxygenation
An encountered issue when evaluating single-cell data was the accounting of cell 
division and cell death. Both issues effect the data as cell death prevents long 
term measurements and cell division results in the doubling of possible number 
of cells. This was an important issue when evaluating the single-cell imaging 
data of re-oxygenation. A large degree of cell death was present when imaging 
over-expressed HIF-a cells (Fig 4.13). When imaging HIF-ia the average 
occurrence of cell death was found to be 71% (total data set of 80 cells over three 
repetitions). For HIF-2Q this average was found to be lower at 60% (total data 
set of 77 cells over three repetitions), but not significantly lower than HIF-ia. 
These data were compared to an EGFP control, in which 11% of imaged cells 
were found to undergo cell death during imaging (concluding data from 94 
cells). The low instance of cell death when imaging unfused EGFP disregards the 
possibility of laser induced ROS contributing towards cell death (Dixit and Cyr 
2003).
Fig 4.13. (A) Confocal imaging of HeLa cells ectopically expressing un-conjugated EGFP, HIF- 
laEGFP or EGFP-HIF2a, showing the merge of bright-field and green channel. Cells were 
exposed to re-oxygenation following 6-hours of hypoxia. (B) Calculated average % of cells died 
during re-oxygenation (n = >77 cells per condition). (n=3 repetitions) Statistical significance 
assessed using one-way ANOVA; * = <Po.05
The results prompted us to revisit the observed relationship between HIF-a 
expression and the advent of cell death, as detailed in the single-cell hypoxic 
imaging (measured earlier in Fig 4.5) (Carmeliet, Dor et al. 1998). From the re-
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oxygenation data we can see that the ectopic expression of either HIF-a vectors 
increases the propensity of a cell for re-oxygenation mediated cell death, 
essentially sensitising the cell to re-oxygenation apoptosis. This has important 
implications in ischaemia-reperfusion injury, a pathological scenario 
characterised by the resurgence of oxygen after a hypoxic episode (Loor and 
Schumacher 2008).
4.2.6 Constructing the mathematical model
The advent of mathematical modelling provides another useful tool in 
understanding and addressing biology. To this end mathematical equations are 
used to describe an arrangement of biological interactions and components 
(Eungdamrong and Iyengar 2004; Eungdamrong and Iyengar 2004; van Riel 
2006). Often for these models to be of meaning, they need to be informed and 
tested against biological data (van Riel 2006). The live-cell imaging data 
acquired throughout this chapter is one such type that is very compatible with 
mathematical modelling, on account of the highly quantitative nature of the 
data (Bartfeld, Hess et al.). The single-cell HIF-a data therefore provided us 
with an insight into the HIF hypoxic response as well as preparing a platform 
from which to build a mathematical model detailing the HIF system. 
Mathematical models are artificial constructs that attempt to recreate 
phenomenon through abstraction (Eungdamrong and Iyengar 2004). It is 
therefore critical to sensibly determine the extent of the abstraction and this 
requires the rational conception of the interactions, components and features 
the model is to encompass. Ideally the scope of the model should be relative to 
the known constraints i.e. biological measurements pertaining to the model. If 
more terms are included than constrained, then the parameter space of the 
model enlarges, increasing the models’ flexibility. This can lead to the scenario 
in which a model may be able to mimic network level behaviour but for the 
wrong reasons, undermining the model as a tool (Eungdamrong and Iyengar 
2004). Previous attempts at modelling HIF have ambitiously attempted to detail 
many of the relevant processes, yet lack high-resolution data pertaining to the 
assumptions; often fitting to several bulk-cell analysis time points (Kohn, Riss et 
al. 2004; Dayan, Roux et al. 2006). These abstractions represent a ‘top-down’ 
approach, in which the essential behaviour of the system is expected to arise 
from the complicated network topology. We propose a ‘bottom-up’ approach, 
building the simplest model able to capture the single-cell imaging of HIF-ia
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transiency. From this model, a cycle of hypothesis and improvements can be 
made, essentially building the model (van Riel 2006). Starting from a more 
thorough conception of the HIF signalling network, we aimed to reduce the 
description to a minimal system designed to recapitulate HIF-a transiency (Fig
4.14).
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Fig 4.14. Early conception of HIF-model abstraction. Species to mathematically define are 
indicated numerically with black squares. Reaction kinetics to define are indicated with white 
diamonds. This topology is similar to those used in previous HIF-models produced by Kohn et 
al. 2004 and Dayan et al. (2009).
The data-set provided by the single-cell imaging provides us with an initial 
constraint with which to build the model around. The principle behaviour we 
attempt to capture is the hypoxia-induced transiency observed by both western 
blot and single-cell imaging (Fig 4.2 & Fig 4.4) We therefore needed to detail 
the oxygen sensitive regulation of HIF-a protein that can give rise to transiency. 
The favoured hypothesis is that the feedback actions of PHD2 and PHD3 convey 
this transiency; in which PHD2 is cited to exert the majority of regulation 
(Berra, Benizri et al. 2003). It was therefore decided to mathematically model 
this regulatory sequence. The PHD-mediated destruction of HIF-a protein is a 
multi-step process involving the proteins pVHL, Ubiquitin as well as the 26S 
proteasome multi-protein structure. We decided to disregard the role of 
ubiquitin and the 26S proteasome under the assumption that they are not 
limiting or dynamic due to their extensive role in cellular biology. Previous 
modelling efforts by Kohn et al. and Dayan et al. had determined HIF-ip to only 
weakly impact HIF-a accumulation. Also work by Chilov et al. 1999 found HIF- 
ip to not effect HIF-ia translocation to the nucleus. For these reasons we also
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disregarded explicitly modelling HIF-ip. Inhibition of FIH hydroxylase activity 
occurs in severe instances of hypoxia, remaining near fully functional in 
tensions below 1% 02 (Stolze, Tian et al. 2004). As our experimentation will 
only regard tensions from 20% to 1% we ruled out including FIH in the first 
incarnation of the model. Finally, pVHL was disregarded from the model 
abstraction on the assumption that the rate limiting step in HIF 02-dependent 
degradation is the hydroxylation of HIF-a and not ubiquitination (Berra, 
Benizri et al. 2003).
This leaves the model abstraction with the PHD proteins and the HIF-ia 
isoform. To further reduce the initial free parameter space, the HIF-a isoforms 
and PHD isoforms were reduced to a generic single form, a transcriptionally 
viable HIF-a and a feedback PHDgeneric. This model is referred to as the 2- 
component model (2C-model) or the generic feedback model, on account of the 
2 ordinary differential equations (ODEs) (Fig 4.15).
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Fig 4.15. Finalised HIF model abstraction. The signalling motif to model is depicted on the left 
with the corresponding ODEs (with described biological function) on the right.
4.2.6.1 Initial fitting of imaging data to 2C-model
After the 2C-model architecture was decided we could now begin to integrate 
our imaging data into the model framework. This work was carried out by 
Joseph Leedale, a PhD student of mathematics under the supervision of Dr. 
Rachel Bearon and Dr. Kieran Sharkey of the University of Liverpool maths 
department. Therefore my role in this section of work was peripheral, though 
there was a large degree of consultation and discourse between us. The aim for 
this body of work was to simulate the HIF-ia imaging data using the 2C-model 
to determine parameter values in process known as fitting (Fig 4.16). For this 
purpose the only parameter that was fixed was h, the parameter corresponding 
to the hydroxylation rate. To represent the switch from normoxia (21% 02) to
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hypoxia (1% 02) the h value was reduced by 87%, a value derived for PHD2 by 
Tuckerman et ah 2004. The reverse was performed to simulate re-oxygenation.
For the model to fit the hypoxic and re-oxygenation perturbations, the model 
requires a steady-state value to initialise from. As part of this fitting procedure, 
the pre-perturbation state of the model (the concentrations of yi and y2) was 
determined for each individual cell, calculated by using the mean values of all 
HIF fluorescence recorded before perturbation. After determining the initial 
conditions, it is then possible to perform the parameter search. This was 
performed using the matlab ‘fminsearch’ function; an algorithm that searches 
for the minimum values of several variables in order to recapitulate a numerical 
solution, in this instance to find the minimum values of model parameters 
needed to trace our experimental data. As only HIF-a fluorescence was imaged, 
the kinetics and response of PHD in relation to HIF-a are left open and 
unconstrained. For the model to aptly account for this, PHD was rescaled by the 
hydroxylation rate resulting in the equation;
dy1
dt
S ay2
/------------A—\
yi
Y1 + Y
\ /
dy2
dt
khNy1 dy2
A series of fitting was then performed; initially parameter estimates were fitted 
to the single-cell imaging of hypoxic transiently responding HIF-ia cells without 
constraint (n = 11 cells) (Fig 4.16). The parameter estimates were then used in 
a constrained round of fitting for all HIF-ia confocal imaging data, allowing up 
to a 50% shift in value from the median value of the original estimates. For this 
purpose the median values were used over the mean due to the order of 
magnitude variance of parameters and thereby the excessive weighting of 
outliers. The median was also considered acceptable as the parameter estimates 
indicated an observable median consensus. Evaluation of the parameter 
variance showed the most deviation for y, followed by d, s and then k. The 
second round of fitting elucidated the final parameter set to be used to finalise 
the 2-component model (Table 4.1).
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Fig 4.16. Results for the fitting of the 2-component model to single-cell HIF-ia imaging data. 
(A) Shows initial unconstrained fitting of the model to eleven cells from the single-cell hypoxic 
imaging data of HIF-ia transiently accumulating cells. (B) Values derived from the 
unconstrained fitting were used for the constrained fitting of all single-cell HIF-ia imaging. 
Only values within 50% of the initial estimates were allowed. The hypoxic and re-oxygenation 
data sets are indicated, with an additional line break to indicate repetition of data (data together 
totals 88 cells).
For both rounds of fitting, a criteria was established to determine a good fit or 
bad fit. An envelope was drawn around each measured cell trace, using the 
equation;
EXP(t) ± P * (max(EXP)-min(EXP))
P = 0.35 (width of error envelope)
EXP(t) = Fluorescence levels at a given time point
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Fig 4.17. Model fitting solutions were compared against the experimental data. To determine a 
good fit versus bad fit an error envelope was defined around the experimental data. If the fit fell 
outside of this envelope for several time points, the fit was considered bad.
Fits deviating outside of this envelope for a defined number of data points 
relevant to the time-course, were considered bad. Using this criteria, all 11 cells 
from the initial unconstrained fitting were considered good (Fig 4.17). The 
constrained fitting resulted in 79% (n= 31/39 cells) good fits for the hypoxic 
data set and 74% (n = 31/42 cells) good fits for the re-oxygenation data set.
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Parameters Units Value
s ‘synthesis rate' AUmin'1 5.14
Y ‘saturation function ’ AU 1.83 x 104
K ‘Induction rate' min'1 7.10 x lO"4
d ‘Degradation rate' min'1 7.07 x lO*4
Table 4.1. Table of parameters, units and values fitted in the 2-component model.
The parameterised model was then used to simulate perturbation by exposure 
to hypoxia (reducing 20% 02 to 1% 02) and also the reverse re-oxygenation (Fig 
4.18). The hypoxic profile showed a HIF accumulation profile qualitatively 
maintaining a transient accumulation. Transiency in both HIF and PHD settled 
to a new steady-state 24 hours after perturbation. The model output for re­
oxygenation showed the rapid loss of HIF-ia, with a half-life of 25.8 minutes, a 
value very comparable to the 26 minutes observed experimentally (measured in 
section 4.2.5.2) After re-oxygenation, the model finally reaches a steady-state 
solution after 40 hours. The 2C-model was deemed to behave appropriately, in 
line with measurements and thereby can be used for further analysis.
----- hifia
------PHD2
0 60 120 1S0 240 300
Tlmo (min)
Fig 4.18. The 2-component model was used to simulate HIF-ia and PHD2 levels responding to 
a hypoxic perturbation (1% 02) and a re-oxygenation event, in which the simulation details the 
HIF system at a steady-state solution in 1% 02 before re-oxygenation back to 20.8% 02.
4.2.7 Heterogeneity and cell cycle
The model has been informed by our single-cell imaging data of HIF-a 
dynamics following hypoxic and re-oxygenation events. The model does not 
attempt to recapture all events seen, especially with regards to the heterogeneity 
observed. The experiments described in the following section attempt to 
validate and quantify the heterogeneity, while also investigating potential 
sources. These results were designed to impact our decision at including 
descriptions of heterogeneity in future model expansions.
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4.2.7-1 A Cell-cycle component explains some heterogeneity in 
response time
The known molecular mechanisms governing the 02-dependent accumulation 
of HIF-a do not lend to response-time heterogeneity as seen by wide-field 
luminescence of the HRE-reporter and time-lapse imaging of fluorescent HIF-a. 
Especially given the sharp profile of the transient accumulations imaged.
The confocal data set afforded us one important observation; often cell division 
preceded the nuclear accumulation of HIF-a fluorescence (Fig 4.19). We re­
evaluated the data-set in this context and found that 50% of the responding cells 
(for both a-isoforms) fell into this category, in which fluorescence accumulation 
occurs within 3-hours after cytokinesis. The asynchrony of cell division 
therefore drives some of the asynchrony in HIF-a accumulation; this 
mechanism partially explains some of the heterogeneity observed. This evidence 
suggested that if the cells were to be cell cycle synchronised, so to would a large 
portion of the HIF accumulations be synchronised.
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Fig 4.19. (A) Time-lapse images of HeLa cells ectopically expressing either pG-HIFiaEGFP or 
pG-EGFP-HIF2a as well as a DsRedxp unfused control. The point of cell division is indicated in 
text. (B) Transiently accumulating cells were classified as occurring within 3 hours after 
metaphase (post division response) or not (other). (C & D) Corresponding traces of nuclear 
fluorescence for representative cells where to is the division time.
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4.2.7-2 Double Thymidine Block synchronises HIF response
The cell cycle can be chemically synchronised using a method referred to a the 
double thymidine block (Whitfield, Zheng et al. 2000). The addition of 
extraneous thymidine to a cell culture disrupts the normal ratio of dNTPs and 
this promotes problems with the fidelity of DNA replication, causing either Gi/S 
checkpoint arrest or apoptosis depending on the genetic status of the cell line 
(Hyland, Keegan et al. 2000; Pietenpol and Stewart 2002). HeLa cells were 
synchronised using the double thymidine block protocol, during which cells 
were also transfected with the expression vectors pG-HIFiaEGFP and pG- 
DsRedxp. Cells were released from cell cycle arrest and immediately imaged in 
hypoxic conditions (1% 02). The nuclear fluorescence levels of suitable cells 
were quantified using Cell Tracker. Cells were found to only accumulate HIF-ia 
after cell division, which occurred on average 7-hours after release from the 
thymidine block (Fig 4.20). All visualised responses were transient and 
occurred with a tightly constrained duration with an average time of ~4hrs, a 
value comparable with the non-synchronised data. The time-to-ist-response was 
more constrained than seen in previous asynchronously dividing cells, occurring 
with a normal distribution around 9-hours. The majority of variance in response 
time was attributable to variance in division time, as even with chemical 
synchronisation the timing of cytokinesis spanned approximately 2-hours. A 
recent publication by Hubbi et al. 2011 has produced exciting evidence to 
suggest this link between the HIF system and the cell cycle, citing that the MOM 
proteins act as negative regulators on HIF stability (Hubbi, Luo et al. 2011). 
However, within our own data the validity of this claim remains unclear due to 
the use of the transient transfection with cationic lipid. Cationic lipid 
transfection reagents such as FuGene use the cell-cycle nuclear envelope 
breakdown to gain access and deliver plasmid to the nucleus. Therefore 
transfection occurs in a cell-cycle dependent fashion in which the newly 
acquired plasmid is first expressed during mitosis (Zabner, Fasbender et al. 
1995). This mechanism would account for the occurrence of HIF-aEGFP 
accumulation within 3 hours of cytokinesis, the criteria used to determine a HIF 
cell cycle related response.
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Fig 4.20. Results for the live-cell confocal imaging of HIF-iaEGFP expressing cells, chemically 
synchronised in the cell cycle to G0/G1 (A) Confocal images of HIFiaEGFP fluorescence with 
time indicated in hours. The corresponding average cell cycle progression is shown. (B) 
Representative plots of EGFP nuclear fluorescence intensity with the average division time of 
the cells indicated. Box-and-whisker plots of data; (C) time to 1st response and (D) 1st peak 
duration for all imaged cells.(n=i repetition)
4.2.7.3 Transient-transfection as a source of heterogeneity
As well as potential cell cycle artefacts, transient transfection has the capacity to 
introduce a degree of heterogeneity as the method may load uneven quantities 
of plasmid into individual cells. This would lead to different expression levels 
from cell-to-cell and thereby varying initial concentrations of exogenous 
protein. Varied protein levels are a source of heterogeneity (Cohen, Kalisky et al. 
2009). Typically the impact of this heterogeneity is experimentally reduced by 
imaging cells displaying a similar signal level, using the assumption that signal 
level corresponds to plasmid concentration. However a technical difficulty 
prevented us taking the same precaution when imaging the HIF system. Prior to 
hypoxic stimulation HIF-a is extensively degraded and the fluorescent form 
near undetectable (in most cases). Those cells that showed sufficiently 
detectable HIF in normoxia may not be a suitable and are perhaps a 
consequence of saturated degradation arising from overexpression, possibly 
stabilised from a number of 02-independent crosstalk events (outlined in Table 
1.2) or are currently transfecting, a scenario in which fluorescent HIF protein is 
initially expressed before being reduced by the activity of the feedback 
mechanisms. To counteract these issues for confocal microscopy cells
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expressing an unlabelled DsRedxp fp were selected and imaged, thereby 
removing a degree of bias. To achieve this, cells were co-transfected with a 
DsRedxp encoding plasmid and a separate HIF-a encoding plasmid. 
Unfortunately, the plasmid content of DsRedxp is not expected to correlate well 
with the plasmid content of HIF-a and therefore red fluorescence was not used 
as a proxy for HIF-a expression level.
To address the myriad of concerns with transient transfection, we aimed to 
produce cells stably expressing fluorescent for HIF-ia and HIF-2a. HeLa cells 
were transfected with either pG-HIFiaEGFP or pG-EGFPHIF2a in a 75cm2 
flask using FuGene 6. After 48 hours of transfection, the cell media was replaced 
with selection media containing img/ml G418 sulphate. After 2-3 weeks the 
majority of cells had died and small colonies had begun to form. At this point 
cells were trypsinised from the flask, counted and plated into 96-well format at 
a density of 1 cell/well. From this we started with an initial selection of 192 
clones each for HIF-iaEGFP and EGFPHIF-2a. After a week of growth, clones 
were inspected by light microscope, selecting 24 clones to propagate for each 
transfection. At this point cells had grown sufficiently to be assayed for stable 
expression of the fluorescent HIF-a isoforms.
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Fig 4.21. Clones of HeLa cells (named as ‘letter’+’number’) stably expressing either HIF- 
laEGFP or EGFHIF-2Q were assessed for HIF-a, PHD2 and EGFP mRNA via qRT-PCR. All 
clones examined were found to have suppressed EGFP mRNA below detectable limits. Control 
samples were prepared from HeLa cells ectopically expressing EGFP.
Eight clones for each condition were grown in 6cm format and then lysed and 
samples prepared for RT-qPCR. Unfortunately, all were found to have 
suppressed the expression of EGFP below detectable limits (Fig 4.21).
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Nevertheless, we remained interested to estimate the heterogeneity in the 
system using stable expressing cells. Fortunately, a cell line stably expressing 
HRE-luciferase (C51 mouse carcinoma cells) were kindly donated by Dr S. 
Lehmann and Prof. R. Wenger. C51 cells were plated and prepared for imaging 
by wide-field luminescence and then imaged either at 1% 02 or atmospheric 02. 
The luminescence levels were quantified at the single-cell level using AQM 
kinetic tracker. From this data, we can contrast to the transient transfection of 
HeLa cells using the pGL2-tk-HRE-luciferase vector in Fig. 4.10. Here we 
found the response time to be more homogenous and still transient (Fig 4.22).
Time (hrs)
Fig 4.22. (A) Wide-field luminescence imaging of C51 mouse carcinoma cells stably transfected 
with a HRE-luciferase reporter plasmid. Cells were imaged either in atmospheric 02 of hypoxic 
conditions of 1% 02. Luminescence levels of responding cells were automatically measured using 
AQM kinetic tracker software. (B) Single-cell traces for 5 representative cells are shown.
4.2.7.4 Cloning fluorescent fusion reporters of HIF-ia ODD domain
Overexpression of HIF-a induces a significant degree of cell death and is 
therefore one argument against the use of these constructs (as shown in Fig 
4.13) The increased cell death or sensitivity to cell death indicates that the 
overexpressed cell does not function entirely as it would in a native state. This is 
further confirmed when examining the effect of ectopic expression HIF-a upon
113
the HRE-luciferase, the signal is significantly higher than control cells 
expressing unlinked EGFP (shown previously in Fig 3.11). HIF signalling is 
therefore higher than the native, untransfected state and thus the negative 
feedback may be over represented. The over representation of the PHD2 and 
PHD3 feedback, coupled with the different expression levels associated with the 
transient transfection method may experimentally introduce a degree of 
heterogeneity. To address some of these issues we decided to make a plasmid 
vector expressing a reporter of HIF-ia (^dependent stability which was 
transcriptionally inert. This new molecular tool could then be used to enhance 
the data of the current study as well as function as a suitable Oa-sensor for other 
studies. To achieve these goals we decided to clone several portions of the HIF- 
la sequence without including the DNA binding domain. This approach has 
been previously been used in the generation of hypoxic reporters, often coupling 
the ODD domain to an EGFP (D’Angelo, Duplan et al. 2003; Kuchimaru, 
Kadonosono et al. 2010). A similar system has been commercialised for 
investigation into cell cycle progression, fusing fluorescent proteins to 
degradation domains of several cell cycle proteins (Sakaue-Sawano, Kurokawa 
et al. 2008). As this study is one of the first to concentrate on the kinetics of the 
transient accumulation of HIF-ia, these previous tools have not been validated 
in this context. We aimed therefore to clone several versions of the HIF-ia 
coding sequence, preserving the ODD domain in each. Three versions were 
cloned using the gateway procedures outlined in chapter 3; the first version 
includes residues 217 aa - 374 aa (termed pG-ODD-EGFP), preserving only the 
first P402 hydroxylase site; the second version is extended to include the P564 
hydroxylation site, taking from residues 271 aa to 652 aa (termed pG-frODD- 
EGFP). Both these two forms lack the nuclear localisation domain, found in the 
c-terminal, this may have implications for the correct degradation of the protein 
(Fandrey, Gorr et al. 2006; Chachami, Paraskeva et al. 2009; Nakayama, Qi et 
al. 2009). A final version therefore was cloned, including almost all coding 
sequence except the DNA binding domain, including therefore residues 217 aa - 
826 aa (termed pG-nucODD-EGFP) (Fig 4.23.). To assess the impact of the 
ODD expression vectors on HIF signalling, all three plasmids were transfected 
into HeLa cells alongside the pGL2-TK-HRE-luciferase for 24-hours. After this 
period, samples were lysed, prepared and analysed by endpoint luminometry. 
No induction of the HRE-luciferase was detected, confirming the loss of
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transcriptional activity (Fig 4.23). All expression plasmids were then 
transfected into HeLa cells and imaged by confocal microscopy, assessing the 
localisation in normoxic conditions. As to be expected, the ODD-EGFP and 
frODD-EGFP expression was mostly detected in the cytoplasm and the 
nucODD-EGFP predominantly found to be localised to the cell nucleus (Fig
4.23O.
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Fig 4.23. (A) Protein domain structure of full length HIF-ia and the ODD-variants. (B) 
Luminometiy measurement of HeLa cells co-expressing the HRE-luciferase reporter and either 
an ODD-variant, an unfused EGFP expression vector or full length HIF-iaEGFP. (C) Live-cell 
confocal microscopy of HeLa cells expressing either an EGFP fused ODD-variant or full length 
HIF-iaEGFP imaged 24-48 hours after transfection. Scale bar denotes logins.
4.S.7.5 Confocal imaging of ODD-EGFP
In the time-line of this project, these endeavours were towards the end and so 
results remain in the preliminary stages, therefore only the ODD-EGFP 
response kinetics have been investigated to date. HeLa cells were plated into 
35mm dishes and transfected with the ODD-EGFP expression vector for 24- 
hours, then imaged by confocal microscopy, imaging either at atmospheric 02, 
1% 02, treated with o.smM DMOG or imaging through re-oxygenation (back to 
atmospheric 02) following 6-hours at 1% 02. All fluorescence levels were 
quantified using Cell Tracker. Dynamic changes in fluorescence were evident 
within the normoxic control (n= total 8 cells), further supporting the previous 
data suggesting a degree of normoxic stabilisation witnessed both by confocal 
imaging of the HIFiaEGFP and wide-field luminescence imaging of HRE- 
luciferase (Fig 4.24). Several 02-independent mechanisms of HIF regulation
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have been postulated, but the dynamic response of the ODD-EGFP reporter 
suggests that these can be integrated through the protein stability of just the 
ODD domain; also of note was the transient accumulation of fluorescence 
following cell division (Li, Wang et al. 2005; Liu, Baek et al. 2007; Liu, Xin et 
ah). Hypoxic imaging of the ODD-EGFP showed fluorescent levels to 
accumulate (n = 28 of 34 cells), although the distinctive sharp peak present 
when imaging full length HIF-ia was lost, replaced with a broader curve. Four 
of the total 34 cells were also found to show multiple accumulations. In contrast 
to our previous experiments, here we also used DMOG treatment to stimulate 
the accumulation of ODD-EGFP. A transient profile was present and the 
response profile found to be homogeneous, reaching peak max at 300 minutes. 
Finally, the kinetics of re-oxygenation degradation of ODD-EGFP were 
measured, in which a broader range of half-lives were found for the ODD-EGFP 
compared to the full length HIF-ia results (attained earlier in section 
4-2.5.2). An average of 100 minutes was observed for the ODD-EGFP 
compared to 28 minutes for full length HIF-ia. The different kinetics observed 
throughout the imaging of ODD-EGFP are explainable by the lack of pro564 
hydroxylation site, as it was reported by Chan et al. 2005 that pro564 is 
necessary for efficient 02-dependent destabilisation of HIF-ia (Chan, Sutphin et 
al. 2005). This hypothesis will be tested in future work by imaging the frODD- 
EGFP, which contains both P402 and P564 hydroxylation sites. Finally, when 
imaging re-oxygenation using the ODD-EGFP only 10.5% (n = 2 of 19 cells) were 
observed to die compared to 73.75% (n = 64 of 87) for full length HIF-iaEGFP. 
These preliminary results highlight the potential usefulness of the ODD reporter 
constructs for future work investigating the single-cell response.
116
15hrs |30hrs
1%02 c| 21% C) 1 O.smM DMOG
I 0 hrs I 6 hrs I 22 hrs I 0 hrs I 6 hrs I 15 hrs
Time (min)
Time (min)
Time (min)
E
No Of CoHf %d.d
EQFF 04 0 26.61
HP1«EQFP 80 87 73 70
ODO-E0FP 10 70 OS 1063
F Re-oxygenation half-lives
•5 200
MIMA
Fig 4.24. HeLa cells were transfected with pG-ODD-EGFP for 24-48 hours before imaging by 
confocal microscopy. (A-D) Representative images and several quantified traces of cellular 
fluorescence are shown for each condition. Scale bar denotes 50pm. Conditions used were (A) 
atmospheric 02 for ~48 hours, (B) atmospheric 02 for i-hour followed by 20-hours of 1% 02 (C) 
atmospheric 02 for i-hour followed by 16-hours o.smM DMOG treatment and (D) a re­
oxygenation switch in which cells are incubated on the microscope stage at 1% 02 for 6-hours 
and then returned to atmospheric 02. (E) Shows the percentage cells died and where
fluorescence was reduced following re-oxygenation, comparing unfused EGFP, HIFiaEGFP and 
ODD-EGFP transfections. (F) Shows the calculated half-life of fluorescence following re­
oxygenation, comparing HIFiaEGFP against ODD-EGFP transfections.
4.3 Discussion
In summary, here we have undertaken the task of live-cell imaging of 
fluorescently labelled and ectopically expressed HIF-ia and HIF-2a in HeLa 
cells, exposed to either hypoxia or the reverse scenario, re-oxygenation. To our 
knowledge this is the first time the HIF-a system has been assessed for 
intracellular dynamic properties, as previous studies have made either tissue 
resolved measurements or have assessed protein binding using FRET studies 
(Serganova, Doubrovin et al. 2004; Liu, Qu et al. 2005; Wotzlaw, Otto et al. 
2007; Choi, Chan et al. 2008; Konietzny, Konig et al. 2009). Our data have 
provided several insight into possible novel understandings of the HIF system; 
(1) ectopically expressed HIF-2Q is similarly sensitive to oxygen as HIF-ia and 
HIF-2a dynamics may mask bulk-cell measurements (2) the possibility that a 
rich-assortment of single-cell accumulation patterns contributes to a 
population-wide response to hypoxia (3) that the duration of transient
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accumulation was found to be robust indicating it may be an important property 
(4) and finally that a simple 2C mathematical model of a transcription factor 
directed feedback loop is sufficient to explain the majority of transient response 
profiles. The next chapter continues the work investigating HIF transiency and 
the PHD feedback, so several issues arising from this chapter are discussed 
later. However, a prominent feature of our single-cell data here was the 
manifestation of cell-to-cell variance. Our findings with regard to this will be 
discussed.
4.3.1 Heterogeneity and Asynchrony in the HIF system
An emerging paradigm shift is an appreciation of the role of cell-to-cell 
variability, especially in managing a robust population-wide response 
(Rausenberger, Fleck et al. 2009; Paszek, Ryan et al. 2010). It is therefore 
considered that heterogeneity is an important feature in many biological 
processes. Cell-to-cell variance was a prevalent part of the single-cell imaging 
data-set within this thesis, evident via the imaging of HIF-a protein and HRE 
transcriptional response. Such cellular heterogeneity is readily discernible via 
the time-lapse imaging of single living cells. This means the techniques 
employed here can offer powerful insights into fundamental aspects of cellular 
processes, albeit caution must be taken without corroborative evidence. It is 
therefore important to assess the validity and extent of the observed cell-to-cell 
variability in the HIF system and comment on the possible sources. A 
relationship between the cell cycle and HIF has been reported several times, 
though solely on the influence HIF-1/-2 has on cell cycle progression, cited that 
HIF-ia induces Gi/S arrest and HIF-2a promotes progression (Hackenbeck, 
Knaup et al. 2009). Only veiy recently has the reverse scenario been proposed, 
in which the cell cycle phase influences both HIF-a signalling. A paper 
published by Liu et ah in 2010 reports that pVHL protein levels vary during the 
course of cell cycle, though our own data fails to support this (data not shown). 
More recently a paper published by Hubbi et al. 2011 has suggested that the cell 
cycle phase influences both HIF-a protein stability and transactivation via the 
activity of the MCM proteins (Hubbi, Luo et al. 2011). The paper also reports 
that the activity of HIF affects the expression of a subset of the MCM proteins, 
presenting then a complex arrangement of feedbacks. These results lends 
credence to our own findings that the cell cycle stage has a role to play in HIF 
protein stability, although more ideally explored without potential artefact from
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transient transfection (Zabner, Fasbender et al. 1995). The conceptual 
relationship between the cell-cycle and the HIF system remains an interesting 
and plausible scenario, in which the cell balances proliferation against hypoxic 
responsiveness. Regardless, the cell cycle only partially explained the 
asynchrony and heterogeneity observed. Transient transfection was identified as 
a further source of heterogeneity, introducing different protein expression at 
both the level of HIF and downstream feedback motifs (Cohen, Kalisky et al. 
2009). In spite of this, a degree of asynchrony was seen when imaging cells 
stably expressing HRE-luciferase (Fig 4.22). We would speculate that this 
asynchrony arises from a combination of cell-tocell variance in crosstalk 
mechanisms (extrinsic events) and stochastic processes (intrinsic events). There 
are numerous routes for crosstalk with the HIF system and other signalling 
systems. And as prior mentioned, cell-to-cell variance at the protein level is to 
be expected, it can therefore be expected that several of the crosstalk 
mechanisms are operating at different levels, sensitising the HIF response 
differently between different cells (Cohen, Kalisky et al. 2009; Majmundar, 
Wong et al. 2010). Additionally, stochastic processes may also contribute to the 
measured heterogeneity and asynchrony. Stochasticity arises from processes 
revolving around small numbers in which the probability of an interaction is a 
dominant/important characteristic. The opposite appreciation is determinism, 
in which there are sufficient numbers of species interacting to treat the process 
as an average. In cell biology two common sources of stochasticity are receptor 
activation and gene expression (Alarcon and Page 2007; Lipniacki, Puszynski et 
al. 2007) (Cai, Friedman et al. 2006); of these only transcription is relevant to 
HIF signalling. The stochasticity of protein expression exists as a consequence 
of the low copy number of genes (normally 2) and mRNA (-ixio2 molecules) 
(Cai, Friedman et al. 2006). From this we could expect a degree of asynchrony 
in the accumulation of both HIF and PHD. This concept is in line with the 
relative homogeneity of the half-life for loss of HIF-a protein following re­
oxygenation, as the degradation of protein falls more into the realms of 
determinism (Chen, Niepel et al.).
4.3.2 Response kinetics; transient duration and possible 
implications
In stark contrast to the extensive heterogeneity observed, the duration of the 
transient response was found to be robust. This is an easily identifiable
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temporal signature of the HIF-a response, indicating that hypoxia-induced gene 
expression via HIF is time limited in response. This has been proposed to be 
protective and enacted by the feedback activity of PHD2 (Ginouves, lie et al. 
2008; Henze, Riedel et al.). Biological systems are capable of encoding 
meaningful information in a numbers of ways; a commonly appreciated form is 
in the amplitude of a response (Roach, Lee et al. 2005; Turner, Paszek et al. 
2010; Schodel, Oikonomopoulos et al. 2011). However, there is an emerging 
appreciation and hypothesis for the ability of temporal kinetics to carry more 
contextual information (Nashat and Langer 2003; Banerjee and Slack 2005; 
Behar, Hao et al. 2008). The duration of HIF-a accumulation may therefore be 
an important aspect to the phenotype of the response, assuming that 
modulation of the duration of the response is possible. The observed cell-to-cell 
variance in response kinetics supports the possibility of modulation, in which 
the slow and persistent accumulation of HIF-a will lead to a varying duration of 
gene expression. The characterisation of transiency in both the accumulation 
and transactivation profile of HIF-a is far from novel and has been shown to 
occur at the population-wide response in several studies (Stiehl, Wirthner et al. 
2006; Moroz, Carlin et al. 2009). However, the high-resolution imaging of HIF- 
a transiency is conducive to the development of a mathematical model, 
providing us with a tool to better explore the feedback responsible for transient 
HIF-a; previous HIF modelling attempts have suffered from lack of available 
suitable data as suggested by Heiner and Siriam 2010 (Heiner and Sriram 
2010). Our imaging data set alongside the feedback model encourages a novel 
appreciation of the meaning and implication of the temporal arrangement of 
HIF signalling. Several studies over the last decade have begun to suggest ways 
in which duration of transcription factor activity can translate to phenotypic 
consequences. The two encompassing modes-of-action occur at the level of gene 
expression and/or in the threshold response to levels of protein (Vousden 
2006).
The genomic landscape is dynamic, switching between active and inactive 
conformations bound at different times to different proteins and complexes 
(Xie, Yang et al. 2007). Over the course of transcription factor activation, the 
genomic landscape can therefore change leading to different gene expression 
(Boellmann, Zhang et al. 2010). In support the possible role of HIF in this level 
mechanism, HIF has been several times cited to affect the histone
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acetyltransferases and histone deacetylases, modulators of chromatin (Johnson 
and Barton 2007). Specifically, it has been reported that jumonji domain 
containing la (JMJDiA) is a HIF-target gene and which acts to alter the 
epigenetic status of a subset of other HIF genes, thereby creating a feed-forward 
method in which HIF gene expression is altered over time (Perez-Perri, Acevedo 
et al. 2011). Alternatively, the duration of activation of a transcription factor 
such as HIF may exert different phenotypes through the triggering of 
downstream protein sensitive thresholds (Callus, Moujallad et al. 2008). For 
example, ongoing expression of a pro-apoptotic protein will need to occur for a 
specific period of time until a threshold decision is reached and the cell commits 
to apoptosis. This has been demonstrated by Schwartz et al (2011) in 
glutocorticoid signalling of cell death (Schwartz, Sarvaiya et al. 2010). Whether 
these concepts are important with regards to HIF-signalling hinges upon 
whether or not the duration of HIF accumulation can be physiologically or 
pathologically altered to a significant enough degree. In the introduction of this 
thesis, the differing ways a hypoxic episode may take place was discussed. The 
insult was described to occur in an acute, prolonged or intermittent manner. 
This represents a very simple way to modulate the duration of the hypoxic 
episode, possibly resulting in differing durations of activated HIF signalling.
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Chapter 5: Dissecting the role of the 
individual PHD proteins on the transient 
accumulation of HIF-a
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5.1 Introduction & Aims
The accumulated results from the previous chapter directed the abstraction and 
parameterisation of a 2-component model detailing the HIF-PHD negative 
feedback motif. However, the data underpinning this has focused only on the 
measurement of the HIF-a component. To increase the fidelity of the model an 
approach was devised to measure parameters pertaining to the PHD feedback. 
Currently the model-described-feedback is a concatenation of all PHD proteins, 
and so the relation of experimental measurements into model terms is difficult 
as we are unable to directly measure the concatenation of parameters with 
confidence. The next rational step was therefore to separate the model- 
described-feedback into the separate PHD components, detailing each 
individual protein.
5.1.1 Sensitivity analysis of 2C-model to support aims
The rationality for this step was further strengthened as parameter analysis of 
the 2-component model indicated that the most sensitive values were both the 
PHD induction rate (k) and PHD protein degradation rate (d) (Fig 5.1) A PHD- 
resolved model can act as a starting point in understanding the role of the 
individual PHDs and the consequences of their pharmacological 
inhibition/induction. This is relevant to the large amount of work designing 
pharmacological agents targeting downstream HIF activity. A common way to 
achieve this is via the targeting of PHDs (Nangaku, Kojima et al. 2006; 
Niatsetskaya, Basso et al. 2010; Smith and Talbot 2010). For all these reasons, 
the model was expanded into a 4-component form describing a generic 
transcriptionally active HIF-a interacting with or influencing PHDi, PHD2 and 
PHD3. This model is referred to as the 4C-model or resolved PHD model.
5.1.2 Expanded model architecture; The resolved PHD model
The expansion of the 2C-model requires little re-formulating of the model 
architecture. The abstractions generally remain untouched for all species 
involved; protein and mRNA remain constrained as a single entity (Fig 5.2). 
The ODE depicting HIF-a (dx/dt) has been expanded to incorporate the 
degradation from the hydroxylase activities of all 3 PHD proteins. This in turn 
requires the resolution of several parameters. The hydroxylation rate now has 
three terms, hi, h2 and I13.
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Fig 5-1- Parameter sensitivity analysis of the 2C-model. Parameter values S, k, y and d were 
altered and the corresponding response profile for HIF-a plotted for both hypoxic and re­
oxygenation simulations. Equilibration value was normalised to 1. (NB. This parameter 
sensitivity was performed on a previous fitting of the 2C-model. Though the parameter values 
have now changed the sensitivity remains the same for the current parameterisation)
Previous publications have suggested the hydroxylation rate to be different 
between the three PHDs and so to take this into account it was necessary to 
separate these terms (Tuckerman, Zhao et al. 2004; Stiehl, Wirthner et al. 
2006). In contrast, the saturation function for all three PHDs is maintained 
using the single parameter y. The rationale behind the use of a single y is the 
apparent insensitivity of the term, having a more qualitative function than 
quantitative (Fig 5.1). Finally, the ODE detailing the generic PHD has been
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resolved to three separate ODE’s describing non-inducible PHDi (yi/dt), 
inducible PHD2 (y2/dt) and inducible PHD3 (ys/dt). This gave rise to an 
important change to the architecture of the model; in the previous model PHD 
synthesis was solely attributable to HIF-a. The inclusion of PHDi and the aim to 
quantify PHD2 and PHD3 inducibility led us to include a synthesis rate for each 
PHD, Si, S2 and S3.
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Fig 5-2. The ODE’s for the resolved PHD model are shown with the corresponding biological 
process highlighted underneath. (Right) A diagrammatic representation of the resolved PHD 
model.
5.2 Results
5.2.1 New molecular tools to investigate PHD feedback
5.2.1.1 Functionality of PHD fluorescent fusion expression vectors
Ideally the 4-component model would be parameterised against single-cell data 
in the same vein as for the HIF-ia component. In order to do this, we aimed to 
attain and validate the use of fluorescent fusion vectors for PHDi, PHD2 and 
PHD3. All three expression vectors were kindly donated to our lab courtesy of 
Dr. Eric Metzen (PHDi and PHD3) and Professor Reinhard Depping (PHD2). 
All PHD expression plasmids were transfected into HeLa cells and the 
localisation of the protein assessed by live-cell confocal microscopy (Fig 5.3). 
As has been previously shown by Metzen et al. (2003), we found PHDi to be 
strongly localised to the cell nucleus, PHD2 to be predominantly cytoplasmic 
and PHD3 to be ubiquitous throughout the cell (Metzen, Berchner-
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Pfannschmidt et al. 2003). Also observed for the expression of PHD3, were 
small punctate fluorescent speckles found in the cytoplasm. A 2008 publication 
from Rantanen et al. have shown this localisation for PHD3, suggesting these 
structures to be oxygen-dependent aggregates related to the proteasomal 
machinery (discussed further in chapter 6) (Rantanen, Pursiheimo et al. 2008). 
To further confirm the functionality of the expressed fluorescent PHD proteins, 
endpoint luminometry was used to assay the effect of co-expression of the PHD 
fusion vectors alongside the HRE luciferase reporter. HeLa cells were plated 
into 24-well plates at a density of 1x105 cells per ml and a volume of 0.5ml per 
well. Cells were then transfected to co-express the HRE-luciferase together with 
either PHDi-EGFP, PHD2-EGFP or PHD3-EGFP. After 24 hours transfection, 
cells either remained un-stimulated or were additionally treated for 6-hours 
with o.smM DMOG or incubated at 1% 02. After this period, cells were lysed 
and samples analysed by luminometry (Fig 5.3).
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Fig 5*3* (A) Confocal images of HeLa cells ectopically expressing fluorescent fusion PHD 
isoforms. (B) Endpoint luminometry assay of samples prepared from cells co-transfected with 
pG-TK-HRE-luc and a PHD isoform expression vector then further treated with either o.smM 
DMOG or 1% 02 for 8 hours. (n=i repetition performed in triplicate)
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Co-expression of all PHD vectors reduced the stimulated induction of the HRE- 
luciferase reporter compared to the EGFP control. For the unstimulted 
condition, no significant difference was observed between the co-expression of 
the PHDs versus the unfused EGFP. This may suggest that the hydroxylase- 
dependent degradation has reached maximal rate and that the addition of more 
PHDs are surplus to requirement. In hypoxia all PHDs were seen to reduce 
luciferase signal equally, although when stimulating the cells with DMOG, PHDi 
was seen to reduce HRE-luciferase to the greatest degree, followed by PHD2 
and then PHD3. This is perhaps surprising given that PHDi has been cited to 
only weakly hydroxylate HIF-a compared to PHD2 and PHD3 (Appelhoff, Tian 
et al. 2004; Tuckerman, Zhao et al. 2004).
5.2.1.2 Generation of HIF-inducible PHD2 and PHD3 expression 
plasmids
In this chapter we aim to image the PHD2 and PHD3 feedback kinetics using 
fluorescent fusion expression plasmids. However, whereas HIF-a accumulation 
kinetics are determined at the protein level phd protein accumulation requires 
mRNA upregulation and therefore the CMV promoter is unsuitable to drive 
expression. To address this we proposed to replace the CMV promoter of the 
PHD fluorescent fusion vectors with a HIF inducible promoter, either proximal 
promoters or consensus promoters. As consensus reporters only have a 
minimum amount of promoter architecture (~5-i5bp) the preferential aim was 
to synthesise expression vectors that use a functional proximal promoter 
sequence (~i00-4000bp). Two luciferase reporter plasmids were purchased 
from SwitchGear Genomics that contain looobp sequences upstream of the 
transcriptional start sequence for PHD2 and PHD3. Before using these 
sequences as templates to generate inducible PHD expression vectors, the 
luciferase reporters were assessed under hypoxic stimulation for up to 24 hours 
by endpoint luminometry (Fig 5.4). HeLa cells were transfected for 24 hours 
with either PHD2~luciferase or PHDs-luciferase. Samples were then introduced 
at staggered time-points over the course of 24-hours into a 1% 02 hypoxic 
chamber. After incubation cells were lysed simultaneously and samples 
prepared for endpoint luminometry analysis. PHD2-luciferase was found to 
significantly increase after 8 hours of incubation whereas no significant 
inducibility was seen when using the PHD3-luciferase. This is in accordance 
with the literature, which indicates that the functional PHD2 HRE consensus is
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o.skb upstream of the translational start site and the functional PHD3 HRE site 
is I2kb away, therefore outside of the looobp proximal promoter sequence 
contained within the PHD3-luciferase (Metzen, Stiehl et al. 2005; Pescador, 
Cuevas et al. 2005).
Concluding from these results, a HIF-inducible PHD2 fusion vector was made 
using the looobp proximal promoter from PHD2-luciferase as a template and 
this sequence was used to replace the existing CMV promoter from the pPHD2- 
EGFP expression plasmid; this new plasmid is termed p-pro-PHD2EGFP. 
However, we decided against doing the same using the PHDs-luciferase signal 
as the promoter architecture was shown to be hypoxia insensitive (Fig 5.4). For 
future work, there are several options available to enable the imaging of the 
PHD3 feedback. Firstly a bacterial artificial chromosome could be employed and 
this would have the advantage of endogenous promoter architecture, 
encompassing on an average 200kb of sequence (Tunster, Van De Pette et al. 
2010). However, there are disadvantages with this approach, most notably the 
construction of a fluorescent protein expressing BAG is considerably more 
difficult and time consuming than a plasmid (Adamson et al. 2011, in 
preparation). For this purpose I have disregarded the imaging of the PHD3 
feedback within the timeframe of my own project.
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Fig 5.4. Endpoint luminometry assay of samples prepared from HeLa cells that had been 
transfected with either a PHD2 or PHD3 luciferase reporter for 24 hours and then exposed to 1% 
O2 for up to a further 24-hours. Results are normalised to 124. Significance was determined 
using one-way anova; values lower than 0.05 are denoted * and values lower than 0.01 as **.
5.2.2 Parameterising the model
The expansion of the model has led to the creation of 10 new parameters and 
thereby has increased the parameter space. The following section describes 
experiments aimed at constraining these parameters to measured values.
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5.2.2.i Measurement of basal synthesis values for PHDs: Si, S2, S3
The 4C-model has introduced a HIF-independent term for synthesis of the 
PHDs, Si, S2 and S3. These function as an encompassing term allowing for a 
degree of non-dynamic PHD expression from other sources, essential for PHDi 
which is not HIF-inducible (Treins, Giorgetti-Peraldi et al. 2005; Fong and 
Takeda 2008; Jokilehto and Jaakkola 2010). RT-qPCR can provide evidence to 
the relative abundance of mRNA within a sample and from these values we can 
extrapolate values for protein synthesis rates, as has been performed in a recent 
publication by Harper et al. (2010) (Harper, Finkenstadt et al. 2011). Following 
this principal, we aimed to relatively measure PHDi, -2 and -3 mRNA using RT- 
qPCR. HeLa cells were plated into 6cm dishes at atmospheric 02 and cultured 
for 24 hours. The rationale behind using a normoxic sample was to minimise 
contamination of the estimation of basal synthesis (S2 and S3) with induced 
synthesis (k2 & ks). At ~8o% cell confluency cells were lysed. RNA was 
extracted from the lysates and then used for cDNA conversion. The cDNA 
templates were then used alongside PHDi, 2 and 3 targeting primers for RT- 
qPCR measurements (Fig 5.5.). Using this approach, PHD3 was found to be the 
most abundant mRNA passing the threshold point i.57±o.i5 cycles before PHDi 
and 8.48±o.49 cycles before PHD2. These differences were then raised to the 
power of the measured efficiency of the primers used in order to determine the 
relative difference in mRNA abundance. Via this calculation, we concluded that 
in relation to PHD3, PHDi and PHD2 are 2.3 and 38.9 fold less abundant. We 
then applied this relationship to the corresponding S values used in the model.
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Fig 5*5* HeLa cells were plated and maintained in atmospheric oxygen prior to sample 
preparation for RT-qPCR analysis. (A) RT-qPCR comparing amplification profile of mRNA in 
which the crossing point has been added on manually and (B) the calculated relative abundance 
of mRNA compared to PHD3; value of reduction is also shown. All conditions are found to be 
significantly different (p=<o.oi = **) by one-way ANOVA. (n=3 biological repetitions, S.E.M. is 
shown)
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In further support of these findings, the luminometry results attained using 
PHD2-luciferase and PHDs-luciferase were revisited (previously measured in 
Fig 5*4) and the signal ratio for the normoxic samples compared (Fig 5.6). 
Mimicking the trend observed by RT-qPCR, signal from PHDs-luc was found to 
be on average 35-fold greater than signal from PHD2-luc.
Fig 5.6. Endpoint luminometry assay of samples prepared from HeLa cells that had been 
transfected with either a PHD2 or PHD3 luciferase reporter for 24 hours. Cells were left 
unstimulated before lysis and sample preparation. Data shows three repetitions of luminescence 
measurement normalised to PHD3 signal. Statistical significance of PHD2 vs PHD3 is <0.05 
measured by one-way ANOVA.
5.2.2.2 Induction of feedback: k2 Sales
The PHD feedback loop hinges upon the assumption that hypoxia up-regulates 
PHD mRNA production in a HIF-dependent manner. This principle is given as 
the rate term k in the 2-component model. Previous reports by Stiehl et al. 
(2006) and Appelhof et al. (2004) suggest that the level of rate of induction may 
differ between PHD2 and PHD3, moreover this difference was found to vary 
across cell types (Appelhoff, Tian et al. 2004; Stiehl, Wirthner et al. 2006). 
Additionally a publication by Erez et al. (2004) suggested PHDi mRNA to be 
down-regulated by hypoxia and this would have ramifications on the 4C-model 
topology (Erez, Stambolsky et al. 2004). As these are critical issue for the 
parameterisation of the model, we sought to investigate the hypoxic induction 
kinetics (and potential) of the individual PHD proteins. Samples were prepared 
from HeLa cells incubated over a time-course of 1% 02. The relative mRNA 
profile was then measured by RT-qPCR for PHDi, PHD2 and PHD3 (primers 
listed in chapter 2) (Fig 5.7).
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Fig 5*7* RT-qPCR measurement of samples prepared from HeLa cells that were incubated for a 
time course of 24-hours at either 1% O2 or atmospheric O2. (n=2 hypoxia and n=i normoxia; 
error bars are from the technical quadruplicates from a single biological repetition)
Both PHD2 and PHD3 were found to be inducible whereas PHDi mRNA levels 
remained largely unchanged, thereby conforming to the general published 
consensus (Epstein, Gleadle et al. 2001; Treins, Giorgetti-Peraldi et al. 2005; 
Stiehl, Wirthner et al. 2006). In contradiction to the findings of Stiehl et al. 
(2006) and Appelhof et al. (2004), the kinetics of PHD2 and PHD3 induction 
were found to be largely similar, suggesting that k2 and ks rate terms can be 
kept equal.
5.2.2.3 Measurement of degradation rate of the PHD proteins: di,d2 
Suds
Parameter sensitivity analysis on the 2-component model indicated that 
variance in the degradation rate of the feedback protein is important for the 
HIF-a accumulation profile (as shown previously in Fig 5.1). The expansion of 
the 2-component model to resolve the individual PHD proteins may require the 
use of three separate intrinsic degradation rates (d) depending on how 
significantly different these values may be. To our knowledge the relative 
protein stabilities of all three PHD isoforms have not been reported, although 
Tian et al. (2006) showed PHDi and PHD3 to differ significantly using cells 
treated with cycloheximide and analysing samples by western blot (Tian, Mole 
et al. 2006). Additionally it has also been shown that PHDi, PHD2 and PHD3 
protein stabilities are regulated by different mechanisms. PHDi and PHD3 are 
subject to destabilisation by the activities of seven in abstentia homology 1 and 2 
(SIAHi & 2) and PHD2 is destabilised by FKBP38 (Barth, Nesper et al. 2007; 
House, Moller et al. 2009). These findings support the likelihood that the PHD 
protein stabilities differ between isoforms and that the controlling parameter 
values would need to be properly resolved for the mathematical model.
Currently the degradation rate (d) fit for the 2-component model can be 
considered as a concatenation of both PHD2 and PHD3, however without
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additional information this value cannot be rationally split and any attempt at 
refitting the expanded model may be subject to excessively free parameter 
space. Thus, to constrain the model appropriately we aimed to measure the 
degradation rate of the individual PHDs. To achieve this we utilised the single­
cell imaging of HeLa cells ectopically expressing fluorescently labelled PHDi, -2 
or -3 and treated cells with cycloheximide, a drug commonly employed to 
induce translational arrest in eukaryotes (Siegel and Sisler 1963; Schneider- 
Poetsch, Ju et al. 2010). The loss of fluorescence was then monitored for up to 
16 hours. All visualised fluorescent cell data was quantified and the half-life of 
fluorescence for each cell calculated. PHD3 was found to degrade the fastest 
with a mean half-life of 98±33 minutes, followed by PHDl at 6i8±303 minutes 
and then PHD2 at 669±369 minutes (Fig 5.8). These values were converted to 
rate constants then subsequently used to parameterise the model (values used 
are shown later in Table 5.1). Once again the single-cell approach also afforded 
us the ability to see cell-to-cell variance in the degradation profiles, indicating 
that average behaviour must be taken with caution as many cells were not 
average (Levsky and Singer 2003). The observed heterogeneity in degradation 
was quantitatively assessed by calculating the Fano factor (variance over the 
mean) for each PHD (Masuda and Doiron 2007; Paszek, Ryan et al. 2010). 
PHD3 was found to have the most homogenous degradation profile with a Fano 
factor of 9, followed by PHDi with 96 and PHD2 with 295.
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Fig 5.8. (A) Time-lapse imaging of HeLa cells ectopically expressing fluorescent PHD and 
treated with lopg/pl cycloheximide. A plot of the normalised average cell fluorescence is shown 
for each condition (showing a single repetition of three), with standard error indicated. (B) A 
box-and-whisker plot shows the calculated half-lives with the mean average half-life numerically 
stated.
Our results concerning PHD protein stability are in agreement with the limited 
selection of other published values (Tian, Mole et al. 2006; Barth, Nesper et al. 
2007). However, our approach taken to measure PHD degradation rates 
remains open to criticism. Firstly, rather than measuring endogenous PHD 
stability we have measured the fluorescent fusion form and it is therefore 
possible that the novel protein degrades differently to the native form 
(Schwanhausser, Busse et al. 2011; Yewdell, Lacsina et al. 2011). Secondly 
cycloheximide is often used as a standard approach towards the measurement 
of protein stability in spite of the possibility of detrimental or confounding 
issues. Cycloheximide is unable to completely arrest translation of the specific 
protein of interest. This means that some degree of protein synthesis is ongoing 
and thereby confounds an accurate measurement of degradation. Also, as 
cycloheximide acts on all protein synthesis it equally acts on proteins that may 
be responsible for the degradation or regulation of the measured protein. Loss 
of a negative regulator would undoubtedly lead to an extended half-life of the 
measured protein of interest (Yewdell, Lacsina et al. 2011), a concept made
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prominent by the purported destabilisation of PHDs by the SIAH proteins 
(House, Moller et al. 2009). Following these concerns, future efforts should be 
made to reinforce these measurements using one of many available 
methodologies, including the recently outlined global protein stability profiling 
by Yen et ah (2008) and the dynamic stable isotope labelling with amino acids 
(dynamic SILAC) reported by Doherty et al. (2009) (Yen, Xu et al. 2008; 
Doherty, Hammond et al. 2009).
5.2.3 Single-cell imaging of HIF-inducible PHD2-EGFP
Constraining the degradation terms {di, d2, ds), basal synthesis rates (si, s2, 53) 
and induction terms (k2, ks) still leaves the PHD feedback kinetics unexplored 
and unaccounted for. In the case of the 2-component feedback model all 
parameters were fit against HIF-ia imaging data, leaving the feedback un­
visualised. The next aim was to therefore image the PHD2 feedback kinetics and 
then use this data to fit against the 4-component model. The proximal promoter 
driven PHD2EGFP expression vector constructed earlier in this chapter was 
used for this purpose. The expression vector was transfected into HeLa cells 
alongside a unfused DsRedxp control vector and after 24-48 hours transfection, 
imaged by confocal microscopy (Fig 5.9). The expression level of PHD2 
appears to have been greatly reduced compared to the CMV version and is 
thereby more difficult to detect. Therefore fields containing DsRedxp expressing 
cells were chosen and these were then imaged for ~2oh in either 1% 02 or 21% 
02. An increase in green fluorescence was observed in 6.98% (n=6 of 86 cells) of 
red expressing cells at 20.8% 02 and 34.6% (n=44 of 131 cells) of instances at 1% 
02. Cells showing a change in green fluorescence had their cytoplasmic 
fluorescence intensity quantified. In contrast to the diverse kinetics seen for 
HIF-a, PHD2 showed a consistent increase which in several cases reaches a 
plateau within the experiment time-frame. Despite the robust accumulation 
pattern the response time was again found to vary over the entirety of the 
experiment time frame. The amplitude was also found to vary though no strong 
correlation was found between amplitude and time of response (data not 
shown). An interesting facet of this experiment is that the PHD2-EGFP 
response is driven by endogenous HIF, this may partially explain the relatively 
subtle amplitude of response when using the p-pro-PHD2-EGFP compared to 
imaging HIF-ia/-2a.
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Fig 5*9* (A) EGFP channel images from time-lapse microscopy of HeLa cells transfected with p- 
proPHD2EGFP and DsRedxp then either incubated in normoxic (~2i% 02)or hypoxic (i%02) 
conditions. (B) Percentage of average red cells that show an induction in PHD2EGFP. (C) 
Representative traces of cellular PHD2 fluorescence during hypoxia. Analysis of quantified cells, 
calculating (D) response time and (E) maximum amplitude.
The 2C-model was raised against imaging of HIF-iaEGFP and this model served 
as the basis for the expansion to the 4C-model. Originally therefore, the HIF-ia 
creation rate (S) was derived from a CMV expressed version of HIF-ia and this 
is likely to be very different to the endogenous value (Qin, Zhang et al. 2010). To 
keep the model in line with the HIF-a imaging data we decided to continue 
using the 2C-model fitted S value and decided against pursuing a measurement 
of endogenous HIF-ia synthesis rate. However, using the imaged PHD2 
feedback data it is very possible to refit this endogenous S value. Previously in 
the 2C-model, the PHD feedback was fit using the HIFia-EGFP imaging data 
(Fig 4.16.). In the same manner, the HIF-ia profile could be reconstructed 
using the pro-PHD2-EGFP data. Importantly, the pro-PHD2-EGFP feedback is 
driven by the endogenous HIF-a and so the endogenous creation rate could 
therefore be suggested from this data.
5.2.4 4C-model parameterised and outputs generated
The parameter measurements carried out throughout this chapter were 
introduced into the 4C-model, leading to the total measurement of eight of 
twelve criteria and six of ten parameter rates (Table 5.1). Additionally the 
hydroxylation rates were expanded to include hydroxylation of HIF-ia by all
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three PHD isoforms, using data published by Tuckerman et al. (2004). Using 
these values PHDi has a slower hydroxylation rate than PHD2 and PHD3 by 
almost five-fold. Finally several unmeasured values were either carried across 
from fitting in the 2C-model or refit using the 4C-model framework; including 
S* (PHD synthesis rate), Sx (HIF-ia synthesis rate), k (PHD induction rate) and 
y (saturation of hydroxylation term).
Parameters Units Value Source
SI :S2:S3=S* “Synthesis ratios’ 0.44:0.03:1 Measured (section 5.2.2.1)
S* ‘HIF Synthesis rate' AUmin1 7.6 x 10'11 Fitted in 4-component model
dl “PHDI degradation rate1 min'1 1.13 x 10'3 Measured (section 5.2.2.3)
d2 *PHD2 degradation rate' min'1 8.83 x 10'4 Measured (section 5.2.2.3)
d3 “PHD3 degradation rate' min' 6.74 x 10'3 Measured (section 5.2.2.3)
k2:k3 = k “Induction ratios' 1:1 Measured (section 5.2.2.2)
k ‘PHD Induction rate’ min' 7.10 x 10'4 Fitted in 2-component model
y “Saturation function' AU 1.83 x 104 Fitted in 2-component model
hi “PHDI hydroxylation rate’ min'1 0.25 —►0.035 Measured (Tuckerman et al. 2004)
h2 ‘PHD2 hydroxylation rate' min' 1 —0.135 Measured (Tuckerman et al. 2004)
H3 “PHD3 hydroxylation rate’ min'1 1.25 — 0.133 Measured (Tuckerman et al. 2004)
Table 5.1. Table of parameters, units and values used in 4C-model. Also included is a list of the 
method of parameter rate determination and corresponding reference to the measurements. 
The hydroxylation rate values are shown for the switch from 21% 02 to 1% 02. (NB. A revision to 
the parameters is underway and so the values for k and s* are likely to change)
After parameterisation, the 4C-model was used to simulate the protein level 
response of HIF-ia, PHDi, PHD2 and PHD3 following an episode of \% 02 
(dropping from atmospheric oxygen) (Fig 5.10). The simulated response 
retained all the qualitative features of the biological response; HIF-ia protein 
accumulated transiently, PHD2 and PHD3 were up-regulated and PHDi levels 
remained constant throughout. The response to re-oxygenation was also 
simulated; occurring as 1% 02 for 6-hours and then re-oxygenation back to 21% 
02.
Hypoxia
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9 0)aoo
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Fig 5.10. The 4c-model was used to simulate the protein level response of HIF-ia, PHDi, PHD2 
and PHD3 following an episode of 1% 02 (dropping from atmospheric oxygen). The response to 
re-oxygenation was also simulated; occurring as 1% 02 for 6-hours and then re-oxygenation 
back to 21% 02.
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5.2.5 Removal of PHD2 feedback
With the completion of the 4C-model, it was considered prudent to further 
validate the model against biological data. The 4C-model is capable of assessing 
the impact of removing PHD2 in silico and this is also readily performed 
biologically. HeLa cells stably expressing short hairpin RNA targeted against 
PHD2 (ShPHD2 cells) were kindly donated by Dr. D. Stiehl and Prof. R. Wenger 
(Zurich). Our initial goal after receiving these SI1PHD2 cells was to confirm the 
knockdown of PHD2.
5.2.5.1 Validation of knockdown
Knockdown of PHD2 was confirmed using western blot analysis (Fig 5.11). 
ShPHD2 and HeLa cells were plated into 6cm dishes and later incubated for 4 
hours in either atmospheric conditions or 1% 02 prior to lysis and sample 
preparation. The absence/reduction of PHD2 protein was confirmed and no 
accumulation of PHD2 protein in hypoxia was seen. Furthermore PHD3 was not 
seen to strongly compensate for the loss of PHD2. Though it is worth noting we 
were unable to convincingly detect an upregulation of PHD2 protein in either 
ShPHD2 cells or wild-type cells, most likely on account of the short time course 
used and low amplitude of response. Both cell lines were found to be inducible 
for HIF-ia within this time frame. The SI1PHD2 cells were deemed suitable for 
further experimentation.
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Fig 5.11. (A) ShPHD2 and HeLa cells were plated into 6cm dishes and later incubated for 4 
hours in either atmospheric conditions or 1% 02 prior to lysis and sample preparation (+) for 4 
hours. Prepared samples were then analysed by western blot, probing for HIF-ia, PHD2 and 
PHD3.protein (B) Samples prepared from ShPHD2 cells were analysed by Western blot to 
examine the HIF-a response to hypoxia and a subsequent 15-minute re-oxygenation back to 
atmospheric levels.
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5.2.5-2 Western blot analysis of HIF-a accumulation in ShPHD2 
cells
Next, using the ShPHD2 cells we examined the population-wide accumulation 
kinetics of both HIF-a isoforms in response to hypoxia (Fig 5.11). A time- 
course of 24 hours with an additional 15 minute atmospheric re-oxygenation 
was used. Once again the HIF-2a response was found to be ambiguous, 
generally indicating no response as can be expected from a HeLa lineage cell 
line (Bracken, Fedele et al. 2006). Importantly, HIF-ia transiency was 
abolished as accumulation continued up to the 24 hour time point. Despite the 
loss of PHD2, HIF-ia protein was effectively reduced to pre-hypoxic levels 
following 15 minutes re-oxygenation. The loss of HIF-a transiency on the 
population-level inspired the pursuit at the single-cell level, again using time- 
lapse microscopy and wide-field luminescence.
5.2.5.3 Time-lapse imaging of HIFi-a expressing ShPHD2cells in 
hypoxia
Following conformation of knockdown, SI1PHD2 cells were transfected with pG- 
HIFiaEGFP and an unfused DsRedxp expression plasmid. After 24-48 hours 
transfection cells were imaged for up to 20-hours by confocal microscopy, either 
at atmospheric 02 or 1% 02 (Fig 5.12). Using the same criteria as outlined in 
section 4.2.2.1, the % responding cells was calculated for both conditions. 
From the normoxic condition, 14.4% of cells (n= 18 of 125 cells) were 
determined to show changes in HIF-iaEGFP fluorescence compared to 36.14% 
of cells (n= 30 of 83 cells) for the hypoxic scenario. These values are comparable 
with those observed for the wild-type HeLa cells imaged in Chapter 4.
A. B.
21 % 02 21 % 02
Fig 5.12. Time-lapse microscopy of ShPHD2 cells co-expressing vectors encoding HIF-iaEGFP 
and DsRedxp. Cells were imaged at either 21% (A) or stimulated with hypoxia using 1% 02 (B). 
Orange scale bar indicates 20|iim.
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Responding cells were analysed using Cell Tracker and nuclear fluorescence 
converted into a quantitative format (Fig 5.13). Analysed cells were then 
categorised in a similar manner to the wild-type responding cells, using the 
classifications (1) persistent accumulation and (2) transient accumulation. 
There were no recorded instances of multiple accumulations of HIF-ia when 
imaging the SI1PHD2 cell line. Within the existing classifications, it was found 
that 63.3% (n= 19 of 30 cells) of cells adhered to persistent accumulations and 
36.7% (11 of 30 cells) belonged to transient accumulations. The reduced 
instances of transient accumulations are in line with the observed loss of 
transiency by western blot analysis (Fig 5.11). The maintenance of some degree 
of transiency can be explained by either the still intact PHD3 feedback, or one of 
the many other reported feedback mechanisms (Stiehl, Wirthner et al. 2006; 
Qutub and Popel 2007; Horak, Crawford et al. 2010; Moslehi, Minamishima et 
al. 2010).
A. Cell 1 Cell 2 Cells
% Cells % Cells
Fig 5.13. Time-lapse microscopy of ShPHD2 HeLa cells co-expressing vectors encoding HIF- 
laEGFP and DsRedxp. Three representative cells are shown above and the corresponding cell 
traces below. Scale bar denotes 20pms and time-steps shown are the same for all three cells. A 
figure of all responding cells is shown in appendix 1.4.
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5.2.5*4 Model prediction of ShPHD2 re-oxygenation
The loss of PHD2 from the feedback network is expected to not only affect HIF- 
a transiency following hypoxia, but to slow the clearance of HIF-a protein upon 
re-oxygenation. The 4C-model output of ShPHD2 reinforces this hypothesis, 
predicting a near ~4-fold increase in HIF-a protein half-life to 101 minutes from 
25 minutes (Fig 5.14.)- This model output was generated assuming a 6h 1% 02 
incubation preceding the re-oxygenation back to atmospheric 02.
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Fig 5.14. 4C-model outputs simulating wild-type cells and ShPHD2 cells experiencing re­
oxygenation after 6 hours incubation at 1% 02. Both simulations were run to equilibrium either 
in with the intact PHD2 feedback or without before simulating hypoxia and re-oxygenation.
5.2.5.5 Time-lapse imaging of HIF-ia expressing SI1PHD2 cells 
through re-oxygenation
To validate the model prediction, we used time-lapse imaging to experimentally 
address the re-oxygenation mediated loss of HIF-a protein in SI1PHD2 cells. 
Cells were plated into 35mm IWAKI dishes and co-transfected with pG- 
HIFiaEGFP and an unfused DsRedxp expression vector, as has been performed 
previously. After 24 hours of transfection cells were placed into the microscope 
stage mounted incubator, which was then set to an oxygen tension of 1%. After 6 
hours of incubation, cells selected for green fluorescence were imaged through 
the re-oxygenation back to atmospheric 02. From this data, 56.76% (n=2i of 37 
cells) of cells showed a loss of green fluorescence as counted by eye, a value 
lower than wild-type but not statistically significant when assessed by one-way 
ANOVA. All green fluorescent cells (that didn’t die or migrate from field of view 
within 150-minutes) were analysed using Cell Tracker to quantify nuclear 
fluorescence levels. The profile of loss of fluorescence was very comparable to 
the model simulation comparing to several cells analysed (Fig 5.15). The slope 
of decreasing fluorescence was used to calculate the half-life values as was
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previously performed on wild-type HeLa cells (measured earlier in Fig 
deriving a half-life average value of 300±145 minutes for the SI1PHD2 cells. 
However, a degree of caution must be exercised when comparing these averages 
as a large degree of heterogeneity was once again observed. The half-life values 
for wild-type HeLa cells ranged from 8.6 minutes to 330 minutes, where as data 
from the ShPHD2 cells were seen to vary from 49 minutes to an outlier at 1300 
minutes. The calculated fano factor further confirmed this heterogeneity, in 
which a value of 139 was contrasted to 497 for wild-type against ShPHD2 cells.
A. B. % Cells showing degradation
ShPHDs
c.
O 20 40 60 80 100
m S 0 .8
5 0.6-
Measured Data
Model simulation
Time (min)
Wildtype
Fig 5*15* Time-lapse microscopy of ShPHD2 cells co-expressing vectors encoding HIF-iaEGFP 
and DsRedxp. (A) Cells were incubated in 1% 02 for 6 hours before imaging through the re­
oxygenation back to atmospheric conditions. Nuclear fluorescence was quantified and a 
selection of cells shown. Also indicated is the model simulation of HIF-ia levels from the same 
experiment performed in silico (B) Chart depicting the % of cells visibly degrading within a 150 
minutes of re-oxygenation; previous data from wild-type cells is included for comparison (data 
from section 4.2.S.3). (C) Box-and-whisker plot shows the calculated half-lives comparing 
wild-type cells to ShPHD2 cells.
5.2.6 Sensitivity analysis of the 4C-model; Model Predictions
Mathematical models of cell signalling systems are built as tools to complement 
biological experiments, achieved through a combination of model predictions 
and insight. The completion of the 4C-model enabled the systematic 
investigation into the model architecture, investigating the sensitivity of the 
signalling features in differing scenarios in silico, making predictions that can 
later be experimentally verified or refuted (Ihekwaba, Broomhead et al. 2004).
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5.2.6.i Parameter Sensitivity Analysis and the Importance for 
potential crosstalk events
Model simulations were run to explore the sensitivity of the parameters and 
their relationship to the HIF-ia hypoxic response profile. In order to achieve 
this, we quantified the features of transient response profile, detailing 
amplitude, duration, steady-state levels and response time. The amplitude of 
response was calculated as the difference between maximum HIF-ia levels 
minus steady-state levels. The duration of response in this instance was 
calculated as the time from the initiation of response until the re-establishment 
of steady-state; otherwise referred to as the transitional period. The steady-state 
levels are calculated as the post-perturbation HIF-a levels when the level of 
changes in values is below 1%. Finally, the response time was determined as the 
time taken to reach maximum response amplitude. Using these criteria, each 
parameter value was doubled and the effect on the outlined signalling features 
scored, normalised to the unaltered qC-model output. The scoring of the 
different parameter alterations is depicted in a heat map format as has been 
similarly performed in the analysis of the NF-kB model by Ashall et al. 2009 
(Ashall, Horton et al. 2009) (Fig 5.16.). The analysis of the system showed that 
the doubling of HIF-ia synthesis affected only the amplitude and steady-state 
levels, elevating them both by a factor of 2.57. In contrary, the doubling of the 
PHD synthesis rate terms negatively affected these features, in which PHDi and 
PHD3 exerted the most influence on account of their substantially higher rate 
values. The only parameter which distinctly affected all signalling features was 
the PHD2 induction rate ks, negatively scoring for all and most prominently 
affecting steady-state levels. In contrast, doubling the PHD3 induction rate kg 
affected only amplitude and response time, decreasing them mildly in 
comparison to fcs. An observation that has been reported several times in the 
literature, first reported by Berra et al. 2003 (Berra, Benizri et al. 2003; 
Natarajan, Salloum et al. 2006). Interestingly, doubling PHD2 degradation rate 
strongly and solely increased steady-state levels where as doubling PHD3 
degradation rate increased both amplitude and steady-state. A feature perhaps 
relevant to FKBP38 mediated destabilisation of PHD2 (Barth, Nesper et al. 
2007).
142
B. Hypoxia
Tension Rate
2% 596 1096 2h 5h lOh
D. Re-oxygenation
Tension Hypoxia
2% 596 10% 2h 5h lOh
HIF-a degradation 
System Reset
Fig 5.16. 2D heat map showing the sensitivity analysis of the 4C-model. A pictorial definition of 
these response features are shown for hypoxia (C) and re-oxygenation (E). (A) All parameter 
values were increased by 2-fold and the corresponding changes to response features plotted. (B) 
Shows how the manifestation of hypoxia affects response features, including the oxygen tension, 
the rate of de-oxygenation and removal of individual PHDs. (D) Shows how the manifestation of 
re-oxygenation affects the response features, including the oxygen tension switch, the prior 
duration of hypoxia and the removal of individual PHDs. (horizontal arrows indicate features 
measured by amount, vertical arrows indicate features measured by time)
5.2.6.2 4C Model sensitivity to oxygen kinetics and levels
Disruption to cellular oxygen homeostasis can occur in numerous ways (Gainer 
1987; Toffoli and Michiels 2008; Shi 2009). In spite of this hypoxia is often 
considered or reduced to an encompassing and single term. We therefore 
investigated the sensitivity of the 4C-model to differing hypoxic and re­
oxygenation scenarios, using a similar heat map sensitivity analysis as 
previously described. The HIF-ia response to hypoxia was assessed using the 
same criteria outlined for the parameter sensitivity analysis, namely; amplitude, 
duration, steady-state levels and time-to-peak-max. However in this analysis,
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rather than altering parameter values, the mode-of-hypoxia was altered. Three 
different severities of hypoxia were arbitrarily selected and used, switching from 
atmospheric 21% to 10%, 5% or 2% 02. Results were normalised and scored 
against a model output using the standard tension switch of 21% 02 to 1% 02 
(Fig 5.16.). Reducing the 02 tension switch was found to reduce amplitude, 
duration, post-perturbation steady-state as well as the time to peak-max. The 
model outputs thereby provide evidence that the severity of the hypoxic switch 
can translate into differing HIF-a response profiles, suggesting that this 
information is perhaps purposefully encoded. A corroborative result for this 
prediction was published by Jiang et ah (1996), in which they used western blot 
densitometry to determine a HIF-a dose response curve to varied oxygen 
tensions (Jiang, Semenza et al. 1996). Next the model was used to investigate 
the HIF-a response to different rates of de-oxygenation, investigating the effect 
of the hypoxic switch from 21% to 1% 02 spanning 2 hours, 5 hours or 10 hours. 
In this instance, the model predicted that the kinetics of HIF accumulation were 
largely insensitive to the rate of de-oxygenation, marginally affecting only 
amplitude although dramatically affecting time-to-peak-max. This sensitivity is 
the result of the non-linear relationship of the hydroxylation rates to oxygen 
tension, creating a switch like mechanism when the tension reduces to values of 
~2%. These results suggest that the HIF-a response does not encode rate of de­
oxygenation on the cellular level when the rate of de-oxygenation is within the 
time frame of a day. However, some tumours may take longer than this to reach 
hypoxia (Ilangovan, Bratasz et al. 2005). In this case the amplitude of response 
may have been sufficiently damped as to be meaningfully different.
As well as investigating hypoxia, the reverse scenario of re-oxygenation was also 
explored by sensitivity analysis as was similarly investigated by Schmierer et al. 
(2010). We explored the sensitivity of HIF-a degradation and HIF-PHD reset 
following re-oxygenation under varying oxygen conditions. HIF-a degradation 
was scored as the time to maximal loss of HIF-a protein and the HIF-PHD reset 
as the time for the system to reach a steady-state solution. First the model 
examined whether the hypoxic tension preceding re-oxygenation altered the 
response kinetics, using 2%, 5% and 10% 02, Results were scored and 
normalised against the model output for 6 hours of 1% 02 followed by a re­
oxygenation to 21% 02. The reduced severity of hypoxia translated to increased 
times for HIF-a degradation and decreased times for HIF-PHD reset. As well as
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assessing hypoxic severity, the preceding duration of the hypoxic episode was 
also investigated. Here three durations of 1% 02 hypoxia were simulated by the 
model, 2 hours, 5 hours and 10 hours. A hypoxic episode of 2 hours was found 
to increase by greater than 3-fold the time for HIF-a degradation when 
compared to 6 hours. This prediction is in line with a report from Marxsen et al. 
(2004) who showed a similar sensitivity of HIF-a re-oxygenation mediated 
degradation to the preceding duration of hypoxia (Marxsen, Stengel et al. 
2004).
5.2.6.3 4C Model sensitivity to individual PHD isoforms
Finally the model was used to quantify the in silico loss of each individual PHD 
on the hypoxic and re-oxygenation profiles of the system. Removal of PHDi had 
the least impact, marginally increasing HIF-a amplitude, steady-state levels, 
degradation time and decreasing system reset time. Loss of PHD3 had a similar 
but more pronounced effect, additionally increasing the time-to-peak-max. 
Lastly, loss of PHD2 affected every feature in the same manner as PHD3 but far 
more substantially. The loss of PHD2 also resulted in the loss of transiency and 
so therefore an alteration to duration could not be calculated (Fig 5.16).
In summary, the 4C-model provides supportive evidence, predicting that the 
oxygen tensions and kinetics of hypoxia, re-oxygenation and intermittent 
hypoxia can translate in the response kinetics of the HIF-PHD feedback axis. 
This alludes to the importance of HIF-a kinetics in relation to gene expression 
and phenotype, a concept that has been suggested for the yeast pheromone 
pathway, ERK oscillations and P53 response pathway (Behar, Hao et al. 2008; 
Shankaran, Ippolito et al. 2009; Batchelor, Loewer et al. 2011). For the 
following systems, the importance of kinetics in phenotype has moved away 
from hypothesis and been directly shown for lineage patterning by Oct-4 in 
embryo development, cell-to-cell communication in synthetic bacterial systems 
and gene expression following TNFa stimulation of NF-kB (Basu, Mehreja et al. 
2004; Plachta, Bollenbach et al. 2011). This thesis has a strong interest in the 
propagation of information through the signalling arrangements such as the 
HIF-PHD signalling motif. It will be interesting for future work to validate the 
encoding of contextual information and to investigate to what extent it may 
affect the HIF-mediated response to hypoxia.
145
5.2.7 Oxygen-dependent destabilisation of PHD proteins explored
Within the last seven years several publications have reported on an additional 
level of Oa-sensitive regulation which negatively impacts the protein stability of 
PHDi and PHD3 (Nakayama, Frew et al. 2004; Calzado, de la Vega et al. 2009). 
This destabilisation of PHDi and PHD3 is carried out by the activity of the E3- 
ubiquin ligases, SIAHi & -2, targeting the PHD proteins for proteasomal 
degradation. Importantly, both SIAHi and SIAH2 have been shown to be 
activated by hypoxia (and DNA damage), thereby incurring a double negative 
feedback loop to the HIF-PHD motif (Matsuzawa, Takayama et al. 1998; 
Nakayama, Qi et al. 2009). This scenario carries with it the possibility to 
dramatically enrich the dynamics and explain the observed variety of HIF-a 
accumulation kinetics. Also as the SIAH proteins do not act equally on all PHD 
isoforms, it may be a prominent mechanism to incorporate into the resolved 
PHD model. We therefore decided to investigate the potential role of the SIAH 
proteins in our own experimental system.
5.2.7.1 Are SIAHi and SIAH2 induced at the transcriptional level
Conflicting information exists describing the mode of hypoxic activation of the 
SIAH proteins. It has been suggested that the ubiquitin ligase activity of the 
proteins is augmented during hypoxia though there has also been evidence to 
suggest that the proteins are up-regulated at the mRNA level following hypoxia 
(Nakayama, Qi et al. 2009). We investigated whether SIAHi or SIAH2 mRNA 
levels changed in response to hypoxia. HeLa cells were incubated at either 21% 
02 or 1% O2 for a time-course of 24 hours and then cells were lysed and samples 
prepared for measurement by RT-qPCR (Fig 5.17.). No significant change to 
mRNA levels was found for either SIAHi or SIAH2. This may imply that the 
SIAH proteins are augmented at the post-translational level in our system. This 
has been suggested by Khurana et al. (2006), reporting the phosphorylation of 
SIAH2 by p38 MAPK to enhance SIAH2 binding to PHD3 (Khurana, Nakayama 
et al. 2006).
146
0 ■ I--------- I -------- 1 ■ I---------------- 1--------■——I o --------- i ■ I---------------- 1 -------- 1---------------- 1---------------- 10 4 8 12 10 20 24 0 4 8 12 10 20 24
Time (hours) Time (hours)
Fig 5 .17. RT-qPCR measurement of samples prepared from HeLa cells that were incubated for 
a time course of 24-hours at either 1% O2 or atmospheric O2. (n=2 hypoxia and n=i normoxia)
5.2.8 Evidence of (^-sensitive PHD protein destabilisation
Cells expressing fluorescent fused PHD were used to assay whether an 02- 
sensitive regulatory mechanism exists in our cell line and whether this may 
impact on PHD protein stability following hypoxia. HeLa cells were transfected 
with either an unfused EGFP expression vector or a plasmid encoding PHDi- 
EGFP, PHD2-EGFP or PHD3-EGFP. After 24 hours transient transfection, cells 
were imaged by confocal microscopy (imaging once every ~5-minutes) for an 
hour at atmospheric 02 before switching to 1% 02 and imaging for a further 300 
minutes (Fig 5.18). All imaged cells were analysed using Cell Tracker. From 
this data we calculated the % cells showing a greater than 50% loss of 
fluorescence within 300 minutes and found 39% (n=9 of 23 cells) for PHDi and 
10% (n=2 of 20 cells) for PHD3. No extensive loss was seen for either PHD2 
(n=total 15 cells) or unfused EGFP (n=total 13 cells).
Additionally, the source of SIAH hypoxic sensitivity is suggested to be ROS 
related rather than via the transcriptional activity of HIF-a. ROS can be 
produced from both a hypoxic episode and re-oxygenation episode (Morita- 
Fujimura, Fujimura et al. 2001; Hamanaka and Chandel 2009). Furthermore, 
ROS can lead to DNA damage and this is cited to also activate SIAHi (Wiseman 
and Halliwell 1996; Matsuzawa and Reed 2001). This led us to consider the 
possible re-oxygenation sensitivity of the PHD protein stability.
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Fig 5.18. HeLa cells were transfected with either un-conjugated EGFP, PHDi-EGFP, PHD2- 
EGFP or PHD3-EGFP. After 24 hours of transfection cells were imaged by time-lapse confocal 
microscopy for 1 hour in atmospheric 02 and then several hours in 1% 02. Time-lapse images are 
shown next to the corresponding quantifications of cell fluorescence. Cell traces of fluorescence 
are normalised to to. Stacked bar chart shows percentage of cells showing more than a 50% loss 
of fluorescence within 300 minutes of experimental start point No. of cells quantified; EGFP 
(n=total cells 13), PHDi (n=total 23 cells), PHD2 (n=total 15 cells) and PHD3 (n=total 20 cells). 
Scale bar denotes 50pm
For these reasons we also decided to image the PHD expression vectors through 
re-oxygenation. HeLa cells were transfected in the same manner using the same 
expression vectors. This time however, after 24 hours of transfection cells were 
incubated at 1% 02 on the microscope stage for 6 hours before confocal imaging 
through the re-oxygenation back to atmospheric 02 and continuing imaging for 
further 1000 minutes. Here 50% loss of signal was calculated for the 1000- 
minute time-point. Using this criteria, 100% (n=20 of 20 cells) of PHD3 cells 
showed a greater than 50% loss of fluorescent signal, 74% (n=3i of 42 cells) for 
PHDi, 36% (n=9 of 25 cells) for PHD2 and 5% (n=i of 21 cells) for EGFP (Fig 
5.19)
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Fig 5.19. HeLa cells were transfected with either un-conjugated EGFP, PHDi-EGFP, PHD2- 
EGFP or PHD3-EGFP. After 24 hours of transfection cells were incubated at 1% O2 for 6 hours 
then imaged by time-lapse confocal microscopy, re-oxygenating the cells back to atmospheric 02 
and then several hours in 1% 02. Time-lapse images are shown next to the corresponding 
quantifications of cell fluorescence. Cell traces of fluorescence are normalised to to. Stacked bar 
chart shows percentage of cells showing more than a 50% loss of fluorescence within 1000 
minutes of experimental start point No. of cells quantified; EGFP (n=total cells 13), PHDl 
(n=total 23 cells), PHD2 (n=total 15 cells) and PHD3 (n=total 20 cells). Scale bar denotes 50pm
These results provide preliminary evidence to warrant further investigation of 
the HIF-PHD-SIAH motif. However, this avenue of work investigating the 02- 
destabilisation of the PHDs remains as of yet incomplete and has therefore not 
been included in the most recent version of the 4C-model. The discovery of the 
hypoxic and re-oxygenation sensitivity of PHDl protein could be explored by 
western blot analysis on the endogenous protein as no compromising hypoxia- 
inducibility would be present. Or the imaging of re-oxygenation could be 
performed in an SIAH knockout background to see if the loss of fluorescence is 
abated. If the 02-sensitive SIAH feedback was validated the imaging data again 
could be readily used alongside the model to drive the parameterisation of the 
new model architecture. These results have the capacity to be very interesting as
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the additional feedback will introduce additional non-linearity into the system 
and provide a more detailed tuning of the HIF-a response to disrupted oxygen 
homeostasis.
5.3 Discussion
In this chapter, the generic PHD model was expanded to include all PHD 
isoforms and this expansion was performed along biological measurements 
aimed at constraining several of the new parameters. This new model is the first 
of the HIF signalling models to attempt the resolution of the individual PHD 
isoforms. This task is likely to be ongoing as highlighted by the preliminary data 
garnered concerning the 02-dependent destabilisation of PHDi and PHD3. 
However, despite room for further development we believe the current 4C- 
model to have been sufficiently developed and constrained as to warrant the 
experimental testing of model predictions, especially with regards to the arising 
hypothesis that the HIF-a kinetics are sensitive to the context of disrupted 
oxygenation.
5.3.1.1 Hydroxylation rates: hi, h2 and I13
Ideally all model parameters would be constrained accurately to biological 
measurements, though this can often be cumbersome and difficult to thoroughly 
perform (Kim and Tidor 2003). Despite effectively measuring and estimating 
the combined synthesis and degradation rates for the 4C-model, we did not 
attempt the measurement of the individual hydroxylation rates of the PHDs. 
Oxygen-sensitive hydroxylation is a critical aspect of HIF-signalling, responsible 
for conferring hypoxia-inducibility to the system. An accurate measurement of 
this process with regards to rate of hydroxylation would therefore be ideal. For 
the purpose of the model the values used were not measured by us, but taken 
from available literature, specifically using measurements from a capture pVHL 
assay performed by Tuckerman et al. 2004. The findings here suggested a non­
linear relationship between oxygen tension and hydroxylation rate, where this 
non-linearity is most pronounced for PHD3. The results further suggested that 
HIF-ia was most rapidly hydroxylated by PHD3, though at a similar rate to 
PHD2 and that PHDx hydroxylation occurred near 5-fold slower in comparison. 
The hydroxylation rate in the model is normalised and arbitrarily set at 1 (PHD2 
rate), when simulating hypoxia these values are scaled down accordingly. The 
values published by Tuckerman et al (2004) were used to inform the scaling for 
each individual PHD. The values reported by Tuckerman et al. (2004) have only
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been contested (as far as I’m aware) by one publication, Stiehl et al. (2006), in 
which the oxygen-sensitivity of hydroxylation was inferred via the antibody 
detection of HIF-a hydroxyproline. Where as Tuckerman et al. (2004) reported 
a ~io-fold reduction in hydroxylation following a switch from 20% 02 to 1% 02, 
Stiehl et al. (2006) found a milder ~3-fold reduction. However, both were in 
agreement with the apparent non-linearity of hydroxylation in relation to 
oxygen availability. The exact fold-reduction will not change dramatically the 
behaviour of the model only alter other values attained through fitting. 
However, the exact non-linearity of the oxygen tensions used may have more of 
an effect, especially regarding the models prediction that response time is 
encoded in the rate of de-oxygenation. A possible caveat of these measurements 
made by Tuckerman et al. (2004) is the use of in vitro biochemistry in 
determining hydroxylation rate. The extension of these values into the model 
framework might not provide a detailed and accurate enough picture of the 
interactions between the individual PHDs and HIF-a. For instance, we are 
unaware if the intracellular localisations of the PHDs and thereby proximity to 
HIF-ia may significantly influence the effective hydroxylation rate (Metzen, 
Berchner-Pfannschmidt et al. 2003). This issue was partially addressed in a 
publication by Yasumoto et al. (2009) who reported that the forced cytoplasmic 
expression of PHDi had no effect on HIF-ia hydroxylation.
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Fig s.zo.Oxygen dependence of PHD isoforms. In vitro enzyme assays were performed using 
HIF-ia, for each PHD isoform at varying oxygen concentrations. The assay measures captured 
pVHL to quantity level of hydroxylated HIF-ia, making use that only hydroxylated HIF-ia binds 
pVHL. Values are expressed as a percent of maximal pVHL captured. Figure taken from 
Tuckerman et al.
5.3.1.2 Role of the individual PHDs
The resolution of individual roles of the PHD isoforms has been often queried 
(Appelhoff, Tian et al. 2004; Fong and Takeda 2008; Thirstrup, Christensen et 
al. 2011). Since the original postulation of these questions a range of 
mechanisms, characteristics and regulatory events specific to each PHD has 
been shown or suggested, including the aforementioned intracellular
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localisations, the role of PHDi in regulating IKKp, PHD3 in mediating apoptosis 
and PHD2 anchorage-independent carcinoma cell growth (Metzen, Berchner- 
Pfannschmidt et al. 2003; Cummins, Berra et al. 2006; Rantanen, Pursiheimo 
et al. 2008; Jokilehto, Hogel et al. 2010). In the framework of the 4C-model, it 
would be an interesting proposition to begin to address these crosstalk 
activities. For example, the model predictions of PHD3 protein concentration 
following hypoxia could be extended to infer the effects on PHD3 aggresomes 
and the associated disposition to cell death (Rantanen, Pursiheimo et al. 2008). 
Or the nuclear levels of PHD2 could be deduced in relation to anchorage- 
independent cell growth (Jokilehto, Hogel et al. 2010). The separable roles of 
the individual PHDs has been further postulated by the reported different 
abundances of PHD mRNA and protein across differing tissues (Jokilehto and 
Jaakkola 2010). Sensitivity analysis of the 4C-model would suggest this to alter 
the characteristics of HIF-a signalling and this may therefore underpin an 
aspect of the cell-type specific hypoxic response, especially relevant given the 
range of physiological normoxia (Carreau, El Hafny-Rahbi et al. 2011). 
Computational investigations into these scenarios amongst others are only 
possible when using a resolved PHD model as a foundation module. To our 
knowledge, the 4C-model is the first model of the HIF system to explicitly 
resolve the PHD isoforms (other models are discussed below) (Kohn, Riss et al. 
2004; Qutub and Popel 2007; Dayan, Monticelli et al. 2009; Schmierer, Novak 
et al. 2010; Bruning, Cerone et al. 2011).
In spite of the emerging divergent functions of the PHD isoforms their remains 
significant overlap and a degree of redundancy in their regulation of HIF-a. This 
is partly due to the evolutionary history of the proteins, evolving from the 
duplication of the PHD2 gene (Taylor 2001; Rytkonen, Williams et al. 2011). 
This evolutionary history supports the near widely accepted dominant role of 
PHD2 in the regulation of HIF-a protein levels (Berra, Benizri et al. 2003). Our 
model produced predictions in line with these findings, suggesting HIF-a 
hypoxic transiency to be chiefly regulated by PHD2 (Fig 5.16). A feature made 
prominent by the reported protective role HIF-a transiency has following 
chronic hypoxia (Ginouves, lie et al. 2008).
Additionally, separable roles were found between PHD2 and PHD3 determined 
by their intrinsic degradation rates. A significant difference was found between 
the protein stability of PHD2 versus PHD3, in which the latter is more rapidly
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turned over. ‘Memory’ of a stimulus can be carried in several forms, one of 
which is the stability of downstream proteins (Locasale 2007). This concept was 
extensively considered by Locasale (2007), in regards to T-cell activation and 
can be extended in shedding light on a functional component of the HIF-PHD 
feedback and a resolving difference between the PHD proteins. After a hypoxic 
episode and subsequent re-oxygenation, HIF-a levels are rapidly degraded but 
do not settle at pre-perturbation concentrations for hours. This is due to the 
elevation of PHD2 and 3 levels. PHD2 levels will remain elevated above the 
resting steady-state for up to 24 hours. The system therefore retains a memory 
of a hypoxic episode dependent on the turnover rate of PHD2. However, though 
PHD2 compromises a long-term memory, PHD3 with a half-life of -100 
minutes, is a component of a short-term memory. This idea is ratified by the 
work of Maxrsen et ah (2004), who found that PHD2-levels remained elevated 
24-hours after re-oxygenation (Marxsen, Stengel et al. 2004). Finally, a similar 
concept of “hypoxic memory” has been suggested before in work from Kamat et 
ah (2007). In this publication it was found that HMEC-i cells exposed to several 
weeks of mild hypoxia retained elevated HIF-i dependent gene expression up to 
a week after return to normoxia. The characterisation of memory in this 
instance is therefore different to our own, though the idea is similar. The 
concept of memory in the HIF system is possibly of importance in instances of 
intermittent hypoxia, in which cells are repeatedly exposed as is found in some 
tumours as well as obstructive sleep apnoea (Toffoli and Michiels 2008; Belaidi, 
Joyeux-Faure et al. 2009). In relation to the feedback PHD proteins, it is 
becomingly increasingly important to regard their individual roles, both to the 
regulation of HIF-a and the reporter crosstalk events.
5.3.1.3 Existing HIF-models
At the onset of this project only a single mathematical model regarding the HIF 
regulatory system had been published by Kohn et ah 2004. Since then a handful 
of models have emerged, each focusing on and detailing certain features of the 
regulatory motifs (Table 5.2). The model produced by Kohn et ah (2004) 
details a complex topology involving 23 species, including HIF-a mRNA, HRE 
binding sites, pVHL, HIF-[3, PHD and in-between binding arrangements (Kohn, 
Riss et al. 2004). These species are governed by an extensive arrangement of 32 
reactions. A fundamental question of their proposed model is, how the switch­
like response of HIF-a protein to decreased oxygen arises. The model suggested
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the affinity of HIF-a to PHD was a determining factor, influenced and 
modulated to some degree by the remaining network topology. In comparison to 
our own model, the switch-like response arises from the non-linear relationship 
of hydroxylase activity to oxygen availability as measured by both Tuckerman et 
al. (2004) and Stiehl et al. (2006). The aim of the Kohn model meant that little 
attention was given to response kinetics, except for the PHD mRNA kinetics in 
response to varied oxygen tensions. Furthermore, the limited available 
quantitative data at the time meant that the numerical assumptions and 
relationships within the model were left unconstrained. As such it would 
therefore be an interesting prospect to parameterise their model using our own 
data and existing published quantifications. However, I believe the parameter 
space of the model to still be too large for this to be sufficiently performed. In 
essence, Kohn et al. 2004 suggest a sensible abstraction of the core regulatory 
network which has been evolutionary conserved and were the first group to 
prepare this signalling system into a mathematical framework. Since then four 
more groups (to our knowledge) have attempted this; Qutub et Popel (2007), Yu 
et al (2007) Dayan et al. (2009), Heimer et al. (20io)Schmierer et al. (2010) 
and most recently Pruning et al. 2011 (Qutub and Popel 2007; Dayan, 
Monticelli et al. 2009; Schmierer, Novak et al. 2010; Pruning, Cerone et al. 
2011). Of these models, the works of Yu et al. Dayan et al. and Heimer et al. 
build on the original Kohn model. Yu et al. and Heimer et al. essentially perform 
analysis on the models, streamlining the equations and concluding aspects from 
the reduced models. A key point made from their work concerns the switch like 
response of HIF-a accumulation, as addressed by Kohn et al. Of the Kohn 
derived models, only the work of Dayan et al. 2009 adds to the original 2004 
model (or alters the topology), extending the model to include FIH. The model 
abstraction remains similarly ambitious, detailing 16 species interacting across 
23 reaction constants. Their analysis of the Kohn model suggested HIF-p to 
have a non-determinant role in HIF-a regulation and so was removed for the 
Dayan et al. model incarnation. A fundamental aim of the Dayan et al. model 
was to address the non-redundancy of the PHD and FIH mechanisms, in 
determining HIF activated gene expression. As such, FIH was introduced into 
the model abstraction. Many of the parameters from Kohn et al. were refit into 
the Dayan et al. model framework, including the total concentration of HIF-ia 
protein at different oxygen concentrations (western blot analysis) and
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downstream gene expression profiles in response to FIH availability (RT-qPCR 
and luminometry analysis) (Dayan, Roux et al. 2006). The model predicted how 
the concentration of FIH determines individual hypoxic sensitivity of a subset of 
HIF activated genes. As in the previous Kohn et al. model, the steady-state 
solutions were the defining outputs and no emphasis was given to kinetics. The 
first model to attempt an overtly time-resolved HIF-a response to hypoxia was 
published by Qutub et Popel (2007). Here, the abstraction of HIF signalling was 
comprised of three feedback motifs. Negative feedbacks were provided by the 
HIF-PHD axis and the metabolically sensitive relationship between HIF and 
succinate production. An autocrine positive feedback was included which 
described HIF-ia regulating itself. The model is inclusive of many determining 
species, including; HIF-ia, hydroxylated HIF-ia, Fe2+, succinate, PHD, 2- 
oxoglutarate and oxygen, pVHL binding and the constituent proteins of the 
pVHL ubiquitin ligase complex. The arrangement of species spans 6 equations 
and includes 18 parameters. Most relevant initial concentrations and rate 
kinetics are referenced to in three publications. A range of values are explored 
for unconstrained parameters. The Qutub et Popel model shares a similar 
ambition to our own, in that it explores how the duration of hypoxia affects 
intracellular concentrations of HIF-a over time, specifically addressing the 
interplay of the three feedbacks in determining the response. The kinetics of 
response hinge on delay terms for the HIF-l production of HIF-ia and PHD2, 
using 3-hours and 4-hours respectively. The model outputs for total HIF-ia and 
PHD2 protein are fit to western blot data, capturing six time-points over the 
course of 72-hours. The model is not contradictory to our own and at a glance, is 
very detailed and considerate of many aspects of HIF-ia regulation. However, 
the model remains largely unproven against biological measurement. This is 
important as the model ambitiously attempts to predict the behaviour of many 
constituent species over the course of 72-hours of hypoxia. This is no trivial task 
given the measured and expected wide-spread changes to cellular biology in 
terms of cell-cycle, redox state, transcription, translation, DNA damage, cellular 
energy status and so on so forth (Gerald, Berra et al. 2004; Lee, Bae et al. 2004; 
Van Hoecke, Prigent-Tessier et al. 2007). The model proposed by Bruning et al. 
(2011) also investigates the HIF-ia protein response to hypoxia over a 
prolonged time-course. In contrast to the HIF-ia positive feedback of the Qutub 
et Popel model, Bruning et al. 2011 describe a negative feedback regulation of
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HIF-ia mRNA and the functioning of this feedback alongside the HIF-PHD 
feedback loop. In this model, the arranged feedback motifs are able to convey an 
oscillatory profile to the downstream transcriptional output of the HIF-i. This 
finding is of interest for explaining the multiple transient accumulations within 
our own imaging data-set, an event left unexplained by our 4C-model. Finally, 
the model proposed by Schmierer et al (2010) approaches the HIF regulation 
from a novel point; the regulation of HIF transcriptional activity by ankyrin 
protein sequestration of FIH. From a series of findings and publications, it is 
now known FIH is able hydroxylate other substrates beyond HIF-a (Cockman, 
Webb et al. 2009). To date, all identified FIH targets except HIF-ia contain an 
ankyrin repeat domain, a 33 aa residue protein motif found in 6% of eukaryotic 
protein sequences (Barrick, Ferreiro et al. 2008). Notable examples include 
P105, IkBq, IkBc and Notch-1 (Cockman, Webb et al. 2009). The exact purpose 
of the individual ankyrin hydroxylations has not yet been convincingly and 
assuredly stated. The model produced by Schmierer et al. reports on plausibility 
that the ankyrin repeat proteins can act as a sink for FIH, which in turn effects 
the transcriptional regulation of HIF-a by FIH. Similar to the models produced 
by Kohn et al. and Dayan et al. there is little suggested about the kinetics of 
response, but instead the steady-state solutions of varied oxygen tensions. 
Notably this model lacks the HIF-PHD feedback loop, the only HIF model to do 
so. It may be an interesting prospect to meld our 4C-model to this model and 
investigate the potential kinetics of FIH sequestration. In summary, although 
several other HIF models have been produced ours remains distinct in the 
central appreciation of the HIF-PHD feedback and the manner by which the 
model was informed against biological measurement. Unlike previous models, 
our own suggests the scope for the sensitivity of the transitional kinetics to 
encode the context of disrupted oxygenation, as well as making transparent 
potential significant crosstalk points. However, our model does not necessarily 
compete as we have attempted a much more restricted topology (a bottom-up 
approach) and only attempt to explain the first 24-hours of hypoxia. Ideally our 
model may work alongside the other existing models, serving as basis for further 
exploration and corroboration of the proposed regulatory mechanisms, whether 
it is the additional positive and negative feedbacks or the sequestration of FIH.
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Reference
Kohn et al. 2004
Qutub et Popel 2007
Yu et al. 2007
Dayan et at. 2009
Schmierer et al. 2010
Heiner et Siriam 2010
Bmning et al. 2011
Model Details
Switch-like properties of HIF bio-re^ulatorv network
The model details 23 species interacting through 32 reaction constants, which 
have either been arbitrarily set or qualitatively fit. The PHD2 & -3 feedback are 
contained within the depicted regulatory network.
a-autocrine feedback model
The model describes three autocrine feedback loops using 17 species and 18 
parameters. The signalling topology is comprised of two negative and one 
positive feedback mechanism, notably including the PHD feedback.
Pathway switching to describe sharp response of HIF network
A model dissecting the contribution of the quantitative arrangements of the 
Kohn et al. model, suggesting how the number interplay results in a sharp 
response profile of HIF accumulation to hypoxia.
Non-redundant roles of PHD and FIH in regulating gene expression
An adaptation of Kohn et 0.1. 2004. The model details 16 species interacting 
through 23 reaction constants. Parameters from Kohn et al. 2004 have been 
carried across and with some updating in accordance with western-blot and gene 
expression data. Notably HIF-iP has been removed from the signalling network.
Hvpoxia-dependent sequestration of FIH
The model describes 5 variables and 4 constant species acted upon via 13 
parameters. The parameter values are derived in several ways, either estimated, 
ranged, arbitrarily set or used published values.
Structural Analysis to determine core HIF response network
Analysis and reduction of the Yu et al. model, a model originating from Kohn et 
al. A principal aim of this model was to reduce the model complexity and 
describe the core HIF module.
MicroRNA-iss feedback model
A model encapsulating the PHD2 feedback motif and a microRNA feedback 
(targeted against HIF-ia mRNA). The model spans 4 ODE equations which 
represent 18 parameters. Model parameterisation was performed via fitting to 
several western blot data.
Table 5.2. Table summarising known published HIF mathematical models and analyses of the 
models
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Chapter 6: Sub-cellular structures and HIF
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6.1 Introduction & Aims
6.1.1 Observed and distinct intracellular localisation of HIF-2U
Throughout the previous chapters, the majority of focus has been on the 
temporal profiling of the HIF signalling pathway. Alongside this, the use of 
high-resolution time-lapse imaging has also afforded us insights into the spatial 
characteristics of the pathway with regards to the cellular distribution pattern. A 
focus on intracellular localisation was spurred on when imaging HIF-2a, as the 
localisation was found to be non-homogenous, occurring as speckles mainly 
localised to the nucleus and excluded from the nucleolus (Fig 6.1). Despite the 
many reported functional similarities between HIF-ia and HIF-2Q, HIF-ia was 
found to be homogenously localised to the cell nucleus. A large body of work is 
focused upon the difference between these two similar isoforms, dissecting their 
individual gene expression profiles, occurrences in pathology or unique 
crosstalk events (Raval, Lau et al. 2005; Bracken, Fedele et al. 2006; Elvidge, 
Glenny et al. 2006). To date, the subcellular localisation pattern of these two 
transcription factors has not been overtly addressed, although HIF-2a speckles 
were observed by Hara et al. as early as 1999 (Hara, Kobayashi et al. 1999). The 
aim for this chapter was to explore further the localisation pattern of HIF-2Q. 
Towards the end of the project time-line, HIF-ip and PHD3 were also seen to 
show sub-cellular aggregates/speckles (Fig 6.1) and so additionally these were 
investigated in relation to the observed HIF-2Q localisation pattern, though this 
avenue of work remains preliminary.
Fig 6.1. Live-cell confocal microscopy of HeLa cells ectopically expressing fluorescent fusion 
proteins of the canonical HIF pathway. Non-homogenous punctate fluorescent structures were 
observed for HIF-2a, HIF-iP and PHD3 (PHD3 aggregates are subtle at this magnification; red 
arrows have been used as a visual aid though a more zoomed image is shown in figure 6.16). 
Large aggregates of protein were seen when imaging FIH-DsRedxp.
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6.1.2 Sub-cellular structures of the eukaryotic cell
The intracellular localisation of components, such as proteins, is often a 
functional and defining feature. Transcription factors elicit their effect on gene 
expression when localised to the cell nucleus, receptor proteins of the outer 
membrane are necessary to communicate extracellular information to the 
intracellular environment and mitochondrial proteins are required in the 
mitochondrial space and disruption to this can commit the cell to apoptosis etc. 
(Tafani, Karpinich et al. 2002; Rubenstein, Zauhar et al. 2006; Farnham 2009). 
Understanding the intracellular localisation of a protein is therefore often a part 
of understanding the function. To further complicate the issue, the eukaryotic 
cell is often portrayed as homogenous compartments separated into organelles 
via lipid membranes. It is through this mechanism that cellular organisation 
and spatial regulation are understood to be achieved. However, over the last few 
decades a very complex picture of the spatial regulation of mammalian cells has 
emerged (Fig 6.2) (Swift 1959; Beck 1961). It is becoming widely recognised 
that many non-lipid bound sub-cellular organisations exist and that these 
structures are integral to an assortment of physiological and pathological 
processes, ranging from autophagy, resistance to viral infection, mRNA splicing, 
ribosome biogenesis, spatially regulated transcription and the misfolded protein 
response (Kopito 2000; Lamond and Spector 2003; Jackson 2005; Sirri, 
Urcuqui-Inchima et al. 2008; Nakamura, Kimple et al. 2009; Geoffrey and 
Chelbi-Alix). These are often self-assembling structures composed of a rich 
variety of proteins, characterised with varying defining traits (listed at the end 
of the chapter in Table 6.1) (Spector 2001; Lamond and Spector 2003). In spite 
of representing membrane-free organisations, the known speckling 
phenomenon are often characterised by the cellular compartment they are 
found in, whether nuclear or cytoplasmic (Spector 2006). The nucleus is known 
to contain a rich assortment of sub-nuclear and punctate structures, including 
nuclear speckles, PML nuclear bodies, paraspeckles, cajal bodies, clastosomes, 
polycomb bodies, transcription factories as well as the nucleolus(Spector 2001; 
Lamond and Spector 2003). Cytoplasmic entities are less well described and not 
grouped as a coherent research field, possibly owing to the greater diversity of 
function and make-up. Focal adhesions are speckle-like (somewhat elongated) 
structures visible in the cytoplasm of the cell, forming part of the machinery 
needed for traction in cellular locomotion and as signalling hubs propagating
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information from the extracellular environment (Fraley, Feng et al. 2010). 
Additionally, inclusion bodies and their sub-type aggresomes appear as speckle­
like structures and these are known to exist in either (or both) the cytoplasm or 
the nucleus (Kopito 2000). Stress granules are irregular shaped entities, 
appearing in the cytoplasm as a result of stalled mRNA translation; additionally 
the stalled mRNA can shuttle between another subcellular body known as 
processing bodies (Yang, Yu et al. 2006).
Fig 6.2. Figure taken from Mao et al. 2011 (Mao, Zhang et al. 2011). The picture is 
representative of a mammalian cell during interphase. Known nuclear cellular bodies are 
shown. For a detailed description of each entity see table 6.1.
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6.2 Results
The non-homogenous spatial distribution of HIF-2a has not been addressed 
and there are very little clues in the literature to suggest to which speckling 
phenomenon HIF-2a belongs. We sought to systematically address key features 
of the various known speckling instances in relationship to the observed HIF-2a 
phenomenon.
6.2.1 Variance in localisation pattern of EGFP-HIF2a
An often fundamental and identifying feature of protein speckling is the cellular 
localisation. The localisation of EGFP-HIF2a expressed in HeLa cells was 
investigated. HeLa cells were plated and then transfected with pG-EGFP-HIF2a 
24-hours prior to confocal imaging. Five by five tile scan images were then taken 
using a 63X objective in order to build a broad high-resolution mosaic image. 
Locations to image were selected at random. Fluorescence levels of both the 
nuclear and cytoplasmic compartment were then determined using the Cell 
Tracker software and nuclear to cytoplasmic ratio (N:C) calculated. The N:C 
ratio was used a determinant for the classification of the localisation pattern 
(Fig 6.3). Of the 74 cells imaged, 81% were found to have a N:C ratio greater 
than 5 appearing very nuclear, 11% were considered ubiquitous with N:C values 
between 1 to 4.99 and finally 8% were found to be preferentially cytoplasmic 
having N:C values below 1. In comparison, HIF-ia is found to be nuclear in 
100% of instances (data not shown).
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Fig 6.3. Live-cell confocal microscopy of HeLa cells (A) 5x5 Tile scan image of HeLa cells 
ectopically expressing EGFP-HIF2cl Three groups of cells are highlighted from the original 
image showing varied localisation patterns. (B) Calculated N:C ratio of all cells imaged. (C) 
Categorisation of localisation as determined using the N:C ratio data.
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6.2.2 Are the speckles artefacts of fluorescent fusion?
The fusion of a fluorescent protein has been previously reported to lead to 
aggregates due to steric hindrance of the native protein (Thomas and Maule 
2000). To investigate this possibility, HeLa cells were plated and then 
transfected with either fused or IRES expression vectors encoding fluorescent 
HIF-ia/-2a; noting the presence of an IRES sequence leads to the separate 
translation of EGFP from the protein of interest (Pelletier and Sonenberg 1988). 
After 24-hours cells were fixed (methodology in section 2.6.4.) and probed 
with anti-HIF-ia or anti-HIF2a primary antibodies, then prepared for imaging 
by labelling with red conjugate secondary antibodies. Confocal microscopy of 
the samples showed antibody detection of HIF-ia to be nuclear and uniform for 
both expression from the IRES and fused vectors (Fig 6.4). However, imaging 
of antibody detected HIF-2a once again showed a predominantly nuclear 
speckle-like localisation pattern, including for the unfused form. There was a 
good degree of correlation between the localisation of the fluorescent fusion 
speckles and the antibody detected proteins. Any discrepancy was argued by the 
fact that not all fluorescent fused EGFP may have fully matured (Harper, 
Finkenstadt et al. 2011).
A
o
Q.
B
Fig 6.4. HeLa cells transiently transfected to express unfused EGFP, or HIF-a expression 
plasmids. 24-hours after transfection cells were fixed by paraformaldehyde and antibody 
labelled (red staining), probing for (A) HIF-ia or (B) HIF-2a.
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6.2.3 Are the speckles the result of overexpression?
Most sub-cellular protein organisations are characterized as being either 
nuclear or cytoplasmic (Spector 2006). Our previous results indicate that EGFP- 
HIFsa speckles can exist in either the cell nucleus, cytoplasm or both. A 
possible explanation is that the over-expression of HIF-2a results in protein 
aggregates able to form in both cytoplasm and nucleus, but with a higher 
propensity for the nucleus due to the higher concentration of HIF-2Q (Mayer 
and Buchner 2004). This would furthermore suggest the speckles to be an 
experimental artefact and likely to have reduced relevance for the endogenous 
level protein. To address this, non-transfected HeLa cells were analysed by 
immunocytochemistry probing for endogenous HIF-ict and HIF-2a protein. 
HeLa cells were plated and incubated for 24 hours, then either remained 
unstimulated or were treated with o.smM DMOG for 6 hours. After this period 
cells were then paraformaldehyde fixed. Samples were then antibody stained as 
for the previous experiment then imaged by confocal microscopy. HIF-ia levels 
were undetectable in the unstimulated sample, though strongly evident in the 
DMOG treated condition (Fig 6.5). The antibody labelling of HIF-ia in this 
condition were found again to be nuclear and homogenous DMOG stimulated. 
HIF-2Q was detected in both unstimulated and stimulated conditions, at levels 
equivalent to one another, thereby mimicking the trend observed from earlier 
efforts of western blotting in chapter 3 and chapter 4. Once again, the 
fluorescent profile was found to be non-homogenous and speckle-like, mostly 
found in the cell nucleus with some observations of cytoplasmic speckling. 
These results strongly suggest that HIF-2a speckles to occur at the endogenous 
level and are not an artefact of over-expression.
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Fig 6.5. Untransfected HeLa cells either remained unstimulated or were treated with o.smM 
DMOG for 6-hours. Cells were then paraformaldehyde fixed and antibody labelled (red 
staining), probing for (A) HIF-ia or (B)HIF-2a.
6.2.4 Is EGFP-HIF2a speckling unique to HeLa cells?
An additional possibility was that speckling of HIF-2Q was unique to our chosen 
cell line of HeLa. Previous reports of cell line discrepancy emerged for the 
investigation of gemini of cajal bodies in HeLa cells, originally investigated by 
Liu and Dreyfuss 1996. A marker protein exclusive to the gemini of cajal bodies 
in HeLa cells was found to have a much more general role in cell speckling in 
other cell lines (Nizami, Deryusheva et al. 2010). Several cell lines were 
therefore used to investigate whether HIF-2a speckling occurs in cell-type 
dependent manner. The cell lines to be used were, the neuroblastomas SK-N-AS 
cell line, the medulloblastoma cell lines D283 and Med8 and a mouse primary 
neuronal cell line. All cells were transiently transfected with pG-EGFP-HIF2a 
using FuGene 6. After 24-48 hours transfection cells were imaged by confocal 
microscopy. Speckling was observed in all instances, obeying a similar profile to 
the images of HeLa HIF-2Q speckles (Fig 6.6).
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Fig 6.6. Live-cell confocal microscopy of five cell lines ectopically expressing EGFP-HIF2Q.
6.2.5 Characteristics of speckles; size, count and velocity
A defining feature of many different speckling types is the size, morphology and 
number present in a cell. Inclusion bodies are cited to occur at a frequency of 1- 
3 per cell whereas up to 50 interchromatin granule clusters have been counted 
in a single-cell (Spector 2006). Revisiting our previous imaging data, the 
speckle occurrence was investigated. Images pertaining to the live-cell imaging 
of HeLa cells expressing were analysed by AQM kinetic tracker as the program
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is able to automatically detect individual speckles after manually setting several 
detection parameters (Fig 6.7). Of the 15 cells analysed, the average number of 
speckles was found to be ic>5±39; a value exceeding records for most speckling 
phenomenon (Spector 2006). Next we quantified the number of HIF-2a 
speckles occurring in the non-transfected immunocytochemistry data described 
previously. Here we found a value of 64±32, measuring only 3 cells. Additionally 
the sizes of the speckles were calculated through these analysis procedures. 
From the EGFPHIF2a data set the average speckle size per cell was found to be 
3.3pm with a standard error of the mean of 0.35. 96.3% (n=!522 of 1580 
speckles) were found to be below lopms. Only a weak correlation (R2 = 0.03) 
was found between speckle size and number of speckles per cell. Finally, the 
ability to image speckles by time-lapse microscopy affords us the chance to 
measure the movement velocity of the speckles. From this we aimed to assay 
whether the speckles move faster or slower than Brownian motion, as similarly 
investigated by Chang et al. examining herpes viral replication compartments 
and nuclear specHes (Chang, Godinez et al. 2011). HeLa cells expressing EGFP- 
HIF2Q were imaged every 0.5 seconds for 60 seconds by live-cell confocal 
microscopy, imaging a total of 16 cells. AQM kinetic tracker was used to detect 
and analyse speckle movements. The average speckle velocity was found to be 
o.29pm/second with a standard error of the mean of 0.01. The majority of 
speckles, 68.2% (n= 175 of 255) were found to move under a distance of 0.3pm 
per second. Similar values were reported by Rino et al. 2007 in a study using 
fluorescence recovery after photobleaching to assess spliceosome movements. 
In this study, brownian motion was used to later computationally model the 
movements of the spliceosome speckles (Rino, Carvalho et al. 2007). Variance 
in speckle movement has been attributed to the density and compactness of the 
nucleus (Shav-Tal, Darzacq et al. 2006). So though we haven’t implicitly tested 
our data against brownian motion models, it would appear that the movements 
of the HIF-2a speckles are within these limits.
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No. of tpscklss per cell Average Velocity (um/s)
Fig 6.7. (A) Live-cell confocal microscopy image of a HeLa cell expressing EGFP-HIF2Q, then 
the automatic detection of speckles using AQM kinetic tracker. Red crosses indicate detected 
speckle. (B) Immunocytochemistry preparation of non-transfected HeLa cell staining with an 
anti-HIF2a antibody and imaged by confocal microscopy, showing both fluorescence and 
brightfield channels. Scale bars for all images denote lopms. (C) Box-and-whisker plot showing 
the average speckle size and individual speckle size calculated from HeLa cells expressing 
EGFP-HIF2Q. (D) Comparison bar chart for the detected number of speckles between 
immunocytochemistry images of anti-HIF2a non-transfected cells and exogenous speckles 
detected in EGFP-HIF2a expressing cells. (E) A scatter plot of the correlation between speckle 
size and number, determined using EGFP-HIF2a expressing HeLa cells. (F) The velocity of the 
movement of speckles was determined after imaging EGFP-HIF2Q for 6o-seconds, imaging 
every 0.5 seconds.
6.2.6 FRAP analysis of speckles
Many speckling phenomenon have been shown to be dynamic, with regards to 
the flux of protein in and out and the movement of the speckle itself 
(Handwerger, Murphy et al. 2003; Chang, Godinez et al. 2011). Fluorescence 
recovery after photobleaching provides a powerful tool to assay protein 
dynamics and several speckling phenomenon have been evaluated using this 
methodology (Rantanen, Pursiheimo et al. 2008; van Royen, Faria et al. 2009). 
They have the capacity to provide highly quantitative data and with sufficient 
analysis can be used to determine diffusion coefficients, mobile and immobile
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fractions present and the rate of exchange between immobile and mobile 
fractions (van Royen, Faria et al. 2009). Using this approach, we were interested 
to determine whether the speckles were static aggregates or dynamic entities. 
HeLa cells were transfected with pG“EGFP-HIF2a, after 24-48 hours cells were 
imaged by confocal microscopy and several cells selected ready for 
photobleaching. Photobleaching was carried, bleaching a circle of a diameter 
6pms briefly and repetitively for 10 seconds using high intensities from a 488 
nm argon ion laser. This process resulted in the immediate loss of speckle 
fluorescence in the bleached area. The fluorescence was found significantly 
recover within a minute of bleaching. Importantly, the fluorescence recovered at 
the same speckle locations strongly suggesting these to be dynamic entities with 
a continuous flux of protein in and out (Fig 6.8). Additional bleaching 
experiments were performed, single circular regions of ipm (corresponding to a 
single-speckle) were bleached. From the 8 cells bleached in this instance, 7 were 
found to recover within 6o-seconds. These data allude to the possibility of 
different HIF-2a speckling phenomenon within the cell.
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Fig 6.8. Fluorescence recovery after photobleaching of EGFP-HIF2a (A) Confocal imaging of 
HeLa cells transfected with EGFP-HIF2Q. A circular of region of 6pms was bleached for losecs 
following 75 iterations of high intensity excitation by a 488 argon ion laser. (B) The fluorescence 
levels of the bleached speckles and inter speckle space were quantified and plotted as an 
average. (C) Single-speckles fluorescence was measured at different proximities to the bleached 
region using Cell Tracker. (D) Representative plots of single speckle fluorescence recovery. (E & 
F) Confocal imaging of HeLa cells in which single speckles have been photobleached. (E) shows 
a representative cell seen to recover (F) shows a representative cell failing to recover 
fluorescence.
6.2.7 FRET analysis on HIF-2« self binding
Forster resonance energy transfer (FRET) is a technique used to investigate 
protein interactions in single living cells. The technique takes advantage of
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overlapping excitation and emission spectra of a pair of fluorophores, in which 
the emission of one of the pair excites the fluorescence of the other when in 
close enough proximity of one another (Periasamy 2001). The photobleaching of 
one of an interacting pair has repercussions to the fluorescent output of the 
other, thereby providing quantifiable information on the interaction. Classically 
CFP and YFP are the FRET pair of choice, though a publication by Erickson et 
al. 2003 demonstrated the functioning of EGFP and DsRed as a FRET pairing. 
We aimed to examine if there was evidence of intermolecular FRET between 
HIF-2Q, using the EGFP and DsRedxp fused forms cloned in chapter 3. HeLa 
cells were co-transfected with these expression vectors for 24-48 hours. Once 
again, single-speckle bleaching was performed, bleaching regions of ipm (Fig 
6.9). However, this time red fluorescence was bleached using high intensity 
emission from a helium/neon 543nm laser. Remarkably, not only was there no 
evidence of FRET but no evidence of fluorescence recovery for the experiment.
A
Bright Field EGFP-HIFaa DsRedxp-HIFaa Merge
Fig 6.9. FRET analysis of intermolecular HIF-2Q interactions. (A) Live cell microscopy of HeLa 
cells co-expressing EGFP-HIF2Q and DsRedxp-HIF2a. (B) DsRedxp fluorescence was 
photobleached using high intensity 543nm laser excitation. (C) Quantified fluorescence of 
bleached speckles, showing EGFP and DsRedxp average cell traces and standard deviation. 
Fluorescence levels were normalised to to.
6.2.8 Negative correlation of speckle-localisation and RNApol2
Speckling can occur when transcription factors associate in high density with 
discrete nuclear structures responsible for gene expression termed transcription 
factories (Jackson 2005; Mitchell and Fraser 2008). Transcription factories add
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a spatial element to our understanding of gene expression. An often defining 
feature of these factories is the presence of RNA pol II, the enzyme tasked with 
the transcription of DNA to RNA, including mRNA and microRNA. We sought 
to investigate the relationship of the nuclear localised speckles with RNA polll. 
HeLa cells were again transfected to express EGFP-HIF2a over a period of 24- 
hours. Cells were then fixed and prepared for immunocytochemistry staining, 
using a primary antibody against RNA pol II. The co-localisation of antibody 
detected RNA pol II fluorescence was compared to EGFP-HIF2a fluorescence. 
In contrast to expectations, RNA polll was found to negatively correlate with 
the localisation of HIF-2Q (Fig 6.10). This may suggest a speckling 
phenomenon such as polycomb bodies, known as gene silencing cellular bodies 
that correlate to the absence of RNA pol II (Sexton, Schober et al. 2007).
HIF-2a | RNApolll
Fig 6.10. Immunocytochemistry of HeLa cells expressing EGFP-HIF2Q and antibody probed 
for RNApol II. The negative correlation of localisation is highlighted by decreasing EGFP 
brightness.
6.2.9 Speckles are evident during mitosis (metaphase)
Several cellular bodies are sensitive to cell cycle progression, including OPT 
(Octi/PTF/transcription) domains and mitotic interchromatin granules (MIG), 
in which the later is reported to become entirely diffuse during metaphase 
through to anaphase (Lamond and Spector 2003; Nizami, Deryusheva et al. 
2010). To better characterise the HIF-2a speckles attention was given to 
dividing cells, and the status of the speckles investigated. Samples prepared 
earlier were imaged by confocal microscopy, using HeLa cells labelled for
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endogenous HIF-2Q (antibody). Cells showing distinct chromosome alignment, 
concordant with formation of the metaphase plate, were searched for and 
selected to image (Jaqaman, King et al. 2010) (Fig 6.10). During metaphase the 
cell morphology changes and depth increases, affecting the amount of 
cytoplasm present within the focal plane. To account for this, metaphase cells 
were imaged through a z-stack. From these images, the speckle like localisation 
of HIF-2Q was once again observed. Thereby suggesting these are not MIGs or 
OPT domains.
Fig 6.11. HeLa cells were fixed and prepared for immunocytochemistry using an anti-HIF2a 
antibody. A cell undergoing mitosis was imaged through the z-plane.
6.2.10 Sensitivity of HIF-2a speckles to microtubule disruption by 
Nocodazole
The active microtubule network is associated with aggresomes, stress granule 
formation, PML bodies and is indirectly associated with several more via the 
relationship of microtubules dynamics with cell cycle progression (Ivanov, 
Chudinova et al. 2003; Daniels, Marson et al. 2004; Bauer and Richter- 
Landsberg 2006; Cardinale, Cisterna et al. 2007). We were interested to 
determine whether HIF-2Q speckles may belong to this subset of microtubule 
sensitive cellular bodies. To investigate this possibility, cells were transfected 
with EGFP-HIF2Q then imaged by live-cell microscopy, remaining either 
unstimulated or treated with ipM Nocodazole, a drug commonly employed to 
rapidly depolymerise microtubules (Vasquez, Howell et al. 1997). A degree of 
dynamism was seen when imaging HIF-2a speckles in the control condition, in 
which fluorescence levels increased or decreased and the morphology of the
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speckles was also seen to change. This is in accordance with our earlier imaging 
of HIF-2a transiency and dynamics in chapter 4 (highlighted in Fig 4.8). 
Nocodazole treatment was found to acutely and dramatically affect the 
morphology and presentation of the speckles, often seen to lead to their 
increased size and irregularity. Though a range of responses was observed, also 
including the opposite situation in which some cells lost entirely the speckles. A 
high degree of cell death prevented a very accurate quantification of the 
response patterns. The data suggests that the HIF-2a speckles do have a 
relationship with the microtubule network, but the relationship appears to be 
complex and does not manifest as a single phenotypic response. Nevertheless, 
the data suggests the HIF-2a speckles to have a relationship with the subset of 
cellular bodies associated with the microtubule network. The resulting irregular 
aggregates after nocodazole treatment appears indicative of 
aggresomes.(Latonen 2011)
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Fig 6.12. Live-cell confocal imaging of HeLa cells ectopically expressing EGFP-HIF2a. (A) Cells 
imaged for 300 minutes without stimulation. (B) Cells imaged for 60 minutes without 
stimulation, then imaged for a further 300 minutes following the addition of ipM Nocodazole.
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6.2.11 Co-localisation of HIF-2a with other speckling transcription 
factors
Many widely known transcription factors have been found to exist in the various 
cellular bodies; ongoing work within our own laboratory investigating 
separately p53 and NRF2, showed that both of these proteins form a type of 
cellular body. Review of both pss and NRF2 attributes the localisation to the 
PML bodies (Fogal, Gostissa et al. 2000; Ben-Dor, Steiner et al. 2005). We were 
interested to see whether co-expression of fluorescent HIF-2Q alongside P53 
and NRF2 resulted in co-localisation of fluorescence, thereby implicating HIF- 
2a speckles with PML bodies. HeLa cells were co-transfected with expression 
vectors for DsRedxp-p53 and EGFP-HIF20 or with NRF2-venus and DsRedxp- 
HIF2o (p53 and NRF2 expression vectors were kindly supplied by Dr. R. Nelson 
and Miss K. Dunne, respectively). Expressing cells were imaged by confocal 
microscopy. A high degree of correlation was seen between the localisation 
patterns of all co-transfections, lending credence to the hypothesis that HIF-2o 
speckles are also related to PML bodies (Fig 6.13). A further observation was 
the reduced number and increased size of the HIF-2Q speckles, though this data 
remains unquantified.
EGFP-HIF2a
NRF2-Venus
Fig 6.13. HeLa cells were co-transfected with HIF-2a and either NRF2 or P53 fluorescent 
fusion expression vectors then imaged by live-cell confocal microscopy.
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6.2.12 Possible Fusion of speckles
A link between aggresomes and PML bodies has been reported, in which the 
fusion of PML bodies or PML-related aggregates is part of the maturation 
process of the nuclear aggresomes (Fu, Gao et al. 2005). This has also been 
shown to occur for Cajal bodies, which are able to associate and dissociate in the 
regulation of speckle size (Platani, Goldberg et al. 2000). Previous time-lapse 
imaging data of HIF-2aEGFP cells was reviewed and examined for fusion events 
(using images from the FRAP experiments of Fig 6.8). Several instances of 
possible fusion were observed, further suggesting the characteristics of the 
speckles to be dynamic and showing the HIF-2a speckles to exhibit a degree of 
plasticity (Fig 6.14). However, we cannot be truly certain that the speckles have 
fused and not just occupied a similar location in the x-y plane. A more detailed 
analysis method would be needed.
Osec Osec 4 sec 8 sec 15 sec 23 sec 23 sec
Fig 6.14. Live-cell confocal microscopy of a HeLa cell ectopically expressing EGFP-HIF2a. 
Magnified images are shown to highlight the possible fusion of speckles.
6.2.13 Evidence of dynamic morphology
Our current working hypothesis is that HIF-2Q relates to several cellular bodies, 
including the aforementioned PML and aggresome structures. This would 
suggest a degree of dynamics in the morphology of the speckles to be presented. 
Control time-lapse images of unstimulated HeLa cells expressing exogenous 
EGFP-HIF-2Q were reviewed in this light. From the time-lapse imaging data of 
-50 cells, there were various instances in which the morphology of the speckles 
could be seen to change, often varying between aggregates and punctate 
speckles as well as re-localising to the perinuclear region or cytoplasm(Fig 
6.15). These results may further suggest interplay between cellular bodies as 
proposed by Fu et al. (2005) between PML bodies and aggresomes.
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Fig 6.15. Live-cell confocal microscopy of a HeLa cell ectopically expressing EGFP-HIF2a. Cells 
were imaged in an unstimulated condition, though dynamics in the morphology of the HIF-2a 
cellular bodies was seen in some instances.
6.2.14 Speckles of other HIF signalling proteins
6.2.14.1 The relationship between HIF-2a and PHD3 aggresomes
From the canonical HIF signalling proteins, only PHD3 has been characterised 
as existing in cellular bodies, specifically found to reside in cytoplasmic 
aggresomes (Rantanen, Pursiheimo et al. 2008). Aggresomes have been 
primarily cited to be microtubule-dependent structures, suggested to have a role 
in the managing the cytotoxicity of misfolded proteins through the regulated 
aggregation of protein (Kopito 2000). Review of our previous confocal imaging 
of PHD3-EGFP showed punctate entities of cellular fluorescence, in accordance 
with the reported profile for PHD3 aggresomes (Fig 6.16). Aggresomes 
structures are sensitive to proteasomal inhibition, having been shown to 
relocalise PHD3-EGFP protein when in the presence of the proteasome 
inhibitor MG132. To further confirm the appearance of PHD3 aggresomes in 
our own experimental system, HeLa cells expressing PHD3-EGFP were imaged 
by live-cell confocal microscopy and stimulated using lopM MG132 (Fig 6.16). 
Additionally, PHDi-EGFP and PHD2-EGFP were imaged to reinforce the data 
that suggests aggresomes to be a defining feature of PHD3 protein. From these 
data, a dramatic effect was observed on PHD3 localisation which appeared to 
gather in the cell nucleus simultaneously while more cellular bodies gathered 
and grew (Fig 6.16). Interestingly cellular bodies were found to accumulate in 
PHD2-EGFP expressing cells, though at a much reduced number and finally 
resulting in irregular large aggregates surrounding the cell nucleus. No such 
response was seen when imaging PHDi-EGFP expressing cells. Similarly we 
were interested to assess whether HIF-2Q speckles were also sensitive to 
proteasome inhibition, thereby implicating them further with the subcellular 
proteolytic machinery. HeLa cells were transfected to express EGFP-HIF2a, 24 
hours post transfection cells were treated with xopM MG132 and imaged by 
time-lapse confocal microscopy. The characteristics and morphology of the
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speckles was also seen to change dramatically, becoming more irregular and 
cytoplasmic.
83 min 455 min0 min 223 min 670 min
0 min 187 min 374 rnin 1076 min
764 min
Fig 6.16. Live-cell confocal microscopy of HeLa cells. (A) Shows a single-cell expressing PHD3- 
EGFP highlighting the punctate cellular bodies detected. (B) Cells were transfected to express a 
fluorescent fusion PHD isoform (PHDi, PHD2 and PHD3). After 24-48 hours transfection cells 
were stimulated with lopM MG132 and imaged. (C) MG132 treatment was also performed on 
cells ectopically expressing EGFP-HIF2Q and the response imaged by live-cell confocal 
microscopy.
6.2.14.2 Preliminary investigation of HIF-ip speckles
Two publications from Prof. J. Fandrey’s group have attempted FRET 
measurements for the interactions of HIF-ia and -2a with HIF-ip (Wotzlaw, 
Otto et al. 2007; Konietzny, Konig et al. 2009). In both papers, speckling was 
present for HIF-ia and HIF-ip, a result in contrast to our imaging of HIF-ia 
localisation. However, as we had not yet imaged HIF-ip we we’re interested to
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determine whether or not ectopic expression of HIF-ip demonstrated cellular 
bodies. Towards the end of my project a fluorescent fusion plasmid vector 
encoding YFP linked to HIF-ip was kindly donated (pG-YFP-HIFip) by Prof. J. 
Fandrey. This plasmid was ectopically expressed in HeLa cells and imaged by 
live-cell confocal microscopy. HIF-ip fluorescence was found to be localised to 
the nucleus and furthermore found to be present as cellular bodies, in 
accordance with both Wotzlaw et al. (2007) and Koneitzny (2009) (shown 
earlier in Fig 6.1). We we’re interested to further adapt from the work by Prof. 
J. Fandrey’s group and co-express the HIF-a and -p isoforms alongside one 
another. However, to enable multiplexing of HIF-iaEGFP with YFP-HIF-ip it 
would be necessary to replace the present fluorescent protein as YFP and GFP 
have overlapping spectra (Harpur, Wouters et al. 2001). The pG-YFP-HIF-iP 
expression vectors was cloned using the gateway methodology and so contained 
sequences akin (but not exact) to the primers used in the production of gateway 
entry vectors, hampering future efforts to use gateway primers. To account for 
this, HIF-ip was cloned using a standard restriction digest approach to remove 
the YFP before ligating in a DsRedxp coding sequence (details in appendix). The 
new plasmid termed pG-DsRedxp-HIFiP was transfected into HeLa cells and 
subsequently imaged. Fluorescence expression from this new plasmid was also 
found to localise to cellular bodies. All images were processed using AQM 
kinetic tracker to measure the size and amount of HIF-ip speckles per cell. An 
average of 87.8 speckles was present per cell at an average size of 7.3pm with a 
SEM of 3.3; both values were found to overlap with the previous measurements 
for EGFP-HIF2a (Fig 6.17). In spite of the similarity in characteristics, one 
distinct difference was present; the HIF-ip speckles co-localised with structures 
visible on the bright field images.
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Fig 6.17. (A) HeLa cells were transfected with DsRedxp-HIFiP for 24-hours before live-cell 
confocal imaging expression. AQM kinetic tracker was used to analyse the speckle size and 
number per cell. (B) Box-and-whisker plot to show the comparative size of HIF-iP speckles 
compared to EGFP-HIF2a speckle. (C) Comparative numbers of HIF-iP and HIF-2Q speckles. 
All data pertaining to EGFP-HIF2a was gathered and imaged previously in Figure 6.7.
6.2.14.3 Co-localisation of HIF-2a with HIF-ia and HIF-ip
Following the visualisation of HIF-ip cellular bodies and reports of HIF-ia 
speckles, we were interested in imaging the co-localisation of these proteins 
using when ectopically expressed (Wotzlaw, Otto et al. 2007; Konietzny, Konig 
et al. 2009). HeLa cells were co-transfected to express DsRedxp-HIF2a with 
either an unfused EGFP control, YFP-HIFip or HIF-iaEGFP. Imaging of the 
expressing cells showed HIF-ip and HIF-2Q fluorescence to co-localise. These 
speckles were again found to co-localise with contrast regions in the bright field 
image, as found when expressing HIF-ip alone (Fig 6.18). Remarkably and 
unexpectedly, co-expression of HIF-2Q was found to alter the homogenous 
localisation of HIF-ia, which then co-localised to HIF-2Q speckles; the speckles 
appeared to have an altered morphology and decreased frequency of occurrence, 
though this relationship remains currently unquantified.
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Fig 6.18. Live-cell confocal microscopy of transiently transfected HeLa cells expressing 
DsREDxp-HIF2a alongside (A) an unfused EGFP (B) YFP-HIFip and (C) HIF-mEGFP.
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6.3 Discussion
In this chapter, we have begun to characterise the complex subcellular spatial 
patterning of HIF-2a. This has been achieved through the use of confocal 
microscopy, a technique which affords us the ability to look at single living-cells 
and their behaviour, not only with a high degree of temporal resolution as seen 
through chapters 4 and 5, but with a high-degree of spatial resolution; 
discerning and resolving structures/organelles to within a 200nm (Toprak, 
Rural et al. 2010). Initially experiments focused on the explanation of HIF-2a 
speckles, though over the course of the project the focus became broader 
identifying cellular bodies for PHD3 and HIF-ip. Of these, PHD3 has been 
previously and most assuredly identified existing as aggresomes which may 
confer hydroxylase sensitive apoptosis to cells, linking the HIF hypoxic response 
with another facet of cell fate. We observed PHD3 aggresomes in our own 
experimental system, though found no obvious link between the occurrence of 
aggresomes and hypoxia or any relationship to apoptosis (investigated in the 
course of chapter 5 experiments, data not shown). This work heavily implicates 
the involvement of the subcellular landscape in the HIF hypoxic signalling, 
suggesting HIF-2a levels to modulate the localisation of HIF-ia. This is the first 
study to implicitly address this possibility.
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Name Identifying characteristics References
Aggresome
(cytoplasmic)
Microtubule-dependent inclusion body, usually existing as only a few 
per cell. Are formed from the result of aggregated protein and are 
often rich in molecular chaperones.
(Kopito 2000)
Cajal Body A nuclear entity, found to be present in all studied eukaryotes, 
containing newly synthesised involved in pre-messenger RNA splicing. 
Typically identified by the presence of coilin.
(Nizami,
Deryusheva et al. 
2010)
Clastosome A sub-type of PML bodies, enriched for ubiquitin conjugates, 
proteasome and proteasome substrates. Found in numbers of 1-3 
bodies per cell nucleus.
(Lafarga,
Berciano et al. 
2002)
Cleavage Body An entity often accompanying and adjacent to Cajal bodies. They exist 
as 1-4 nuclear localised structures with a diameter ranging from 0.3- 
1.0 pms. Characterised by the presence of CPSF-100* and CstF-64* 
and known to be more prominent at S and G2 phases of the cell cycle.
(Li, Roy et al. 
2006)
Gems Gemini of cajal bodies are found adjacent to cajal bodies. Defined by the 
presence of SMN protein, this definition has been subsequently 
contested as being cell type dependent. Several reports are unable to 
distinguish gems from Cajal bodies and so significant overlap in 
function and morphology is expected.
(Sleeman, 
Trinkle-Mulcahy 
*et al. 2003; 
Nizami,
Deryusheva et al.
2010)
Inclusion Body
Interchromatin
Granules Clusters
A general term used to describe aggregated or wantonly polymerised 
protein, as occurs in several disease states or when expressing non­
native protein or insoluble protein. Usually seeded at a single site and 
grow with addition of more protein.
See Nuclear Speckles.
(Kopito 2000)
Mitotic Interchromatin Nuclear Speckles are freed from the nucleus during the course of (Lamond and
Granules nuclear breakdown and cell division. Speckling is lost during metaphase 
to anaphase.
Spector 2003)
Nuclear Aggresome
Nuclear Bodies
A class of aggresome, in which the proteolytic machinery is often 
hampered or overwhelmed leading to the translocation of nuclear 
aggresome to within the nucleolus. Nuclear Aggresomes are rich in a 
variety of proteins and RNA, but are distinct entities from their 
surrounding nucleolar environment.
See PML bodies.
(Latonen 2011)
Nuclear Speckles Nuclear speckles are enriched in splicing speckles, found to exist in the 
cell nucleus in sizes of one to several pms. Cited to contain 
transcription factors and machinery but be relatively inactive.
(Lamond and 
Spector 2003)
Nucleolus A sub-nuclear region clearly apparent by light microscopy, known as the 
site of ribosome biogenesis. Size varies from 0.5 - 5.0 pins.
(Raska, Shaw et 
al. 2006)
Nucleolar Caps Nuclear entities that form adjacent to the nucleolus, known to contain 
markers of Cajal bodies and PML bodies. The morphology of nucleolar
(Shav-Tal, 
Blechman et al.
caps is sensitive to transcriptional arrest by Actinomycin D. 2005)
OPT domain A cell cycle sensitive nuclear body, appearing in Gi and disappearing 
in S-phase. Contains nascent transcripts and transcription factors, 
existing at sizes from 1.0-1.5 prns.
(Spector 2001)
P62 Aggregates Sometimes referred to as sequestosomes, these are cytoplasmic 
aggregates of p62 protein. Linked to autophagy and the organisation of 
upstream NF-kB signalling.
(Nakamura, 
Kimple et al.
2009)
Paraspeckle Interchromatin speckles distinct from nuclear speckles. 5-20 entities 
are found in the nucleus. The speckles are characterised by the presence 
of paraspeckle protein 1 (pspci).
(Fox and
Lamond 2010)
PM L bodies Are a well established nuclear speckling phenomenon. Suggested to 
function as nuclear stores of inactive protein and viral infection 
resistance. Occurring as 1-30 per nucleus, at sizes ranging from 0.2- 
1.0 pins. Distinctly characterised by the presence of PML protein.
(Maul 1998; 
Geoffroy and 
Chelbi-Alix)
Polycomb body Polycomb bodies are a part of a gene silencing organisation, often 
correlating to the absence of RNA pol II. They exist as dynamic 
structures in the cell nucleus found in numbers of 12-16 per cell at sizes 
of 0.3-i.opms.
(Spector 2006; 
Sexton, Schober 
et al. 2007)
Table 6.1. A list of commonly referred to cellular bodies. A very well produced and similar table 
(with corresponding images of speckles) can be found in a publication from Spector (2006)
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6.3.1 Identification of HIF-aa subcellular entities
The variety and complexity of subcellular organisation is vast. Ongoing research 
within this field is still discovering new phenomenon and redefining the 
characteristics of cellular bodies previously elucidated (Fox, Lam et al. 2002). 
This is evident with the PML bodies, in which the proposed function has become 
broader and broader over the last two decades. They we’re originally discovered 
by electron microscopy from the separate works of Swift et al. (1959) and Beck 
et al. (1961) and then re-discovered in 1992 with the advent of antibody staining 
against key components (Brasch and Ochs 1992). As of now, they have been 
ascribed functions from antiviral defence, protein depots, transcriptional 
regulators as well as an arm of the misfolded protein degradation pathway 
(Tashiro, Muto et al. 2004; Fu, Gao et al. 2005; Geoffroy and Chelbi-Alix 2011). 
PML bodies are only one example from the list of many cellular bodies. 
Amongst the rich backdrop of known cellular bodies we have attempted to 
identify whether HIF-2a belongs to any known example. Originally, HIF-2a 
speckles were identified in bovine arterial endothelial cells in 1999 using the 
ectopic expression of fluorescent linked HIF-2Q. The localisation pattern was 
stated but not explained and has remained largely unqueried in subsequent 
papers (Kara, Kobayashi et al. 1999; Konietzny, Konig et al. 2009). Although a 
paper published from the group of Prof. J. Fandrey reported in 2004 a possible 
link between PML protein distribution and HIF-i localisation (Berchner- 
Pfannschmidt, Wotzlaw et al. 2004). However, our own work to concretely 
identify the HIF-2a speckles will undoubtedly be ongoing beyond this thesis. 
From the data gathered so far we can begin to hypothesise and discuss the 
identification of the HIF-2a cellular bodies. Firstly, from the frequency of HIF- 
2a speckles, there is no recorded cellular body known to exist in similar 
numbers. Transcription factories occur in high numbers in HeLa cells to the 
order of the thousands (Razin, Gavrilov et al. 2011). Paraspeckles occur in 
numbers of 10-20, nuclear speckles 25-50 and PML bodies occur at numbers 
ranging from 10-30 (Spector 2006). HIF-ia has been additionally been linked to 
PML protein in work published by Bernardi et al. (2006), who found PML 
protein to inhibit expression of HIF-ia mRNA during hypoxia via a physical 
interaction with mTOR; a facilitator of HIF-ia translation (Bernardi, Guernah 
et al. 2006; Knaup, Jozefowski et al. 2009). Our observed co-localisation of 
HIF-2a with pss and NRF2 suggest that in spite of the frequency of occurrence,
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HIF~2a and PML bodies are related. However, the sheer variety of HIF-2Q 
speckle characteristics suggests this to not be the only explanation. HIF-2a 
cellular bodies were found to be cytoplasmic or nuclear, as dynamic and static 
structures, to be partially sensitive to nocodazole, to respond to proteasome 
inhibition and to fuse and aggregate. Several of these data collected suggested 
HIF-2a speckles to share a relationship with the aggresome phenomenon. Also 
of the measured size, HIF-2a fits the defined characteristic of stress granules, 
aggresomes and nuclear stress bodies (Spector 2006). This observed 
relationship is further reinforced as HIF-2a speckles often manifested as 
irregular aggregates, not just as neat nuclear punctate structures (Markossian 
and Kurganov 2004). Many citations for aggresomes focus on them as 
cytoplasmic entities, though aggresomes can exist in a nuclear form as 
thoroughly discussed by Latonen 2011 (Latonen 2011). A publication from Fu et 
al. (2005) suggests that the co-existence and relationship of HIF-2a PML bodies 
and aggresomes is plausible; reporting that the fusion of PML bodies is a route 
for aggresome formation. Although, if HIF-2a is indeed a part of the aggresomal 
system, it reinforces the hypothesis from Bedaouin et al that aggresomes 
function beyond simple aggregates of misfolded protein (Beaudoin, Goggin et al. 
2008). For certain our HIF-2a construct was fluorescent in bodies and therefore 
the GFP protein at least intact to some degree. Also, analysis of HIF-2Q 
expression plasmids on HRE-luciferase carried out in chapter 3 shows the 
fluorescent fusion forms to be transcriptionally active. To further account for 
the diversity in HIF-2a speckle characteristics, PML bodies have been shown to 
have a relationship with Cajal bodies; structures commonly found in low 
number in highly transcriptionally active cells (Sun, Xu et al. 2005). The 
interplay of these subcellular entities may therefore explain the atypical 
manifestation of the HIF-2a speckles, which may occur as an amalgamation of 
several phenomena (Platani, Goldberg et al. 2000; Markossian and Kurganov 
2004; Fu, Gao et al. 2005; Latonen 2011). Together these form an axis of 
cellular bodies involved in the proteolytic response to protein and it is therefore 
not surprising that proteins extensively degraded such as HIF-2Q and PHD3 
may associate with these structures (Tian, McKnight et al. 1997; Nakayama, Qi 
et al. 2009; Latonen). Though it remains unexplained and an interesting 
question, what role HIF-2Q plays in the recruitment of HIF-ia to these foci and 
how the aggregation of various protein components of the HIF signalling
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network affects hypoxic signalling (with special regards to the HIF-PHD 
feedback loop).
In summary of the chapter, we have (further) identified the novel subcellular 
localisation of the HIF-2a isoform and provided evidence to suggest that HIF» 
2a enters into several speckling phenomenon with different dynamic properties. 
However, the mechanisms’ regulating the interplay of these speckles remains 
unknown, as does the possible interjection of the HIF-2Q speckles with the 
canonical hypoxic signalling network.
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Chapter 7: Nuclear membrane instability 
results in unstimulated asynchronous 
translocations
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7.1 Introduction
This project has made extensive use of live-cell confocal microscopy in order to 
explore the spatial and temporal dynamics of the HIF-signalling network. This 
work is part of a drive towards a greater appreciation of dynamic events and the 
power of live-cell imaging in elucidating these (Haraguchi 2002). However, as 
the approach is still relatively new there are undiscussed issues that may 
compromise the study of translocation dynamics. There are numerous signalling 
systems that are currently being researched and evaluated for dynamism, in 
terms of synthesis/degradation cycles and/or nuclear-cytoplasmic 
translocations, including ERK, NRF2, NF-kB, STAT, GR, p53, glucocorticoid 
receptor signalling as well as our own work with the HIF signalling system 
(Pariante, Pearce et al. 1997; Lahav, Rosenfeld et al. 2004; Nelson, Ihekwaba et 
al. 2004; Yoshiura, Ohtsuka et al. 2007; Shankaran, Ippolito et al. 2009; Zhang, 
Pi et al.). Often when a dynamic translocation event of a specific protein is 
discovered, a large amount of work can go into the understanding and 
dissection of this event with little regard to non-specificity or artefact. During 
the course of these experiments and primarily through the imaging of a variety 
of different fluorescent proteins, asynchronous and unstimulated nuclear- 
cytoplasmic translocations were often found to be present. This chapter 
describes the determination and characterisation of these spontaneous 
translocations.
7.2 Results
7.2.1.1 Analysis of PHD2EGFP spontaneous cytoplasmic:nuclear 
translocations
Throughout chapter 5, the various PHD proteins were imaged by live-cell 
confocal microscopy and this data strongly alluded to the presence of nuclear- 
cytoplasmic translocations. This was particularly visible when imaging 
fluorescent-tagged PHD2, a cytoplasmic protein that was observed to 
spontaneously flood into the nucleus. Here we re-examined this data in the light 
of these translocation events.
HeLa cells were transiently transfected using the CMV containing plasmid, 
pPHD2-EGFP. After 24-48 hours of transfection, cells visibly expressing PHD2 
were imaged every ~5-minutes for up to ^25-hours. Images of cells showing 
spontaneous translocations were processed using the small-circle cell-tracking
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analysis method, used to measure both cytoplasmic and nuclear fluorescence 
and thereby determine the nuclear:cytoplasmic ratio (N:C ratio). The 
translocation profile is seemingly subtle and at times difficult to detect with a 
degree of certainty. This is partly due to the low amplitude change from a 
resting N:C of -0.4 to a peak max of ~i.o (Fig 7.1). Also multiple peaks were 
apparent. The presence of multiple-peaks means that some peaks occur in such 
close proximity as to obscure whether one or multiple events transpired. These 
difficulties prompted the development of a more systematic analysis method. 
7.2.1.2 Systematic identification of PHD2 translocation peaks 
Using the translocation data imaging data, a series of processing steps were 
developed (Fig 7.1.). The raw data produced by Cell Tracker image processing 
was smoothed by averaging every three data points along the time-series. This 
reduced the noise apparent in the data, which made the data suitable to apply a 
peak detection threshold to.
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Fig 7.1. Process of fluorescence quantification and data preparation. (A) shows a PHD2EGFP 
transfected and expressing HeLa cell. (B) shows the tracking method used to measure the 
nuclear/cytoplasmic ratio of the translocations. (C) Is the raw data from the tracking 
measurement and (D) the smoothed data, performed by averaging every 3-data points.
The desire for the rapid and unbiased identification of the PHD2-EGFP 
translocations led us to consider several thresholding mechanisms to be used 
for the identification of translocation peaks within the cell traces of 
fluorescence. In work published by Turner et al. (2010) a similar thresholding 
system was employed in the identification of p6s nuclear-cytoplasmic
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oscillations. In their work, a pre-stimulus threshold was applied which was 
determined as the average fluorescence levels of the pre-stimulus period plus 
two standard deviations. The PHD2 translocations are asynchronous and 
spontaneous, preventing us from adapting this threshold. This led us to develop 
and considered four alternative methods, termed; (i) Jumping threshold (2) 
Local minima (3) Modal threshold and (4) Cell mean threshold (Fig 7.2.)- The 
jumping threshold functions by calculating if the current fluorescence value is 
more than 0.3 of the value 5-time points previously; the value of 0.3 was 
empirically determined after investigating the amplitude of the translocations 
and assessing the noise in measurements (from several tracked cells). The 
jumping threshold was therefore designed to capitalise on the sharp rise of the 
peak. However, this methodology suffered when peaks occurred close together 
and of varied amplitudes. A second methodology was attempted, the local 
minima threshold. Here, the minimum value within 100 minutes at any given 
time point was calculated and this served as the basis for the threshold (100 
minutes either way was determined as an appropriate width for a peak). Next 
we adapted the pre-stimulus threshold from Turner et ah (2010), this time 
using the entire cell fluorescence to calculate the average plus one standard 
deviation. Alongside this methodology, we also used a modal threshold which 
rounds all cell fluorescence values up to the nearest 0.1, and then calculates the 
mode from all these values plus one standard deviation. The ability of the four 
threshold methods to detect the translocation peaks were validated against by 
eye scoring. Each threshold was asked to find 53 human identified peaks, of this 
number, the jump method found 54.7% (29 peaks), the local minima found 
66.0% (35 peaks), the modal found 94.3% (50 peaks) and the cell mean 96.2% 
(51 peaks). For all further work, all peak translocations were automatically 
detected and scored by the cell mean threshold.
191
APHDa-EGFP
0 min 280 min 585 min 625 min 730 min
c
Fig 7.2. (A) Live-cell confocal microscopy of a HeLa cell expressing PHD2-EGFP undergoing 
spontaneous cytoplasmic-nuclear translocations. This cell was one of many used in the 
validation of a threshold method for the detection of the translocations. Four threshold methods 
were developed and applied to the data. The threshold line, where applicable, is shown in blue 
and the peaks detected shown as a red box. (B) The jump method determines whether the 
fluorescence data is £0.3 than levels 5-time points ago. The jump scale is indicated. (C) The cell 
mean method sets the threshold as an average of all fluorescence over the time course plus one 
standard deviation. (D) The local minima set the threshold as the lowest fluorescence level 
within 100-minutes of each time point plus 0.3. The width of the local minimum is shown. (E) 
The modal threshold works by rounding up every fluorescent value to the nearest 0.1, then 
calculating the modal average of these values plus one standard deviation.
7.2.2 Characterisation of PHD2-EGFP translocations; timing, 
frequency and profile
Using the analysis approach outlined, the N:C traces for 88 translocating cells 
were analysed. Of the 88 translocating cells, 78 were found to show a 2nd peak, 
62 a 3rd peak and 34 cells a 4th peak. The time to first observed translocation 
spanned the experiment time-course, though 42 cells were found to translocate 
within 200 minutes (Fig 7.3). Subsequent peaks displayed a similar timing, in 
which the majority (>50%) of repeat translocations occurred within 200 
minutes of the previous translocation. Despite the asynchrony in onset and
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frequency there was a strong synchrony in the normalised translocation profile. 
The peaks are easily superimposable; the import rate shows the greatest 
homogeneity and the export rate a relatively higher degree of variability (Fig 
7.3). The average peak was found to have a duration of -120 minutes, counting 
from the initial rise of fluorescence to the re-establishment of a steady-state.
0’ 120' 295’ . 395' 705'
/
/ /
/ /
1030'
B. C. D.
1.2 I . -------------------- - ' I 1.2 --------------- 1-------------- 1 ' 1 ■ 1-------------- 80
Fig 7.3* Characterisation of PHD2EGFP spontaneous cytoplasmic:nuclear translocations using 
HeLa cells ectopically expressing PHD2EGFP. (A) shows time-lapse imaging of PHD2EGFP 
with translocations indicated and (B) is the corresponding quantified N:C profile of the shown 
cells. (C) Shows all peak profiles isolated and superimposed and (D) a histogram of no. of 
translocations observed per cell. (E-G) Show histogram of the timing of translocations for the 
(E) experimental start point to initial peak, (F) the first peak to second peak and (G) the second 
peak to third peak.
7.2.3 Inheritability of nuclear membrane instability
From our data set of PHD2-EGFP time-lapse confocal imaging, we isolated 
several dividing cells and quantified the N:C ratio of fluorescence for both 
daughters in order to examine the inheritability of the translocations. Of the 11 
pairs analysed, 10 were found to both show a single translocation, 6 were found 
to both show two translocations and 2 were found to both show three 
translocations. Analysis of the synchrony of daughter cell 1st peak translocations 
(after division) showed that 2 pairs translocated within 30-minutes of each 
other, 4 pairs within 60-minutes and 6 pairs within 90-minutes (Fig 7.4).
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Taken together, the data indicates that the propensity for translocations is to 
some degree inheritable or the process predetermined before division.
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Fig 7.4. (A) Confocal microscopy images of a HeLa cells ectopically expressing PHD2-EGFP. 
The cell is followed through cell division. (B) The N:C ratio for fluorescence was followed from 
the parent cell to the daughters. A representative plot is shown corresponding to the images 
shown in (A). (C) A box-and-whisker plot showing the timing difference between daughter 
translocations for the three successive peaks. (D) Comparison of the occurrence of 
translocations in daughter cells, shown as % of daughter pairs both translocating for a number 
of peaks. (E) The synchrony of daughter cells is plotted as the % of daughter in which the 1st 
peak occurs within 30, 60 or 90-minutes of one another.
7.2.4 Are PHD2EGFP translocations sensitive to expression level of 
PHD2EGFP?
Under the hypothesis that the PHD2 translocations are facilitated through 
protein-protein interactions (such as may occur for the regulated transport into 
the nucleus) we could expect that this mechanism may be sensitive to different 
levels of PHD2 (Steinhoff, Pientka et al. 2009). The use of transient transfection 
affords us the chance to investigate the effect of different expression levels of 
PHD2 on the characteristics of the translocations. Previously attained imaging 
data were segregated into three categories of overall fluorescence intensity, 
namely, high, medium and low fluorescence intensity. The fluorescence 
intensity correlates with the expression-level and is therefore a readout of 
cellular PHD2 expression (Yen, Xu et al. 2008). The translocation profile 
between these three groups was compared (Fig 7.5). There was little evidence 
that varying degrees of PHD2 expression affected the translocation of PHD2. All
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response curves remained superimposable, and the frequency of translocations 
failed to show a strong correlation with fluorescence intensity.
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Fig 7.5. (A) Confocal microscopy images of transiently transfected HeLa cells expressing 
PHD2-EGFP. Images have been artificially synchronised to compare translocation, arbitrarily 
setting to as to just before translocation point. Cells of different fluorescence levels are shown. 
(B) Cell traces of nuclear fluorescence levels, showing three cells with different expression 
levels, separated into low, medium and high expression determined from their cytoplasmic 
fluorescence (C) Scatter plot comparing average cytoplasmic fluorescence with the occurrence of 
translocations.
7.2.5 Are PHD2EGFP translocations cell-type specific?
So far these translocation events have only been investigated in HeLa cells 
which leaves open an important question as to whether the phenomenon is a 
general or cell type specific feature. Previously SK-N-AS cells were optimised for 
use with live-cell confocal microscopy and further validated for work with 
hypoxia and the HIF system. We therefore used SK-N-AS cells transiently 
transfecting them with the pPHD2-EGFP plasmid vector for 24-48 hours. Cells 
were imaged by confocal microscopy for a time-course over 20-hours. Whereas 
for HeLa cells translocations were observed in 24% of all cells (n= 19 of 79 total 
cells), no translocations were observed in SK-N-AS cells. This prompted us to 
investigate another available cell line, the medulloblastoma DAOY cell line 
(Jacobsen, Jenkyn et al. 1985). DAOY cells were transiently transfected with the 
pPHD2-EGFP expression vector in the same manner as for the HeLa cells. After 
24-48 hours cells were imaged by confocal microscopy for up to 24 hours. In 
this instance, 21% (n=n of 52 cells) of imaged DAOY cells were seen to 
translocate (Fig 7.6). The translocation profile remained similar to HeLa cells,
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comparing Cell Tracker quantified normalised N:C fluorescence traces (data not 
shown).
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Fig 7.6. (A) Time-lapse confocal microscopy of three cell lines transiently transfected with 
PHD2EGFP and the (B) % of imaged cells showing a visible translocation event over a period of 
~20-hours.
7.2.6 The affect of mutating PHD2 on PHD2EGFP localisation 
dynamics
Next we examined whether any sequences or motifs within the PHD2 protein 
are necessary for the translocations to occur. To this end several fluorescent 
tagged PHD2 mutants were used, kind donations from Prof. R. Depping, 
Liiebeck. The mutants available were; A1-100, A101-200, A180-220, A201-300 
and A301-426. The amino acid residues between 6 and20 have been shown to 
contain the function nuclear export sequence for PHD2 (Yasumoto, Kowata et 
al. 2009). We hypothesised that one these domains may have a role in the 
spontaneous translocations of the PHD2 protein. Initially, all mutant PHD2 
forms were examined for their resting localisation in both HeLa and SK-N-AS 
cells using single time-point imaging. Cells were each transfected with either an 
unfused EGFP, wild-type PHD2-EGFP or one of the mutant PHD2 expression 
vectors. Cells were then imaged by confocal microscopy for up to 20 hours. For 
the first images, the N:C ratio of all cells was determined using Cell Tracker to 
quantify fluorescence levels (Fig 7.7). All mutants were found to be 
predominantly cytoplasmic, except for A1-100 which was found to be near
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ubiquitous in HeLa and SK-N-AS cells with an average N:C ratio of -1.4 and 
~i.o correspondingly, in line with the findings from Yasumoto et al. (2009).
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Fig 7.7. (A) Imaging of HeLa and SK-N-AS cells ectopically expressing either an unfused EGFP 
vector, wild-type PHD2-EGFP or a mutant PHD2EGFP. (B) Cell Tracker was used to quantify 
the N:C ratios of fluorescence for a number of cells, the values are plotted in a box-and-whisker 
format.
From the same experiment, the translocation potential of the cytoplasmic 
mutants was investigated (in the HeLa cells). Time-lapse imaging showed all 
cytoplasmic mutants were able to undergo translocations in a manner akin to 
the wild-type protein (Fig 7.8). This data strongly suggested that either the 
critical regulatory sequence is contained within the first 100 amino acids of the 
PHD2 protein, or that the domain structure of the PHD2 protein is unimportant 
for the generation of the spontaneous translocations.
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Fig 7.8. HeLa cells were transfected with various fluorescent fusion PHD2 expression vectors, 
encoding either wild-type PHD2 or a mutant form. All images are shown from the initiation of a 
spontaneous translocation event.
7.2.7 Evidence of spontaneous nuclear-cytoplasmic translocations of 
other proteins
Throughout the live-cell imaging of various proteins in this project there has 
been multiple suggestions of translocation-style events. Re-evaluation of the 
data has indicated this for HIF-ip, PHDi as well as HIF-2Q (Fig 7.9). These 
proteins are localised to the nucleus in basal conditions and so the 
translocations involve the movement of nuclear protein to the cytoplasm, the 
reverse of the PHD2 scenario. The presence of translocation events within other 
protein members of the HIF pathway prompted the further examination as to 
whether these events were connected.
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Fig 7*9* Live-cell confocal microscopy of HeLa cells expressing various fluorescent fusion 
plasmids related to the HIF signalling network. All images are shown from the initiation of a 
spontaneous translocation event.
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7.2.8 Are the translocations specific to complexes of the HIF system 
or a general feature?
To assess the specificity of the translocations to the HIF system, HeLa cells were 
co-transfected with two unrelated proteins. The proteins selected were HIF-ip 
and Rel-B of the NF-kB pathway. The proteins were considered unrelated after 
confirmation by literature review (retrieving no papers in a pubmed search 
together). Once transfected cells were then imaged by confocal microscopy and 
then fluorescence levels quantified using Cell Tracker. Confirmation by eye and 
quantification of nuclear intensity profile indicated that both proteins 
translocated (nucleus to cytoplasm) simultaneously in all instances and with the 
same export rate (Fig 7.10). This further conforms to the hypothesis that the 
translocation events are a general cell-type specific event, while non-specific for 
the proteins involved. This would therefore imply that the nuclear-cytoplasmic 
translocations may occur simultaneously alongside cytoplasmic-nuclear 
translocations.
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Fig 7.10. Time-lapse imaging of HeLa cells transiently transfected with YFP-HIFiP and RelB- 
DsRedxp. Images are of a single translocation event. Plotted data shows the nuclear 
fluorescence trace for the cell for the experiment duration.
7.2.9 Vesicle formation as a source of disruption to nuclear envelope 
integrity
The evidence gathered supports nuclear envelope disruption as a source of the 
translocations. The previous images were then carefully scrutinised for visual 
clues pertaining towards this hypothesised nuclear envelope disruption. Several 
of the translocating cells were found to have distinct vesicle-like formations that
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grow in size, before seemingly bursting and disappearing and then reforming 
again. The bursting of these vesicles coincides with the translocation of the 
observed protein (Fig 7.11). We conclude that this process is responsible for the 
disruption of nuclear envelope integrity which leads to the re-localisation of all 
the observed proteins so far.
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Fig 7.11. Time-lapse imaging of HeLa cells transiently transfected with PHD2EGFP. Red arrow 
indicates nuclear vesicle-like formation, which grows and ruptures, coinciding with the 
translocation of fluorescent PHD2 at 120 minutes.
7.3 Discussion
Throughout the live-cell imaging of the HIF system we have been able to 
observe a seemingly novel biological phenomenon that gives rise to 
dysregulated cellular localisation patterns in several transformed cell lines. 
Evidence suggests that these events occur due to disruption in the nuclear 
envelope mediated via nuclear vesicle formation and subsequent bursting. This 
process is dynamic and asynchronous throughout a population of cells and 
thereby difficult to detect with standard bulk-cell assays (Levsky and Singer 
2003). These nuclear envelope disruption events effect the general cell 
architecture and thus can be expected to affect a large amount of cellular 
components allowing nuclear proteins untimely exposure to the cytoplasm and 
vice versa; perhaps even organelles such as mitochondria may gain access to the 
nucleus due to these events (Bakeeva, Skulachev et al. 2001). The potential 
scope of detrimental affects is vastly diverse. For certain it refocuses a 
cautionary approach to research grade cell lines as both HeLa and Daoy are 
extensively used as models in cell biology (Jacobsen, Jenkyn et al. 1985; Chilov, 
Camenisch et al. 1999; Taylor, Furuta et al. 2000; Hofer, Desbaillets et al. 2002; 
Peyrl, Krapfenbauer et al. 2003; Meley, Spiller et al. 2010).
7.3.1 Nuclear membrane instability resembles Vpr-induced 
herniations
At the onset of this work describing nuclear membrane instability we were 
unaware of any such publication detailing this phenomenon. Since the 
significant completion of this body of data we have since found a publication
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which most likely describes what was witnessed here. The paper was published 
in Science by de Norohna et al (2001), titled ‘Dynamic Disruptions in Nuclear 
Envelope Architecture and Integrity Induced by HIV-i Vpr\ The paper reports 
that the presence of viral protein R, a HIV gene product, affects the lamin 
structures and induces nuclear herniations in HeLa cells that occasionally 
rupture and disrupt nuclear membrane integrity. The loss of nuclear membrane 
integrity is then shown to affect the regulated localisation of components of the 
cell cycle machinery, including weel, cdc25 and cyclin Bi. The dysregulated 
localisation of these components has consequences on the cells ability to 
proliferate (de Noronha, Sherman et al. 2001). Rupturing nuclear herniations 
were also identified in a study by Hoyt et al. (2004) using mouse L929 cells. In 
this case, reovirus infection and subsequent expression of <ris viral protein were 
found to be responsible for inducing herniations (Hoyt, Bouchard et al. 2004). 
In opposition to these publications, we have not purposely instigated viral 
infection and have still managed to detect nuclear herniation events in two cell 
lines, namely the HeLa cervical carcinoma cells and DaoY medulloblastoma 
cells (Gey GO 1952; Jacobsen, Jenkyn et al. 1985). This contradiction is made 
more important as the de Norohna et al. (2001) study also used HeLa cells in 
their investigation into nuclear herniations. One explanation for these 
differences between the same cell line is HeLa cells across different labs and at 
differing times may have differing genetic statuses, owing to the genomic 
instability of the cell line (Irelan, Wu et al. 2011). However, this would also 
imply that the virally induced nuclear herniations can be mimicked through 
accumulations of mutations. Both de Noronha et al. and Hoyt et al found the 
underlying mechanism to be the disruption of the nuclear lamins and nuclear 
pore complexes. The nuclear lamins constitute a structural element to the 
nucleus, providing shape and mechanical stability as well as effecting the 
genomic organization (Dechat, Adam et al. 2010). Their position in the nuclear 
integrity would suggest that the nuclear lamins would be a likely candidate in 
explaining the underlying molecular causes of the nuclear herniations in our 
system.
7.3.2 Consequence of nuclear herniations
Regardless, the un-stimulated occurrence of herniations in two unrelated cell 
lines may suggest the mechanism to be present in other transformed cells. In 
spite of this speculation, de Noronha et al. 2001 showed that the herniations
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actually induced cell cycle arrest, a feature that would not expectantly be 
favourable or selected for. Analysis of our own cells showed no compromising 
effect to cell cycle (data not shown). Currently, there is limited work regarding 
nuclear herniations and therefore it is difficult to speculate the consequences. 
The compromising of nuclear integrity may aid in the transfection of certain cell 
lines. Typically cationic lipid transfection requires the nuclear envelope 
breakdown and reformation in order for the plasmid to reach the nucleus and to 
be expressed (Zabner, Fasbender et al. 1995). Cells lines undergoing nuclear 
herniations would not be dependent on this step and transfections may occur in 
a cell-division independent manner. This may explain a portion of the 
heterogeneity observed when imaging fluorescent HIF-a and the HRE- 
luciferase in Chapter 4. Beyond research methodology, the occurrence of 
disrupted nuclear membrane integrity is likely to have other repercussions. It is 
known that the nuclear lamina is disrupted in many diseases, though the exact 
relationship of dysfunctional lamina to the pathology of the disease often 
remains unknown (Dechat, Adam et al. 2010). If these dysfunctions lead to 
herniations, it may be that the mislocalisation of a diverse set of cellular make­
up contributes to these pathologies. The involvement of mislocalisation of 
protein in the etiology of disease was thoroughly addressed by Park et al. 2011, 
who reported a direct correlation of protein localisation and disease association 
(Park, Yang et al. 2011). Broadly speaking, many processes, proteins, RNA and 
cellular components are influenced by the regulated separation of the cell 
nucleus from the cytoplasm. It could thereby be expected that the untimely 
mislocalisation of cellular components could have a broad range of effects 
beyond the documented cell cycle arrest; including the disturbance of inhibitory 
cytoplasmic sequestration of NRF2, activation of Rho via loss of Neti nuclear 
sequestration and the expression of migration stimulating factor by nuclear 
sequestered precursor mRNA to name but a few (Table 7.1) (Graef, Chen et al. 
2001; Zipper and Mulcahy 2002; Kay, Ellis et al. 2005). The presence of 
asynchronous translocations also introduces heterogeneity into the population 
of cells. Work published by Paszek et al. suggested that heterogeneity to be 
protective for tissues, some of this concept may carry across to populations of 
cells experiencing spontaneous herniations (Paszek, Ryan et al. 2010). In our 
own work it is possible these nuclear herniations contributed to the cytoplasmic 
localization patterns of HIF-2a (Chapter 6). Within available literature on the
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HIF system, several localisation sensitive mechanisms have been reported, 
including work by Jokilehto et al. (2010) who reported that the mislocalisation 
of PHD2 to the cell nucleus promotes anchorage-independent carcinoma cell 
growth, promoting malignancy (Jokilehto, Hogel et al. 2010). Additionally the 
regulation of HIF-PHD binding is facilitated by the localization of the OS-9 
protein (Back, Mahon et al. 2005; Brockmeier, Platzek et al. 2011). Lastly, 
SIAH2 specificity for targeting PHD3 over PHD2 for degradation is also cited to 
be localisation dependent (Nakayama, Qi et al. 2009). All these reasons alone 
warrant caution when investigating cellular processes in cell lines that are 
known or suspected to undergo spontaneous nuclear herniations.
Known processes using: Cytoplasmic sequestration
NF-kB Cytoplasmic sequestration of p6s by IkBu prior to receiving an inducing (Nelson, Ihekwaba 
stimulus, allowing p6s to move to the nucleus et al. 2004)
NRFa The redox-sensitive transcription factor is sequestered by KEAP-i until (Zipper and
an activating stimuli allows NRF2 to translocate to the nucleus. Mulcahy 2002)
NFAT The dephosphorylation of the NFAT transcription factor complex (Graef, Chen et al. 
unmasks a nuclear localisation domain, resulting in translocation. 2001)
ERK ERK is sequestered in the cytoplasm by MEK. Upon stimulation ERK (Shankaran, 
translocates to the nucleus. Under continuous stimulation ERK Ippolito et al. 
oscillates. 2009)
GR GR is sequestered in an unliganded state in the cytoplasm. When bound (Biddie and Hager 
to cortisol the GR NLS become exposed, stimulating nuclear 2009) 
translocation
NFAT Cytoplasmic localisation of NFAT is promoted via basal (Mancini and
hyperphosphorylation. Dephosphorylation of NFAT following calcium Toker 2009) 
influx allows NFAT to travel to the nucleus.
Cell
Cycle
The regulated compartmentalisation of several components such as (Kong, Barnes et 
cyclin B is part of the series of events controlling cell cycle progression. al. 2000)
Known processes using: Nuclear sequestration
Neti Neti is a nuclear sequestered guanine nucleotide exchange factor, (Schmidt and Hall
relocation of Neti to the cytoplasm leads to the activation of Rho. 2002)
P53 Typically P53 is localised and functional as a transcription factor in (Liu and Xirodimas
the cell nucleus. The localisation of P53 to the cytoplasm is cited to 2010)
have diverse implications. One such is the promotion of apoptosis.
Table 7.1. A non-exhaustive list of known examples in which the regulated nuclear or 
cytoplasmic sequestration of a protein is important to function.
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ChapterS: Discussion
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8.1 General Discussion
This project has used a combination of single-cell imaging and mathematical 
modelling alongside traditional molecular biology techniques to investigate the 
oxygen-sensitive hypoxia-inducible factor (HIF) signalling system.
8.1.1 Reflection on thesis aims
The project initially set out to confirm and characterise the existence of 
intracellular dynamics of the HIF-a transcription factor in response to 
perturbed oxygen levels. Such dynamics were previously hypothesised with 
reference to the presence of a delayed negative feedback within the HIF system 
(Marxsen, Stengel et al. 2004; Stiehl, Wirthner et al. 2006). To this end, several 
subsidiary aims were established; (1) To assess the suitability of both fluorescent 
proteins and bioluminescence for use in low oxygen conditions; (2) To clone and 
then validate the use of plasmid constructs to enable the single-cell visualisation 
of this system; (3) To image the HIF system using the generated molecular 
tools, investigating both the protein and transcriptional response to hypoxia. 
During the course of addressing these aims, several further questions became 
apparent. The single-cell data provided evidence for previously unreported 
distinctive patterns of HIF-2a subcellular localisation, whilst also showing the 
nuclear-cytoplasmic translocations of several canonical members of the HIF 
pathway. These phenomena were investigated in Chapters 6 and 7 respectively. 
Additionally, the quantitative nature of the HIF-a imaging experimentation, and 
the emerging complexity of the HIF system provided strong arguments for the 
use of mathematical modelling to further investigate feedback dynamics (Sung 
and McNally 2010). To this end, a collaboration was successfully built with the 
University of Liverpool Department of Mathematics following extensive training 
in mathematical modelling by (our now collaborator) Dr. Rachel Bearon.
During the course of the project some further undiscussed goals and aims were 
briefly investigated only to be subsequently found impractical or largely 
unparsed. Nevertheless, I believe the main aims of this thesis were met.
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8.2 HIF-signalling: Current Relevance and Future 
Perspective
The work carried out spanned three broad themes: the use of molecular 
reporters in hypoxia, the kinetics of HIF-a and the subcellular localisation 
pattern of HIF-2<x. The project was mainly focussed on the dynamic properties 
of the system and their characterisation using single-cell imaging and 
mathematical modelling.
8.2.1 The Dynamics of HIF signalling
Dynamics is a broad term encapsulating the continuous changes that 
perpetuate through signalling systems (nicely reviewed by Kholodennko 2006) 
(Kholodenko 2006). We characterised some of the spatial and temporal 
dynamics present in the HIF system, finding them to be influenced by both 
intrinsic and extrinsic perturbations.
To our knowledge, this is the first study to attempt an in-depth analysis of the 
dynamics of the hypoxia response system (as governed by HIF). For future 
work, it will no doubt be interesting to investigate these dynamics away from the 
potential pit falls of HIF-a overexpression. The use of the ODD-EGFP in chapter 
4 presented one such possibility and currently our laboratory is also preparing a 
lentiviral system in which to achieve stable expression of full length fluorescent 
HIF-ia and HIF-2a. This approach will be used to further validate the cell cycle- 
related modulation of HIF, whilst also providing more assured information on 
the occurrence of normoxic stabilisation.
In the context of the HIF-2a system, the cellular speckles (observed in chapter 
6) could be explored across a population of cells without varied expression 
levels possibly contributing to heterogeneity. This may represent an interesting 
avenue of research, as the consequence of the speckles on HIF signalling 
remains an entirely open question.
The dynamics of pVHL have been left relatively unexplored. In light of the 
citations suggesting the shuttling of pVHL to be important to HIF (as well as the 
proposed cell cycle regulation of pVHL), it may be interesting to characterise 
these events with respect to HIF dynamics (Lee, Neumann et al. 1999; Liu, Xin 
et al. 2010).
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8.2.2 Modelling HIF signalling
Unlike many signalling systems there have been relatively few mathematical 
models developed for HIF signalling. The most established being the model 
proposed by Kohn et al. which was further developed through the works of 
Dayan et al, Yu et al. and Heiner et al. We would propose that the 4C-model 
may offer additional insights, appraising the signalling network from a bottom- 
up approach as opposed to the top-down approaches taken by other HIF- 
models to date. For the 4C-model to truly achieve this, the mathematical model 
(and the predictive power) will need to be further developed and become more 
relative to data from other groups. Here we discuss the future perspectives for 
the further development of the model in light of current and emerging 
technologies.
8.2.2.1 Beyond the 4C-model
There is significant potential for further development of the current 4C-model 
and therefore every development should be qualified with a specific question. 
For example, should future data be unexplainable using the current model, an 
effort would be made to adjust the model accordingly. Despite the very broad 
and near limitless possibility for further model elaboration, it is possible to 
suggest several directions for progress (Fig 8.i).
Stochastic
Scaling
Spatial: Tlssus level modelling 
Temporal: Days to weeks
Gene expression
Crosstalk events 
Downstream gene expression 
HIF specific: FIH, ROS, pVHL, HIF-1P
Sub-cellular localisation 
Transcription and translation
Fig 8.1. Outline of future development routes for the 4C-model
Firstly the model details a single isolated cell and lacks the additional 
complexity of scaling to tissue levels. Many remaining questions concerning HIF 
are questions targeted to multicellular arrangements in which blood supply, cell 
division, apoptosis, cytokine production, Oa-consumption and diffusion are all
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implicit. The tumour environment is one such example of a multicellular 
arrangement and muscles under exercise another. Work from Dr. A Popel’s 
group has attempted to model the unity of features such as VEGF, HIF 
expression with muscle during exercise (Mac Gabhann, Ji et al. 2007; Schnell 
2007; Lai, Zhou et al. 2009). A perhaps interesting aspect to this scale model 
would be the inclusion of tissue level feedback motifs occurring in the forms of 
VEGF and EPO, controlling vasculature and erythropoiesis respectively. 
Although this task is far from trivial, a model of HIF transcriptional activity and 
downstream gene expression would need the regulating intracellular feedbacks. 
Bringing these ideas to our 4C-model might involve the resolution of gene 
expression profiles of important HIF genes such as VEGF, EPO, BNIP3 or one of 
the hundreds of others possible relevant to tissue level function (perhaps even 
going as far to include stochasticity) (Althaus, Bernaudin et al. 2006). 
Microarray data makes this more realistic when working within a mathematical 
model framework (Wolkenhauer 2002). As the 4C-model already describes gene 
expression of PHD2 and PHD3, these parameters can be used to normalise 
expression to other genes.
A further possible route of model-development is to expand the model 
architecture to include new components. Our data suggests the involvement of 
cell cycle in HIF-signalling. From further investigation into cell cycle, the 
responsiveness of HIF at different phases at varying oxygen conditions could be 
assessed, particularly as Gi/S arrest is purported to occur in hypoxia (Alarcon, 
Byrne et al. 2004; Hubbi, Luo et al.). This would constitute an inter-system 
feedback mechanism by which HIF regulates cell cycle and cell cycle regulates 
HIF-a abundance, something that may be important in highly proliferating 
cancer cells (Hubbi, Luo et al. 2011). The expansion of model components can 
also be envisaged for other members of the pathway, such as pVHL, FIH, HIF- 
3a or HIF-ip and perhaps even the SIAH proteins. This would be in line with 
work from Heiner et al. (2010) whose analysis of the core components of the 
HIF-model included pVHL. The addition of new components may allow us to 
consider model simulations over longer time-scales, moving from hours to days 
to weeks (Bruning, Cerone et al. 2011). Similarly, it may be of interest to model 
HIF-2a, which is cited to accumulate at later time points (or possibly with 
different dynamics) and investigate the impact on downstream gene 
transcription Bracken, 2006 #310}.
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Alternatively, the core model components could be further resolved. There has 
been much speculation and discussion regarding the compartmentalisation of 
the PHD proteins. From our own 4c-model framework the spatial 
characteristics could be explored by introducing nuclear import and export rates 
of the HIF-a and the PHD proteins which may now be quantifiable using single­
cell imaging experiments such as FRAP and FCS(Wu, Corbett et al. 2009; 
Pfeifer, Kaschek et al.). Such spatial consideration may allow the effect of the 
localisation on hydroxylation to be further explored. It may also be relevant to 
resolve the synthesis terms of the qC-model into separate mRNA and 
translation rates. In support for this, a recent global study on protein expression 
by Yen et al. found translational rates to be the defining point for protein 
abundance, a finding in contrast to our use of mRNA abundance (Yen, Xu et al. 
2008).
Finally, the qC-model was built on data using arbitrary units of fluorescence. A 
desirable goal for future model fitting would be to have the units of the model 
more reflective of those encountered in the cellular environment and for the 
model to work with absolute quantification. This would help us to understand 
the exact ratio of HIF to PHD protein, address the relevance of stochasticity and 
to investigate the saturation potential of the system. A recent technology 
developed by Beynon et al. 2005 enables the absolute measurement of protein 
in a technique termed QconCAT (Beynon, Doherty et al. 2005). This technology 
may allow us to adopt absolute protein abundance into our current 4C-model, a 
level of detail which has not been truly achieved by any HIF model to date.
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8.3 General principles
Our work investigating HIF signalling dynamics has relevance beyond the 
immediate hypoxia field of research, raising several general points for 
discussion.
8.3.1 Delayed Negative Feedback motifs
Our work has highlighted that non-overtly dynamic signalling systems can still 
be regulated by more subtle, dynamic mechanisms. We believe other signalling 
systems could well be approached in a similar manner and these endeavours 
may enrich our understanding. It is common practice to measure the average 
amplitude of response, sometimes with little consideration to possible shifts in 
kinetics or asynchrony between cells. This is partially due to the practicalities of 
population-wide techniques such as western blot, RTq-PCR, microarrays etc. 
Here we have implemented the live-cell imaging of the HIF system to enable the 
development of a mathematical model, both of which are useful tools to 
understand regulatory events at high spatial and/or temporal resolution. Such 
regulatory features are emerging to be important in managing the phenotype of 
response. The encoding of information is of importance to our understanding of 
cell signalling and thereby our ability to manage and manipulate intra-cellular 
signalling systems with therapeutics, which is a principal goal for our field of 
biological research (Patel, Heyward et al. 2011). We have investigated to some 
extent how the HIF system may encode information: from memory of stimulus, 
to amplitude, duration and steady-state levels. Underlying this notion is the 
delayed negative feedback loop supplied by the relationship between HIF and 
PHD.
Negative feedback loops exist on many levels of biological signalling networks: 
from transcriptional cycles (Harper, Finkenstadt et al. 2011), to subcellular 
protein feedbacks (Ihekwaba, Broomhead et al. 2004; Nelson, Ihekwaba et al. 
2004), to tissue-level feedbacks (Forsythe, Jiang et al. 1996), to behavioural 
(Worland 1976; Turrigiano 2007). Typically, a negative feedback loop requires 
an inducing species and repressing species. From this architecture alone a 
steady-state solution is reached or homeostasis maintained. This can be 
considered to be the case in many biochemical reactions which are fast acting 
and sensitive to changes in product or substrate. Homeostasis can also be a 
much more complicated situation, in which the maintenance of a set state in 
face of extrinsic perturbations is necessary for function. Such a situation has
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been shown for the maintenance of neuronal function in spite of changes in cell 
size and condition (Turrigiano 2007). In considering the HIF negative feedback 
loops, we have explored the addition of a further feature: an intrinsic delay. The 
inclusion of a delay opens the possibility of transitional-state dynamics 
(dynamic instability), manifesting as either simple transiency or complex 
oscillatory profiles. Although dynamic instability may be an unstimulated 
feature of certain biological events, such as transcription, in cell signalling 
dynamic instability is often in response to an external cue. The resulting 
transitional dynamics offer the potential to encode contextual information. The 
most dynamic and striking example of this is found in the various intracellular 
oscillators that have been discovered, including ERK (Shankaran, Ippolito et al. 
2009), p53 (Lahav, Rosenfeld et al. 2004), NF-kB (Nelson, Ihekwaba et al. 
2004) and calcium (Dolmetsch, Xu et al. 1998). The transitional-state dynamics 
of the latter two have both been shown to alter the downstream gene expression 
profile.
Oscillatory systems also require a sufficient degree of non-linearity. If such non­
linearity is absent, the potential for complex dynamics is markedly reduced (or 
impossible). Many signalling systems may not have such vivid oscillatory 
outputs but still have meaningful dynamic properties (Plachta, Bollenbach et al. 
2011). Our own model has highlighted the flexibility of a simple delayed 
negative feedback loop. We would hypothesise that the plasticity of this motif 
encourages context-specific response patterns which oscillatory systems would 
be more robust against. Our work with a simpler system should highlight that 
other signalling networks could perhaps be assessed for the way these feedbacks 
encode information and whether this has phenotypic consequences.
Dynamics can be quantified and appraised in various ways ranging from 
amplitude, period, peak-duration, steady-state levels and reset periods all 
changing over the course of different stimuli and cell type (Kholodenko 2006). 
Many of these features have been shown to have an impact on the phenotype of 
response in other signalling systems, including the dose-to-duration response of 
yeast Saccharomyces cerevisiae after exposure to mating pheromone, in which 
growth or mating is selected for based on duration of the intracellular signalling 
components(Behar, Hao et al. 2008). The amplitude of calcium entry into 
developing B-cells affects the sensitivity to ligand induced cell death 
(Limnander, Depeille et al. 2011). Both duration and amplitude are thought to
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be important for sonic hedgehog ligand induced differentiation of cells in 
development, as the temporal profile of signalling translates to the formation of 
different cell types (Ribes, Balaskas et al. 2010). The steady-state protein levels 
(albeit a fluctuating stochastic steady-state) of Bcl-xl determine the propensity 
of the cell to commit to apoptosis.
In a goal beyond the scope of this thesis, an improved appreciation and 
knowledge of encoding could lead to therapeutics which may act to edit the 
message of transcription factors rather than simply activating or repressing, or 
allow a better appraisal of a disease and therefore the course of treatment. Also 
as hypoxia plays a role in stem cell maintenance and proliferation, it may be 
possible that the kinetics of oxygen and hypoxia are also important to this field 
(Barnhart and Simon 2007; Seton-Rogers).
8.3.2 Live-cell imaging; versatility and applicability 
Live-cell imaging allows for the unparalled measurement and observation of 
many of the processes of life. Developments in technology and methodology in 
this field are therefore very important for the scope of biological questions that 
we can answer. Of the current technologies, confocal microscopy and the 
imaging of fluorescence is the most popular, owing to the comparative 
resolution, relevant fluorescent probes and versatile speed of image acquisition. 
Nevertheless, other technologies have their own merits, including bright field 
imaging and wide-field luminescence (Stephens and Allan 2003; Troy, Jekic- 
McMullen et al. 2004; Selinummi, Ruusuvuori et al. 2009).
The application of confocal microscopy to cell biology is generally limited to our 
ability to fluorescently label cellular components. The list of labelling methods 
and targets is extensive, easily covering the components of the central dogma, 
DNA, RNA and protein and additional elements such as lipids (Lindhout, 
Fransz et al. 2007; Mac Gabhann, Ji et al. 2007; Bao, Rhee et al. 2009; Spandl, 
White et al. 2009). The use of fluorescent proteins and genetic manipulation 
make it almost possible to label any protein-of-interest (Wiedenmann, Oswald 
et al. 2009). Additionally, many probes exist that are reactive with the 
biochemical status and changes of the cellular environment, sensitive to redox- 
state, concentration of dissolved oxygen, metabolites etc (O'Riordan, Fitzgerald 
et al. 2007; Hilderbrand ; van Lith, Tiwari et al. 2011). A recent and very well 
cited paper by Wang et al. 2008 has also managed to measure superoxide 
flashes in single-mitochondria when exposed to anoxia, hypoxia and re-
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oxygenation, imaging a dramatic increase in superoxide production following 
re-oxygenation (Wang, Fang et al. 2008). The possible probes and proteins 
alone offer a huge scope of relating oxygen consumption dynamics, redox state 
and mitochondrial status with HIF protein dynamics. Improvements to 
labelling are typically made by reducing the toxicity, invasiveness and non­
specificity as well as improving the spectral characteristics of the labels 
available. Furthermore, the advent of superresolution has circumvented the 
issue of the diffraction limit and we’re thereby able to resolve structures smaller 
~200nm while still gaining all the benefits associated with confocal microscopy 
(Toprak, Kural et al. 2010). Super-resolution imaging may prove useful in the 
characterisation of the various cellular bodies of the HIF signalling system, 
providing quantitative data on the amount of protein present via the single­
molecule level imaging. Beyond this, many other techniques may also prove to 
be of worth for this avenue of work such as FRAP, FRET and fluorescence cross 
correlation spectroscopy (FCCS), which are able to provide a rich variety of 
quantitative data regarding diffusion and binding affinities, enabling us to 
further calculate the percentage of HIF-2a localised to the possible protein 
stores and evaluating the visible complexes. From such data we can begin to 
hypothesise the likely impact of the subcellular localisation of HIF components 
on overall HIF signalling (alongside other experiments). During the course of 
the project, we attempted the live-cell measurement of protein turnover. New 
technologies can permit us to revisit this. The live-cell measurement of protein 
stability is possible using plasmid expression vectors encoding a fusion protein 
of interest and an IRES separated unfused DsRedxp, thereby green and red 
fluorescence are from the same mRNA. The relative ratio of green fluorescence 
to red fluorescence can be used in the quantification of protein turnover, as 
originally reported by Yen et al. (2008) and known as global protein stability 
analysis. Separately to this knowledge we have begun to clone expression 
vectors in line with this thinking for HIF-ia and HIF-2a. This approach has the 
additional benefit when coupled with transient transfection to relate expression 
level of the reference red fluorescent protein to the fused protein of interest, 
relating either HIF-nx accumulation profile or HIF-2Q speckle morphology to 
expression.
Live-cell confocal microscopy is therefore able to generate data greater than the 
initial specific research questions. The live imaging of single-cells almost
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automatically provides information on cell morphology, migratory response, 
viability, cell division rates and cell-to-cell variance. Some of these principals 
were demonstrated during our investigation into intracellular signalling 
dynamics with the HIF system. Cell death rates were calculated after imaging 
cells transfected with HIF-a, division rates were explored to calculate whether 
overexpression of HIF-ia induced cell-cycle arrest and also cell-to-cell variance 
was ardently assessed.
The major limitation encountered with taking into account the total available 
information was with the analysis software and the quantification of the visual 
data. Several image analysis tools were used, Cell Tracker, AQM kinetic analysis 
and LSM image browser and many more exist that were largely untried 
including Cell Profiler, Image J and Carnegie web based Cell Tracking Software. 
With the development of suitable software our imaging data could be revisited, 
further analysed and intracellular dynamics correlated with other visual data. 
This would make the investigation more systematic and less biased towards 
specific outcomes. The power of the available software is far from ideal; the 
tracking of a single-cell by fluorescence for a 20-hour time-course can take up 
to several hours due to the very semi-automatic processing. This is cause for 
concern for two reasons; firstly there may be discrepancies between the way the 
two independent researchers analyse and track the cell and secondly the 
inefficiency of the tracking process limits the number of cells that can effectively 
be analysed. The statistical power of the data is subject to the number of cells 
analysed and some patterns may only be truly evident with more cells. In 
current opinion, the considerable versatility and applicability of live-cell 
imaging to the study of signalling systems such as HIF, is limited by the ability 
to systematically and computationally quantify the visual data.
8.3.3 The purpose and practice of mathematical modelling 
Mathematical modelling is often employed alongside biology, improving the 
analytical capacity and insight biologists are able to gain from data. This 
relationship has been in development over the course of centuries, though has 
now considerably expanded with the advent of new technology and biological 
measurements, into the current field of systems biology (Hester, Iliescu et al. 
2011). A conventional role for the mathematical modelling used by systems 
biology is to investigate emergent properties not predicted by the component 
make-up and to computationally address information too complex for intuition
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alone to process, while also allowing the real-time predicted measurement of all 
model features (Bhalla and Iyengar 1999; Sung and McNally 2010). Almost 
every biological event discussed throughout this thesis has been mathematically 
modelled, whether it is the motion and formation of cellular bodies, the 
biochemical networks underlying energy production, single-cell and tissue-level 
modelling of inflammation, mitochondrial bioenergetics, the process of 
apoptosis and cell cycle, gene transcription, tumour growth, vascular biology or 
intracellular dynamics of HIF signalling (Kohn, Riss et al. 2004; Nelson, 
Ihekwaba et al. 2004; Goel, Chou et al. 2006; Vodovotz, Chow et al. 2006; von 
Stosch, Peres et al. 2010).
There are numerous examples of successful predictions arising from 
mathematical models of cell signalling systems. Oscillations of p53 were 
predicted before they were measured. In actin dynamics, the transition rate of 
asters to stars was successfully predicted to be scaled to the ratio of available 
fascin protein to total actin. The centralisation of the C. elegans nucleus was 
predicted to arise from a pulling mechanism, as opposed to the equally favoured 
pushing hypothesis of the time (Bhalla and Iyengar 1999; Mogilner, Wollman et 
al. 2006). Many of these models have also begun to inform clinical and practical 
applications. Mathematical models of cardiac electrophysiology have been used 
to predict the ideal tissue contact points for electro-stimulation and fibrillation 
regime to prevent damage (Trayanova 2006; Vigmond, Vadakkumpadan et al. 
2009). As well as the predictive power of modelling, a further advantage is in 
the recording of a functional description of our understanding of the signalling 
events. Commonly still, a model is often a pictorial representation of the 
components involved and these picture networks have become increasingly 
complex with the integration of -omic data. In contrast to this, a mathematical 
model is functional, testable and is able to readily integrate more information - 
potentially to the point in which it would be too complex for intuition to process. 
In essence, a single mathematical model could embody a large degree of 
literature, an important concept due to the rate of information gain in biological 
science.
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8.4 Final Comments
At the outset of my PhD my knowledge basis and viewpoint of cell signalling was 
very much fixed from textbook static diagrams of signalling pathways. The 
backdrop of my own and adjacent projects has helped me develop an 
appreciation and awareness of the complexity and fluidity inherent in cellular 
signalling networks. This awareness naturally leads to the question of how to 
best facilitate our understanding of such complexity and this has led to my 
personal involvement and interest in the field of systems biology. I now 
appreciate that there has been a slow and continuous movement to integrate 
complex biological information and this movement has recently and rapidly 
expanded in the post genomic era, giving rise to the current incarnation of 
systems biology. Systems biology is known in many guises and the exact 
definition is still somewhat variable between practitioners, although the use of 
computational power and mathematics is a commonly employed tool within this 
field. Mathematics provides a very natural framework to address cell signalling 
as models and equations are not only descriptive but functional. From this 
functionality models are able to provide biologists with predictions and testable 
hypotheses. For these models to be meaningful, they require the sensible 
abstraction of signalling networks and constraint against biological 
measurements. These series of realisations have led to my understanding of the 
continued importance of an interdisciplinary approach; how development in the 
physics of microscopy enhances our ability to measure biological events and 
how engineering is required in the building of complex apparatus for use in 
these measurements; how software developers enhance our ability to analyse, 
present, record, retrieve and exchange data. These contributions occur before a 
biologist and mathematician are able to collaborate over information and to 
advance the understanding over a particular problem. I believe we have shown 
that this process was worthwhile for the investigation of the HIF system and this 
approach has advanced the insight into the spatiotemporal dynamics of this 
pathway as well as the plausibility that the kinetics of HIF-a accumulation 
encode context.
Finally, I look forward to witnessing and being apart of the continued 
progression of systems biology, applying and developing my knowledge 
accordingly.
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i.i Plasmid Expression Vectors and Reporters used and produced
All confocal images are of living HeLa cells transiently transfected shown at various magnifications.
i. pG-HIFia-IRES-EGFP
Diagnostic Digest: Aflll (4913bp, 2939bp)
History
Parent Plasmid: pHIF-ia (donated by Prof S. Edwards) 
Cloned using Gateway® Invitrogen Recombination 
5’ primer:
gggacaagtttgtacaaaaaagcaggcttcaccatggagggcgccggcggc  
3’ primer: ggggaccactttgtacaagaaagctgggtcgttaacttgatccaaagc
3. pG-EGFP-HIFla
Diagnostic Digest: Agel (5408bp, 1872bp)
History
Parent Plasmid: pHIF-ia (donated by Prof S. Edwards) 
Cloned using Gateway® Invitrogen Recombination 
5’ primer:
gggacaagtttgtacaaaaaagcaggcttcaccatggagggcgccggcggc 
3’ primer: ggggaccactttgtacaagaaagctgggtctcagttaacttgatccaa
Diagnostic Digest: Aflll (4914bp, 2361bp)
History
Parent Plasmid: pHIF-ia (donated by Prof S. Edwards 
Cloned using Gateway® Invitrogen Recombination 
5’ primer:
gggacaagtttgtacaaaaaagcaggcttcaccatggagggcgccggcggc 
3’ primer: ggggaccactttgtacaagaaagctgggtcgttaacttgatccaaagc
Diagnostic Digest: Hindlll (6419bp, 2017bp)
History
Replaced CMV promoter from pG-HIFiaEGFP with a 
i.ykb cloned human HIFia promoter using a digest- 
ligation protocol [Very Weak Expression!
5’ primer (Kpnl): gcgtgggtacccttctcttcaggcatttcccatggttc 
3’ primer: (Nhel): agagagctagcggtgaatcggtccccgccat
5. YFP-HlFl|$ 6. pG-DsRedxp-HIFiP
c
I
alto?
rsv-* ! I
HIF1B f sv4r '“a”, ~
f PG^R«.H.F1B I KanR ^ ' 1 - :
■ 'H'. ip ■
aiioi L1 =1 _"i’ ,? lyi.jJ
dsRLDXf’ fr^
pl.’MV
Diagnostic Digest: Kpnl (7056bp, 1191 bp) Diagnostic Digest: Aarl (6118bp, 998bp)
History History
Donated by Prof. J. Fandrey, University of Duisburg Replaced fluorophore from YFP-HIFiP by restriction
Ref: Eur Respir J 2008; 32: 210-217 digest (using bmti and xhoi) and subsequent ligation.
DsRedxp was removed from pG-DsRedxp-FIIF2a.
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y. pcDNA3-hEPAS
No Map Not Fluorescent
Diagnostic Digest: N/A
History
Donated by Dr. S. McKnight, UT Southwestern Medical 
Center
Ref: Oncogene (2007) 26, 7480-7489
Diagnostic Digest: Xhol (5253bp, 2106bp)
History
Parent Plasmid: hEPAS myc-pcDNA3 
Cloned using Gateway® Invitrogen Recombination 
5’ primer: ggggacaagtttgtacaaaaaagcaggcttcaccatgacagctgacaaggag 
3’ primer: ggggaccactttgtacaagaaagctgggtctcaggtggcctcgtccag
9. pG-HIF2a-IRES-EGFP
Diagnostic Digest: EcoRl (6166bp, 1818bp)
History
Parent Plasmid: hEPAS myc-pcDNA3
Cloned using Gateway® Invitrogen Recombination
5’ primer:
ggggacaagtttgtacaaaaaagcaggcttcaccatgacagctgacaaggag 
3’ primer: ggggaccactttgtacaagaaagctgggtctcaggtggcctcgtccag
Diagnostic Digest: EcoRl (5593bp, 1819bp)
History
Parent Plasmid: hEPAS myc-pcDNA3
Cloned using Gateway® Invitrogen Recombination
5’ primer:
ggggacaagtttgtacaaaaaagcaggcttcaccatgacagctgacaaggag 
3’ primer: ggggaccactttgtacaagaaagctgggtctcaggtggcctcgtccag
11. pRC-CMV-HA-VHL
SV40 promoter
'jfavtvon^
Not Fluorescent
Diagnostic Digest: AflUI (4149bp, 2044bp)
History
Donated by Dr. Michael Ohh (MD. William G. Kaelin) 
Ref: Nat Med. 1995 Aug. i(8):822-6
12. pG-VHL-IRES-DsRedxp
Diagnostic Digest: Notl (4100bp, 1743bp)
History
Parent Plasmid: hEPAS myc-pcDNA3
Cloned by digest-ligation into pIRES2-DsRedxp (Clontech)
5’ primer (Nhel): attcagctagcatgccccggagggcggag
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| 3’ primer(BamHI): gtcatggatcctcaatctcccatccgttg
13. pG-VHL-DsRedxp
Diagnostic Digest: Notl (4156bp, 1236bp)
History
Parent Plasmid: hEPAS myc-pcDNAs
Cloned using Gateway® Invitrogen Recombination
5’ primer:
ggggacaagtttgtacaaaaaagcaggcttcaccatgccccggagggcggagaa
3’ primer: ggggaccactttgtacaagaaagctgggtcatctcccatccgttgatcac
14. pG-DsRedxp-VHL
Diagnostic Digest: BspHI (3616bp, 1772bp)
History
Parent Plasmid: hEPAS myc-pcDNAs
Cloned using Gateway® Invitrogen Recombination
5’ primer:
ggggacaagtttgtacaaaaaagcaggcttcaccatgccccggagggcggagaa 
3’ primer: ggggaccactttgtacaagaaagctgggtctcaatctcccatccgttgat
16. pG-FIH-IRES-DsRedxp
Diagnostic Digest: Asel (5153bp, 1098bp)
History
Parent Plasmid: pEGFP-Ni-FIH
Cloned by digest-ligation into pIRES2-DsRedxp
(Clontech)
5’ primer (Nhel): attcagctagcatggcggcgacagcggcg 
3’ primer (BamHI): gtcatggatccctagttgtatcggcccttgat
17. pG-FIH-DsRedxp ! 18. PEGFP-N1-PHD2
attB2 !
al!B1 p«v4o t i»iv
-KRmxP rf pG-<liRFDip*tC)-flHdsRFDXP ■ |
\ M KanR
PUCom /'•/HI 1
Diagnostic Digest: Asel (3962bp, 1834bp) Diagnostic Digest: Xhol (5399bp, 603bp)
History History
Parent Plasmid: pEGFP-Ni-FIH Donated by PhD Dr. Med. Eric Metzen
Cloned using Gateway® Invitrogen Recombination Reference: J Cell Sci. 2003 Apr 1. n6(Pt 7):i3i9-26.
5’ primer:
gggacaagtttgtacaaaaaagcaggcttcaccatggcggcgacagcggcg
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| 3’ primer: RgRKaccactttRtacaaRaaagctKftgtcctaRttRtatCRRCcctt
19. pEGFP-PHDs A6-20
Diagnostic Digest: Xhol (5399bp, 558bp)
History
Donated by Prof. R. Depping, University of Liiebeck 
Ref: Biochem Biophys Res Commun. 2009. 387(4): 705- 
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20. pEGFP-N 1-PHD2 A181-220
Diagnostic Digest: Xhol (5882bp) or Afllll (4338bp, 1544bp)
History
Donated by Prof. R. Depping, University of Liiebeck 
Ref: Biochem Biophys Res Commun. 2009. 387(4): 705-
211
Diagnostic Digest: Xhol (5399bp, 306bp)
History
Donated by Prof. R. Depping, University of Liiebeck 
Ref: Biochem Biophys Res Commun. 2009. 387(4): 705- 
21L-
Diagnostic Digest: Afllll (4388bp, 1367bp)
History
Donated by Prof. R. Depping, University of Liiebeck 
Ref: Biochem Biophys Res Commun. 2009. 387(4): 705- 
Zil
Diagnostic Digest: Xhol (5102bp, 603bp)
History
Donated by Prof. R. Depping, University of Liiebeck 
Ref: Biochem Biophys Res Commun. 2009. 387(4): 
705-711
Diagnostic Digest: Xhol (5016bp, 603bp)
History
Donated by Prof. R.Depping, University of Liiebeck 
Ref: Biochem Biophys Res Commun. 2009. 387(4): 705-711
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Diagnostic Digest: Bmtl (4733bp, 1200bp)
History
Retrieved from the Addgene plasmid database under 
reference number 21400. Originally deposited by Dr. E. 
Metzen , University of Duisburg
Diagnostic Digest: Afllll (4338bp, 2021 bp)
History
Replaced CMV promoter from pPHD2-EGFP with a ikb 
cloned human PHD2 promoter using a digest-ligation 
protocol.
26. pEGFP-N 1-PHD3
Diagnostic Digest:BamHl (5188bp, 244bp)
History
Retrieved from the Addgene plasmid database under 
reference number 21402. Originally deposited by Dr. E. 
Metzen , University of Duisburg
27. pG-ODD-EGFP
Diagnostic Digest: BspHl (3397bp, 1772bp)
History
Parent Plasmid: pG-HIFiaEGFP
Cloned Oxygen-Dependent Degradation domain of H1F- 
ia using Gateway® Invitrogen Recombination 
5’ primer:
ggggacaagtttgtacaaaaaagcaggcttcaccatggaattcaagttggaa
3’ primer: ggggaccactttgtacaagaaagctgggtcagtagtttctttatgtat
28. pG-frODD-EGFP
Diagnostic Digest: Aflll (4226bp, 1839bp)
History
Parent Plasmid: pG-HIFiaEGFP
Cloned Oxygen-Dependent Degradation domain of HIF-
ia using Gateway® Invitrogen Recombination.
5’ primer:
ggggacaagtttgtacaaaaaagcaggcttcaccatggaattcaagttggaa
3’ primer:
Diagnostic Digest: Sail (4829bp, 1798bp)
History
Parent Plasmid: pG-HIFiaEGFP
Cloned Oxygen-Dependent Degradation domain of HIF- 
ia using Gateway® Invitrogen Recombination 
5’ primer:
ggggacaagtttgtacaaaaaagcaggcttcaccatggaattcaagttggaa
3’ primer: ggggaccactttgtacaagaaagctgggtcgttaacttgatccaaagc
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ggggacaagtttgtacaaaaaagcaggcttcaccatgacctgcttggtgctg
30. EGLNi PROM_oi
Luciferase reporter
History
Purchased from SwitchGear Genomics. Contains a 
looobp PHD2 promoter sequence upstream of the 
transcriptional start site. Information available on the 
website. 
31. EGLN3 PROM_oi
Luciferase reporter
History
Purchased from SwitchGear Genomics. Contains a 
looobp PHD3 promoter sequence upstream of the 
transcriptional start site. Information available on the 
website^
Luciferase reporterLuciferase reporter
Diagnostic Digest: Asel (4168bp, 1649bp)
HistoryHistory
i.ykb promoter removed by restriction digest from pG- 
proHIF-ia-EGFP and ligated into PGL4.16 promega 
luciferase vector.
Donated by Dr. Giovanni Mellilo 
Ref: Oncogene 2007 (26) 3920-3929
32. PGLS.HRE-luc 33. PGL4i6.HIFia-luc
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All Cell Tracker Analysed Cells
1.2 Nuclear Fluorescence levels of HIF-ioEGFP in 1% O2; 
Experiment described in Chapter 4.2.2
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1.3 Nuclear Fluorescence levels of EGFPHIF-2a in 1% O2; 
Experiment described in Chapter 4.2.3
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1.4 Nuclear Fluorescence levels of HIF-ia in 1% 02 for SHPHD2 cells; 
Experiment described in Chapter 5.2.5.3
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